{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 158,
   "id": "56b56215",
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "import sys\n",
    "from selenium.webdriver.support.ui import WebDriverWait\n",
    "from selenium.webdriver.common.by import By\n",
    "from selenium.webdriver.support import expected_conditions as EC\n",
    "from selenium.webdriver import ActionChains\n",
    "import selenium\n",
    "from selenium import webdriver\n",
    "from selenium.webdriver.common.keys import Keys\n",
    "import time\n",
    "from webdriver_manager.chrome import ChromeDriverManager"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 234,
   "id": "3f75f900",
   "metadata": {},
   "outputs": [],
   "source": [
    "driver=webdriver.Chrome()\n",
    "driver.get(\"https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/session/calendar\")\n",
    "driver.maximize_window()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "e49a6e4b",
   "metadata": {},
   "outputs": [],
   "source": [
    "/html/body/div[1]/div[3]/div/div/div/div[7]/div/div/div/div[2]/div[2]/div[2]/div[1]/ul/li[1]/div/div[2]/div[2]/a\n",
    "/html/body/div[1]/div[3]/div/div/div/div[7]/div/div/div/div[2]/div[2]/div[2]/div[1]/ul/li[2]/div/div[2]/div[2]/a\n",
    "/html/body/div[1]/div[3]/div/div/div/div[7]/div/div/div/div[2]/div[2]/div[2]/div[1]/ul/li[3]/div/div[2]/div[2]/a\n",
    "/html/body/div[1]/div[3]/div/div/div/div[7]/div/div/div/div[2]/div[2]/div[2]/div[2]/ul/li[1]/div/div[2]/div[2]/a\n",
    "\n",
    "/html/body/div[1]/div[3]/div/div/div/div[7]/div/div/div/div[2]/div[2]/div[2]/div[17]/ul/li[1]/div/div[2]/div[2]/a\n",
    "/html/body/div[1]/div[3]/div/div/div/div[7]/div/div/div/div[2]/div[2]/div[2]/div[19]/ul/li/div/div[2]/div[2]/a"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 172,
   "id": "a25d55d8",
   "metadata": {},
   "outputs": [],
   "source": [
    "days=[]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 181,
   "id": "eb0ce60e",
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "# for i in range():\n",
    "ll=driver.find_element(By.XPATH,'/html/body/div[1]/div[3]/div/div/div/div[7]/div/div/div/div[2]/div[2]')\n",
    "lin=ll.find_elements(By.TAG_NAME,'a')\n",
    "k=[]\n",
    "for l in range(len(lin)):\n",
    "    k.append(lin[l].get_attribute('href'))\n",
    "for l in range(len(k)):\n",
    "    if('esmo.org' not in k[l]):\n",
    "        days.append(k[l])\n",
    "#     driver.find_element(By.XPATH,'/html/body/div[1]/div[3]/div/div/div/div[3]/ul/li['+str(i)+']/a').click()\n",
    "#     driver.implicitly_wait(3)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 164,
   "id": "14d7e022",
   "metadata": {},
   "outputs": [],
   "source": [
    "driver.find_element(By.XPATH,'/html/body/div[1]/div[3]/div/div/div/div[3]/ul/li[3]/a').click()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "9ebf7a21",
   "metadata": {},
   "outputs": [],
   "source": [
    "day1=[]\n",
    "for i in range(len(links)):\n",
    "    if('esmo.org' not in links[i]):\n",
    "        day1.append(links[i])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 182,
   "id": "7afc993d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "233"
      ]
     },
     "execution_count": 182,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(days)\n",
    "#32"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "2115d3cd",
   "metadata": {
    "collapsed": true
   },
   "outputs": [
    {
     "ename": "NameError",
     "evalue": "name 'html' is not defined",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mNameError\u001b[0m                                 Traceback (most recent call last)",
      "Input \u001b[1;32mIn [21]\u001b[0m, in \u001b[0;36m<cell line: 1>\u001b[1;34m()\u001b[0m\n\u001b[1;32m----> 1\u001b[0m \u001b[43mhtml\u001b[49m\u001b[38;5;241m/\u001b[39mbody\u001b[38;5;241m/\u001b[39mdiv[\u001b[38;5;241m1\u001b[39m]\u001b[38;5;241m/\u001b[39mdiv[\u001b[38;5;241m3\u001b[39m]\u001b[38;5;241m/\u001b[39mdiv\u001b[38;5;241m/\u001b[39mdiv\u001b[38;5;241m/\u001b[39mdiv\u001b[38;5;241m/\u001b[39mdiv[\u001b[38;5;241m7\u001b[39m]\u001b[38;5;241m/\u001b[39mdiv\u001b[38;5;241m/\u001b[39mdiv\u001b[38;5;241m/\u001b[39mdiv\u001b[38;5;241m/\u001b[39mdiv[\u001b[38;5;241m2\u001b[39m]\u001b[38;5;241m/\u001b[39mdiv[\u001b[38;5;241m2\u001b[39m]\u001b[38;5;241m/\u001b[39mdiv[\u001b[38;5;241m2\u001b[39m]\u001b[38;5;241m/\u001b[39mdiv[\u001b[38;5;241m1\u001b[39m]\u001b[38;5;241m/\u001b[39mul\u001b[38;5;241m/\u001b[39mli[\u001b[38;5;241m1\u001b[39m]\u001b[38;5;241m/\u001b[39mdiv\u001b[38;5;241m/\u001b[39mdiv[\u001b[38;5;241m2\u001b[39m]\u001b[38;5;241m/\u001b[39mdiv[\u001b[38;5;241m2\u001b[39m]\u001b[38;5;241m/\u001b[39ma()\n\u001b[0;32m      2\u001b[0m html\u001b[38;5;241m/\u001b[39mbody\u001b[38;5;241m/\u001b[39mdiv[\u001b[38;5;241m1\u001b[39m]\u001b[38;5;241m/\u001b[39mdiv[\u001b[38;5;241m3\u001b[39m]\u001b[38;5;241m/\u001b[39mdiv\u001b[38;5;241m/\u001b[39mdiv\u001b[38;5;241m/\u001b[39mdiv\u001b[38;5;241m/\u001b[39mdiv[\u001b[38;5;241m7\u001b[39m]\u001b[38;5;241m/\u001b[39mdiv\u001b[38;5;241m/\u001b[39mdiv\u001b[38;5;241m/\u001b[39mdiv\u001b[38;5;241m/\u001b[39mdiv[\u001b[38;5;241m2\u001b[39m]\u001b[38;5;241m/\u001b[39mdiv[\u001b[38;5;241m2\u001b[39m]\u001b[38;5;241m/\u001b[39mdiv[\u001b[38;5;241m2\u001b[39m]\u001b[38;5;241m/\u001b[39mdiv[\u001b[38;5;241m1\u001b[39m]\u001b[38;5;241m/\u001b[39mul\u001b[38;5;241m/\u001b[39mli[\u001b[38;5;241m2\u001b[39m]\u001b[38;5;241m/\u001b[39mdiv\u001b[38;5;241m/\u001b[39mdiv[\u001b[38;5;241m2\u001b[39m]\u001b[38;5;241m/\u001b[39mdiv[\u001b[38;5;241m2\u001b[39m]\u001b[38;5;241m/\u001b[39ma()\n\u001b[0;32m      3\u001b[0m html\u001b[38;5;241m/\u001b[39mbody\u001b[38;5;241m/\u001b[39mdiv[\u001b[38;5;241m1\u001b[39m]\u001b[38;5;241m/\u001b[39mdiv[\u001b[38;5;241m3\u001b[39m]\u001b[38;5;241m/\u001b[39mdiv\u001b[38;5;241m/\u001b[39mdiv\u001b[38;5;241m/\u001b[39mdiv\u001b[38;5;241m/\u001b[39mdiv[\u001b[38;5;241m7\u001b[39m]\u001b[38;5;241m/\u001b[39mdiv\u001b[38;5;241m/\u001b[39mdiv\u001b[38;5;241m/\u001b[39mdiv\u001b[38;5;241m/\u001b[39mdiv[\u001b[38;5;241m2\u001b[39m]\u001b[38;5;241m/\u001b[39mdiv[\u001b[38;5;241m2\u001b[39m]\u001b[38;5;241m/\u001b[39mdiv[\u001b[38;5;241m2\u001b[39m]\u001b[38;5;241m/\u001b[39mdiv[\u001b[38;5;241m1\u001b[39m]\u001b[38;5;241m/\u001b[39mul\u001b[38;5;241m/\u001b[39mli[\u001b[38;5;241m3\u001b[39m]\u001b[38;5;241m/\u001b[39mdiv\u001b[38;5;241m/\u001b[39mdiv[\u001b[38;5;241m2\u001b[39m]\u001b[38;5;241m/\u001b[39mdiv[\u001b[38;5;241m2\u001b[39m]\u001b[38;5;241m/\u001b[39ma()\n",
      "\u001b[1;31mNameError\u001b[0m: name 'html' is not defined"
     ]
    }
   ],
   "source": [
    "/html/body/div[1]/div[3]/div/div/div/div[7]/div/div/div/div[2]/div[2]/div[2]/div[1]/ul/li[1]/div/div[2]/div[2]/a\n",
    "/html/body/div[1]/div[3]/div/div/div/div[7]/div/div/div/div[2]/div[2]/div[2]/div[1]/ul/li[2]/div/div[2]/div[2]/a\n",
    "/html/body/div[1]/div[3]/div/div/div/div[7]/div/div/div/div[2]/div[2]/div[2]/div[1]/ul/li[3]/div/div[2]/div[2]/a\n",
    "/html/body/div[1]/div[3]/div/div/div/div[7]/div/div/div/div[2]/div[2]/div[2]/div[1]/ul/li[4]/div/div[2]/div[2]/a\n",
    "\n",
    "/html/body/div[1]/div[3]/div/div/div/div[7]/div/div/div/div[2]/div[2]/div[2]/div[20]/ul/li/div/div[2]/div[2]/a\n",
    "/html/body/div[1]/div[3]/div/div/div/div[7]/div/div/div/div[2]/div[2]/div[2]/div[19]/ul/li/div/div[2]/div[2]/a\n",
    "/html/body/div[1]/div[3]/div/div/div/div[7]/div/div/div/div[2]/div[2]/div[2]/div[18]/ul/li/div/div[2]/div[2]/a"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "id": "5f14bae8",
   "metadata": {},
   "outputs": [],
   "source": [
    "ll=driver.find_element(By.XPATH,'/html/body/div[1]/div[3]/div/div/div/div[7]/div/div/div/div[2]/div[2]')\n",
    "lin=ll.find_elements(By.TAG_NAME,'a')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "id": "a0aefafa",
   "metadata": {},
   "outputs": [],
   "source": [
    "k=[]\n",
    "for i in range(len(lin)):\n",
    "    k.append(lin[i].get_attribute('href'))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "id": "aceb6719",
   "metadata": {},
   "outputs": [],
   "source": [
    "day2=[]\n",
    "for i in range(len(k)):\n",
    "    if('esmo.org' not in k[i]):\n",
    "        day2.append(k[i])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "id": "6b1bb480",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "67"
      ]
     },
     "execution_count": 37,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(day2)\n",
    "#67"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "id": "3553024c",
   "metadata": {},
   "outputs": [],
   "source": [
    "ll=driver.find_element(By.XPATH,'/html/body/div[1]/div[3]/div/div/div/div[7]/div/div/div/div[2]/div[2]')\n",
    "lin=ll.find_elements(By.TAG_NAME,'a')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "id": "913d9690",
   "metadata": {},
   "outputs": [],
   "source": [
    "k=[]\n",
    "for i in range(len(lin)):\n",
    "    k.append(lin[i].get_attribute('href'))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "id": "cabb454d",
   "metadata": {},
   "outputs": [],
   "source": [
    "day3=[]\n",
    "for i in range(len(k)):\n",
    "    if('esmo.org' not in k[i]):\n",
    "        day3.append(k[i])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "id": "7a4113e4",
   "metadata": {
    "collapsed": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/71',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/73',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/90',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/264',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/234',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/227',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/63',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/89',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/255',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/19',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/27',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/59',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/14',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/15',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/239',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/220',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/22',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/229',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/256',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/209',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/279',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/203',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/204',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/277',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/81',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/242',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/49',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/35',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/237',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/20',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/52',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/221',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/40',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/45',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/84',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/142',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/28',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/79',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/241',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/17',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/139',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/64',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/215',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/182',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/69',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/61',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/54',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/33',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/261',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/13',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/286',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/271',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/290',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/207',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/129',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/130',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/282',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/131',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/127',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/128',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/113',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/258',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/136',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/110',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/137',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/99',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/96',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/288',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/289',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/211',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/283']"
      ]
     },
     "execution_count": 40,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#71\n",
    "day3"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "id": "915e670f",
   "metadata": {},
   "outputs": [],
   "source": [
    "day4=[]\n",
    "for i in range(len(k)):\n",
    "    if('esmo.org' not in k[i]):\n",
    "        day4.append(k[i])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "id": "8fe625df",
   "metadata": {
    "collapsed": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/223',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/238',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/269',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/265',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/257',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/66',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/7',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/78',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/46',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/75',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/88',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/23',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/246',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/267',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/72',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/236',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/216',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/276',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/29',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/278',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/83',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/67',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/25',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/6',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/250',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/92',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/249',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/21',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/48',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/85',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/36',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/262',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/86',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/56',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/2',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/53',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/117',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/70',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/32',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/254',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/80',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/244',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/143',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/16',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/107',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/266',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/206',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/115',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/140',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/126',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/124',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/121',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/284',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/122',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/119',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/138',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/112',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/100',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/102',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/212',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/285']"
      ]
     },
     "execution_count": 45,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# len(day4)\n",
    "#64\n",
    "day4"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "id": "d69b5e49",
   "metadata": {},
   "outputs": [],
   "source": [
    "day5=[]\n",
    "for i in range(len(k)):\n",
    "    if('esmo.org' not in k[i]):\n",
    "        day5.append(k[i])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "id": "34b796a5",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/93',\n",
       " 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/94']"
      ]
     },
     "execution_count": 51,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "day5"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 80,
   "id": "7a6090d9",
   "metadata": {},
   "outputs": [],
   "source": [
    "days=day1+day2+day3+day4+day5"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 81,
   "id": "fd79eab5",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "233"
      ]
     },
     "execution_count": 81,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(days)\n",
    "#233"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "id": "c2ecd2fd",
   "metadata": {},
   "outputs": [],
   "source": [
    "driver.find_element(By.XPATH,'/html/body/div[1]/div[3]/div/div/div/div[3]/ul/li[5]').click()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 77,
   "id": "6245f0c4",
   "metadata": {
    "collapsed": true
   },
   "outputs": [
    {
     "ename": "InvalidSelectorException",
     "evalue": "Message: invalid selector: Unable to locate an element with the xpath expression /html/body/div[1]/div[3]/div/div/div/div[3]/ul/li[['https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/199', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/12', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/247', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/225', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/76', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/228', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/18', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/41', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/232', 'https://www.esmo.org/Meetings/ESMO-Congress-2019/Industry-Sponsored-Satellite-Symposia/Understanding-the-Emerging-Role-of-I-O-in-GI-Cancers?hit=prog', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/68', 'https://www.esmo.org/Meetings/ESMO-Congress-2019/Industry-Sponsored-Satellite-Symposia/Multi-Disciplinary-Perspectives-on-Optimising-Patient-Outcomes-in-HER2-Positive-eBC?hit=prog', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/58', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/274', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/198', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/270', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/55', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/11', 'https://www.esmo.org/Meetings/ESMO-Congress-2019/Industry-Sponsored-Satellite-Symposia/How-Immuno-Oncology-Has-Changed-the-Melanoma-Treatment-Landscape?hit=prog', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/219', 'https://www.esmo.org/Meetings/ESMO-Congress-2019/Industry-Sponsored-Satellite-Symposia/Long-Term-Experience-and-Survival-An-Overview-of-I-O-Therapy-in-RCC-and-Future-Research-in-GU-Cancers?hit=prog', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/65', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/30', 'https://www.esmo.org/Meetings/ESMO-Congress-2019/Industry-Sponsored-Satellite-Symposia/Cracking-the-Code-of-Personalised-Healthcare?hit=prog', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/10', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/51', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/268', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/95', 'https://www.esmo.org/Meetings/ESMO-Congress-2019/Industry-Sponsored-Satellite-Symposia/Putting-Immunotherapy-into-Perspective-How-Should-I-be-Treating-my-SCCHN-Patients?hit=prog', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/116', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/145', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/287', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/144', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/132', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/133', 'https://www.esmo.org/Meetings/ESMO-Congress-2019/Industry-Sponsored-Satellite-Symposia/From-Trial-Evidence-to-Clinical-Practice-Focusing-on-Patients-with-mGC-and-mCRC?hit=prog', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/103', 'https://www.esmo.org/Meetings/ESMO-Congress-2019/Industry-Sponsored-Satellite-Symposia/Integrating-Precision-Medicine-Are-We-Ready-for-a-Paradigm-Shift-in-Advanced-Urothelial-Carcinoma?hit=prog', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/97', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/105']] because of the following error:\nSyntaxError: Failed to execute 'evaluate' on 'Document': The string '/html/body/div[1]/div[3]/div/div/div/div[3]/ul/li[['https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/199', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/12', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/247', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/225', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/76', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/228', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/18', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/41', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/232', 'https://www.esmo.org/Meetings/ESMO-Congress-2019/Industry-Sponsored-Satellite-Symposia/Understanding-the-Emerging-Role-of-I-O-in-GI-Cancers?hit=prog', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/68', 'https://www.esmo.org/Meetings/ESMO-Congress-2019/Industry-Sponsored-Satellite-Symposia/Multi-Disciplinary-Perspectives-on-Optimising-Patient-Outcomes-in-HER2-Positive-eBC?hit=prog', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/58', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/274', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/198', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/270', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/55', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/11', 'https://www.esmo.org/Meetings/ESMO-Congress-2019/Industry-Sponsored-Satellite-Symposia/How-Immuno-Oncology-Has-Changed-the-Melanoma-Treatment-Landscape?hit=prog', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/219', 'https://www.esmo.org/Meetings/ESMO-Congress-2019/Industry-Sponsored-Satellite-Symposia/Long-Term-Experience-and-Survival-An-Overview-of-I-O-Therapy-in-RCC-and-Future-Research-in-GU-Cancers?hit=prog', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/65', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/30', 'https://www.esmo.org/Meetings/ESMO-Congress-2019/Industry-Sponsored-Satellite-Symposia/Cracking-the-Code-of-Personalised-Healthcare?hit=prog', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/10', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/51', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/268', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/95', 'https://www.esmo.org/Meetings/ESMO-Congress-2019/Industry-Sponsored-Satellite-Symposia/Putting-Immunotherapy-into-Perspective-How-Should-I-be-Treating-my-SCCHN-Patients?hit=prog', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/116', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/145', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/287', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/144', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/132', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/133', 'https://www.esmo.org/Meetings/ESMO-Congress-2019/Industry-Sponsored-Satellite-Symposia/From-Trial-Evidence-to-Clinical-Practice-Focusing-on-Patients-with-mGC-and-mCRC?hit=prog', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/103', 'https://www.esmo.org/Meetings/ESMO-Congress-2019/Industry-Sponsored-Satellite-Symposia/Integrating-Precision-Medicine-Are-We-Ready-for-a-Paradigm-Shift-in-Advanced-Urothelial-Carcinoma?hit=prog', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/97', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/105']]' is not a valid XPath expression.\n  (Session info: chrome=109.0.5414.120)\nStacktrace:\nBacktrace:\n\t(No symbol) [0x005C6643]\n\t(No symbol) [0x0055BE21]\n\t(No symbol) [0x0045DA9D]\n\t(No symbol) [0x004609E4]\n\t(No symbol) [0x004608AD]\n\t(No symbol) [0x00460B30]\n\t(No symbol) [0x00490FAC]\n\t(No symbol) [0x0049147B]\n\t(No symbol) [0x004C8DC2]\n\t(No symbol) [0x004AFDC4]\n\t(No symbol) [0x004C6B09]\n\t(No symbol) [0x004AFB76]\n\t(No symbol) [0x004849C1]\n\t(No symbol) [0x00485E5D]\n\tGetHandleVerifier [0x0083A142+2497106]\n\tGetHandleVerifier [0x008685D3+2686691]\n\tGetHandleVerifier [0x0086BB9C+2700460]\n\tGetHandleVerifier [0x00673B10+635936]\n\t(No symbol) [0x00564A1F]\n\t(No symbol) [0x0056A418]\n\t(No symbol) [0x0056A505]\n\t(No symbol) [0x0057508B]\n\tBaseThreadInitThunk [0x77D000F9+25]\n\tRtlGetAppContainerNamedObjectPath [0x77EB7BBE+286]\n\tRtlGetAppContainerNamedObjectPath [0x77EB7B8E+238]\n",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mInvalidSelectorException\u001b[0m                  Traceback (most recent call last)",
      "Input \u001b[1;32mIn [77]\u001b[0m, in \u001b[0;36m<cell line: 2>\u001b[1;34m()\u001b[0m\n\u001b[0;32m      9\u001b[0m     \u001b[38;5;28;01mif\u001b[39;00m(\u001b[38;5;124m'\u001b[39m\u001b[38;5;124mesmo.org\u001b[39m\u001b[38;5;124m'\u001b[39m \u001b[38;5;129;01mnot\u001b[39;00m \u001b[38;5;129;01min\u001b[39;00m k[i]):\n\u001b[0;32m     10\u001b[0m         day\u001b[38;5;241m.\u001b[39mappend(k[i])\n\u001b[1;32m---> 11\u001b[0m \u001b[43mdriver\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mfind_element\u001b[49m\u001b[43m(\u001b[49m\u001b[43mBy\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mXPATH\u001b[49m\u001b[43m,\u001b[49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m/html/body/div[1]/div[3]/div/div/div/div[3]/ul/li[\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;241;43m+\u001b[39;49m\u001b[38;5;28;43mstr\u001b[39;49m\u001b[43m(\u001b[49m\u001b[43mk\u001b[49m\u001b[43m)\u001b[49m\u001b[38;5;241;43m+\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m]\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[43m)\u001b[49m\u001b[38;5;241m.\u001b[39mclick()\n\u001b[0;32m     12\u001b[0m driver\u001b[38;5;241m.\u001b[39mimplicitly_wait(\u001b[38;5;241m2\u001b[39m)\n",
      "File \u001b[1;32m~\\AppData\\Roaming\\Python\\Python39\\site-packages\\selenium\\webdriver\\remote\\webdriver.py:857\u001b[0m, in \u001b[0;36mWebDriver.find_element\u001b[1;34m(self, by, value)\u001b[0m\n\u001b[0;32m    854\u001b[0m     by \u001b[38;5;241m=\u001b[39m By\u001b[38;5;241m.\u001b[39mCSS_SELECTOR\n\u001b[0;32m    855\u001b[0m     value \u001b[38;5;241m=\u001b[39m \u001b[38;5;124m'\u001b[39m\u001b[38;5;124m[name=\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;132;01m%s\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m]\u001b[39m\u001b[38;5;124m'\u001b[39m \u001b[38;5;241m%\u001b[39m value\n\u001b[1;32m--> 857\u001b[0m \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mexecute\u001b[49m\u001b[43m(\u001b[49m\u001b[43mCommand\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mFIND_ELEMENT\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43m{\u001b[49m\n\u001b[0;32m    858\u001b[0m \u001b[43m    \u001b[49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43musing\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[43m:\u001b[49m\u001b[43m \u001b[49m\u001b[43mby\u001b[49m\u001b[43m,\u001b[49m\n\u001b[0;32m    859\u001b[0m \u001b[43m    \u001b[49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mvalue\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[43m:\u001b[49m\u001b[43m \u001b[49m\u001b[43mvalue\u001b[49m\u001b[43m}\u001b[49m\u001b[43m)\u001b[49m[\u001b[38;5;124m'\u001b[39m\u001b[38;5;124mvalue\u001b[39m\u001b[38;5;124m'\u001b[39m]\n",
      "File \u001b[1;32m~\\AppData\\Roaming\\Python\\Python39\\site-packages\\selenium\\webdriver\\remote\\webdriver.py:435\u001b[0m, in \u001b[0;36mWebDriver.execute\u001b[1;34m(self, driver_command, params)\u001b[0m\n\u001b[0;32m    433\u001b[0m response \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mcommand_executor\u001b[38;5;241m.\u001b[39mexecute(driver_command, params)\n\u001b[0;32m    434\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m response:\n\u001b[1;32m--> 435\u001b[0m     \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43merror_handler\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mcheck_response\u001b[49m\u001b[43m(\u001b[49m\u001b[43mresponse\u001b[49m\u001b[43m)\u001b[49m\n\u001b[0;32m    436\u001b[0m     response[\u001b[38;5;124m'\u001b[39m\u001b[38;5;124mvalue\u001b[39m\u001b[38;5;124m'\u001b[39m] \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_unwrap_value(\n\u001b[0;32m    437\u001b[0m         response\u001b[38;5;241m.\u001b[39mget(\u001b[38;5;124m'\u001b[39m\u001b[38;5;124mvalue\u001b[39m\u001b[38;5;124m'\u001b[39m, \u001b[38;5;28;01mNone\u001b[39;00m))\n\u001b[0;32m    438\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m response\n",
      "File \u001b[1;32m~\\AppData\\Roaming\\Python\\Python39\\site-packages\\selenium\\webdriver\\remote\\errorhandler.py:247\u001b[0m, in \u001b[0;36mErrorHandler.check_response\u001b[1;34m(self, response)\u001b[0m\n\u001b[0;32m    245\u001b[0m         alert_text \u001b[38;5;241m=\u001b[39m value[\u001b[38;5;124m'\u001b[39m\u001b[38;5;124malert\u001b[39m\u001b[38;5;124m'\u001b[39m]\u001b[38;5;241m.\u001b[39mget(\u001b[38;5;124m'\u001b[39m\u001b[38;5;124mtext\u001b[39m\u001b[38;5;124m'\u001b[39m)\n\u001b[0;32m    246\u001b[0m     \u001b[38;5;28;01mraise\u001b[39;00m exception_class(message, screen, stacktrace, alert_text)  \u001b[38;5;66;03m# type: ignore[call-arg]  # mypy is not smart enough here\u001b[39;00m\n\u001b[1;32m--> 247\u001b[0m \u001b[38;5;28;01mraise\u001b[39;00m exception_class(message, screen, stacktrace)\n",
      "\u001b[1;31mInvalidSelectorException\u001b[0m: Message: invalid selector: Unable to locate an element with the xpath expression /html/body/div[1]/div[3]/div/div/div/div[3]/ul/li[['https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/199', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/12', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/247', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/225', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/76', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/228', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/18', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/41', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/232', 'https://www.esmo.org/Meetings/ESMO-Congress-2019/Industry-Sponsored-Satellite-Symposia/Understanding-the-Emerging-Role-of-I-O-in-GI-Cancers?hit=prog', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/68', 'https://www.esmo.org/Meetings/ESMO-Congress-2019/Industry-Sponsored-Satellite-Symposia/Multi-Disciplinary-Perspectives-on-Optimising-Patient-Outcomes-in-HER2-Positive-eBC?hit=prog', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/58', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/274', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/198', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/270', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/55', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/11', 'https://www.esmo.org/Meetings/ESMO-Congress-2019/Industry-Sponsored-Satellite-Symposia/How-Immuno-Oncology-Has-Changed-the-Melanoma-Treatment-Landscape?hit=prog', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/219', 'https://www.esmo.org/Meetings/ESMO-Congress-2019/Industry-Sponsored-Satellite-Symposia/Long-Term-Experience-and-Survival-An-Overview-of-I-O-Therapy-in-RCC-and-Future-Research-in-GU-Cancers?hit=prog', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/65', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/30', 'https://www.esmo.org/Meetings/ESMO-Congress-2019/Industry-Sponsored-Satellite-Symposia/Cracking-the-Code-of-Personalised-Healthcare?hit=prog', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/10', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/51', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/268', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/95', 'https://www.esmo.org/Meetings/ESMO-Congress-2019/Industry-Sponsored-Satellite-Symposia/Putting-Immunotherapy-into-Perspective-How-Should-I-be-Treating-my-SCCHN-Patients?hit=prog', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/116', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/145', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/287', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/144', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/132', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/133', 'https://www.esmo.org/Meetings/ESMO-Congress-2019/Industry-Sponsored-Satellite-Symposia/From-Trial-Evidence-to-Clinical-Practice-Focusing-on-Patients-with-mGC-and-mCRC?hit=prog', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/103', 'https://www.esmo.org/Meetings/ESMO-Congress-2019/Industry-Sponsored-Satellite-Symposia/Integrating-Precision-Medicine-Are-We-Ready-for-a-Paradigm-Shift-in-Advanced-Urothelial-Carcinoma?hit=prog', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/97', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/105']] because of the following error:\nSyntaxError: Failed to execute 'evaluate' on 'Document': The string '/html/body/div[1]/div[3]/div/div/div/div[3]/ul/li[['https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/199', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/12', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/247', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/225', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/76', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/228', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/18', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/41', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/232', 'https://www.esmo.org/Meetings/ESMO-Congress-2019/Industry-Sponsored-Satellite-Symposia/Understanding-the-Emerging-Role-of-I-O-in-GI-Cancers?hit=prog', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/68', 'https://www.esmo.org/Meetings/ESMO-Congress-2019/Industry-Sponsored-Satellite-Symposia/Multi-Disciplinary-Perspectives-on-Optimising-Patient-Outcomes-in-HER2-Positive-eBC?hit=prog', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/58', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/274', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/198', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/270', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/55', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/11', 'https://www.esmo.org/Meetings/ESMO-Congress-2019/Industry-Sponsored-Satellite-Symposia/How-Immuno-Oncology-Has-Changed-the-Melanoma-Treatment-Landscape?hit=prog', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/219', 'https://www.esmo.org/Meetings/ESMO-Congress-2019/Industry-Sponsored-Satellite-Symposia/Long-Term-Experience-and-Survival-An-Overview-of-I-O-Therapy-in-RCC-and-Future-Research-in-GU-Cancers?hit=prog', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/65', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/30', 'https://www.esmo.org/Meetings/ESMO-Congress-2019/Industry-Sponsored-Satellite-Symposia/Cracking-the-Code-of-Personalised-Healthcare?hit=prog', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/10', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/51', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/268', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/95', 'https://www.esmo.org/Meetings/ESMO-Congress-2019/Industry-Sponsored-Satellite-Symposia/Putting-Immunotherapy-into-Perspective-How-Should-I-be-Treating-my-SCCHN-Patients?hit=prog', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/116', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/145', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/287', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/144', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/132', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/133', 'https://www.esmo.org/Meetings/ESMO-Congress-2019/Industry-Sponsored-Satellite-Symposia/From-Trial-Evidence-to-Clinical-Practice-Focusing-on-Patients-with-mGC-and-mCRC?hit=prog', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/103', 'https://www.esmo.org/Meetings/ESMO-Congress-2019/Industry-Sponsored-Satellite-Symposia/Integrating-Precision-Medicine-Are-We-Ready-for-a-Paradigm-Shift-in-Advanced-Urothelial-Carcinoma?hit=prog', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/97', 'https://cslide.ctimeetingtech.com/esmo2019/attendee/confcal/show/session/105']]' is not a valid XPath expression.\n  (Session info: chrome=109.0.5414.120)\nStacktrace:\nBacktrace:\n\t(No symbol) [0x005C6643]\n\t(No symbol) [0x0055BE21]\n\t(No symbol) [0x0045DA9D]\n\t(No symbol) [0x004609E4]\n\t(No symbol) [0x004608AD]\n\t(No symbol) [0x00460B30]\n\t(No symbol) [0x00490FAC]\n\t(No symbol) [0x0049147B]\n\t(No symbol) [0x004C8DC2]\n\t(No symbol) [0x004AFDC4]\n\t(No symbol) [0x004C6B09]\n\t(No symbol) [0x004AFB76]\n\t(No symbol) [0x004849C1]\n\t(No symbol) [0x00485E5D]\n\tGetHandleVerifier [0x0083A142+2497106]\n\tGetHandleVerifier [0x008685D3+2686691]\n\tGetHandleVerifier [0x0086BB9C+2700460]\n\tGetHandleVerifier [0x00673B10+635936]\n\t(No symbol) [0x00564A1F]\n\t(No symbol) [0x0056A418]\n\t(No symbol) [0x0056A505]\n\t(No symbol) [0x0057508B]\n\tBaseThreadInitThunk [0x77D000F9+25]\n\tRtlGetAppContainerNamedObjectPath [0x77EB7BBE+286]\n\tRtlGetAppContainerNamedObjectPath [0x77EB7B8E+238]\n"
     ]
    }
   ],
   "source": [
    "day=[]\n",
    "for k in range(2,6):\n",
    "    ll=driver.find_element(By.XPATH,'/html/body/div[1]/div[3]/div/div/div/div[7]/div/div/div/div[2]/div[2]')\n",
    "    lin=ll.find_elements(By.TAG_NAME,'a')\n",
    "    k=[]\n",
    "    for i in range(len(lin)):\n",
    "        k.append(lin[i].get_attribute('href'))\n",
    "    for i in range(len(k)):\n",
    "        if('esmo.org' not in k[i]):\n",
    "            day.append(k[i])\n",
    "    driver.find_element(By.XPATH,'/html/body/div[1]/div[3]/div/div/div/div[3]/ul/li['+str(k)+']').click()\n",
    "    driver.implicitly_wait(2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 82,
   "id": "616c8759",
   "metadata": {},
   "outputs": [],
   "source": [
    "items = days\n",
    "file = open('ESMO2019LINKS.txt','w')\n",
    "for item in items:\n",
    "    file.write(item+\"\\n\")\n",
    "file.close()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 85,
   "id": "7a3a994c",
   "metadata": {},
   "outputs": [
    {
     "ename": "NoSuchElementException",
     "evalue": "Message: no such element: Unable to locate element: {\"method\":\"xpath\",\"selector\":\"/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[1]/h4/a\"}\n  (Session info: chrome=109.0.5414.120)\nStacktrace:\nBacktrace:\n\t(No symbol) [0x005C6643]\n\t(No symbol) [0x0055BE21]\n\t(No symbol) [0x0045DA9D]\n\t(No symbol) [0x00491342]\n\t(No symbol) [0x0049147B]\n\t(No symbol) [0x004C8DC2]\n\t(No symbol) [0x004AFDC4]\n\t(No symbol) [0x004C6B09]\n\t(No symbol) [0x004AFB76]\n\t(No symbol) [0x004849C1]\n\t(No symbol) [0x00485E5D]\n\tGetHandleVerifier [0x0083A142+2497106]\n\tGetHandleVerifier [0x008685D3+2686691]\n\tGetHandleVerifier [0x0086BB9C+2700460]\n\tGetHandleVerifier [0x00673B10+635936]\n\t(No symbol) [0x00564A1F]\n\t(No symbol) [0x0056A418]\n\t(No symbol) [0x0056A505]\n\t(No symbol) [0x0057508B]\n\tBaseThreadInitThunk [0x77D000F9+25]\n\tRtlGetAppContainerNamedObjectPath [0x77EB7BBE+286]\n\tRtlGetAppContainerNamedObjectPath [0x77EB7B8E+238]\n",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mNoSuchElementException\u001b[0m                    Traceback (most recent call last)",
      "Input \u001b[1;32mIn [85]\u001b[0m, in \u001b[0;36m<cell line: 1>\u001b[1;34m()\u001b[0m\n\u001b[1;32m----> 1\u001b[0m \u001b[43mdriver\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mfind_element\u001b[49m\u001b[43m(\u001b[49m\u001b[43mBy\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mXPATH\u001b[49m\u001b[43m,\u001b[49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[1]/h4/a\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[43m)\u001b[49m\u001b[38;5;241m.\u001b[39mtext\n",
      "File \u001b[1;32m~\\AppData\\Roaming\\Python\\Python39\\site-packages\\selenium\\webdriver\\remote\\webdriver.py:857\u001b[0m, in \u001b[0;36mWebDriver.find_element\u001b[1;34m(self, by, value)\u001b[0m\n\u001b[0;32m    854\u001b[0m     by \u001b[38;5;241m=\u001b[39m By\u001b[38;5;241m.\u001b[39mCSS_SELECTOR\n\u001b[0;32m    855\u001b[0m     value \u001b[38;5;241m=\u001b[39m \u001b[38;5;124m'\u001b[39m\u001b[38;5;124m[name=\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;132;01m%s\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m]\u001b[39m\u001b[38;5;124m'\u001b[39m \u001b[38;5;241m%\u001b[39m value\n\u001b[1;32m--> 857\u001b[0m \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mexecute\u001b[49m\u001b[43m(\u001b[49m\u001b[43mCommand\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mFIND_ELEMENT\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43m{\u001b[49m\n\u001b[0;32m    858\u001b[0m \u001b[43m    \u001b[49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43musing\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[43m:\u001b[49m\u001b[43m \u001b[49m\u001b[43mby\u001b[49m\u001b[43m,\u001b[49m\n\u001b[0;32m    859\u001b[0m \u001b[43m    \u001b[49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mvalue\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[43m:\u001b[49m\u001b[43m \u001b[49m\u001b[43mvalue\u001b[49m\u001b[43m}\u001b[49m\u001b[43m)\u001b[49m[\u001b[38;5;124m'\u001b[39m\u001b[38;5;124mvalue\u001b[39m\u001b[38;5;124m'\u001b[39m]\n",
      "File \u001b[1;32m~\\AppData\\Roaming\\Python\\Python39\\site-packages\\selenium\\webdriver\\remote\\webdriver.py:435\u001b[0m, in \u001b[0;36mWebDriver.execute\u001b[1;34m(self, driver_command, params)\u001b[0m\n\u001b[0;32m    433\u001b[0m response \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mcommand_executor\u001b[38;5;241m.\u001b[39mexecute(driver_command, params)\n\u001b[0;32m    434\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m response:\n\u001b[1;32m--> 435\u001b[0m     \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43merror_handler\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mcheck_response\u001b[49m\u001b[43m(\u001b[49m\u001b[43mresponse\u001b[49m\u001b[43m)\u001b[49m\n\u001b[0;32m    436\u001b[0m     response[\u001b[38;5;124m'\u001b[39m\u001b[38;5;124mvalue\u001b[39m\u001b[38;5;124m'\u001b[39m] \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_unwrap_value(\n\u001b[0;32m    437\u001b[0m         response\u001b[38;5;241m.\u001b[39mget(\u001b[38;5;124m'\u001b[39m\u001b[38;5;124mvalue\u001b[39m\u001b[38;5;124m'\u001b[39m, \u001b[38;5;28;01mNone\u001b[39;00m))\n\u001b[0;32m    438\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m response\n",
      "File \u001b[1;32m~\\AppData\\Roaming\\Python\\Python39\\site-packages\\selenium\\webdriver\\remote\\errorhandler.py:247\u001b[0m, in \u001b[0;36mErrorHandler.check_response\u001b[1;34m(self, response)\u001b[0m\n\u001b[0;32m    245\u001b[0m         alert_text \u001b[38;5;241m=\u001b[39m value[\u001b[38;5;124m'\u001b[39m\u001b[38;5;124malert\u001b[39m\u001b[38;5;124m'\u001b[39m]\u001b[38;5;241m.\u001b[39mget(\u001b[38;5;124m'\u001b[39m\u001b[38;5;124mtext\u001b[39m\u001b[38;5;124m'\u001b[39m)\n\u001b[0;32m    246\u001b[0m     \u001b[38;5;28;01mraise\u001b[39;00m exception_class(message, screen, stacktrace, alert_text)  \u001b[38;5;66;03m# type: ignore[call-arg]  # mypy is not smart enough here\u001b[39;00m\n\u001b[1;32m--> 247\u001b[0m \u001b[38;5;28;01mraise\u001b[39;00m exception_class(message, screen, stacktrace)\n",
      "\u001b[1;31mNoSuchElementException\u001b[0m: Message: no such element: Unable to locate element: {\"method\":\"xpath\",\"selector\":\"/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[1]/h4/a\"}\n  (Session info: chrome=109.0.5414.120)\nStacktrace:\nBacktrace:\n\t(No symbol) [0x005C6643]\n\t(No symbol) [0x0055BE21]\n\t(No symbol) [0x0045DA9D]\n\t(No symbol) [0x00491342]\n\t(No symbol) [0x0049147B]\n\t(No symbol) [0x004C8DC2]\n\t(No symbol) [0x004AFDC4]\n\t(No symbol) [0x004C6B09]\n\t(No symbol) [0x004AFB76]\n\t(No symbol) [0x004849C1]\n\t(No symbol) [0x00485E5D]\n\tGetHandleVerifier [0x0083A142+2497106]\n\tGetHandleVerifier [0x008685D3+2686691]\n\tGetHandleVerifier [0x0086BB9C+2700460]\n\tGetHandleVerifier [0x00673B10+635936]\n\t(No symbol) [0x00564A1F]\n\t(No symbol) [0x0056A418]\n\t(No symbol) [0x0056A505]\n\t(No symbol) [0x0057508B]\n\tBaseThreadInitThunk [0x77D000F9+25]\n\tRtlGetAppContainerNamedObjectPath [0x77EB7BBE+286]\n\tRtlGetAppContainerNamedObjectPath [0x77EB7B8E+238]\n"
     ]
    }
   ],
   "source": [
    "driver.find_element(By.XPATH,'/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[1]/h4/a').text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 93,
   "id": "ed09ee39",
   "metadata": {},
   "outputs": [],
   "source": [
    "driver.get(days[0])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 94,
   "id": "ea9aaa81",
   "metadata": {},
   "outputs": [],
   "source": [
    "tt=driver.find_element(By.XPATH,'/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[1]/h4/a').text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 95,
   "id": "ab9658ea",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'ESMO 2019 Opening ceremony (ID 199)'"
      ]
     },
     "execution_count": 95,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "tt"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 96,
   "id": "b0a5c5e2",
   "metadata": {},
   "outputs": [],
   "source": [
    "# date=/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[2]/div[1]/div[2]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "9fd2cc16",
   "metadata": {},
   "outputs": [],
   "source": [
    "#subsess\n",
    "/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[4]/div[1]/div[2]/h4\n",
    "/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[4]/div[2]/div[2]/h4\n",
    "/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[4]/div[5]/div[2]/h4\n",
    "/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[4]/div[6]/div[2]/h4"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "0508b29e",
   "metadata": {},
   "outputs": [],
   "source": [
    "#time\n",
    "/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[4]/div[1]/div[2]/div[1]/div[2]/div[2]\n",
    "/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[4]/div[2]/div[2]/div[1]/div[2]/div[2]\n",
    "/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[4]/div[3]/div[2]/div[1]/div[2]/div[2]\n",
    "/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[4]/div[6]/div[2]/div[1]/div[2]/div[2]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "64676cfe",
   "metadata": {},
   "outputs": [],
   "source": [
    "#person\n",
    "/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[4]/div[1]/div[2]/div[1]/div[3]/div[2]/ul/li\n",
    "/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[4]/div[2]/div[2]/div[1]/div[3]/div[2]/ul/li"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 139,
   "id": "045692ff",
   "metadata": {},
   "outputs": [],
   "source": [
    "SESSION=[]\n",
    "SUB_SESSION=[]\n",
    "TIME=[]\n",
    "SPEAKERS=[]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 140,
   "id": "a0ac2843",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0 1\n",
      "0 2\n",
      "0 3\n",
      "0 4\n",
      "0 5\n",
      "0 6\n",
      "p:  0\n",
      "1 1\n",
      "1 2\n",
      "1 3\n",
      "1 4\n",
      "p:  1\n",
      "2 1\n",
      "2 2\n",
      "2 3\n",
      "2 4\n",
      "2 5\n",
      "2 6\n",
      "2 7\n",
      "p:  2\n",
      "3 1\n",
      "3 2\n",
      "3 3\n",
      "3 4\n",
      "3 5\n",
      "3 6\n",
      "p:  3\n",
      "4 1\n",
      "4 2\n",
      "4 3\n",
      "4 4\n",
      "p:  4\n",
      "5 1\n",
      "5 2\n",
      "5 3\n",
      "5 4\n",
      "5 5\n",
      "5 6\n",
      "p:  5\n",
      "6 1\n",
      "6 2\n",
      "6 3\n",
      "6 4\n",
      "p:  6\n",
      "7 1\n",
      "7 2\n",
      "7 3\n",
      "7 4\n",
      "7 5\n",
      "p:  7\n",
      "8 1\n",
      "8 2\n",
      "8 3\n",
      "8 4\n",
      "8 5\n",
      "8 6\n",
      "p:  8\n",
      "9 1\n",
      "9 2\n",
      "9 3\n",
      "9 4\n",
      "p:  9\n",
      "10 1\n",
      "10 2\n",
      "10 3\n",
      "10 4\n",
      "p:  10\n",
      "11 1\n",
      "11 2\n",
      "11 3\n",
      "11 4\n",
      "p:  11\n",
      "12 1\n",
      "12 2\n",
      "12 3\n",
      "12 4\n",
      "12 5\n",
      "12 6\n",
      "p:  12\n",
      "13 1\n",
      "13 2\n",
      "13 3\n",
      "13 4\n",
      "13 5\n",
      "13 6\n",
      "13 7\n",
      "13 8\n",
      "p:  13\n",
      "14 1\n",
      "14 2\n",
      "p:  14\n",
      "15 1\n",
      "15 2\n",
      "p:  15\n",
      "16 1\n",
      "16 2\n",
      "16 3\n",
      "16 4\n",
      "16 5\n",
      "16 6\n",
      "16 7\n",
      "p:  16\n",
      "17 1\n",
      "17 2\n",
      "p:  17\n",
      "18 1\n",
      "18 2\n",
      "18 3\n",
      "18 4\n",
      "18 5\n",
      "18 6\n",
      "p:  18\n",
      "19 1\n",
      "19 2\n",
      "19 3\n",
      "19 4\n",
      "p:  19\n",
      "20 1\n",
      "20 2\n",
      "p:  20\n",
      "21 1\n",
      "21 2\n",
      "21 3\n",
      "21 4\n",
      "21 5\n",
      "21 6\n",
      "21 7\n",
      "p:  21\n",
      "22 1\n",
      "22 2\n",
      "22 3\n",
      "22 4\n",
      "22 5\n",
      "22 6\n",
      "p:  22\n",
      "23 1\n",
      "23 2\n",
      "23 3\n",
      "23 4\n",
      "23 5\n",
      "23 6\n",
      "p:  23\n",
      "24 1\n",
      "24 2\n",
      "24 3\n",
      "24 4\n",
      "24 5\n",
      "24 6\n",
      "24 7\n",
      "p:  24\n",
      "25 1\n",
      "25 2\n",
      "25 3\n",
      "25 4\n",
      "25 5\n",
      "25 6\n",
      "25 7\n",
      "25 8\n",
      "p:  25\n",
      "26 1\n",
      "26 2\n",
      "26 3\n",
      "26 4\n",
      "26 5\n",
      "p:  26\n",
      "27 1\n",
      "27 2\n",
      "27 3\n",
      "27 4\n",
      "27 5\n",
      "27 6\n",
      "p:  27\n",
      "28 1\n",
      "28 2\n",
      "28 3\n",
      "28 4\n",
      "28 5\n",
      "28 6\n",
      "p:  28\n",
      "29 1\n",
      "29 2\n",
      "29 3\n",
      "29 4\n",
      "29 5\n",
      "29 6\n",
      "29 7\n",
      "p:  29\n",
      "30 1\n",
      "p:  30\n",
      "31 1\n",
      "31 2\n",
      "31 3\n",
      "p:  31\n",
      "32 1\n",
      "32 2\n",
      "32 3\n",
      "32 4\n",
      "32 5\n",
      "32 6\n",
      "p:  32\n",
      "33 1\n",
      "33 2\n",
      "33 3\n",
      "33 4\n",
      "33 5\n",
      "33 6\n",
      "33 7\n",
      "p:  33\n",
      "34 1\n",
      "34 2\n",
      "34 3\n",
      "34 4\n",
      "34 5\n",
      "34 6\n",
      "p:  34\n",
      "35 1\n",
      "35 2\n",
      "35 3\n",
      "35 4\n",
      "35 5\n",
      "35 6\n",
      "35 7\n",
      "35 8\n",
      "35 9\n",
      "p:  35\n",
      "36 1\n",
      "36 2\n",
      "36 3\n",
      "36 4\n",
      "36 5\n",
      "36 6\n",
      "p:  36\n",
      "37 1\n",
      "37 2\n",
      "37 3\n",
      "37 4\n",
      "37 5\n",
      "37 6\n",
      "p:  37\n",
      "38 1\n",
      "p:  38\n",
      "39 1\n",
      "39 2\n",
      "39 3\n",
      "39 4\n",
      "39 5\n",
      "39 6\n",
      "p:  39\n",
      "40 1\n",
      "40 2\n",
      "40 3\n",
      "40 4\n",
      "p:  40\n",
      "41 1\n",
      "41 2\n",
      "41 3\n",
      "41 4\n",
      "41 5\n",
      "41 6\n",
      "p:  41\n",
      "42 1\n",
      "42 2\n",
      "42 3\n",
      "42 4\n",
      "42 5\n",
      "42 6\n",
      "p:  42\n",
      "43 1\n",
      "43 2\n",
      "43 3\n",
      "43 4\n",
      "43 5\n",
      "p:  43\n",
      "44 1\n",
      "44 2\n",
      "44 3\n",
      "44 4\n",
      "44 5\n",
      "p:  44\n",
      "45 1\n",
      "45 2\n",
      "45 3\n",
      "45 4\n",
      "45 5\n",
      "45 6\n",
      "p:  45\n",
      "46 1\n",
      "46 2\n",
      "46 3\n",
      "46 4\n",
      "46 5\n",
      "46 6\n",
      "p:  46\n",
      "47 1\n",
      "47 2\n",
      "47 3\n",
      "47 4\n",
      "p:  47\n",
      "48 1\n",
      "48 2\n",
      "48 3\n",
      "48 4\n",
      "48 5\n",
      "48 6\n",
      "48 7\n",
      "48 8\n",
      "p:  48\n",
      "49 1\n",
      "49 2\n",
      "49 3\n",
      "49 4\n",
      "p:  49\n",
      "50 1\n",
      "50 2\n",
      "50 3\n",
      "50 4\n",
      "50 5\n",
      "50 6\n",
      "50 7\n",
      "p:  50\n",
      "51 1\n",
      "51 2\n",
      "51 3\n",
      "51 4\n",
      "p:  51\n",
      "52 1\n",
      "52 2\n",
      "52 3\n",
      "52 4\n",
      "p:  52\n",
      "53 1\n",
      "53 2\n",
      "53 3\n",
      "53 4\n",
      "53 5\n",
      "53 6\n",
      "53 7\n",
      "53 8\n",
      "53 9\n",
      "53 10\n",
      "53 11\n",
      "53 12\n",
      "53 13\n",
      "53 14\n",
      "53 15\n",
      "53 16\n",
      "53 17\n",
      "53 18\n",
      "53 19\n",
      "p:  53\n",
      "54 1\n",
      "54 2\n",
      "54 3\n",
      "54 4\n",
      "54 5\n",
      "54 6\n",
      "p:  54\n",
      "55 1\n",
      "55 2\n",
      "55 3\n",
      "55 4\n",
      "55 5\n",
      "p:  55\n",
      "56 1\n",
      "56 2\n",
      "56 3\n",
      "56 4\n",
      "56 5\n",
      "56 6\n",
      "56 7\n",
      "p:  56\n",
      "57 1\n",
      "57 2\n",
      "57 3\n",
      "57 4\n",
      "57 5\n",
      "57 6\n",
      "57 7\n",
      "57 8\n",
      "57 9\n",
      "57 10\n",
      "57 11\n",
      "57 12\n",
      "57 13\n",
      "57 14\n",
      "57 15\n",
      "p:  57\n",
      "58 1\n",
      "58 2\n",
      "58 3\n",
      "58 4\n",
      "58 5\n",
      "58 6\n",
      "58 7\n",
      "p:  58\n",
      "59 1\n",
      "59 2\n",
      "59 3\n",
      "59 4\n",
      "59 5\n",
      "59 6\n",
      "p:  59\n",
      "60 1\n",
      "60 2\n",
      "60 3\n",
      "60 4\n",
      "60 5\n",
      "60 6\n",
      "60 7\n",
      "60 8\n",
      "60 9\n",
      "60 10\n",
      "60 11\n",
      "60 12\n",
      "60 13\n",
      "60 14\n",
      "p:  60\n",
      "61 1\n",
      "61 2\n",
      "61 3\n",
      "61 4\n",
      "61 5\n",
      "61 6\n",
      "p:  61\n",
      "62 1\n",
      "62 2\n",
      "62 3\n",
      "62 4\n",
      "62 5\n",
      "62 6\n",
      "62 7\n",
      "62 8\n",
      "62 9\n",
      "62 10\n",
      "62 11\n",
      "62 12\n",
      "62 13\n",
      "62 14\n",
      "62 15\n",
      "p:  62\n",
      "63 1\n",
      "63 2\n",
      "p:  63\n",
      "64 1\n",
      "64 2\n",
      "64 3\n",
      "64 4\n",
      "64 5\n",
      "64 6\n",
      "64 7\n",
      "64 8\n",
      "64 9\n",
      "64 10\n",
      "64 11\n",
      "64 12\n",
      "64 13\n",
      "64 14\n",
      "p:  64\n",
      "65 1\n",
      "65 2\n",
      "65 3\n",
      "65 4\n",
      "65 5\n",
      "65 6\n",
      "65 7\n",
      "65 8\n",
      "65 9\n",
      "65 10\n",
      "65 11\n",
      "65 12\n",
      "65 13\n",
      "p:  65\n",
      "66 1\n",
      "66 2\n",
      "p:  66\n",
      "67 1\n",
      "67 2\n",
      "67 3\n",
      "67 4\n",
      "67 5\n",
      "p:  67\n",
      "68 1\n",
      "68 2\n",
      "68 3\n",
      "68 4\n",
      "68 5\n",
      "p:  68\n",
      "69 1\n",
      "69 2\n",
      "69 3\n",
      "69 4\n",
      "69 5\n",
      "69 6\n",
      "69 7\n",
      "69 8\n",
      "69 9\n",
      "69 10\n",
      "69 11\n",
      "69 12\n",
      "69 13\n",
      "69 14\n",
      "69 15\n",
      "69 16\n",
      "69 17\n",
      "69 18\n",
      "69 19\n",
      "p:  69\n",
      "70 1\n",
      "70 2\n",
      "70 3\n",
      "70 4\n",
      "70 5\n",
      "70 6\n",
      "p:  70\n",
      "71 1\n",
      "71 2\n",
      "p:  71\n",
      "72 1\n",
      "72 2\n",
      "72 3\n",
      "72 4\n",
      "72 5\n",
      "p:  72\n",
      "73 1\n",
      "73 2\n",
      "73 3\n",
      "73 4\n",
      "73 5\n",
      "73 6\n",
      "73 7\n",
      "73 8\n",
      "73 9\n",
      "73 10\n",
      "73 11\n",
      "73 12\n",
      "73 13\n",
      "73 14\n",
      "73 15\n",
      "73 16\n",
      "73 17\n",
      "73 18\n",
      "73 19\n",
      "p:  73\n",
      "74 1\n",
      "74 2\n",
      "p:  74\n",
      "75 1\n",
      "75 2\n",
      "p:  75\n",
      "76 1\n",
      "76 2\n",
      "76 3\n",
      "76 4\n",
      "76 5\n",
      "76 6\n",
      "76 7\n",
      "76 8\n",
      "76 9\n",
      "76 10\n",
      "76 11\n",
      "76 12\n",
      "76 13\n",
      "76 14\n",
      "p:  76\n",
      "77 1\n",
      "77 2\n",
      "p:  77\n",
      "78 1\n",
      "78 2\n",
      "p:  78\n",
      "79 1\n",
      "79 2\n",
      "79 3\n",
      "79 4\n",
      "79 5\n",
      "79 6\n",
      "p:  79\n",
      "80 1\n",
      "80 2\n",
      "80 3\n",
      "80 4\n",
      "80 5\n",
      "80 6\n",
      "80 7\n",
      "80 8\n",
      "80 9\n",
      "80 10\n",
      "80 11\n",
      "80 12\n",
      "80 13\n",
      "80 14\n",
      "80 15\n",
      "p:  80\n",
      "81 1\n",
      "81 2\n",
      "81 3\n",
      "81 4\n",
      "81 5\n",
      "81 6\n",
      "81 7\n",
      "81 8\n",
      "p:  81\n",
      "82 1\n",
      "82 2\n",
      "82 3\n",
      "82 4\n",
      "82 5\n",
      "82 6\n",
      "p:  82\n",
      "83 1\n",
      "83 2\n",
      "83 3\n",
      "83 4\n",
      "83 5\n",
      "83 6\n",
      "83 7\n",
      "p:  83\n",
      "84 1\n",
      "84 2\n",
      "84 3\n",
      "84 4\n",
      "84 5\n",
      "84 6\n",
      "p:  84\n",
      "85 1\n",
      "85 2\n",
      "85 3\n",
      "85 4\n",
      "p:  85\n",
      "86 1\n",
      "86 2\n",
      "86 3\n",
      "86 4\n",
      "p:  86\n",
      "87 1\n",
      "87 2\n",
      "87 3\n",
      "87 4\n",
      "87 5\n",
      "87 6\n",
      "p:  87\n",
      "88 1\n",
      "88 2\n",
      "88 3\n",
      "88 4\n",
      "88 5\n",
      "88 6\n",
      "p:  88\n",
      "89 1\n",
      "89 2\n",
      "89 3\n",
      "89 4\n",
      "89 5\n",
      "89 6\n",
      "p:  89\n",
      "90 1\n",
      "90 2\n",
      "90 3\n",
      "90 4\n",
      "90 5\n",
      "90 6\n",
      "p:  90\n",
      "91 1\n",
      "91 2\n",
      "91 3\n",
      "91 4\n",
      "91 5\n",
      "p:  91\n",
      "92 1\n",
      "92 2\n",
      "92 3\n",
      "92 4\n",
      "92 5\n",
      "p:  92\n",
      "93 1\n",
      "93 2\n",
      "93 3\n",
      "93 4\n",
      "93 5\n",
      "93 6\n",
      "93 7\n",
      "93 8\n",
      "93 9\n",
      "93 10\n",
      "p:  93\n",
      "94 1\n",
      "94 2\n",
      "94 3\n",
      "p:  94\n",
      "95 1\n",
      "p:  95\n",
      "96 1\n",
      "96 2\n",
      "96 3\n",
      "p:  96\n",
      "97 1\n",
      "97 2\n",
      "97 3\n",
      "97 4\n",
      "97 5\n",
      "97 6\n",
      "97 7\n",
      "97 8\n",
      "97 9\n",
      "97 10\n",
      "97 11\n",
      "97 12\n",
      "97 13\n",
      "97 14\n",
      "97 15\n",
      "97 16\n",
      "97 17\n",
      "97 18\n",
      "97 19\n",
      "p:  97\n",
      "98 1\n",
      "98 2\n",
      "98 3\n",
      "98 4\n",
      "98 5\n",
      "p:  98\n",
      "99 1\n",
      "99 2\n",
      "99 3\n",
      "99 4\n",
      "99 5\n",
      "99 6\n",
      "p:  99\n",
      "100 1\n",
      "100 2\n",
      "100 3\n",
      "100 4\n",
      "100 5\n",
      "100 6\n",
      "100 7\n",
      "p:  100\n",
      "101 1\n",
      "101 2\n",
      "101 3\n",
      "101 4\n",
      "101 5\n",
      "101 6\n",
      "p:  101\n",
      "102 1\n",
      "102 2\n",
      "102 3\n",
      "102 4\n",
      "102 5\n",
      "102 6\n",
      "p:  102\n",
      "103 1\n",
      "103 2\n",
      "103 3\n",
      "103 4\n",
      "103 5\n",
      "103 6\n",
      "p:  103\n",
      "104 1\n",
      "104 2\n",
      "104 3\n",
      "104 4\n",
      "104 5\n",
      "104 6\n",
      "p:  104\n",
      "105 1\n",
      "p:  105\n",
      "106 1\n",
      "106 2\n",
      "106 3\n",
      "106 4\n",
      "106 5\n",
      "106 6\n",
      "p:  106\n",
      "107 1\n",
      "107 2\n",
      "107 3\n",
      "107 4\n",
      "107 5\n",
      "107 6\n",
      "107 7\n",
      "107 8\n",
      "107 9\n",
      "107 10\n",
      "107 11\n",
      "107 12\n",
      "107 13\n",
      "107 14\n",
      "107 15\n",
      "107 16\n",
      "p:  107\n",
      "108 1\n",
      "108 2\n",
      "108 3\n",
      "108 4\n",
      "108 5\n",
      "108 6\n",
      "p:  108\n",
      "109 1\n",
      "109 2\n",
      "109 3\n",
      "109 4\n",
      "p:  109\n",
      "110 1\n",
      "110 2\n",
      "110 3\n",
      "110 4\n",
      "p:  110\n",
      "111 1\n",
      "111 2\n",
      "111 3\n",
      "111 4\n",
      "111 5\n",
      "111 6\n",
      "p:  111\n",
      "112 1\n",
      "112 2\n",
      "112 3\n",
      "112 4\n",
      "p:  112\n",
      "113 1\n",
      "113 2\n",
      "113 3\n",
      "113 4\n",
      "113 5\n",
      "113 6\n",
      "113 7\n",
      "113 8\n",
      "113 9\n",
      "113 10\n",
      "113 11\n",
      "113 12\n",
      "113 13\n",
      "113 14\n",
      "113 15\n",
      "113 16\n",
      "113 17\n",
      "113 18\n",
      "113 19\n",
      "p:  113\n",
      "114 1\n",
      "114 2\n",
      "114 3\n",
      "114 4\n",
      "114 5\n",
      "114 6\n",
      "114 7\n",
      "114 8\n",
      "114 9\n",
      "114 10\n",
      "114 11\n",
      "114 12\n",
      "114 13\n",
      "114 14\n",
      "114 15\n",
      "114 16\n",
      "p:  114\n",
      "115 1\n",
      "115 2\n",
      "p:  115\n",
      "116 1\n",
      "116 2\n",
      "116 3\n",
      "116 4\n",
      "116 5\n",
      "116 6\n",
      "116 7\n",
      "116 8\n",
      "116 9\n",
      "116 10\n",
      "116 11\n",
      "116 12\n",
      "116 13\n",
      "116 14\n",
      "116 15\n",
      "116 16\n",
      "p:  116\n",
      "117 1\n",
      "117 2\n",
      "117 3\n",
      "117 4\n",
      "117 5\n",
      "117 6\n",
      "117 7\n",
      "117 8\n",
      "117 9\n",
      "117 10\n",
      "117 11\n",
      "117 12\n",
      "117 13\n",
      "117 14\n",
      "117 15\n",
      "117 16\n",
      "117 17\n",
      "117 18\n",
      "p:  117\n",
      "118 1\n",
      "118 2\n",
      "118 3\n",
      "118 4\n",
      "118 5\n",
      "118 6\n",
      "118 7\n",
      "118 8\n",
      "118 9\n",
      "118 10\n",
      "p:  118\n",
      "119 1\n",
      "119 2\n",
      "119 3\n",
      "119 4\n",
      "p:  119\n",
      "120 1\n",
      "120 2\n",
      "120 3\n",
      "120 4\n",
      "120 5\n",
      "120 6\n",
      "120 7\n",
      "120 8\n",
      "120 9\n",
      "120 10\n",
      "120 11\n",
      "120 12\n",
      "120 13\n",
      "120 14\n",
      "p:  120\n",
      "121 1\n",
      "121 2\n",
      "121 3\n",
      "121 4\n",
      "121 5\n",
      "121 6\n",
      "121 7\n",
      "121 8\n",
      "121 9\n",
      "121 10\n",
      "121 11\n",
      "121 12\n",
      "121 13\n",
      "121 14\n",
      "p:  121\n",
      "122 1\n",
      "122 2\n",
      "122 3\n",
      "122 4\n",
      "p:  122\n",
      "123 1\n",
      "123 2\n",
      "123 3\n",
      "123 4\n",
      "123 5\n",
      "p:  123\n",
      "124 1\n",
      "124 2\n",
      "124 3\n",
      "124 4\n",
      "124 5\n",
      "124 6\n",
      "124 7\n",
      "124 8\n",
      "124 9\n",
      "124 10\n",
      "124 11\n",
      "p:  124\n",
      "125 1\n",
      "125 2\n",
      "125 3\n",
      "125 4\n",
      "125 5\n",
      "125 6\n",
      "125 7\n",
      "125 8\n",
      "125 9\n",
      "p:  125\n",
      "126 1\n",
      "126 2\n",
      "126 3\n",
      "126 4\n",
      "p:  126\n",
      "127 1\n",
      "127 2\n",
      "127 3\n",
      "127 4\n",
      "127 5\n",
      "127 6\n",
      "127 7\n",
      "127 8\n",
      "127 9\n",
      "127 10\n",
      "127 11\n",
      "127 12\n",
      "127 13\n",
      "127 14\n",
      "127 15\n",
      "127 16\n",
      "127 17\n",
      "127 18\n",
      "p:  127\n",
      "128 1\n",
      "128 2\n",
      "128 3\n",
      "128 4\n",
      "128 5\n",
      "128 6\n",
      "p:  128\n",
      "129 1\n",
      "129 2\n",
      "129 3\n",
      "129 4\n",
      "129 5\n",
      "p:  129\n",
      "130 1\n",
      "130 2\n",
      "130 3\n",
      "130 4\n",
      "130 5\n",
      "130 6\n",
      "130 7\n",
      "p:  130\n",
      "131 1\n",
      "131 2\n",
      "131 3\n",
      "131 4\n",
      "131 5\n",
      "p:  131\n",
      "132 1\n",
      "132 2\n",
      "132 3\n",
      "132 4\n",
      "132 5\n",
      "p:  132\n",
      "133 1\n",
      "133 2\n",
      "133 3\n",
      "133 4\n",
      "p:  133\n",
      "134 1\n",
      "134 2\n",
      "134 3\n",
      "134 4\n",
      "134 5\n",
      "134 6\n",
      "p:  134\n",
      "135 1\n",
      "135 2\n",
      "135 3\n",
      "p:  135\n",
      "136 1\n",
      "136 2\n",
      "136 3\n",
      "136 4\n",
      "p:  136\n",
      "137 1\n",
      "137 2\n",
      "137 3\n",
      "137 4\n",
      "137 5\n",
      "137 6\n",
      "137 7\n",
      "p:  137\n",
      "138 1\n",
      "138 2\n",
      "p:  138\n",
      "139 1\n",
      "139 2\n",
      "139 3\n",
      "139 4\n",
      "139 5\n",
      "139 6\n",
      "139 7\n",
      "139 8\n",
      "p:  139\n",
      "140 1\n",
      "140 2\n",
      "140 3\n",
      "140 4\n",
      "140 5\n",
      "140 6\n",
      "p:  140\n",
      "141 1\n",
      "141 2\n",
      "141 3\n",
      "141 4\n",
      "141 5\n",
      "141 6\n",
      "141 7\n",
      "141 8\n",
      "141 9\n",
      "141 10\n",
      "141 11\n",
      "141 12\n",
      "141 13\n",
      "141 14\n",
      "141 15\n",
      "141 16\n",
      "p:  141\n",
      "142 1\n",
      "142 2\n",
      "142 3\n",
      "142 4\n",
      "142 5\n",
      "p:  142\n",
      "143 1\n",
      "143 2\n",
      "p:  143\n",
      "144 1\n",
      "144 2\n",
      "144 3\n",
      "144 4\n",
      "144 5\n",
      "p:  144\n",
      "145 1\n",
      "145 2\n",
      "p:  145\n",
      "146 1\n",
      "146 2\n",
      "146 3\n",
      "146 4\n",
      "p:  146\n",
      "147 1\n",
      "147 2\n",
      "147 3\n",
      "147 4\n",
      "147 5\n",
      "147 6\n",
      "147 7\n",
      "147 8\n",
      "147 9\n",
      "147 10\n",
      "147 11\n",
      "147 12\n",
      "p:  147\n",
      "148 1\n",
      "148 2\n",
      "148 3\n",
      "148 4\n",
      "148 5\n",
      "p:  148\n",
      "149 1\n",
      "149 2\n",
      "149 3\n",
      "149 4\n",
      "149 5\n",
      "p:  149\n",
      "150 1\n",
      "150 2\n",
      "150 3\n",
      "150 4\n",
      "150 5\n",
      "150 6\n",
      "150 7\n",
      "150 8\n",
      "150 9\n",
      "150 10\n",
      "p:  150\n",
      "151 1\n",
      "151 2\n",
      "151 3\n",
      "151 4\n",
      "151 5\n",
      "151 6\n",
      "151 7\n",
      "151 8\n",
      "151 9\n",
      "p:  151\n",
      "152 1\n",
      "152 2\n",
      "152 3\n",
      "152 4\n",
      "152 5\n",
      "152 6\n",
      "p:  152\n",
      "153 1\n",
      "153 2\n",
      "153 3\n",
      "p:  153\n",
      "154 1\n",
      "154 2\n",
      "154 3\n",
      "154 4\n",
      "154 5\n",
      "154 6\n",
      "p:  154\n",
      "155 1\n",
      "155 2\n",
      "155 3\n",
      "155 4\n",
      "155 5\n",
      "p:  155\n",
      "156 1\n",
      "156 2\n",
      "156 3\n",
      "156 4\n",
      "156 5\n",
      "156 6\n",
      "p:  156\n",
      "157 1\n",
      "157 2\n",
      "157 3\n",
      "157 4\n",
      "p:  157\n",
      "158 1\n",
      "158 2\n",
      "158 3\n",
      "p:  158\n",
      "159 1\n",
      "159 2\n",
      "159 3\n",
      "159 4\n",
      "159 5\n",
      "159 6\n",
      "p:  159\n",
      "160 1\n",
      "160 2\n",
      "160 3\n",
      "160 4\n",
      "160 5\n",
      "160 6\n",
      "160 7\n",
      "160 8\n",
      "160 9\n",
      "160 10\n",
      "160 11\n",
      "160 12\n",
      "160 13\n",
      "160 14\n",
      "160 15\n",
      "160 16\n",
      "160 17\n",
      "160 18\n",
      "160 19\n",
      "p:  160\n",
      "161 1\n",
      "161 2\n",
      "161 3\n",
      "161 4\n",
      "161 5\n",
      "161 6\n",
      "p:  161\n",
      "162 1\n",
      "162 2\n",
      "162 3\n",
      "162 4\n",
      "p:  162\n",
      "163 1\n",
      "163 2\n",
      "163 3\n",
      "163 4\n",
      "163 5\n",
      "163 6\n",
      "p:  163\n",
      "164 1\n",
      "164 2\n",
      "p:  164\n",
      "165 1\n",
      "165 2\n",
      "165 3\n",
      "165 4\n",
      "165 5\n",
      "165 6\n",
      "165 7\n",
      "165 8\n",
      "165 9\n",
      "p:  165\n",
      "p:  166\n",
      "167 1\n",
      "p:  167\n",
      "168 1\n",
      "168 2\n",
      "168 3\n",
      "168 4\n",
      "168 5\n",
      "168 6\n",
      "168 7\n",
      "168 8\n",
      "168 9\n",
      "168 10\n",
      "168 11\n",
      "168 12\n",
      "168 13\n",
      "168 14\n",
      "168 15\n",
      "168 16\n",
      "168 17\n",
      "168 18\n",
      "168 19\n",
      "p:  168\n",
      "169 1\n",
      "169 2\n",
      "169 3\n",
      "169 4\n",
      "p:  169\n",
      "170 1\n",
      "170 2\n",
      "170 3\n",
      "170 4\n",
      "170 5\n",
      "170 6\n",
      "p:  170\n",
      "171 1\n",
      "171 2\n",
      "171 3\n",
      "171 4\n",
      "171 5\n",
      "171 6\n",
      "p:  171\n",
      "172 1\n",
      "172 2\n",
      "172 3\n",
      "172 4\n",
      "172 5\n",
      "172 6\n",
      "172 7\n",
      "172 8\n",
      "172 9\n",
      "p:  172\n",
      "173 1\n",
      "173 2\n",
      "173 3\n",
      "173 4\n",
      "173 5\n",
      "173 6\n",
      "173 7\n",
      "173 8\n",
      "173 9\n",
      "p:  173\n",
      "174 1\n",
      "174 2\n",
      "174 3\n",
      "174 4\n",
      "174 5\n",
      "174 6\n",
      "p:  174\n",
      "175 1\n",
      "175 2\n",
      "175 3\n",
      "175 4\n",
      "175 5\n",
      "175 6\n",
      "p:  175\n",
      "176 1\n",
      "p:  176\n",
      "177 1\n",
      "177 2\n",
      "177 3\n",
      "177 4\n",
      "177 5\n",
      "p:  177\n",
      "178 1\n",
      "178 2\n",
      "178 3\n",
      "178 4\n",
      "p:  178\n",
      "179 1\n",
      "179 2\n",
      "179 3\n",
      "179 4\n",
      "179 5\n",
      "179 6\n",
      "p:  179\n",
      "180 1\n",
      "180 2\n",
      "180 3\n",
      "180 4\n",
      "180 5\n",
      "180 6\n",
      "p:  180\n",
      "181 1\n",
      "181 2\n",
      "181 3\n",
      "181 4\n",
      "p:  181\n",
      "182 1\n",
      "182 2\n",
      "182 3\n",
      "182 4\n",
      "182 5\n",
      "182 6\n",
      "182 7\n",
      "p:  182\n",
      "183 1\n",
      "183 2\n",
      "183 3\n",
      "183 4\n",
      "183 5\n",
      "p:  183\n",
      "184 1\n",
      "184 2\n",
      "184 3\n",
      "184 4\n",
      "184 5\n",
      "184 6\n",
      "p:  184\n",
      "185 1\n",
      "185 2\n",
      "185 3\n",
      "185 4\n",
      "185 5\n",
      "185 6\n",
      "185 7\n",
      "p:  185\n",
      "186 1\n",
      "186 2\n",
      "186 3\n",
      "186 4\n",
      "186 5\n",
      "186 6\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "p:  186\n",
      "187 1\n",
      "187 2\n",
      "187 3\n",
      "187 4\n",
      "p:  187\n",
      "188 1\n",
      "188 2\n",
      "188 3\n",
      "188 4\n",
      "188 5\n",
      "188 6\n",
      "188 7\n",
      "p:  188\n",
      "189 1\n",
      "189 2\n",
      "189 3\n",
      "189 4\n",
      "p:  189\n",
      "190 1\n",
      "190 2\n",
      "190 3\n",
      "190 4\n",
      "190 5\n",
      "p:  190\n",
      "191 1\n",
      "191 2\n",
      "191 3\n",
      "p:  191\n",
      "192 1\n",
      "192 2\n",
      "192 3\n",
      "192 4\n",
      "192 5\n",
      "192 6\n",
      "192 7\n",
      "p:  192\n",
      "193 1\n",
      "193 2\n",
      "193 3\n",
      "193 4\n",
      "p:  193\n",
      "194 1\n",
      "194 2\n",
      "194 3\n",
      "194 4\n",
      "194 5\n",
      "194 6\n",
      "194 7\n",
      "194 8\n",
      "194 9\n",
      "194 10\n",
      "194 11\n",
      "194 12\n",
      "p:  194\n",
      "195 1\n",
      "195 2\n",
      "195 3\n",
      "195 4\n",
      "195 5\n",
      "p:  195\n",
      "196 1\n",
      "196 2\n",
      "196 3\n",
      "196 4\n",
      "196 5\n",
      "196 6\n",
      "196 7\n",
      "196 8\n",
      "196 9\n",
      "p:  196\n",
      "197 1\n",
      "197 2\n",
      "p:  197\n",
      "198 1\n",
      "198 2\n",
      "198 3\n",
      "198 4\n",
      "198 5\n",
      "198 6\n",
      "p:  198\n",
      "199 1\n",
      "199 2\n",
      "199 3\n",
      "199 4\n",
      "199 5\n",
      "p:  199\n",
      "200 1\n",
      "200 2\n",
      "200 3\n",
      "200 4\n",
      "p:  200\n",
      "201 1\n",
      "201 2\n",
      "201 3\n",
      "201 4\n",
      "201 5\n",
      "201 6\n",
      "201 7\n",
      "201 8\n",
      "201 9\n",
      "201 10\n",
      "201 11\n",
      "p:  201\n",
      "202 1\n",
      "202 2\n",
      "202 3\n",
      "202 4\n",
      "202 5\n",
      "p:  202\n",
      "203 1\n",
      "203 2\n",
      "203 3\n",
      "203 4\n",
      "203 5\n",
      "p:  203\n",
      "204 1\n",
      "204 2\n",
      "204 3\n",
      "p:  204\n",
      "205 1\n",
      "205 2\n",
      "205 3\n",
      "205 4\n",
      "205 5\n",
      "p:  205\n",
      "206 1\n",
      "206 2\n",
      "206 3\n",
      "206 4\n",
      "206 5\n",
      "206 6\n",
      "206 7\n",
      "206 8\n",
      "206 9\n",
      "206 10\n",
      "p:  206\n",
      "207 1\n",
      "207 2\n",
      "p:  207\n",
      "208 1\n",
      "208 2\n",
      "p:  208\n",
      "209 1\n",
      "209 2\n",
      "209 3\n",
      "209 4\n",
      "209 5\n",
      "209 6\n",
      "209 7\n",
      "209 8\n",
      "209 9\n",
      "209 10\n",
      "209 11\n",
      "209 12\n",
      "209 13\n",
      "209 14\n",
      "209 15\n",
      "p:  209\n",
      "210 1\n",
      "210 2\n",
      "p:  210\n",
      "211 1\n",
      "211 2\n",
      "211 3\n",
      "211 4\n",
      "211 5\n",
      "211 6\n",
      "211 7\n",
      "211 8\n",
      "p:  211\n",
      "212 1\n",
      "212 2\n",
      "212 3\n",
      "212 4\n",
      "212 5\n",
      "212 6\n",
      "p:  212\n",
      "213 1\n",
      "213 2\n",
      "p:  213\n",
      "214 1\n",
      "214 2\n",
      "p:  214\n",
      "215 1\n",
      "215 2\n",
      "215 3\n",
      "215 4\n",
      "215 5\n",
      "215 6\n",
      "215 7\n",
      "p:  215\n",
      "216 1\n",
      "216 2\n",
      "216 3\n",
      "216 4\n",
      "216 5\n",
      "216 6\n",
      "216 7\n",
      "216 8\n",
      "216 9\n",
      "216 10\n",
      "p:  216\n",
      "217 1\n",
      "217 2\n",
      "217 3\n",
      "217 4\n",
      "217 5\n",
      "217 6\n",
      "p:  217\n",
      "218 1\n",
      "218 2\n",
      "218 3\n",
      "218 4\n",
      "218 5\n",
      "218 6\n",
      "218 7\n",
      "218 8\n",
      "p:  218\n",
      "219 1\n",
      "219 2\n",
      "219 3\n",
      "p:  219\n",
      "220 1\n",
      "220 2\n",
      "220 3\n",
      "220 4\n",
      "220 5\n",
      "220 6\n",
      "p:  220\n",
      "221 1\n",
      "221 2\n",
      "221 3\n",
      "p:  221\n",
      "222 1\n",
      "222 2\n",
      "222 3\n",
      "222 4\n",
      "p:  222\n",
      "223 1\n",
      "223 2\n",
      "223 3\n",
      "223 4\n",
      "223 5\n",
      "223 6\n",
      "p:  223\n",
      "224 1\n",
      "224 2\n",
      "224 3\n",
      "224 4\n",
      "224 5\n",
      "224 6\n",
      "224 7\n",
      "224 8\n",
      "224 9\n",
      "224 10\n",
      "224 11\n",
      "p:  224\n",
      "225 1\n",
      "p:  225\n",
      "226 1\n",
      "226 2\n",
      "226 3\n",
      "226 4\n",
      "226 5\n",
      "226 6\n",
      "p:  226\n",
      "227 1\n",
      "227 2\n",
      "p:  227\n",
      "228 1\n",
      "228 2\n",
      "228 3\n",
      "228 4\n",
      "228 5\n",
      "228 6\n",
      "p:  228\n",
      "229 1\n",
      "229 2\n",
      "229 3\n",
      "229 4\n",
      "229 5\n",
      "229 6\n",
      "229 7\n",
      "229 8\n",
      "229 9\n",
      "229 10\n",
      "229 11\n",
      "229 12\n",
      "229 13\n",
      "229 14\n",
      "229 15\n",
      "229 16\n",
      "229 17\n",
      "229 18\n",
      "229 19\n",
      "p:  229\n",
      "230 1\n",
      "230 2\n",
      "230 3\n",
      "230 4\n",
      "p:  230\n",
      "231 1\n",
      "231 2\n",
      "231 3\n",
      "231 4\n",
      "231 5\n",
      "231 6\n",
      "231 7\n",
      "231 8\n",
      "231 9\n",
      "231 10\n",
      "231 11\n",
      "231 12\n",
      "p:  231\n",
      "232 1\n",
      "232 2\n",
      "232 3\n",
      "232 4\n",
      "232 5\n",
      "232 6\n",
      "232 7\n",
      "232 8\n",
      "232 9\n",
      "232 10\n",
      "232 11\n",
      "p:  232\n"
     ]
    }
   ],
   "source": [
    "for i in range(0,1):\n",
    "    driver.get(days[i])\n",
    "    driver.implicitly_wait(3)\n",
    "    for j in range(1,20):\n",
    "        try:\n",
    "            driver.find_element(By.XPATH,'/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[4]/div['+str(j)+']/div[2]')\n",
    "            s=driver.find_element(By.XPATH,'/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[1]/h4/a').text\n",
    "            SESSION.append(s)\n",
    "            try:\n",
    "                su=driver.find_element(By.XPATH,'/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[4]/div['+str(j)+']/div[2]/h4').text\n",
    "                SUB_SESSION.append(su)\n",
    "            except:\n",
    "                SUB_SESSION.append(None)\n",
    "            try:\n",
    "                t=driver.find_element(By.XPATH,'/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[4]/div['+str(j)+']/div[2]/div[1]/div[2]/div[2]').text\n",
    "                TIME.append(t)\n",
    "            except:\n",
    "                TIME.append(None)\n",
    "            try:\n",
    "                p=driver.find_element(By.XPATH,'/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[4]/div['+str(j)+']/div[2]/div[1]/div[3]/div[2]/ul/li').text\n",
    "                SPEAKERS.append(p)\n",
    "            except:\n",
    "                SPEAKERS.append(None)\n",
    "            print(i,j)\n",
    "        except:\n",
    "            break\n",
    "    print('p: ',i)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 141,
   "id": "77ae17d7",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['ESMO 2019 Opening ceremony (ID 199)',\n",
       " 'ESMO 2019 Opening ceremony (ID 199)',\n",
       " 'ESMO 2019 Opening ceremony (ID 199)',\n",
       " 'ESMO 2019 Opening ceremony (ID 199)',\n",
       " 'ESMO 2019 Opening ceremony (ID 199)',\n",
       " 'ESMO 2019 Opening ceremony (ID 199)',\n",
       " 'Current markers in immunotherapy (ID 12)',\n",
       " 'Current markers in immunotherapy (ID 12)',\n",
       " 'Current markers in immunotherapy (ID 12)',\n",
       " 'Current markers in immunotherapy (ID 12)',\n",
       " 'Proffered Paper 1 - NSCLC, metastatic (ID 247)',\n",
       " 'Proffered Paper 1 - NSCLC, metastatic (ID 247)',\n",
       " 'Proffered Paper 1 - NSCLC, metastatic (ID 247)',\n",
       " 'Proffered Paper 1 - NSCLC, metastatic (ID 247)',\n",
       " 'Proffered Paper 1 - NSCLC, metastatic (ID 247)',\n",
       " 'Proffered Paper 1 - NSCLC, metastatic (ID 247)',\n",
       " 'Proffered Paper 1 - NSCLC, metastatic (ID 247)',\n",
       " 'Proffered Paper 1 – Gastrointestinal tumours, non-colorectal (ID 225)',\n",
       " 'Proffered Paper 1 – Gastrointestinal tumours, non-colorectal (ID 225)',\n",
       " 'Proffered Paper 1 – Gastrointestinal tumours, non-colorectal (ID 225)',\n",
       " 'Proffered Paper 1 – Gastrointestinal tumours, non-colorectal (ID 225)',\n",
       " 'Proffered Paper 1 – Gastrointestinal tumours, non-colorectal (ID 225)',\n",
       " 'Proffered Paper 1 – Gastrointestinal tumours, non-colorectal (ID 225)',\n",
       " 'The clinical utility of analysing circulating tumor DNA in patients with colorectal cancer (CRC) (ID 76)',\n",
       " 'The clinical utility of analysing circulating tumor DNA in patients with colorectal cancer (CRC) (ID 76)',\n",
       " 'The clinical utility of analysing circulating tumor DNA in patients with colorectal cancer (CRC) (ID 76)',\n",
       " 'The clinical utility of analysing circulating tumor DNA in patients with colorectal cancer (CRC) (ID 76)',\n",
       " 'Proffered Paper – Genitourinary tumours, prostate (ID 228)',\n",
       " 'Proffered Paper – Genitourinary tumours, prostate (ID 228)',\n",
       " 'Proffered Paper – Genitourinary tumours, prostate (ID 228)',\n",
       " 'Proffered Paper – Genitourinary tumours, prostate (ID 228)',\n",
       " 'Proffered Paper – Genitourinary tumours, prostate (ID 228)',\n",
       " 'Proffered Paper – Genitourinary tumours, prostate (ID 228)',\n",
       " 'Frontline in mRCC: Ready to select treatment? (ID 18)',\n",
       " 'Frontline in mRCC: Ready to select treatment? (ID 18)',\n",
       " 'Frontline in mRCC: Ready to select treatment? (ID 18)',\n",
       " 'Frontline in mRCC: Ready to select treatment? (ID 18)',\n",
       " 'Multidisciplinary management of germline and somatic gene alterations in patients with metastatic breast cancer (ID 41)',\n",
       " 'Multidisciplinary management of germline and somatic gene alterations in patients with metastatic breast cancer (ID 41)',\n",
       " 'Multidisciplinary management of germline and somatic gene alterations in patients with metastatic breast cancer (ID 41)',\n",
       " 'Multidisciplinary management of germline and somatic gene alterations in patients with metastatic breast cancer (ID 41)',\n",
       " 'Multidisciplinary management of germline and somatic gene alterations in patients with metastatic breast cancer (ID 41)',\n",
       " 'Proffered Paper 1 – Gynaecological cancers (ID 232)',\n",
       " 'Proffered Paper 1 – Gynaecological cancers (ID 232)',\n",
       " 'Proffered Paper 1 – Gynaecological cancers (ID 232)',\n",
       " 'Proffered Paper 1 – Gynaecological cancers (ID 232)',\n",
       " 'Proffered Paper 1 – Gynaecological cancers (ID 232)',\n",
       " 'Proffered Paper 1 – Gynaecological cancers (ID 232)',\n",
       " 'Special clinical scenarios in management of advanced melanoma (ID 68)',\n",
       " 'Special clinical scenarios in management of advanced melanoma (ID 68)',\n",
       " 'Special clinical scenarios in management of advanced melanoma (ID 68)',\n",
       " 'Special clinical scenarios in management of advanced melanoma (ID 68)',\n",
       " 'Preclinical models and imaging to guide clinical therapy (ID 58)',\n",
       " 'Preclinical models and imaging to guide clinical therapy (ID 58)',\n",
       " 'Preclinical models and imaging to guide clinical therapy (ID 58)',\n",
       " 'Preclinical models and imaging to guide clinical therapy (ID 58)',\n",
       " 'Is there a role for the addition of platinum-based chemotherapy to standard neoadjuvant chemotherapy in triple negative breast cancer (TNBC)? (ID 274)',\n",
       " 'Is there a role for the addition of platinum-based chemotherapy to standard neoadjuvant chemotherapy in triple negative breast cancer (TNBC)? (ID 274)',\n",
       " 'Is there a role for the addition of platinum-based chemotherapy to standard neoadjuvant chemotherapy in triple negative breast cancer (TNBC)? (ID 274)',\n",
       " 'Is there a role for the addition of platinum-based chemotherapy to standard neoadjuvant chemotherapy in triple negative breast cancer (TNBC)? (ID 274)',\n",
       " 'ESMO-EACR Collaborative session: From cancer genomes to combinatorial therapies (ID 198)',\n",
       " 'ESMO-EACR Collaborative session: From cancer genomes to combinatorial therapies (ID 198)',\n",
       " 'ESMO-EACR Collaborative session: From cancer genomes to combinatorial therapies (ID 198)',\n",
       " 'ESMO-EACR Collaborative session: From cancer genomes to combinatorial therapies (ID 198)',\n",
       " 'ESMO-EACR Collaborative session: From cancer genomes to combinatorial therapies (ID 198)',\n",
       " 'ESMO-EACR Collaborative session: From cancer genomes to combinatorial therapies (ID 198)',\n",
       " 'Biosimilars use in oncology: Clarifying concepts (ID 270)',\n",
       " 'Biosimilars use in oncology: Clarifying concepts (ID 270)',\n",
       " 'Biosimilars use in oncology: Clarifying concepts (ID 270)',\n",
       " 'Biosimilars use in oncology: Clarifying concepts (ID 270)',\n",
       " 'Biosimilars use in oncology: Clarifying concepts (ID 270)',\n",
       " 'Biosimilars use in oncology: Clarifying concepts (ID 270)',\n",
       " 'Biosimilars use in oncology: Clarifying concepts (ID 270)',\n",
       " 'Biosimilars use in oncology: Clarifying concepts (ID 270)',\n",
       " 'Practical use of liquid biopsy for advanced NSCLC (ID 55)',\n",
       " 'Practical use of liquid biopsy for advanced NSCLC (ID 55)',\n",
       " 'Combination and sequence in advanced melanoma (ID 11)',\n",
       " 'Combination and sequence in advanced melanoma (ID 11)',\n",
       " 'Proffered Paper – CNS tumours (ID 219)',\n",
       " 'Proffered Paper – CNS tumours (ID 219)',\n",
       " 'Proffered Paper – CNS tumours (ID 219)',\n",
       " 'Proffered Paper – CNS tumours (ID 219)',\n",
       " 'Proffered Paper – CNS tumours (ID 219)',\n",
       " 'Proffered Paper – CNS tumours (ID 219)',\n",
       " 'Proffered Paper – CNS tumours (ID 219)',\n",
       " 'SCLC: Is it time for novel therapies? (ID 65)',\n",
       " 'SCLC: Is it time for novel therapies? (ID 65)',\n",
       " 'Innate immune system and anti-mitotic agents: Two fields getting together (ID 30)',\n",
       " 'Innate immune system and anti-mitotic agents: Two fields getting together (ID 30)',\n",
       " 'Innate immune system and anti-mitotic agents: Two fields getting together (ID 30)',\n",
       " 'Innate immune system and anti-mitotic agents: Two fields getting together (ID 30)',\n",
       " 'Innate immune system and anti-mitotic agents: Two fields getting together (ID 30)',\n",
       " 'Innate immune system and anti-mitotic agents: Two fields getting together (ID 30)',\n",
       " 'CNS complications and management in systemic cancer patients (ID 10)',\n",
       " 'CNS complications and management in systemic cancer patients (ID 10)',\n",
       " 'CNS complications and management in systemic cancer patients (ID 10)',\n",
       " 'CNS complications and management in systemic cancer patients (ID 10)',\n",
       " 'Partial breast radiation therapy: Which patients, when, and with what technique? (ID 51)',\n",
       " 'Partial breast radiation therapy: Which patients, when, and with what technique? (ID 51)',\n",
       " 'ESMO-ESTRO Collaborative session: RTCT in stage III NSCLC: Prevention and management of toxicity including the use of immunotherapy (ID 268)',\n",
       " 'ESMO-ESTRO Collaborative session: RTCT in stage III NSCLC: Prevention and management of toxicity including the use of immunotherapy (ID 268)',\n",
       " 'ESMO-ESTRO Collaborative session: RTCT in stage III NSCLC: Prevention and management of toxicity including the use of immunotherapy (ID 268)',\n",
       " 'ESMO-ESTRO Collaborative session: RTCT in stage III NSCLC: Prevention and management of toxicity including the use of immunotherapy (ID 268)',\n",
       " 'ESMO-ESTRO Collaborative session: RTCT in stage III NSCLC: Prevention and management of toxicity including the use of immunotherapy (ID 268)',\n",
       " 'ESMO-ESTRO Collaborative session: RTCT in stage III NSCLC: Prevention and management of toxicity including the use of immunotherapy (ID 268)',\n",
       " 'ESMO-ESTRO Collaborative session: RTCT in stage III NSCLC: Prevention and management of toxicity including the use of immunotherapy (ID 268)',\n",
       " 'ESMO-MASCC Collaborative session: Management of cancer and anticancer therapy induced side effects (ID 95)',\n",
       " 'ESMO-MASCC Collaborative session: Management of cancer and anticancer therapy induced side effects (ID 95)',\n",
       " 'ESMO-MASCC Collaborative session: Management of cancer and anticancer therapy induced side effects (ID 95)',\n",
       " 'ESMO-MASCC Collaborative session: Management of cancer and anticancer therapy induced side effects (ID 95)',\n",
       " 'ESMO-MASCC Collaborative session: Management of cancer and anticancer therapy induced side effects (ID 95)',\n",
       " 'ESMO-MASCC Collaborative session: Management of cancer and anticancer therapy induced side effects (ID 95)',\n",
       " 'The role of the medical oncologist in health policy: Using national cancer control plans to translate science into better patient care (ID 116)',\n",
       " 'The role of the medical oncologist in health policy: Using national cancer control plans to translate science into better patient care (ID 116)',\n",
       " 'The role of the medical oncologist in health policy: Using national cancer control plans to translate science into better patient care (ID 116)',\n",
       " 'The role of the medical oncologist in health policy: Using national cancer control plans to translate science into better patient care (ID 116)',\n",
       " 'The role of the medical oncologist in health policy: Using national cancer control plans to translate science into better patient care (ID 116)',\n",
       " 'The role of the medical oncologist in health policy: Using national cancer control plans to translate science into better patient care (ID 116)',\n",
       " 'Universal health coverage and cancer: What you and your country need to know (ID 145)',\n",
       " 'Universal health coverage and cancer: What you and your country need to know (ID 145)',\n",
       " 'Universal health coverage and cancer: What you and your country need to know (ID 145)',\n",
       " 'Universal health coverage and cancer: What you and your country need to know (ID 145)',\n",
       " 'Universal health coverage and cancer: What you and your country need to know (ID 145)',\n",
       " 'Universal health coverage and cancer: What you and your country need to know (ID 145)',\n",
       " 'Universal health coverage and cancer: What you and your country need to know (ID 145)',\n",
       " 'ESMO-ESOP: Cytotoxic contamination in wards: Is it an occupational hazard? (ID 287)',\n",
       " 'ESMO-ESOP: Cytotoxic contamination in wards: Is it an occupational hazard? (ID 287)',\n",
       " 'ESMO-ESOP: Cytotoxic contamination in wards: Is it an occupational hazard? (ID 287)',\n",
       " 'ESMO-ESOP: Cytotoxic contamination in wards: Is it an occupational hazard? (ID 287)',\n",
       " 'ESMO-ESOP: Cytotoxic contamination in wards: Is it an occupational hazard? (ID 287)',\n",
       " 'ESMO-ESOP: Cytotoxic contamination in wards: Is it an occupational hazard? (ID 287)',\n",
       " 'ESMO-ESOP: Cytotoxic contamination in wards: Is it an occupational hazard? (ID 287)',\n",
       " 'ESMO-ESOP: Cytotoxic contamination in wards: Is it an occupational hazard? (ID 287)',\n",
       " 'ESMO-ESOI Collaborative session: Gastrointestinal stromal tumours: Imaging and treatment (ID 144)',\n",
       " 'ESMO-ESOI Collaborative session: Gastrointestinal stromal tumours: Imaging and treatment (ID 144)',\n",
       " 'ESMO-ESOI Collaborative session: Gastrointestinal stromal tumours: Imaging and treatment (ID 144)',\n",
       " 'ESMO-ESOI Collaborative session: Gastrointestinal stromal tumours: Imaging and treatment (ID 144)',\n",
       " 'ESMO-ESOI Collaborative session: Gastrointestinal stromal tumours: Imaging and treatment (ID 144)',\n",
       " 'Placing the patient at the center of care (ID 132)',\n",
       " 'Placing the patient at the center of care (ID 132)',\n",
       " 'Placing the patient at the center of care (ID 132)',\n",
       " 'Placing the patient at the center of care (ID 132)',\n",
       " 'Placing the patient at the center of care (ID 132)',\n",
       " 'Placing the patient at the center of care (ID 132)',\n",
       " 'Drugs in combination (ID 133)',\n",
       " 'Drugs in combination (ID 133)',\n",
       " 'Drugs in combination (ID 133)',\n",
       " 'Drugs in combination (ID 133)',\n",
       " 'Drugs in combination (ID 133)',\n",
       " 'Drugs in combination (ID 133)',\n",
       " 'YO Mentorship session: Career paths in oncology (ID 103)',\n",
       " 'YO Mentorship session: Career paths in oncology (ID 103)',\n",
       " 'YO Mentorship session: Career paths in oncology (ID 103)',\n",
       " 'YO Mentorship session: Career paths in oncology (ID 103)',\n",
       " 'YO Mentorship session: Career paths in oncology (ID 103)',\n",
       " 'YO Mentorship session: Career paths in oncology (ID 103)',\n",
       " 'YO Mentorship session: Career paths in oncology (ID 103)',\n",
       " 'YO Vesalius talk: How to start your own group: Moving from fellow to PI without burnout (ID 97)',\n",
       " 'Clinical cases of solid tumours: Discussion forum for young oncologists (ID 105)',\n",
       " 'Clinical cases of solid tumours: Discussion forum for young oncologists (ID 105)',\n",
       " 'Clinical cases of solid tumours: Discussion forum for young oncologists (ID 105)',\n",
       " 'Proffered Paper 1 – Genitourinary tumours, non-prostate (ID 230)',\n",
       " 'Proffered Paper 1 – Genitourinary tumours, non-prostate (ID 230)',\n",
       " 'Proffered Paper 1 – Genitourinary tumours, non-prostate (ID 230)',\n",
       " 'Proffered Paper 1 – Genitourinary tumours, non-prostate (ID 230)',\n",
       " 'Proffered Paper 1 – Genitourinary tumours, non-prostate (ID 230)',\n",
       " 'Proffered Paper 1 – Genitourinary tumours, non-prostate (ID 230)',\n",
       " 'Proffered Paper - Breast cancer, metastatic (ID 217)',\n",
       " 'Proffered Paper - Breast cancer, metastatic (ID 217)',\n",
       " 'Proffered Paper - Breast cancer, metastatic (ID 217)',\n",
       " 'Proffered Paper - Breast cancer, metastatic (ID 217)',\n",
       " 'Proffered Paper - Breast cancer, metastatic (ID 217)',\n",
       " 'Proffered Paper - Breast cancer, metastatic (ID 217)',\n",
       " 'Proffered Paper - Breast cancer, metastatic (ID 217)',\n",
       " 'Proffered Paper 1 – Gastrointestinal tumours, colorectal (ID 222)',\n",
       " 'Proffered Paper 1 – Gastrointestinal tumours, colorectal (ID 222)',\n",
       " 'Proffered Paper 1 – Gastrointestinal tumours, colorectal (ID 222)',\n",
       " 'Proffered Paper 1 – Gastrointestinal tumours, colorectal (ID 222)',\n",
       " 'Proffered Paper 1 – Gastrointestinal tumours, colorectal (ID 222)',\n",
       " 'Proffered Paper 1 – Gastrointestinal tumours, colorectal (ID 222)',\n",
       " 'Presidential Symposium I (ID 263)',\n",
       " 'Presidential Symposium I (ID 263)',\n",
       " 'Presidential Symposium I (ID 263)',\n",
       " 'Presidential Symposium I (ID 263)',\n",
       " 'Presidential Symposium I (ID 263)',\n",
       " 'Presidential Symposium I (ID 263)',\n",
       " 'Presidential Symposium I (ID 263)',\n",
       " 'Presidential Symposium I (ID 263)',\n",
       " 'Presidential Symposium I (ID 263)',\n",
       " 'Beyond initial radical treatment of patients with lung cancer (ID 3)',\n",
       " 'Beyond initial radical treatment of patients with lung cancer (ID 3)',\n",
       " 'Beyond initial radical treatment of patients with lung cancer (ID 3)',\n",
       " 'Beyond initial radical treatment of patients with lung cancer (ID 3)',\n",
       " 'Beyond initial radical treatment of patients with lung cancer (ID 3)',\n",
       " 'Beyond initial radical treatment of patients with lung cancer (ID 3)',\n",
       " 'Next immunotherapy strategies for lung cancer (ID 43)',\n",
       " 'Next immunotherapy strategies for lung cancer (ID 43)',\n",
       " 'Next immunotherapy strategies for lung cancer (ID 43)',\n",
       " 'Next immunotherapy strategies for lung cancer (ID 43)',\n",
       " 'Next immunotherapy strategies for lung cancer (ID 43)',\n",
       " 'Next immunotherapy strategies for lung cancer (ID 43)',\n",
       " 'HPV vaccination for everybody? (ID 26)',\n",
       " 'Optimal delivery of immuno-oncology (I-O) in advanced NSCLC (ID 47)',\n",
       " 'Optimal delivery of immuno-oncology (I-O) in advanced NSCLC (ID 47)',\n",
       " 'Optimal delivery of immuno-oncology (I-O) in advanced NSCLC (ID 47)',\n",
       " 'Optimal delivery of immuno-oncology (I-O) in advanced NSCLC (ID 47)',\n",
       " 'Optimal delivery of immuno-oncology (I-O) in advanced NSCLC (ID 47)',\n",
       " 'Optimal delivery of immuno-oncology (I-O) in advanced NSCLC (ID 47)',\n",
       " 'Challenges in the management of luminal ER + MBC (ID 9)',\n",
       " 'Challenges in the management of luminal ER + MBC (ID 9)',\n",
       " 'Challenges in the management of luminal ER + MBC (ID 9)',\n",
       " 'Challenges in the management of luminal ER + MBC (ID 9)',\n",
       " 'Next challenges for cancer immunotherapy (ID 42)',\n",
       " 'Next challenges for cancer immunotherapy (ID 42)',\n",
       " 'Next challenges for cancer immunotherapy (ID 42)',\n",
       " 'Next challenges for cancer immunotherapy (ID 42)',\n",
       " 'Next challenges for cancer immunotherapy (ID 42)',\n",
       " 'Next challenges for cancer immunotherapy (ID 42)',\n",
       " 'Pushing forward with immunotherapy in upper GI cancers (ID 60)',\n",
       " 'Pushing forward with immunotherapy in upper GI cancers (ID 60)',\n",
       " 'Pushing forward with immunotherapy in upper GI cancers (ID 60)',\n",
       " 'Pushing forward with immunotherapy in upper GI cancers (ID 60)',\n",
       " 'Pushing forward with immunotherapy in upper GI cancers (ID 60)',\n",
       " 'Pushing forward with immunotherapy in upper GI cancers (ID 60)',\n",
       " 'Proffered Paper 2 – Genitourinary tumours, non-prostate (ID 231)',\n",
       " 'Proffered Paper 2 – Genitourinary tumours, non-prostate (ID 231)',\n",
       " 'Proffered Paper 2 – Genitourinary tumours, non-prostate (ID 231)',\n",
       " 'Proffered Paper 2 – Genitourinary tumours, non-prostate (ID 231)',\n",
       " 'Proffered Paper 2 – Genitourinary tumours, non-prostate (ID 231)',\n",
       " 'Pancreatic cancer: Where are we now and where are we going? (ID 50)',\n",
       " 'Pancreatic cancer: Where are we now and where are we going? (ID 50)',\n",
       " 'Pancreatic cancer: Where are we now and where are we going? (ID 50)',\n",
       " 'Pancreatic cancer: Where are we now and where are we going? (ID 50)',\n",
       " 'Pancreatic cancer: Where are we now and where are we going? (ID 50)',\n",
       " 'Proffered Paper – Translational research (ID 252)',\n",
       " 'Proffered Paper – Translational research (ID 252)',\n",
       " 'Proffered Paper – Translational research (ID 252)',\n",
       " 'Proffered Paper – Translational research (ID 252)',\n",
       " 'Proffered Paper – Translational research (ID 252)',\n",
       " 'Proffered Paper – Translational research (ID 252)',\n",
       " 'Precision medicine in melanoma therapy (ID 57)',\n",
       " 'Precision medicine in melanoma therapy (ID 57)',\n",
       " 'Precision medicine in melanoma therapy (ID 57)',\n",
       " 'Precision medicine in melanoma therapy (ID 57)',\n",
       " 'Precision medicine in melanoma therapy (ID 57)',\n",
       " 'Precision medicine in melanoma therapy (ID 57)',\n",
       " 'Treating endometrial cancer in the molecular age (ID 82)',\n",
       " 'Treating endometrial cancer in the molecular age (ID 82)',\n",
       " 'Treating endometrial cancer in the molecular age (ID 82)',\n",
       " 'Treating endometrial cancer in the molecular age (ID 82)',\n",
       " 'Proffered Paper – Melanoma and other skin tumours (ID 240)',\n",
       " 'Proffered Paper – Melanoma and other skin tumours (ID 240)',\n",
       " 'Proffered Paper – Melanoma and other skin tumours (ID 240)',\n",
       " 'Proffered Paper – Melanoma and other skin tumours (ID 240)',\n",
       " 'Proffered Paper – Melanoma and other skin tumours (ID 240)',\n",
       " 'Proffered Paper – Melanoma and other skin tumours (ID 240)',\n",
       " 'Proffered Paper – Melanoma and other skin tumours (ID 240)',\n",
       " 'Proffered Paper – Melanoma and other skin tumours (ID 240)',\n",
       " 'Novel therapeutic strategies in ABC: Immunotherapy, Antibody Drug Conjugates (ADCs) and beyond (ID 44)',\n",
       " 'Novel therapeutic strategies in ABC: Immunotherapy, Antibody Drug Conjugates (ADCs) and beyond (ID 44)',\n",
       " 'Novel therapeutic strategies in ABC: Immunotherapy, Antibody Drug Conjugates (ADCs) and beyond (ID 44)',\n",
       " 'Novel therapeutic strategies in ABC: Immunotherapy, Antibody Drug Conjugates (ADCs) and beyond (ID 44)',\n",
       " 'Proffered Paper 1 – Non-metastatic NSCLC and other thoracic malignancies (SCLC) (ID 243)',\n",
       " 'Proffered Paper 1 – Non-metastatic NSCLC and other thoracic malignancies (SCLC) (ID 243)',\n",
       " 'Proffered Paper 1 – Non-metastatic NSCLC and other thoracic malignancies (SCLC) (ID 243)',\n",
       " 'Proffered Paper 1 – Non-metastatic NSCLC and other thoracic malignancies (SCLC) (ID 243)',\n",
       " 'Proffered Paper 1 – Non-metastatic NSCLC and other thoracic malignancies (SCLC) (ID 243)',\n",
       " 'Proffered Paper 1 – Non-metastatic NSCLC and other thoracic malignancies (SCLC) (ID 243)',\n",
       " 'Proffered Paper 1 – Non-metastatic NSCLC and other thoracic malignancies (SCLC) (ID 243)',\n",
       " 'Meeting the liquid biopsy family (ID 38)',\n",
       " 'Meeting the liquid biopsy family (ID 38)',\n",
       " 'Meeting the liquid biopsy family (ID 38)',\n",
       " 'Meeting the liquid biopsy family (ID 38)',\n",
       " 'ctDNA vs. tissue biopsy (ID 275)',\n",
       " 'ctDNA vs. tissue biopsy (ID 275)',\n",
       " 'ctDNA vs. tissue biopsy (ID 275)',\n",
       " 'ctDNA vs. tissue biopsy (ID 275)',\n",
       " 'Poster Discussion – Melanoma and other skin tumours (ID 253)',\n",
       " 'Poster Discussion – Melanoma and other skin tumours (ID 253)',\n",
       " 'Poster Discussion – Melanoma and other skin tumours (ID 253)',\n",
       " 'Poster Discussion – Melanoma and other skin tumours (ID 253)',\n",
       " 'Poster Discussion – Melanoma and other skin tumours (ID 253)',\n",
       " 'Poster Discussion – Melanoma and other skin tumours (ID 253)',\n",
       " 'Poster Discussion – Melanoma and other skin tumours (ID 253)',\n",
       " 'Poster Discussion – Melanoma and other skin tumours (ID 253)',\n",
       " 'Poster Discussion – Melanoma and other skin tumours (ID 253)',\n",
       " 'Poster Discussion – Melanoma and other skin tumours (ID 253)',\n",
       " 'Poster Discussion – Melanoma and other skin tumours (ID 253)',\n",
       " 'Poster Discussion – Melanoma and other skin tumours (ID 253)',\n",
       " 'Poster Discussion – Melanoma and other skin tumours (ID 253)',\n",
       " 'Poster Discussion – Melanoma and other skin tumours (ID 253)',\n",
       " 'Poster Discussion – Melanoma and other skin tumours (ID 253)',\n",
       " 'Poster Discussion – Melanoma and other skin tumours (ID 253)',\n",
       " 'Poster Discussion – Melanoma and other skin tumours (ID 253)',\n",
       " 'Poster Discussion – Melanoma and other skin tumours (ID 253)',\n",
       " 'Poster Discussion – Melanoma and other skin tumours (ID 253)',\n",
       " 'Treatment of the primary tumour in the metastatic setting (ID 87)',\n",
       " 'Treatment of the primary tumour in the metastatic setting (ID 87)',\n",
       " 'Treatment of the primary tumour in the metastatic setting (ID 87)',\n",
       " 'Treatment of the primary tumour in the metastatic setting (ID 87)',\n",
       " 'Treatment of the primary tumour in the metastatic setting (ID 87)',\n",
       " 'Treatment of the primary tumour in the metastatic setting (ID 87)',\n",
       " 'A family with MEN1 syndrome (ID 1)',\n",
       " 'A family with MEN1 syndrome (ID 1)',\n",
       " 'A family with MEN1 syndrome (ID 1)',\n",
       " 'A family with MEN1 syndrome (ID 1)',\n",
       " 'A family with MEN1 syndrome (ID 1)',\n",
       " 'Proffered Paper – Supportive and palliative care (ID 251)',\n",
       " 'Proffered Paper – Supportive and palliative care (ID 251)',\n",
       " 'Proffered Paper – Supportive and palliative care (ID 251)',\n",
       " 'Proffered Paper – Supportive and palliative care (ID 251)',\n",
       " 'Proffered Paper – Supportive and palliative care (ID 251)',\n",
       " 'Proffered Paper – Supportive and palliative care (ID 251)',\n",
       " 'Proffered Paper – Supportive and palliative care (ID 251)',\n",
       " 'Poster Discussion - Breast cancer, early stage (ID 218)',\n",
       " 'Poster Discussion - Breast cancer, early stage (ID 218)',\n",
       " 'Poster Discussion - Breast cancer, early stage (ID 218)',\n",
       " 'Poster Discussion - Breast cancer, early stage (ID 218)',\n",
       " 'Poster Discussion - Breast cancer, early stage (ID 218)',\n",
       " 'Poster Discussion - Breast cancer, early stage (ID 218)',\n",
       " 'Poster Discussion - Breast cancer, early stage (ID 218)',\n",
       " 'Poster Discussion - Breast cancer, early stage (ID 218)',\n",
       " 'Poster Discussion - Breast cancer, early stage (ID 218)',\n",
       " 'Poster Discussion - Breast cancer, early stage (ID 218)',\n",
       " 'Poster Discussion - Breast cancer, early stage (ID 218)',\n",
       " 'Poster Discussion - Breast cancer, early stage (ID 218)',\n",
       " 'Poster Discussion - Breast cancer, early stage (ID 218)',\n",
       " 'Poster Discussion - Breast cancer, early stage (ID 218)',\n",
       " 'Poster Discussion - Breast cancer, early stage (ID 218)',\n",
       " 'Proffered Paper session - Basic Science (ID 214)',\n",
       " 'Proffered Paper session - Basic Science (ID 214)',\n",
       " 'Proffered Paper session - Basic Science (ID 214)',\n",
       " 'Proffered Paper session - Basic Science (ID 214)',\n",
       " 'Proffered Paper session - Basic Science (ID 214)',\n",
       " 'Proffered Paper session - Basic Science (ID 214)',\n",
       " 'Proffered Paper session - Basic Science (ID 214)',\n",
       " 'Biology and early diagnosis of blood malignancies (ID 4)',\n",
       " 'Biology and early diagnosis of blood malignancies (ID 4)',\n",
       " 'Biology and early diagnosis of blood malignancies (ID 4)',\n",
       " 'Biology and early diagnosis of blood malignancies (ID 4)',\n",
       " 'Biology and early diagnosis of blood malignancies (ID 4)',\n",
       " 'Biology and early diagnosis of blood malignancies (ID 4)',\n",
       " 'Poster Discussion – Sarcoma (ID 259)',\n",
       " 'Poster Discussion – Sarcoma (ID 259)',\n",
       " 'Poster Discussion – Sarcoma (ID 259)',\n",
       " 'Poster Discussion – Sarcoma (ID 259)',\n",
       " 'Poster Discussion – Sarcoma (ID 259)',\n",
       " 'Poster Discussion – Sarcoma (ID 259)',\n",
       " 'Poster Discussion – Sarcoma (ID 259)',\n",
       " 'Poster Discussion – Sarcoma (ID 259)',\n",
       " 'Poster Discussion – Sarcoma (ID 259)',\n",
       " 'Poster Discussion – Sarcoma (ID 259)',\n",
       " 'Poster Discussion – Sarcoma (ID 259)',\n",
       " 'Poster Discussion – Sarcoma (ID 259)',\n",
       " 'Poster Discussion – Sarcoma (ID 259)',\n",
       " 'Poster Discussion – Sarcoma (ID 259)',\n",
       " 'The even rarer sarcomas: Treating the untreatable (ID 77)',\n",
       " 'The even rarer sarcomas: Treating the untreatable (ID 77)',\n",
       " 'The even rarer sarcomas: Treating the untreatable (ID 77)',\n",
       " 'The even rarer sarcomas: Treating the untreatable (ID 77)',\n",
       " 'The even rarer sarcomas: Treating the untreatable (ID 77)',\n",
       " 'The even rarer sarcomas: Treating the untreatable (ID 77)',\n",
       " 'Poster Discussion – Head and neck cancer (ID 245)',\n",
       " 'Poster Discussion – Head and neck cancer (ID 245)',\n",
       " 'Poster Discussion – Head and neck cancer (ID 245)',\n",
       " 'Poster Discussion – Head and neck cancer (ID 245)',\n",
       " 'Poster Discussion – Head and neck cancer (ID 245)',\n",
       " 'Poster Discussion – Head and neck cancer (ID 245)',\n",
       " 'Poster Discussion – Head and neck cancer (ID 245)',\n",
       " 'Poster Discussion – Head and neck cancer (ID 245)',\n",
       " 'Poster Discussion – Head and neck cancer (ID 245)',\n",
       " 'Poster Discussion – Head and neck cancer (ID 245)',\n",
       " 'Poster Discussion – Head and neck cancer (ID 245)',\n",
       " 'Poster Discussion – Head and neck cancer (ID 245)',\n",
       " 'Poster Discussion – Head and neck cancer (ID 245)',\n",
       " 'Poster Discussion – Head and neck cancer (ID 245)',\n",
       " 'Poster Discussion – Head and neck cancer (ID 245)',\n",
       " 'How to sequence treatment in platinum-sensitive relapsed ovarian cancer (ID 24)',\n",
       " 'How to sequence treatment in platinum-sensitive relapsed ovarian cancer (ID 24)',\n",
       " 'Poster Discussion – Supportive and palliative care (ID 260)',\n",
       " 'Poster Discussion – Supportive and palliative care (ID 260)',\n",
       " 'Poster Discussion – Supportive and palliative care (ID 260)',\n",
       " 'Poster Discussion – Supportive and palliative care (ID 260)',\n",
       " 'Poster Discussion – Supportive and palliative care (ID 260)',\n",
       " 'Poster Discussion – Supportive and palliative care (ID 260)',\n",
       " 'Poster Discussion – Supportive and palliative care (ID 260)',\n",
       " 'Poster Discussion – Supportive and palliative care (ID 260)',\n",
       " 'Poster Discussion – Supportive and palliative care (ID 260)',\n",
       " 'Poster Discussion – Supportive and palliative care (ID 260)',\n",
       " 'Poster Discussion – Supportive and palliative care (ID 260)',\n",
       " 'Poster Discussion – Supportive and palliative care (ID 260)',\n",
       " 'Poster Discussion – Supportive and palliative care (ID 260)',\n",
       " 'Poster Discussion – Supportive and palliative care (ID 260)',\n",
       " 'Poster Discussion 1 – Immunotherapy of cancer (ID 248)',\n",
       " 'Poster Discussion 1 – Immunotherapy of cancer (ID 248)',\n",
       " 'Poster Discussion 1 – Immunotherapy of cancer (ID 248)',\n",
       " 'Poster Discussion 1 – Immunotherapy of cancer (ID 248)',\n",
       " 'Poster Discussion 1 – Immunotherapy of cancer (ID 248)',\n",
       " 'Poster Discussion 1 – Immunotherapy of cancer (ID 248)',\n",
       " 'Poster Discussion 1 – Immunotherapy of cancer (ID 248)',\n",
       " 'Poster Discussion 1 – Immunotherapy of cancer (ID 248)',\n",
       " 'Poster Discussion 1 – Immunotherapy of cancer (ID 248)',\n",
       " 'Poster Discussion 1 – Immunotherapy of cancer (ID 248)',\n",
       " 'Poster Discussion 1 – Immunotherapy of cancer (ID 248)',\n",
       " 'Poster Discussion 1 – Immunotherapy of cancer (ID 248)',\n",
       " 'Poster Discussion 1 – Immunotherapy of cancer (ID 248)',\n",
       " 'Locally advanced rectal cancer: What is the best perioperative treatment in 2019? (ID 34)',\n",
       " 'Locally advanced rectal cancer: What is the best perioperative treatment in 2019? (ID 34)',\n",
       " 'WHO grade II and III gliomas: State of the art management (ID 91)',\n",
       " 'WHO grade II and III gliomas: State of the art management (ID 91)',\n",
       " 'WHO grade II and III gliomas: State of the art management (ID 91)',\n",
       " 'WHO grade II and III gliomas: State of the art management (ID 91)',\n",
       " 'WHO grade II and III gliomas: State of the art management (ID 91)',\n",
       " 'Managing the frail patients (ID 37)',\n",
       " 'Managing the frail patients (ID 37)',\n",
       " 'Managing the frail patients (ID 37)',\n",
       " 'Managing the frail patients (ID 37)',\n",
       " 'Managing the frail patients (ID 37)',\n",
       " 'Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)',\n",
       " 'Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)',\n",
       " 'Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)',\n",
       " 'Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)',\n",
       " 'Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)',\n",
       " 'Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)',\n",
       " 'Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)',\n",
       " 'Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)',\n",
       " 'Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)',\n",
       " 'Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)',\n",
       " 'Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)',\n",
       " 'Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)',\n",
       " 'Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)',\n",
       " 'Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)',\n",
       " 'Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)',\n",
       " 'Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)',\n",
       " 'Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)',\n",
       " 'Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)',\n",
       " 'Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)',\n",
       " 'Proffered Paper session: Artificial intelligence and machine learning as tools for practice in oncology (ID 273)',\n",
       " 'Proffered Paper session: Artificial intelligence and machine learning as tools for practice in oncology (ID 273)',\n",
       " 'Proffered Paper session: Artificial intelligence and machine learning as tools for practice in oncology (ID 273)',\n",
       " 'Proffered Paper session: Artificial intelligence and machine learning as tools for practice in oncology (ID 273)',\n",
       " 'Proffered Paper session: Artificial intelligence and machine learning as tools for practice in oncology (ID 273)',\n",
       " 'Proffered Paper session: Artificial intelligence and machine learning as tools for practice in oncology (ID 273)',\n",
       " 'Metastasis, dormancy and late recurrence (ID 39)',\n",
       " 'Metastasis, dormancy and late recurrence (ID 39)',\n",
       " 'Is randomisation of clinical trials still the gold standard? (ID 31)',\n",
       " 'Is randomisation of clinical trials still the gold standard? (ID 31)',\n",
       " 'Is randomisation of clinical trials still the gold standard? (ID 31)',\n",
       " 'Is randomisation of clinical trials still the gold standard? (ID 31)',\n",
       " 'Is randomisation of clinical trials still the gold standard? (ID 31)',\n",
       " 'Poster Discussion – Developmental therapeutics (ID 226)',\n",
       " 'Poster Discussion – Developmental therapeutics (ID 226)',\n",
       " 'Poster Discussion – Developmental therapeutics (ID 226)',\n",
       " 'Poster Discussion – Developmental therapeutics (ID 226)',\n",
       " 'Poster Discussion – Developmental therapeutics (ID 226)',\n",
       " 'Poster Discussion – Developmental therapeutics (ID 226)',\n",
       " 'Poster Discussion – Developmental therapeutics (ID 226)',\n",
       " 'Poster Discussion – Developmental therapeutics (ID 226)',\n",
       " 'Poster Discussion – Developmental therapeutics (ID 226)',\n",
       " 'Poster Discussion – Developmental therapeutics (ID 226)',\n",
       " 'Poster Discussion – Developmental therapeutics (ID 226)',\n",
       " 'Poster Discussion – Developmental therapeutics (ID 226)',\n",
       " 'Poster Discussion – Developmental therapeutics (ID 226)',\n",
       " 'Poster Discussion – Developmental therapeutics (ID 226)',\n",
       " 'Poster Discussion – Developmental therapeutics (ID 226)',\n",
       " 'Poster Discussion – Developmental therapeutics (ID 226)',\n",
       " 'Poster Discussion – Developmental therapeutics (ID 226)',\n",
       " 'Poster Discussion – Developmental therapeutics (ID 226)',\n",
       " 'Poster Discussion – Developmental therapeutics (ID 226)',\n",
       " 'Challenges in advanced GIST: Are we approaching cure? (ID 8)',\n",
       " 'Challenges in advanced GIST: Are we approaching cure? (ID 8)',\n",
       " 'Radiopharmaceuticals to treat lethal prostate cancer (ID 62)',\n",
       " 'Radiopharmaceuticals to treat lethal prostate cancer (ID 62)',\n",
       " 'Decision making at the point of care: When evidence-based medicines can’t help (ID 114)',\n",
       " 'Decision making at the point of care: When evidence-based medicines can’t help (ID 114)',\n",
       " 'Decision making at the point of care: When evidence-based medicines can’t help (ID 114)',\n",
       " 'Decision making at the point of care: When evidence-based medicines can’t help (ID 114)',\n",
       " 'Decision making at the point of care: When evidence-based medicines can’t help (ID 114)',\n",
       " 'Decision making at the point of care: When evidence-based medicines can’t help (ID 114)',\n",
       " 'Decision making at the point of care: When evidence-based medicines can’t help (ID 114)',\n",
       " 'Decision making at the point of care: When evidence-based medicines can’t help (ID 114)',\n",
       " 'Decision making at the point of care: When evidence-based medicines can’t help (ID 114)',\n",
       " 'Decision making at the point of care: When evidence-based medicines can’t help (ID 114)',\n",
       " 'Decision making at the point of care: When evidence-based medicines can’t help (ID 114)',\n",
       " 'Decision making at the point of care: When evidence-based medicines can’t help (ID 114)',\n",
       " 'Decision making at the point of care: When evidence-based medicines can’t help (ID 114)',\n",
       " 'Decision making at the point of care: When evidence-based medicines can’t help (ID 114)',\n",
       " 'Tackling the treatment options in triple negative metastatic breast cancer (ID 74)',\n",
       " 'Tackling the treatment options in triple negative metastatic breast cancer (ID 74)',\n",
       " 'Biomarkers for patient selection for checkpoint inhibitors in HNSCC: Where do we stand? (ID 5)',\n",
       " 'Biomarkers for patient selection for checkpoint inhibitors in HNSCC: Where do we stand? (ID 5)',\n",
       " 'ESMO-MCBS: What have we learnt and how can we expand? (ID 205)',\n",
       " 'ESMO-MCBS: What have we learnt and how can we expand? (ID 205)',\n",
       " 'ESMO-MCBS: What have we learnt and how can we expand? (ID 205)',\n",
       " 'ESMO-MCBS: What have we learnt and how can we expand? (ID 205)',\n",
       " 'ESMO-MCBS: What have we learnt and how can we expand? (ID 205)',\n",
       " 'ESMO-MCBS: What have we learnt and how can we expand? (ID 205)',\n",
       " 'Poster Discussion – CNS tumours (ID 224)',\n",
       " 'Poster Discussion – CNS tumours (ID 224)',\n",
       " 'Poster Discussion – CNS tumours (ID 224)',\n",
       " 'Poster Discussion – CNS tumours (ID 224)',\n",
       " 'Poster Discussion – CNS tumours (ID 224)',\n",
       " 'Poster Discussion – CNS tumours (ID 224)',\n",
       " 'Poster Discussion – CNS tumours (ID 224)',\n",
       " 'Poster Discussion – CNS tumours (ID 224)',\n",
       " 'Poster Discussion – CNS tumours (ID 224)',\n",
       " 'Poster Discussion – CNS tumours (ID 224)',\n",
       " 'Poster Discussion – CNS tumours (ID 224)',\n",
       " 'Poster Discussion – CNS tumours (ID 224)',\n",
       " 'Poster Discussion – CNS tumours (ID 224)',\n",
       " 'Poster Discussion – CNS tumours (ID 224)',\n",
       " 'Poster Discussion – CNS tumours (ID 224)',\n",
       " 'ESMO Colloquium funded by Eisai Europe - Emerging Biotherapy Strategies in the treatment of solid tumours: Hope, Hype and Hurdles (ID 208)',\n",
       " 'ESMO Colloquium funded by Eisai Europe - Emerging Biotherapy Strategies in the treatment of solid tumours: Hope, Hype and Hurdles (ID 208)',\n",
       " 'ESMO Colloquium funded by Eisai Europe - Emerging Biotherapy Strategies in the treatment of solid tumours: Hope, Hype and Hurdles (ID 208)',\n",
       " 'ESMO Colloquium funded by Eisai Europe - Emerging Biotherapy Strategies in the treatment of solid tumours: Hope, Hype and Hurdles (ID 208)',\n",
       " 'ESMO Colloquium funded by Eisai Europe - Emerging Biotherapy Strategies in the treatment of solid tumours: Hope, Hype and Hurdles (ID 208)',\n",
       " 'ESMO Colloquium funded by Eisai Europe - Emerging Biotherapy Strategies in the treatment of solid tumours: Hope, Hype and Hurdles (ID 208)',\n",
       " 'ESMO Colloquium funded by Eisai Europe - Emerging Biotherapy Strategies in the treatment of solid tumours: Hope, Hype and Hurdles (ID 208)',\n",
       " 'ESMO Colloquium funded by Eisai Europe - Emerging Biotherapy Strategies in the treatment of solid tumours: Hope, Hype and Hurdles (ID 208)',\n",
       " 'Proffered Paper – Haematological malignancies & pediatric oncology (ID 235)',\n",
       " 'Proffered Paper – Haematological malignancies & pediatric oncology (ID 235)',\n",
       " 'Proffered Paper – Haematological malignancies & pediatric oncology (ID 235)',\n",
       " 'Proffered Paper – Haematological malignancies & pediatric oncology (ID 235)',\n",
       " 'Proffered Paper – Haematological malignancies & pediatric oncology (ID 235)',\n",
       " 'Proffered Paper – Haematological malignancies & pediatric oncology (ID 235)',\n",
       " 'EONS 12: Opening session (ID 118)',\n",
       " 'EONS 12: Opening session (ID 118)',\n",
       " 'EONS 12: Opening session (ID 118)',\n",
       " 'EONS 12: Opening session (ID 118)',\n",
       " 'EONS 12: Opening session (ID 118)',\n",
       " 'EONS 12: Opening session (ID 118)',\n",
       " 'EONS 12: Opening session (ID 118)',\n",
       " 'EONS 12: Patient safety in cancer care (ID 120)',\n",
       " 'EONS 12: Patient safety in cancer care (ID 120)',\n",
       " 'EONS 12: Patient safety in cancer care (ID 120)',\n",
       " 'EONS 12: Patient safety in cancer care (ID 120)',\n",
       " 'EONS 12: Patient safety in cancer care (ID 120)',\n",
       " 'EONS 12: Patient safety in cancer care (ID 120)',\n",
       " 'EONS 12 Symposium: Car-T Cells therapy: A New Treatment Challenge for Cancer Nurses (ID 280)',\n",
       " 'EONS 12 Symposium: Car-T Cells therapy: A New Treatment Challenge for Cancer Nurses (ID 280)',\n",
       " 'EONS 12 Symposium: Car-T Cells therapy: A New Treatment Challenge for Cancer Nurses (ID 280)',\n",
       " 'EONS 12 Symposium: Car-T Cells therapy: A New Treatment Challenge for Cancer Nurses (ID 280)',\n",
       " 'EONS 12: Living with and beyond cancer (ID 123)',\n",
       " 'EONS 12: Living with and beyond cancer (ID 123)',\n",
       " 'EONS 12: Living with and beyond cancer (ID 123)',\n",
       " 'EONS 12: Living with and beyond cancer (ID 123)',\n",
       " 'EONS 12: Recent trends in palliative care (ID 125)',\n",
       " 'EONS 12: Recent trends in palliative care (ID 125)',\n",
       " 'EONS 12: Recent trends in palliative care (ID 125)',\n",
       " 'EONS 12: Recent trends in palliative care (ID 125)',\n",
       " 'EONS 12: Recent trends in palliative care (ID 125)',\n",
       " 'EONS 12: Recent trends in palliative care (ID 125)',\n",
       " 'Essential medicines, but not always available (ID 109)',\n",
       " 'Essential medicines, but not always available (ID 109)',\n",
       " 'Essential medicines, but not always available (ID 109)',\n",
       " 'Essential medicines, but not always available (ID 109)',\n",
       " 'Essential medicines, but not always available (ID 109)',\n",
       " 'Essential medicines, but not always available (ID 109)',\n",
       " 'How can truly innovative drugs be available for all patients? (ID 111)',\n",
       " 'How can truly innovative drugs be available for all patients? (ID 111)',\n",
       " 'How can truly innovative drugs be available for all patients? (ID 111)',\n",
       " 'How can truly innovative drugs be available for all patients? (ID 111)',\n",
       " 'How can truly innovative drugs be available for all patients? (ID 111)',\n",
       " 'How can truly innovative drugs be available for all patients? (ID 111)',\n",
       " 'Common but still rare: What happens when common cancers split into subgroups? (ID 134)',\n",
       " 'Common but still rare: What happens when common cancers split into subgroups? (ID 134)',\n",
       " 'Common but still rare: What happens when common cancers split into subgroups? (ID 134)',\n",
       " 'Common but still rare: What happens when common cancers split into subgroups? (ID 134)',\n",
       " 'Common but still rare: What happens when common cancers split into subgroups? (ID 134)',\n",
       " 'Common but still rare: What happens when common cancers split into subgroups? (ID 134)',\n",
       " 'Bedside rationing: To prescribe or not to prescribe? (ID 108)',\n",
       " 'Bedside rationing: To prescribe or not to prescribe? (ID 108)',\n",
       " 'Bedside rationing: To prescribe or not to prescribe? (ID 108)',\n",
       " 'Bedside rationing: To prescribe or not to prescribe? (ID 108)',\n",
       " 'Bedside rationing: To prescribe or not to prescribe? (ID 108)',\n",
       " 'Fertility and pregnancy of cancer patients during and after treatment (ID 135)',\n",
       " 'Fertility and pregnancy of cancer patients during and after treatment (ID 135)',\n",
       " 'Fertility and pregnancy of cancer patients during and after treatment (ID 135)',\n",
       " 'Fertility and pregnancy of cancer patients during and after treatment (ID 135)',\n",
       " 'Fertility and pregnancy of cancer patients during and after treatment (ID 135)',\n",
       " 'YO “boxing” session (ID 106)',\n",
       " 'YO “boxing” session (ID 106)',\n",
       " 'YO “boxing” session (ID 106)',\n",
       " 'YO “boxing” session (ID 106)',\n",
       " 'YO “boxing” session (ID 106)',\n",
       " 'YO “boxing” session (ID 106)',\n",
       " 'YO “boxing” session (ID 106)',\n",
       " 'YO “boxing” session (ID 106)',\n",
       " 'YO “boxing” session (ID 106)',\n",
       " 'YO “boxing” session (ID 106)',\n",
       " 'YO Brunch: Survivorship care for young adults with cancer (ID 98)',\n",
       " 'YO Brunch: Survivorship care for young adults with cancer (ID 98)',\n",
       " 'YO Brunch: Survivorship care for young adults with cancer (ID 98)',\n",
       " '2019 ESMO Annual General Assembly (ID 291)',\n",
       " 'ESMO for medical students and young physicians (ID 104)',\n",
       " 'ESMO for medical students and young physicians (ID 104)',\n",
       " 'ESMO for medical students and young physicians (ID 104)',\n",
       " 'Poster Display session 1 (ID 210)',\n",
       " 'Poster Display session 1 (ID 210)',\n",
       " 'Poster Display session 1 (ID 210)',\n",
       " 'Poster Display session 1 (ID 210)',\n",
       " 'Poster Display session 1 (ID 210)',\n",
       " 'Poster Display session 1 (ID 210)',\n",
       " 'Poster Display session 1 (ID 210)',\n",
       " 'Poster Display session 1 (ID 210)',\n",
       " 'Poster Display session 1 (ID 210)',\n",
       " 'Poster Display session 1 (ID 210)',\n",
       " 'Poster Display session 1 (ID 210)',\n",
       " 'Poster Display session 1 (ID 210)',\n",
       " 'Poster Display session 1 (ID 210)',\n",
       " 'Poster Display session 1 (ID 210)',\n",
       " 'Poster Display session 1 (ID 210)',\n",
       " 'Poster Display session 1 (ID 210)',\n",
       " 'Poster Display session 1 (ID 210)',\n",
       " 'Poster Display session 1 (ID 210)',\n",
       " 'Poster Display session 1 (ID 210)',\n",
       " 'EONS 12 Workshop: Present experiences and future directions of immunotherapy (ID 281)',\n",
       " 'EONS 12 Workshop: Present experiences and future directions of immunotherapy (ID 281)',\n",
       " 'EONS 12 Workshop: Present experiences and future directions of immunotherapy (ID 281)',\n",
       " 'EONS 12 Workshop: Present experiences and future directions of immunotherapy (ID 281)',\n",
       " 'EONS 12 Workshop: Present experiences and future directions of immunotherapy (ID 281)',\n",
       " 'Stratified treatment in metastatic colorectal cancer (ID 71)',\n",
       " 'Stratified treatment in metastatic colorectal cancer (ID 71)',\n",
       " 'Stratified treatment in metastatic colorectal cancer (ID 71)',\n",
       " 'Stratified treatment in metastatic colorectal cancer (ID 71)',\n",
       " 'Stratified treatment in metastatic colorectal cancer (ID 71)',\n",
       " 'Stratified treatment in metastatic colorectal cancer (ID 71)',\n",
       " 'Tackling the diversity of triple negative early breast cancer (TNBC) (ID 73)',\n",
       " 'Tackling the diversity of triple negative early breast cancer (TNBC) (ID 73)',\n",
       " 'Tackling the diversity of triple negative early breast cancer (TNBC) (ID 73)',\n",
       " 'Tackling the diversity of triple negative early breast cancer (TNBC) (ID 73)',\n",
       " 'Tackling the diversity of triple negative early breast cancer (TNBC) (ID 73)',\n",
       " 'Tackling the diversity of triple negative early breast cancer (TNBC) (ID 73)',\n",
       " 'Tackling the diversity of triple negative early breast cancer (TNBC) (ID 73)',\n",
       " 'Where will future technologies take us in metastatic breast cancer? (ID 90)',\n",
       " 'Where will future technologies take us in metastatic breast cancer? (ID 90)',\n",
       " 'Where will future technologies take us in metastatic breast cancer? (ID 90)',\n",
       " 'Where will future technologies take us in metastatic breast cancer? (ID 90)',\n",
       " 'Where will future technologies take us in metastatic breast cancer? (ID 90)',\n",
       " 'Where will future technologies take us in metastatic breast cancer? (ID 90)',\n",
       " 'Presidential Symposium II (ID 264)',\n",
       " 'Presidential Symposium II (ID 264)',\n",
       " 'Presidential Symposium II (ID 264)',\n",
       " 'Presidential Symposium II (ID 264)',\n",
       " 'Presidential Symposium II (ID 264)',\n",
       " 'Presidential Symposium II (ID 264)',\n",
       " 'Proffered Paper 2 – Gynaecological cancers (ID 234)',\n",
       " 'Proffered Paper 2 – Gynaecological cancers (ID 234)',\n",
       " 'Proffered Paper 2 – Gynaecological cancers (ID 234)',\n",
       " 'Proffered Paper 2 – Gynaecological cancers (ID 234)',\n",
       " 'Proffered Paper 2 – Gynaecological cancers (ID 234)',\n",
       " 'Proffered Paper 2 – Gynaecological cancers (ID 234)',\n",
       " 'Proffered Paper 2 – Gastrointestinal tumours, non-colorectal (ID 227)',\n",
       " 'Proffered Paper 2 – Gastrointestinal tumours, non-colorectal (ID 227)',\n",
       " 'Proffered Paper 2 – Gastrointestinal tumours, non-colorectal (ID 227)',\n",
       " 'Proffered Paper 2 – Gastrointestinal tumours, non-colorectal (ID 227)',\n",
       " 'Proffered Paper 2 – Gastrointestinal tumours, non-colorectal (ID 227)',\n",
       " 'Proffered Paper 2 – Gastrointestinal tumours, non-colorectal (ID 227)',\n",
       " 'RAS signalling and cancer (ID 63)',\n",
       " 'Update on novel therapies in ovarian cancer (ID 89)',\n",
       " 'Update on novel therapies in ovarian cancer (ID 89)',\n",
       " 'Update on novel therapies in ovarian cancer (ID 89)',\n",
       " 'Update on novel therapies in ovarian cancer (ID 89)',\n",
       " 'Update on novel therapies in ovarian cancer (ID 89)',\n",
       " 'Update on novel therapies in ovarian cancer (ID 89)',\n",
       " 'Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies (ID 255)',\n",
       " 'Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies (ID 255)',\n",
       " 'Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies (ID 255)',\n",
       " 'Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies (ID 255)',\n",
       " 'Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies (ID 255)',\n",
       " 'Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies (ID 255)',\n",
       " 'Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies (ID 255)',\n",
       " 'Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies (ID 255)',\n",
       " 'Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies (ID 255)',\n",
       " 'Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies (ID 255)',\n",
       " 'Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies (ID 255)',\n",
       " 'Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies (ID 255)',\n",
       " 'Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies (ID 255)',\n",
       " 'Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies (ID 255)',\n",
       " 'Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies (ID 255)',\n",
       " 'Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies (ID 255)',\n",
       " 'Genomic tumour boards to deliver better prostate cancer care (ID 19)',\n",
       " 'Genomic tumour boards to deliver better prostate cancer care (ID 19)',\n",
       " 'Genomic tumour boards to deliver better prostate cancer care (ID 19)',\n",
       " 'Genomic tumour boards to deliver better prostate cancer care (ID 19)',\n",
       " 'Genomic tumour boards to deliver better prostate cancer care (ID 19)',\n",
       " 'Genomic tumour boards to deliver better prostate cancer care (ID 19)',\n",
       " 'Immunotherapy in thoracic malignancies: What has been achieved in 2019? (ID 27)',\n",
       " 'Immunotherapy in thoracic malignancies: What has been achieved in 2019? (ID 27)',\n",
       " 'Immunotherapy in thoracic malignancies: What has been achieved in 2019? (ID 27)',\n",
       " 'Immunotherapy in thoracic malignancies: What has been achieved in 2019? (ID 27)',\n",
       " 'Progress in the management of non-melanoma skin cancers (ID 59)',\n",
       " 'Progress in the management of non-melanoma skin cancers (ID 59)',\n",
       " 'Progress in the management of non-melanoma skin cancers (ID 59)',\n",
       " 'Progress in the management of non-melanoma skin cancers (ID 59)',\n",
       " 'DNA damage response modification as a therapeutic strategy in head and neck cancer (ID 14)',\n",
       " 'DNA damage response modification as a therapeutic strategy in head and neck cancer (ID 14)',\n",
       " 'DNA damage response modification as a therapeutic strategy in head and neck cancer (ID 14)',\n",
       " 'DNA damage response modification as a therapeutic strategy in head and neck cancer (ID 14)',\n",
       " 'DNA damage response modification as a therapeutic strategy in head and neck cancer (ID 14)',\n",
       " 'DNA damage response modification as a therapeutic strategy in head and neck cancer (ID 14)',\n",
       " 'DNA repair: From basic science to the clinic and back (ID 15)',\n",
       " 'DNA repair: From basic science to the clinic and back (ID 15)',\n",
       " 'DNA repair: From basic science to the clinic and back (ID 15)',\n",
       " 'DNA repair: From basic science to the clinic and back (ID 15)',\n",
       " 'Poster Discussion – Genitourinary tumours, non-prostate (ID 239)',\n",
       " 'Poster Discussion – Genitourinary tumours, non-prostate (ID 239)',\n",
       " 'Poster Discussion – Genitourinary tumours, non-prostate (ID 239)',\n",
       " 'Poster Discussion – Genitourinary tumours, non-prostate (ID 239)',\n",
       " 'Poster Discussion – Genitourinary tumours, non-prostate (ID 239)',\n",
       " 'Poster Discussion – Genitourinary tumours, non-prostate (ID 239)',\n",
       " 'Poster Discussion – Genitourinary tumours, non-prostate (ID 239)',\n",
       " 'Poster Discussion – Genitourinary tumours, non-prostate (ID 239)',\n",
       " 'Poster Discussion – Genitourinary tumours, non-prostate (ID 239)',\n",
       " 'Poster Discussion – Genitourinary tumours, non-prostate (ID 239)',\n",
       " 'Poster Discussion – Genitourinary tumours, non-prostate (ID 239)',\n",
       " 'Poster Discussion – Genitourinary tumours, non-prostate (ID 239)',\n",
       " 'Poster Discussion – Genitourinary tumours, non-prostate (ID 239)',\n",
       " 'Poster Discussion – Genitourinary tumours, non-prostate (ID 239)',\n",
       " 'Poster Discussion – Genitourinary tumours, non-prostate (ID 239)',\n",
       " 'Poster Discussion – Genitourinary tumours, non-prostate (ID 239)',\n",
       " 'Poster Discussion – Genitourinary tumours, non-prostate (ID 239)',\n",
       " 'Poster Discussion – Genitourinary tumours, non-prostate (ID 239)',\n",
       " 'Poster Discussion – Genitourinary tumours, non-prostate (ID 239)',\n",
       " 'Poster Discussion - Breast cancer, metastatic (ID 220)',\n",
       " 'Poster Discussion - Breast cancer, metastatic (ID 220)',\n",
       " 'Poster Discussion - Breast cancer, metastatic (ID 220)',\n",
       " 'Poster Discussion - Breast cancer, metastatic (ID 220)',\n",
       " 'Poster Discussion - Breast cancer, metastatic (ID 220)',\n",
       " 'Poster Discussion - Breast cancer, metastatic (ID 220)',\n",
       " 'Poster Discussion - Breast cancer, metastatic (ID 220)',\n",
       " 'Poster Discussion - Breast cancer, metastatic (ID 220)',\n",
       " 'Poster Discussion - Breast cancer, metastatic (ID 220)',\n",
       " 'Poster Discussion - Breast cancer, metastatic (ID 220)',\n",
       " 'Poster Discussion - Breast cancer, metastatic (ID 220)',\n",
       " 'Poster Discussion - Breast cancer, metastatic (ID 220)',\n",
       " 'Poster Discussion - Breast cancer, metastatic (ID 220)',\n",
       " 'Poster Discussion - Breast cancer, metastatic (ID 220)',\n",
       " 'Poster Discussion - Breast cancer, metastatic (ID 220)',\n",
       " 'Poster Discussion - Breast cancer, metastatic (ID 220)',\n",
       " 'How to choose between single agent and combination immunotherapy (ID 22)',\n",
       " 'How to choose between single agent and combination immunotherapy (ID 22)',\n",
       " 'Poster Discussion – Gastrointestinal tumours, colorectal (ID 229)',\n",
       " 'Poster Discussion – Gastrointestinal tumours, colorectal (ID 229)',\n",
       " 'Poster Discussion – Gastrointestinal tumours, colorectal (ID 229)',\n",
       " 'Poster Discussion – Gastrointestinal tumours, colorectal (ID 229)',\n",
       " 'Poster Discussion – Gastrointestinal tumours, colorectal (ID 229)',\n",
       " 'Poster Discussion – Gastrointestinal tumours, colorectal (ID 229)',\n",
       " 'Poster Discussion – Gastrointestinal tumours, colorectal (ID 229)',\n",
       " 'Poster Discussion – Gastrointestinal tumours, colorectal (ID 229)',\n",
       " 'Poster Discussion – Gastrointestinal tumours, colorectal (ID 229)',\n",
       " 'Poster Discussion – Gastrointestinal tumours, colorectal (ID 229)',\n",
       " 'Poster Discussion – Gastrointestinal tumours, colorectal (ID 229)',\n",
       " 'Poster Discussion – Gastrointestinal tumours, colorectal (ID 229)',\n",
       " 'Poster Discussion – Gastrointestinal tumours, colorectal (ID 229)',\n",
       " 'Poster Discussion – Gastrointestinal tumours, colorectal (ID 229)',\n",
       " 'Poster Discussion – Gastrointestinal tumours, colorectal (ID 229)',\n",
       " 'Poster Discussion – Gastrointestinal tumours, colorectal (ID 229)',\n",
       " 'Poster Discussion – NSCLC, metastatic (ID 256)',\n",
       " 'Poster Discussion – NSCLC, metastatic (ID 256)',\n",
       " 'Poster Discussion – NSCLC, metastatic (ID 256)',\n",
       " 'Poster Discussion – NSCLC, metastatic (ID 256)',\n",
       " 'Poster Discussion – NSCLC, metastatic (ID 256)',\n",
       " 'Poster Discussion – NSCLC, metastatic (ID 256)',\n",
       " 'Poster Discussion – NSCLC, metastatic (ID 256)',\n",
       " 'Poster Discussion – NSCLC, metastatic (ID 256)',\n",
       " 'Poster Discussion – NSCLC, metastatic (ID 256)',\n",
       " 'Poster Discussion – NSCLC, metastatic (ID 256)',\n",
       " 'Poster Discussion – NSCLC, metastatic (ID 256)',\n",
       " 'Poster Discussion – NSCLC, metastatic (ID 256)',\n",
       " 'Poster Discussion – NSCLC, metastatic (ID 256)',\n",
       " 'Poster Discussion – NSCLC, metastatic (ID 256)',\n",
       " 'Poster Discussion – NSCLC, metastatic (ID 256)',\n",
       " 'Poster Discussion – NSCLC, metastatic (ID 256)',\n",
       " 'Poster Discussion – NSCLC, metastatic (ID 256)',\n",
       " 'Poster Discussion – NSCLC, metastatic (ID 256)',\n",
       " 'ESMO Colloquium supported by Ipsen - Metastatic clear cell renal cell carcinoma How to navigate within multiple options and risk groups? What is the best sequence in a multi-line setting? (ID 209)',\n",
       " 'ESMO Colloquium supported by Ipsen - Metastatic clear cell renal cell carcinoma How to navigate within multiple options and risk groups? What is the best sequence in a multi-line setting? (ID 209)',\n",
       " 'ESMO Colloquium supported by Ipsen - Metastatic clear cell renal cell carcinoma How to navigate within multiple options and risk groups? What is the best sequence in a multi-line setting? (ID 209)',\n",
       " 'ESMO Colloquium supported by Ipsen - Metastatic clear cell renal cell carcinoma How to navigate within multiple options and risk groups? What is the best sequence in a multi-line setting? (ID 209)',\n",
       " 'ESMO Colloquium supported by Ipsen - Metastatic clear cell renal cell carcinoma How to navigate within multiple options and risk groups? What is the best sequence in a multi-line setting? (ID 209)',\n",
       " 'ESMO Colloquium supported by Ipsen - Metastatic clear cell renal cell carcinoma How to navigate within multiple options and risk groups? What is the best sequence in a multi-line setting? (ID 209)',\n",
       " 'ESMO Colloquium supported by Ipsen - Metastatic clear cell renal cell carcinoma How to navigate within multiple options and risk groups? What is the best sequence in a multi-line setting? (ID 209)',\n",
       " 'ESMO Colloquium supported by Ipsen - Metastatic clear cell renal cell carcinoma How to navigate within multiple options and risk groups? What is the best sequence in a multi-line setting? (ID 209)',\n",
       " 'ESMO Colloquium supported by Ipsen - Metastatic clear cell renal cell carcinoma How to navigate within multiple options and risk groups? What is the best sequence in a multi-line setting? (ID 209)',\n",
       " 'ESMO Colloquium supported by Ipsen - Metastatic clear cell renal cell carcinoma How to navigate within multiple options and risk groups? What is the best sequence in a multi-line setting? (ID 209)',\n",
       " 'Neo-adjuvant vs. adjuvant therapy or combination for locoregional / oligometastatic melanoma (ID 279)',\n",
       " 'Neo-adjuvant vs. adjuvant therapy or combination for locoregional / oligometastatic melanoma (ID 279)',\n",
       " 'Neo-adjuvant vs. adjuvant therapy or combination for locoregional / oligometastatic melanoma (ID 279)',\n",
       " 'Neo-adjuvant vs. adjuvant therapy or combination for locoregional / oligometastatic melanoma (ID 279)',\n",
       " 'ESMO Clinical Practice Guidelines 1 (ID 203)',\n",
       " 'ESMO Clinical Practice Guidelines 1 (ID 203)',\n",
       " 'ESMO Clinical Practice Guidelines 1 (ID 203)',\n",
       " 'ESMO Clinical Practice Guidelines 1 (ID 203)',\n",
       " 'ESMO Clinical Practice Guidelines 1 (ID 203)',\n",
       " 'ESMO Clinical Practice Guidelines 1 (ID 203)',\n",
       " 'ESMO Clinical Practice Guidelines 1 (ID 203)',\n",
       " 'ESMO Clinical Practice Guidelines 1 (ID 203)',\n",
       " 'ESMO Clinical Practice Guidelines 1 (ID 203)',\n",
       " 'ESMO Clinical Practice Guidelines 1 (ID 203)',\n",
       " 'ESMO Clinical Practice Guidelines 1 (ID 203)',\n",
       " 'ESMO Clinical Practice Guidelines 1 (ID 203)',\n",
       " 'ESMO Clinical Practice Guidelines 1 (ID 203)',\n",
       " 'ESMO Clinical Practice Guidelines 1 (ID 203)',\n",
       " 'ESMO Clinical Practice Guidelines 2 (ID 204)',\n",
       " 'ESMO Clinical Practice Guidelines 2 (ID 204)',\n",
       " 'ESMO Clinical Practice Guidelines 2 (ID 204)',\n",
       " 'ESMO Clinical Practice Guidelines 2 (ID 204)',\n",
       " 'ESMO Clinical Practice Guidelines 2 (ID 204)',\n",
       " 'ESMO Clinical Practice Guidelines 2 (ID 204)',\n",
       " 'ESMO Clinical Practice Guidelines 2 (ID 204)',\n",
       " 'ESMO Clinical Practice Guidelines 2 (ID 204)',\n",
       " 'ESMO Clinical Practice Guidelines 2 (ID 204)',\n",
       " 'ESMO Clinical Practice Guidelines 2 (ID 204)',\n",
       " 'ESMO Clinical Practice Guidelines 2 (ID 204)',\n",
       " 'ESMO Clinical Practice Guidelines 2 (ID 204)',\n",
       " 'ESMO Clinical Practice Guidelines 2 (ID 204)',\n",
       " 'ESMO Clinical Practice Guidelines 2 (ID 204)',\n",
       " 'Circulating tumour cell counts as clinical trial endpoint in prostate cancer? (ID 277)',\n",
       " 'Circulating tumour cell counts as clinical trial endpoint in prostate cancer? (ID 277)',\n",
       " 'Circulating tumour cell counts as clinical trial endpoint in prostate cancer? (ID 277)',\n",
       " 'Circulating tumour cell counts as clinical trial endpoint in prostate cancer? (ID 277)',\n",
       " 'Toxicity profiling of immunotherapy of cancer (ID 81)',\n",
       " 'Toxicity profiling of immunotherapy of cancer (ID 81)',\n",
       " 'Toxicity profiling of immunotherapy of cancer (ID 81)',\n",
       " 'Toxicity profiling of immunotherapy of cancer (ID 81)',\n",
       " 'Toxicity profiling of immunotherapy of cancer (ID 81)',\n",
       " 'Poster Discussion – Gynaecological cancers (ID 242)',\n",
       " 'Poster Discussion – Gynaecological cancers (ID 242)',\n",
       " 'Poster Discussion – Gynaecological cancers (ID 242)',\n",
       " 'Poster Discussion – Gynaecological cancers (ID 242)',\n",
       " 'Poster Discussion – Gynaecological cancers (ID 242)',\n",
       " 'Poster Discussion – Gynaecological cancers (ID 242)',\n",
       " 'Poster Discussion – Gynaecological cancers (ID 242)',\n",
       " 'Poster Discussion – Gynaecological cancers (ID 242)',\n",
       " 'Poster Discussion – Gynaecological cancers (ID 242)',\n",
       " 'Poster Discussion – Gynaecological cancers (ID 242)',\n",
       " 'Poster Discussion – Gynaecological cancers (ID 242)',\n",
       " 'Overcoming symptom burden in upper GI cancer (ID 49)',\n",
       " 'Overcoming symptom burden in upper GI cancer (ID 49)',\n",
       " 'Overcoming symptom burden in upper GI cancer (ID 49)',\n",
       " 'Overcoming symptom burden in upper GI cancer (ID 49)',\n",
       " 'Overcoming symptom burden in upper GI cancer (ID 49)',\n",
       " 'Overcoming symptom burden in upper GI cancer (ID 49)',\n",
       " 'Overcoming symptom burden in upper GI cancer (ID 49)',\n",
       " 'Overcoming symptom burden in upper GI cancer (ID 49)',\n",
       " 'Overcoming symptom burden in upper GI cancer (ID 49)',\n",
       " 'Management of body resources in patients with advanced cancer (ID 35)',\n",
       " 'Management of body resources in patients with advanced cancer (ID 35)',\n",
       " 'Management of body resources in patients with advanced cancer (ID 35)',\n",
       " 'Management of body resources in patients with advanced cancer (ID 35)',\n",
       " 'Poster Discussion – Genitourinary tumours, prostate (ID 237)',\n",
       " 'Poster Discussion – Genitourinary tumours, prostate (ID 237)',\n",
       " 'Poster Discussion – Genitourinary tumours, prostate (ID 237)',\n",
       " 'Poster Discussion – Genitourinary tumours, prostate (ID 237)',\n",
       " 'Poster Discussion – Genitourinary tumours, prostate (ID 237)',\n",
       " 'Poster Discussion – Genitourinary tumours, prostate (ID 237)',\n",
       " 'Poster Discussion – Genitourinary tumours, prostate (ID 237)',\n",
       " 'Poster Discussion – Genitourinary tumours, prostate (ID 237)',\n",
       " 'Poster Discussion – Genitourinary tumours, prostate (ID 237)',\n",
       " 'Poster Discussion – Genitourinary tumours, prostate (ID 237)',\n",
       " 'Poster Discussion – Genitourinary tumours, prostate (ID 237)',\n",
       " 'Poster Discussion – Genitourinary tumours, prostate (ID 237)',\n",
       " 'Poster Discussion – Genitourinary tumours, prostate (ID 237)',\n",
       " 'Poster Discussion – Genitourinary tumours, prostate (ID 237)',\n",
       " 'Poster Discussion – Genitourinary tumours, prostate (ID 237)',\n",
       " 'Poster Discussion – Genitourinary tumours, prostate (ID 237)',\n",
       " 'Poster Discussion – Genitourinary tumours, prostate (ID 237)',\n",
       " 'Poster Discussion – Genitourinary tumours, prostate (ID 237)',\n",
       " 'Glioblastoma treatment: Where should the future lead? (ID 20)',\n",
       " 'Glioblastoma treatment: Where should the future lead? (ID 20)',\n",
       " 'Glioblastoma treatment: Where should the future lead? (ID 20)',\n",
       " 'Glioblastoma treatment: Where should the future lead? (ID 20)',\n",
       " 'Glioblastoma treatment: Where should the future lead? (ID 20)',\n",
       " 'Glioblastoma treatment: Where should the future lead? (ID 20)',\n",
       " 'Perioperative therapy in melanoma (ID 52)',\n",
       " 'Perioperative therapy in melanoma (ID 52)',\n",
       " 'Perioperative therapy in melanoma (ID 52)',\n",
       " 'Perioperative therapy in melanoma (ID 52)',\n",
       " 'Perioperative therapy in melanoma (ID 52)',\n",
       " 'Proffered Paper – Developmental therapeutics (ID 221)',\n",
       " 'Proffered Paper – Developmental therapeutics (ID 221)',\n",
       " 'Proffered Paper – Developmental therapeutics (ID 221)',\n",
       " 'Proffered Paper – Developmental therapeutics (ID 221)',\n",
       " 'Proffered Paper – Developmental therapeutics (ID 221)',\n",
       " 'Proffered Paper – Developmental therapeutics (ID 221)',\n",
       " 'Proffered Paper – Developmental therapeutics (ID 221)',\n",
       " 'Molecular tumour board: Where do we stand? What’s next? (ID 40)',\n",
       " 'Molecular tumour board: Where do we stand? What’s next? (ID 40)',\n",
       " 'Molecular tumour board: Where do we stand? What’s next? (ID 40)',\n",
       " 'Molecular tumour board: Where do we stand? What’s next? (ID 40)',\n",
       " 'Molecular tumour board: Where do we stand? What’s next? (ID 40)',\n",
       " 'Oligorecurrent and oligoprogressive NSCLC (ID 45)',\n",
       " 'Oligorecurrent and oligoprogressive NSCLC (ID 45)',\n",
       " 'Oligorecurrent and oligoprogressive NSCLC (ID 45)',\n",
       " 'Oligorecurrent and oligoprogressive NSCLC (ID 45)',\n",
       " 'Oligorecurrent and oligoprogressive NSCLC (ID 45)',\n",
       " 'Treatment developments in viral-associated HN malignancies (ID 84)',\n",
       " 'Treatment developments in viral-associated HN malignancies (ID 84)',\n",
       " 'Treatment developments in viral-associated HN malignancies (ID 84)',\n",
       " 'Treatment developments in viral-associated HN malignancies (ID 84)',\n",
       " 'ESMO-SIOG Collaborative session: Immunotherapy in older patients: Challenges and opportunities (ID 142)',\n",
       " 'ESMO-SIOG Collaborative session: Immunotherapy in older patients: Challenges and opportunities (ID 142)',\n",
       " 'ESMO-SIOG Collaborative session: Immunotherapy in older patients: Challenges and opportunities (ID 142)',\n",
       " 'ESMO-SIOG Collaborative session: Immunotherapy in older patients: Challenges and opportunities (ID 142)',\n",
       " 'ESMO-SIOG Collaborative session: Immunotherapy in older patients: Challenges and opportunities (ID 142)',\n",
       " 'ESMO-SIOG Collaborative session: Immunotherapy in older patients: Challenges and opportunities (ID 142)',\n",
       " 'Improving the outcomes from anal cancer treatment: Radiotherapy strategies and systemic therapies (ID 28)',\n",
       " 'Improving the outcomes from anal cancer treatment: Radiotherapy strategies and systemic therapies (ID 28)',\n",
       " 'Improving the outcomes from anal cancer treatment: Radiotherapy strategies and systemic therapies (ID 28)',\n",
       " 'The past year in sarcoma: Impact on clinical practice (ID 79)',\n",
       " 'The past year in sarcoma: Impact on clinical practice (ID 79)',\n",
       " 'The past year in sarcoma: Impact on clinical practice (ID 79)',\n",
       " 'The past year in sarcoma: Impact on clinical practice (ID 79)',\n",
       " 'Proffered Paper – NETs and endocrine tumours (ID 241)',\n",
       " 'Proffered Paper – NETs and endocrine tumours (ID 241)',\n",
       " 'Proffered Paper – NETs and endocrine tumours (ID 241)',\n",
       " 'Proffered Paper – NETs and endocrine tumours (ID 241)',\n",
       " 'Proffered Paper – NETs and endocrine tumours (ID 241)',\n",
       " 'Proffered Paper – NETs and endocrine tumours (ID 241)',\n",
       " 'Proffered Paper – NETs and endocrine tumours (ID 241)',\n",
       " 'Early diagnosis of neuroendocrine tumours (NETs): Increasing awareness and optimising diagnostic work up (ID 17)',\n",
       " 'Early diagnosis of neuroendocrine tumours (NETs): Increasing awareness and optimising diagnostic work up (ID 17)',\n",
       " 'Practicing oncology in elderly cancer patients (ID 139)',\n",
       " 'Practicing oncology in elderly cancer patients (ID 139)',\n",
       " 'Practicing oncology in elderly cancer patients (ID 139)',\n",
       " 'Practicing oncology in elderly cancer patients (ID 139)',\n",
       " 'Practicing oncology in elderly cancer patients (ID 139)',\n",
       " 'Practicing oncology in elderly cancer patients (ID 139)',\n",
       " 'Practicing oncology in elderly cancer patients (ID 139)',\n",
       " 'Practicing oncology in elderly cancer patients (ID 139)',\n",
       " 'Recent advances in thyroid cancer (ID 64)',\n",
       " 'Recent advances in thyroid cancer (ID 64)',\n",
       " 'Recent advances in thyroid cancer (ID 64)',\n",
       " 'Recent advances in thyroid cancer (ID 64)',\n",
       " 'Recent advances in thyroid cancer (ID 64)',\n",
       " 'Recent advances in thyroid cancer (ID 64)',\n",
       " 'Poster Discussion session - Basic science (ID 215)',\n",
       " 'Poster Discussion session - Basic science (ID 215)',\n",
       " 'Poster Discussion session - Basic science (ID 215)',\n",
       " 'Poster Discussion session - Basic science (ID 215)',\n",
       " 'Poster Discussion session - Basic science (ID 215)',\n",
       " 'Poster Discussion session - Basic science (ID 215)',\n",
       " 'Poster Discussion session - Basic science (ID 215)',\n",
       " 'Poster Discussion session - Basic science (ID 215)',\n",
       " 'Poster Discussion session - Basic science (ID 215)',\n",
       " 'Poster Discussion session - Basic science (ID 215)',\n",
       " 'Poster Discussion session - Basic science (ID 215)',\n",
       " 'Poster Discussion session - Basic science (ID 215)',\n",
       " 'Poster Discussion session - Basic science (ID 215)',\n",
       " 'Poster Discussion session - Basic science (ID 215)',\n",
       " 'Poster Discussion session - Basic science (ID 215)',\n",
       " 'Poster Discussion session - Basic science (ID 215)',\n",
       " 'ESMO Colloquium supported by Lilly Oncology - Metastatic gastro-intestinal cancer: Multiple treatment lines, extended pipeline of available drugs and use of predictive markers. How to best sequence the treatment proposal? (ID 182)',\n",
       " 'ESMO Colloquium supported by Lilly Oncology - Metastatic gastro-intestinal cancer: Multiple treatment lines, extended pipeline of available drugs and use of predictive markers. How to best sequence the treatment proposal? (ID 182)',\n",
       " 'ESMO Colloquium supported by Lilly Oncology - Metastatic gastro-intestinal cancer: Multiple treatment lines, extended pipeline of available drugs and use of predictive markers. How to best sequence the treatment proposal? (ID 182)',\n",
       " 'ESMO Colloquium supported by Lilly Oncology - Metastatic gastro-intestinal cancer: Multiple treatment lines, extended pipeline of available drugs and use of predictive markers. How to best sequence the treatment proposal? (ID 182)',\n",
       " 'ESMO Colloquium supported by Lilly Oncology - Metastatic gastro-intestinal cancer: Multiple treatment lines, extended pipeline of available drugs and use of predictive markers. How to best sequence the treatment proposal? (ID 182)',\n",
       " 'Specificity of upper tract urothelial carcinoma biology and management (ID 69)',\n",
       " 'Specificity of upper tract urothelial carcinoma biology and management (ID 69)',\n",
       " 'Radiation-associated sarcoma (ID 61)',\n",
       " 'Radiation-associated sarcoma (ID 61)',\n",
       " 'Radiation-associated sarcoma (ID 61)',\n",
       " 'Radiation-associated sarcoma (ID 61)',\n",
       " 'Radiation-associated sarcoma (ID 61)',\n",
       " 'Tumour educated platelets (ID 54)',\n",
       " 'Tumour educated platelets (ID 54)',\n",
       " 'Liquid biopsies, tumour dormancy and minimal residual disease detection (ID 33)',\n",
       " 'Liquid biopsies, tumour dormancy and minimal residual disease detection (ID 33)',\n",
       " 'Liquid biopsies, tumour dormancy and minimal residual disease detection (ID 33)',\n",
       " 'Liquid biopsies, tumour dormancy and minimal residual disease detection (ID 33)',\n",
       " 'Poster Discussion 1 – Translational research (ID 261)',\n",
       " 'Poster Discussion 1 – Translational research (ID 261)',\n",
       " 'Poster Discussion 1 – Translational research (ID 261)',\n",
       " 'Poster Discussion 1 – Translational research (ID 261)',\n",
       " 'Poster Discussion 1 – Translational research (ID 261)',\n",
       " 'Poster Discussion 1 – Translational research (ID 261)',\n",
       " 'Poster Discussion 1 – Translational research (ID 261)',\n",
       " 'Poster Discussion 1 – Translational research (ID 261)',\n",
       " 'Poster Discussion 1 – Translational research (ID 261)',\n",
       " 'Poster Discussion 1 – Translational research (ID 261)',\n",
       " 'Poster Discussion 1 – Translational research (ID 261)',\n",
       " 'Poster Discussion 1 – Translational research (ID 261)',\n",
       " 'Defining optimal response in myeloma (ID 13)',\n",
       " 'Defining optimal response in myeloma (ID 13)',\n",
       " 'Defining optimal response in myeloma (ID 13)',\n",
       " 'Defining optimal response in myeloma (ID 13)',\n",
       " 'Defining optimal response in myeloma (ID 13)',\n",
       " 'Proffered Paper session: Genomic characterization of cancer cells to guide precision medicine: Next steps (ID 286)',\n",
       " 'Proffered Paper session: Genomic characterization of cancer cells to guide precision medicine: Next steps (ID 286)',\n",
       " 'Proffered Paper session: Genomic characterization of cancer cells to guide precision medicine: Next steps (ID 286)',\n",
       " 'Proffered Paper session: Genomic characterization of cancer cells to guide precision medicine: Next steps (ID 286)',\n",
       " 'Proffered Paper session: Genomic characterization of cancer cells to guide precision medicine: Next steps (ID 286)',\n",
       " 'Level playing field: Working for gender balance in oncology (ID 271)',\n",
       " 'Level playing field: Working for gender balance in oncology (ID 271)',\n",
       " 'Level playing field: Working for gender balance in oncology (ID 271)',\n",
       " 'Level playing field: Working for gender balance in oncology (ID 271)',\n",
       " 'Level playing field: Working for gender balance in oncology (ID 271)',\n",
       " 'Level playing field: Working for gender balance in oncology (ID 271)',\n",
       " ...]"
      ]
     },
     "execution_count": 141,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "SESSION"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 120,
   "id": "39167915",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'Welcome to ESMO 2019, opening speeches and award presentations (ID 6253)'"
      ]
     },
     "execution_count": 120,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "driver.find_element(By.XPATH,'/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[4]/div[1]/div[2]/h4').text\n",
    "                              /html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[4]/div[2]/div[2]/h4"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 131,
   "id": "b4de0ee9",
   "metadata": {},
   "outputs": [],
   "source": [
    "driver.get(days[0])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 101,
   "id": "c1651496",
   "metadata": {},
   "outputs": [
    {
     "ename": "NoSuchElementException",
     "evalue": "Message: no such element: Unable to locate element: {\"method\":\"xpath\",\"selector\":\"/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[4]/div[5]/div[2]\"}\n  (Session info: chrome=109.0.5414.120)\nStacktrace:\nBacktrace:\n\t(No symbol) [0x005C6643]\n\t(No symbol) [0x0055BE21]\n\t(No symbol) [0x0045DA9D]\n\t(No symbol) [0x00491342]\n\t(No symbol) [0x0049147B]\n\t(No symbol) [0x004C8DC2]\n\t(No symbol) [0x004AFDC4]\n\t(No symbol) [0x004C6B09]\n\t(No symbol) [0x004AFB76]\n\t(No symbol) [0x004849C1]\n\t(No symbol) [0x00485E5D]\n\tGetHandleVerifier [0x0083A142+2497106]\n\tGetHandleVerifier [0x008685D3+2686691]\n\tGetHandleVerifier [0x0086BB9C+2700460]\n\tGetHandleVerifier [0x00673B10+635936]\n\t(No symbol) [0x00564A1F]\n\t(No symbol) [0x0056A418]\n\t(No symbol) [0x0056A505]\n\t(No symbol) [0x0057508B]\n\tBaseThreadInitThunk [0x77D000F9+25]\n\tRtlGetAppContainerNamedObjectPath [0x77EB7BBE+286]\n\tRtlGetAppContainerNamedObjectPath [0x77EB7B8E+238]\n",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mNoSuchElementException\u001b[0m                    Traceback (most recent call last)",
      "Input \u001b[1;32mIn [101]\u001b[0m, in \u001b[0;36m<cell line: 3>\u001b[1;34m()\u001b[0m\n\u001b[0;32m      1\u001b[0m \u001b[38;5;66;03m# /html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[4]/div[1]/div[2]\u001b[39;00m\n\u001b[0;32m      2\u001b[0m \u001b[38;5;66;03m# /html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[4]/div[4]/div[2]\u001b[39;00m\n\u001b[1;32m----> 3\u001b[0m \u001b[43mdriver\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mfind_element\u001b[49m\u001b[43m(\u001b[49m\u001b[43mBy\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mXPATH\u001b[49m\u001b[43m,\u001b[49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[4]/div[5]/div[2]\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[43m)\u001b[49m\n",
      "File \u001b[1;32m~\\AppData\\Roaming\\Python\\Python39\\site-packages\\selenium\\webdriver\\remote\\webdriver.py:857\u001b[0m, in \u001b[0;36mWebDriver.find_element\u001b[1;34m(self, by, value)\u001b[0m\n\u001b[0;32m    854\u001b[0m     by \u001b[38;5;241m=\u001b[39m By\u001b[38;5;241m.\u001b[39mCSS_SELECTOR\n\u001b[0;32m    855\u001b[0m     value \u001b[38;5;241m=\u001b[39m \u001b[38;5;124m'\u001b[39m\u001b[38;5;124m[name=\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;132;01m%s\u001b[39;00m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m]\u001b[39m\u001b[38;5;124m'\u001b[39m \u001b[38;5;241m%\u001b[39m value\n\u001b[1;32m--> 857\u001b[0m \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mexecute\u001b[49m\u001b[43m(\u001b[49m\u001b[43mCommand\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mFIND_ELEMENT\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43m{\u001b[49m\n\u001b[0;32m    858\u001b[0m \u001b[43m    \u001b[49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43musing\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[43m:\u001b[49m\u001b[43m \u001b[49m\u001b[43mby\u001b[49m\u001b[43m,\u001b[49m\n\u001b[0;32m    859\u001b[0m \u001b[43m    \u001b[49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mvalue\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[43m:\u001b[49m\u001b[43m \u001b[49m\u001b[43mvalue\u001b[49m\u001b[43m}\u001b[49m\u001b[43m)\u001b[49m[\u001b[38;5;124m'\u001b[39m\u001b[38;5;124mvalue\u001b[39m\u001b[38;5;124m'\u001b[39m]\n",
      "File \u001b[1;32m~\\AppData\\Roaming\\Python\\Python39\\site-packages\\selenium\\webdriver\\remote\\webdriver.py:435\u001b[0m, in \u001b[0;36mWebDriver.execute\u001b[1;34m(self, driver_command, params)\u001b[0m\n\u001b[0;32m    433\u001b[0m response \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mcommand_executor\u001b[38;5;241m.\u001b[39mexecute(driver_command, params)\n\u001b[0;32m    434\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m response:\n\u001b[1;32m--> 435\u001b[0m     \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43merror_handler\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mcheck_response\u001b[49m\u001b[43m(\u001b[49m\u001b[43mresponse\u001b[49m\u001b[43m)\u001b[49m\n\u001b[0;32m    436\u001b[0m     response[\u001b[38;5;124m'\u001b[39m\u001b[38;5;124mvalue\u001b[39m\u001b[38;5;124m'\u001b[39m] \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_unwrap_value(\n\u001b[0;32m    437\u001b[0m         response\u001b[38;5;241m.\u001b[39mget(\u001b[38;5;124m'\u001b[39m\u001b[38;5;124mvalue\u001b[39m\u001b[38;5;124m'\u001b[39m, \u001b[38;5;28;01mNone\u001b[39;00m))\n\u001b[0;32m    438\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m response\n",
      "File \u001b[1;32m~\\AppData\\Roaming\\Python\\Python39\\site-packages\\selenium\\webdriver\\remote\\errorhandler.py:247\u001b[0m, in \u001b[0;36mErrorHandler.check_response\u001b[1;34m(self, response)\u001b[0m\n\u001b[0;32m    245\u001b[0m         alert_text \u001b[38;5;241m=\u001b[39m value[\u001b[38;5;124m'\u001b[39m\u001b[38;5;124malert\u001b[39m\u001b[38;5;124m'\u001b[39m]\u001b[38;5;241m.\u001b[39mget(\u001b[38;5;124m'\u001b[39m\u001b[38;5;124mtext\u001b[39m\u001b[38;5;124m'\u001b[39m)\n\u001b[0;32m    246\u001b[0m     \u001b[38;5;28;01mraise\u001b[39;00m exception_class(message, screen, stacktrace, alert_text)  \u001b[38;5;66;03m# type: ignore[call-arg]  # mypy is not smart enough here\u001b[39;00m\n\u001b[1;32m--> 247\u001b[0m \u001b[38;5;28;01mraise\u001b[39;00m exception_class(message, screen, stacktrace)\n",
      "\u001b[1;31mNoSuchElementException\u001b[0m: Message: no such element: Unable to locate element: {\"method\":\"xpath\",\"selector\":\"/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[4]/div[5]/div[2]\"}\n  (Session info: chrome=109.0.5414.120)\nStacktrace:\nBacktrace:\n\t(No symbol) [0x005C6643]\n\t(No symbol) [0x0055BE21]\n\t(No symbol) [0x0045DA9D]\n\t(No symbol) [0x00491342]\n\t(No symbol) [0x0049147B]\n\t(No symbol) [0x004C8DC2]\n\t(No symbol) [0x004AFDC4]\n\t(No symbol) [0x004C6B09]\n\t(No symbol) [0x004AFB76]\n\t(No symbol) [0x004849C1]\n\t(No symbol) [0x00485E5D]\n\tGetHandleVerifier [0x0083A142+2497106]\n\tGetHandleVerifier [0x008685D3+2686691]\n\tGetHandleVerifier [0x0086BB9C+2700460]\n\tGetHandleVerifier [0x00673B10+635936]\n\t(No symbol) [0x00564A1F]\n\t(No symbol) [0x0056A418]\n\t(No symbol) [0x0056A505]\n\t(No symbol) [0x0057508B]\n\tBaseThreadInitThunk [0x77D000F9+25]\n\tRtlGetAppContainerNamedObjectPath [0x77EB7BBE+286]\n\tRtlGetAppContainerNamedObjectPath [0x77EB7B8E+238]\n"
     ]
    }
   ],
   "source": [
    "/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[4]/div[1]/div[2]\n",
    "/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[4]/div[4]/div[2]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 142,
   "id": "8a48d54b",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 143,
   "id": "bd3107df",
   "metadata": {},
   "outputs": [],
   "source": [
    "Data=pd.DataFrame()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 144,
   "id": "6646ae79",
   "metadata": {},
   "outputs": [],
   "source": [
    "Data['SESSION_NAMES']=SESSION\n",
    "Data[\"SUB_SESSION\"]=SUB_SESSION\n",
    "Data[\"NAMES\"]=SPEAKERS\n",
    "Data[\"TIMINGS\"]=TIME"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 145,
   "id": "89e5407e",
   "metadata": {},
   "outputs": [
    {
     "ename": "IndexError",
     "evalue": "index 4 is out of bounds for axis 0 with size 4",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mIndexError\u001b[0m                                Traceback (most recent call last)",
      "Input \u001b[1;32mIn [145]\u001b[0m, in \u001b[0;36m<cell line: 1>\u001b[1;34m()\u001b[0m\n\u001b[1;32m----> 1\u001b[0m Data\u001b[38;5;241m=\u001b[39mData\u001b[38;5;241m.\u001b[39mdrop(\u001b[43mData\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mcolumns\u001b[49m\u001b[43m[\u001b[49m\u001b[43m[\u001b[49m\u001b[38;5;241;43m4\u001b[39;49m\u001b[43m]\u001b[49m\u001b[43m]\u001b[49m,axis\u001b[38;5;241m=\u001b[39m\u001b[38;5;241m1\u001b[39m)\n",
      "File \u001b[1;32mC:\\ProgramData\\Anaconda3\\lib\\site-packages\\pandas\\core\\indexes\\base.py:5055\u001b[0m, in \u001b[0;36mIndex.__getitem__\u001b[1;34m(self, key)\u001b[0m\n\u001b[0;32m   5048\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m com\u001b[38;5;241m.\u001b[39mis_bool_indexer(key):\n\u001b[0;32m   5049\u001b[0m     \u001b[38;5;66;03m# if we have list[bools, length=1e5] then doing this check+convert\u001b[39;00m\n\u001b[0;32m   5050\u001b[0m     \u001b[38;5;66;03m#  takes 166 µs + 2.1 ms and cuts the ndarray.__getitem__\u001b[39;00m\n\u001b[0;32m   5051\u001b[0m     \u001b[38;5;66;03m#  time below from 3.8 ms to 496 µs\u001b[39;00m\n\u001b[0;32m   5052\u001b[0m     \u001b[38;5;66;03m# if we already have ndarray[bool], the overhead is 1.4 µs or .25%\u001b[39;00m\n\u001b[0;32m   5053\u001b[0m     key \u001b[38;5;241m=\u001b[39m np\u001b[38;5;241m.\u001b[39masarray(key, dtype\u001b[38;5;241m=\u001b[39m\u001b[38;5;28mbool\u001b[39m)\n\u001b[1;32m-> 5055\u001b[0m result \u001b[38;5;241m=\u001b[39m \u001b[43mgetitem\u001b[49m\u001b[43m(\u001b[49m\u001b[43mkey\u001b[49m\u001b[43m)\u001b[49m\n\u001b[0;32m   5056\u001b[0m \u001b[38;5;66;03m# Because we ruled out integer above, we always get an arraylike here\u001b[39;00m\n\u001b[0;32m   5057\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m result\u001b[38;5;241m.\u001b[39mndim \u001b[38;5;241m>\u001b[39m \u001b[38;5;241m1\u001b[39m:\n",
      "\u001b[1;31mIndexError\u001b[0m: index 4 is out of bounds for axis 0 with size 4"
     ]
    }
   ],
   "source": [
    "Data=Data.drop(Data.columns[[4]],axis=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 146,
   "id": "45c5b5b2",
   "metadata": {},
   "outputs": [],
   "source": [
    "Data.to_excel(\"ESMO_2019.xlsx\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 147,
   "id": "acdf73d0",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>SESSION_NAMES</th>\n",
       "      <th>SUB_SESSION</th>\n",
       "      <th>NAMES</th>\n",
       "      <th>AFFILIATION</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>ESMO 2019 Opening ceremony (ID 199)</td>\n",
       "      <td>Welcome to ESMO 2019, opening speeches and awa...</td>\n",
       "      <td>Emile E. Voest (Amsterdam, Netherlands)</td>\n",
       "      <td>11:45 - 11:48</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>ESMO 2019 Opening ceremony (ID 199)</td>\n",
       "      <td>ESMO Award lecture: Innovative thinking and re...</td>\n",
       "      <td>Eric Van Cutsem (Leuven, Belgium)</td>\n",
       "      <td>11:48 - 12:05</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>ESMO 2019 Opening ceremony (ID 199)</td>\n",
       "      <td>ESMO Award for Translational Resesarch lecture...</td>\n",
       "      <td>Charles Swanton (London, United Kingdom)</td>\n",
       "      <td>12:05 - 12:22</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>ESMO 2019 Opening ceremony (ID 199)</td>\n",
       "      <td>ESMO Women for Oncology Award lecture: Fosteri...</td>\n",
       "      <td>Cristiana Sessa (Bellinzona, Switzerland)</td>\n",
       "      <td>12:22 - 12:39</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>ESMO 2019 Opening ceremony (ID 199)</td>\n",
       "      <td>ESMO Lifetime Achievement Award lecture: Adjuv...</td>\n",
       "      <td>Angelo Di Leo (Prato, PO, Italy)</td>\n",
       "      <td>12:39 - 12:56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1496</th>\n",
       "      <td>Congress Highlights 2 (ID 94)</td>\n",
       "      <td>Sarcoma (ID 410)</td>\n",
       "      <td>Javier Martin Broto (Seville, Spain)</td>\n",
       "      <td>11:00 - 11:20</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1497</th>\n",
       "      <td>Congress Highlights 2 (ID 94)</td>\n",
       "      <td>Supportive and palliative care (ID 411)</td>\n",
       "      <td>Florian Scotté (Suresnes, France)</td>\n",
       "      <td>11:20 - 11:40</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1498</th>\n",
       "      <td>Congress Highlights 2 (ID 94)</td>\n",
       "      <td>Melanoma and other skin tumours (ID 412)</td>\n",
       "      <td>Piotr Rutkowski (Warsaw, Poland)</td>\n",
       "      <td>11:40 - 12:00</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1499</th>\n",
       "      <td>Congress Highlights 2 (ID 94)</td>\n",
       "      <td>Non-metastatic NSCLC and other thoracic malign...</td>\n",
       "      <td>Silvia Novello (Orbassano, Italy)</td>\n",
       "      <td>12:00 - 12:20</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1500</th>\n",
       "      <td>Congress Highlights 2 (ID 94)</td>\n",
       "      <td>NSCLC, metastatic (ID 414)</td>\n",
       "      <td>Simon Ekman (Solna, Sweden)</td>\n",
       "      <td>12:20 - 12:40</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1501 rows × 4 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                            SESSION_NAMES  \\\n",
       "0     ESMO 2019 Opening ceremony (ID 199)   \n",
       "1     ESMO 2019 Opening ceremony (ID 199)   \n",
       "2     ESMO 2019 Opening ceremony (ID 199)   \n",
       "3     ESMO 2019 Opening ceremony (ID 199)   \n",
       "4     ESMO 2019 Opening ceremony (ID 199)   \n",
       "...                                   ...   \n",
       "1496        Congress Highlights 2 (ID 94)   \n",
       "1497        Congress Highlights 2 (ID 94)   \n",
       "1498        Congress Highlights 2 (ID 94)   \n",
       "1499        Congress Highlights 2 (ID 94)   \n",
       "1500        Congress Highlights 2 (ID 94)   \n",
       "\n",
       "                                            SUB_SESSION  \\\n",
       "0     Welcome to ESMO 2019, opening speeches and awa...   \n",
       "1     ESMO Award lecture: Innovative thinking and re...   \n",
       "2     ESMO Award for Translational Resesarch lecture...   \n",
       "3     ESMO Women for Oncology Award lecture: Fosteri...   \n",
       "4     ESMO Lifetime Achievement Award lecture: Adjuv...   \n",
       "...                                                 ...   \n",
       "1496                                   Sarcoma (ID 410)   \n",
       "1497            Supportive and palliative care (ID 411)   \n",
       "1498           Melanoma and other skin tumours (ID 412)   \n",
       "1499  Non-metastatic NSCLC and other thoracic malign...   \n",
       "1500                         NSCLC, metastatic (ID 414)   \n",
       "\n",
       "                                          NAMES    AFFILIATION  \n",
       "0       Emile E. Voest (Amsterdam, Netherlands)  11:45 - 11:48  \n",
       "1             Eric Van Cutsem (Leuven, Belgium)  11:48 - 12:05  \n",
       "2      Charles Swanton (London, United Kingdom)  12:05 - 12:22  \n",
       "3     Cristiana Sessa (Bellinzona, Switzerland)  12:22 - 12:39  \n",
       "4              Angelo Di Leo (Prato, PO, Italy)  12:39 - 12:56  \n",
       "...                                         ...            ...  \n",
       "1496       Javier Martin Broto (Seville, Spain)  11:00 - 11:20  \n",
       "1497          Florian Scotté (Suresnes, France)  11:20 - 11:40  \n",
       "1498           Piotr Rutkowski (Warsaw, Poland)  11:40 - 12:00  \n",
       "1499          Silvia Novello (Orbassano, Italy)  12:00 - 12:20  \n",
       "1500                Simon Ekman (Solna, Sweden)  12:20 - 12:40  \n",
       "\n",
       "[1501 rows x 4 columns]"
      ]
     },
     "execution_count": 147,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "Data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 271,
   "id": "9d0309e6",
   "metadata": {},
   "outputs": [],
   "source": [
    "SESSION=[]\n",
    "SUB_SESSION=[]\n",
    "TIME=[]\n",
    "PERSONS=[]\n",
    "DATE=[]\n",
    "ROLE=[]\n",
    "COUNTRY=[]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 280,
   "id": "7e4bde79",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "p:  166\n",
      "167 1\n",
      "p:  167\n",
      "168 1\n",
      "168 2\n",
      "168 3\n",
      "168 4\n",
      "168 5\n",
      "168 6\n",
      "168 7\n",
      "168 8\n",
      "168 9\n",
      "168 10\n",
      "168 11\n",
      "168 12\n",
      "168 13\n",
      "168 14\n",
      "168 15\n",
      "168 16\n",
      "168 17\n",
      "168 18\n",
      "168 19\n",
      "p:  168\n",
      "169 1\n",
      "169 2\n",
      "169 3\n",
      "169 4\n",
      "p:  169\n",
      "170 1\n",
      "170 2\n",
      "170 3\n",
      "170 4\n",
      "170 5\n",
      "170 6\n",
      "p:  170\n",
      "171 1\n",
      "171 2\n",
      "171 3\n",
      "171 4\n",
      "171 5\n",
      "171 6\n",
      "p:  171\n",
      "172 1\n",
      "172 2\n",
      "172 3\n",
      "172 4\n",
      "172 5\n",
      "172 6\n",
      "172 7\n",
      "172 8\n",
      "172 9\n",
      "p:  172\n",
      "173 1\n",
      "173 2\n",
      "173 3\n",
      "173 4\n",
      "173 5\n",
      "173 6\n",
      "173 7\n",
      "173 8\n",
      "173 9\n",
      "p:  173\n",
      "174 1\n",
      "174 2\n",
      "174 3\n",
      "174 4\n",
      "174 5\n",
      "174 6\n",
      "p:  174\n",
      "175 1\n",
      "175 2\n",
      "175 3\n",
      "175 4\n",
      "175 5\n",
      "175 6\n",
      "p:  175\n",
      "176 1\n",
      "p:  176\n",
      "177 1\n",
      "177 2\n",
      "177 3\n",
      "177 4\n",
      "177 5\n",
      "p:  177\n",
      "178 1\n",
      "178 2\n",
      "178 3\n",
      "178 4\n",
      "p:  178\n",
      "179 1\n",
      "179 2\n",
      "179 3\n",
      "179 4\n",
      "179 5\n",
      "179 6\n",
      "p:  179\n",
      "180 1\n",
      "180 2\n",
      "180 3\n",
      "180 4\n",
      "180 5\n",
      "180 6\n",
      "p:  180\n",
      "181 1\n",
      "181 2\n",
      "181 3\n",
      "181 4\n",
      "p:  181\n",
      "182 1\n",
      "182 2\n",
      "182 3\n",
      "182 4\n",
      "182 5\n",
      "182 6\n",
      "182 7\n",
      "p:  182\n",
      "183 1\n",
      "183 2\n",
      "183 3\n",
      "183 4\n",
      "183 5\n",
      "p:  183\n",
      "184 1\n",
      "184 2\n",
      "184 3\n",
      "184 4\n",
      "184 5\n",
      "184 6\n",
      "p:  184\n",
      "185 1\n",
      "185 2\n",
      "185 3\n",
      "185 4\n",
      "185 5\n",
      "185 6\n",
      "185 7\n",
      "p:  185\n",
      "186 1\n",
      "186 2\n",
      "186 3\n",
      "186 4\n",
      "186 5\n",
      "186 6\n",
      "p:  186\n",
      "187 1\n",
      "187 2\n",
      "187 3\n",
      "187 4\n",
      "p:  187\n",
      "188 1\n",
      "188 2\n",
      "188 3\n",
      "188 4\n",
      "188 5\n",
      "188 6\n",
      "188 7\n",
      "p:  188\n",
      "189 1\n",
      "189 2\n",
      "189 3\n",
      "189 4\n",
      "p:  189\n",
      "190 1\n",
      "190 2\n",
      "190 3\n",
      "190 4\n",
      "190 5\n",
      "p:  190\n",
      "191 1\n",
      "191 2\n",
      "191 3\n",
      "p:  191\n",
      "192 1\n",
      "192 2\n",
      "192 3\n",
      "192 4\n",
      "192 5\n",
      "192 6\n",
      "192 7\n",
      "p:  192\n",
      "193 1\n",
      "193 2\n",
      "193 3\n",
      "193 4\n",
      "p:  193\n",
      "194 1\n",
      "194 2\n",
      "194 3\n",
      "194 4\n",
      "194 5\n",
      "194 6\n",
      "194 7\n",
      "194 8\n",
      "194 9\n",
      "194 10\n",
      "194 11\n",
      "194 12\n",
      "p:  194\n",
      "195 1\n",
      "195 2\n",
      "195 3\n",
      "195 4\n",
      "195 5\n",
      "p:  195\n",
      "196 1\n",
      "196 2\n",
      "196 3\n",
      "196 4\n",
      "196 5\n",
      "196 6\n",
      "196 7\n",
      "196 8\n",
      "196 9\n",
      "p:  196\n",
      "197 1\n",
      "197 2\n",
      "p:  197\n",
      "198 1\n",
      "198 2\n",
      "198 3\n",
      "198 4\n",
      "198 5\n",
      "198 6\n",
      "p:  198\n",
      "199 1\n",
      "199 2\n",
      "199 3\n",
      "199 4\n",
      "199 5\n",
      "p:  199\n",
      "200 1\n",
      "200 2\n",
      "200 3\n",
      "200 4\n",
      "p:  200\n",
      "201 1\n",
      "201 2\n",
      "201 3\n",
      "201 4\n",
      "201 5\n",
      "201 6\n",
      "201 7\n",
      "201 8\n",
      "201 9\n",
      "201 10\n",
      "201 11\n",
      "p:  201\n",
      "202 1\n",
      "202 2\n",
      "202 3\n",
      "202 4\n",
      "202 5\n",
      "p:  202\n",
      "203 1\n",
      "203 2\n",
      "203 3\n",
      "203 4\n",
      "203 5\n",
      "p:  203\n",
      "204 1\n",
      "204 2\n",
      "204 3\n",
      "p:  204\n",
      "205 1\n",
      "205 2\n",
      "205 3\n",
      "205 4\n",
      "205 5\n",
      "p:  205\n",
      "206 1\n",
      "206 2\n",
      "206 3\n",
      "206 4\n",
      "206 5\n",
      "206 6\n",
      "206 7\n",
      "206 8\n",
      "206 9\n",
      "206 10\n",
      "p:  206\n",
      "207 1\n",
      "207 2\n",
      "p:  207\n",
      "208 1\n",
      "208 2\n",
      "p:  208\n",
      "209 1\n",
      "209 2\n",
      "209 3\n",
      "209 4\n",
      "209 5\n",
      "209 6\n",
      "209 7\n",
      "209 8\n",
      "209 9\n",
      "209 10\n",
      "209 11\n",
      "209 12\n",
      "209 13\n",
      "209 14\n",
      "209 15\n",
      "p:  209\n",
      "210 1\n",
      "210 2\n",
      "p:  210\n",
      "211 1\n",
      "211 2\n",
      "211 3\n",
      "211 4\n",
      "211 5\n",
      "211 6\n",
      "211 7\n",
      "211 8\n",
      "p:  211\n",
      "212 1\n",
      "212 2\n",
      "212 3\n",
      "212 4\n",
      "212 5\n",
      "212 6\n",
      "p:  212\n",
      "213 1\n",
      "213 2\n",
      "p:  213\n",
      "214 1\n",
      "214 2\n",
      "p:  214\n",
      "215 1\n",
      "215 2\n",
      "215 3\n",
      "215 4\n",
      "215 5\n",
      "215 6\n",
      "215 7\n",
      "p:  215\n",
      "216 1\n",
      "216 2\n",
      "216 3\n",
      "216 4\n",
      "216 5\n",
      "216 6\n",
      "216 7\n",
      "216 8\n",
      "216 9\n",
      "216 10\n",
      "p:  216\n",
      "217 1\n",
      "217 2\n",
      "217 3\n",
      "217 4\n",
      "217 5\n",
      "217 6\n",
      "p:  217\n",
      "218 1\n",
      "218 2\n",
      "218 3\n",
      "218 4\n",
      "218 5\n",
      "218 6\n",
      "218 7\n",
      "218 8\n",
      "p:  218\n",
      "219 1\n",
      "219 2\n",
      "219 3\n",
      "p:  219\n",
      "220 1\n",
      "220 2\n",
      "220 3\n",
      "220 4\n",
      "220 5\n",
      "220 6\n",
      "p:  220\n",
      "221 1\n",
      "221 2\n",
      "221 3\n",
      "p:  221\n",
      "222 1\n",
      "222 2\n",
      "222 3\n",
      "222 4\n",
      "p:  222\n",
      "223 1\n",
      "223 2\n",
      "223 3\n",
      "223 4\n",
      "223 5\n",
      "223 6\n",
      "p:  223\n",
      "224 1\n",
      "224 2\n",
      "224 3\n",
      "224 4\n",
      "224 5\n",
      "224 6\n",
      "224 7\n",
      "224 8\n",
      "224 9\n",
      "224 10\n",
      "224 11\n",
      "p:  224\n",
      "225 1\n",
      "p:  225\n",
      "226 1\n",
      "226 2\n",
      "226 3\n",
      "226 4\n",
      "226 5\n",
      "226 6\n",
      "p:  226\n",
      "227 1\n",
      "227 2\n",
      "p:  227\n",
      "228 1\n",
      "228 2\n",
      "228 3\n",
      "228 4\n",
      "228 5\n",
      "228 6\n",
      "p:  228\n",
      "229 1\n",
      "229 2\n",
      "229 3\n",
      "229 4\n",
      "229 5\n",
      "229 6\n",
      "229 7\n",
      "229 8\n",
      "229 9\n",
      "229 10\n",
      "229 11\n",
      "229 12\n",
      "229 13\n",
      "229 14\n",
      "229 15\n",
      "229 16\n",
      "229 17\n",
      "229 18\n",
      "229 19\n",
      "p:  229\n",
      "230 1\n",
      "230 2\n",
      "230 3\n",
      "230 4\n",
      "p:  230\n",
      "231 1\n",
      "231 2\n",
      "231 3\n",
      "231 4\n",
      "231 5\n",
      "231 6\n",
      "231 7\n",
      "231 8\n",
      "231 9\n",
      "231 10\n",
      "231 11\n",
      "231 12\n",
      "p:  231\n",
      "232 1\n",
      "232 2\n",
      "232 3\n",
      "232 4\n",
      "232 5\n",
      "232 6\n",
      "232 7\n",
      "232 8\n",
      "232 9\n",
      "232 10\n",
      "232 11\n",
      "p:  232\n"
     ]
    }
   ],
   "source": [
    "for i in range(166,len(days)):\n",
    "    driver.get(days[i])\n",
    "    driver.implicitly_wait(3)\n",
    "    \n",
    "    ch=driver.find_element(By.CLASS_NAME,'internal_moderators')\n",
    "    chai=ch.find_elements(By.TAG_NAME,'li')\n",
    "    cc=[]\n",
    "    for l in range(len(chai)):\n",
    "        cc.append(chai[l].text)\n",
    "    tchairs=[]\n",
    "    country=[]\n",
    "    for n in range(len(cc)):\n",
    "        lc=cc[n].split('(')\n",
    "        tchairs.append(lc[0])\n",
    "        try:\n",
    "            lc[1]=lc[1].replace(')','')\n",
    "            country.append(lc[1])\n",
    "        except:\n",
    "            country.append('')\n",
    "            \n",
    "    for l in range(len(tchairs)):\n",
    "        PERSONS.append(tchairs[l])\n",
    "        COUNTRY.append(country[l])\n",
    "        SESSION.append(driver.find_element(By.XPATH,'/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[1]/h4').text)\n",
    "        SUB_SESSION.append('Introduction')\n",
    "        TIME.append(driver.find_element(By.XPATH,'/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[2]/div[2]/div[2]').text)\n",
    "        DATE.append(driver.find_element(By.XPATH,'/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[2]/div[1]/div[2]').text)\n",
    "        ROLE.append('Chair')  \n",
    "        \n",
    "    for j in range(1,20):\n",
    "        try:\n",
    "            driver.find_element(By.XPATH,'/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[4]/div['+str(j)+']/div[2]/h4')\n",
    "            try:\n",
    "                spp=driver.find_element(By.XPATH,'/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[4]/div['+str(j)+']/div[2]/div[1]/div[3]/div[2]/ul')\n",
    "                sp=spp.find_elements(By.TAG_NAME,'li')\n",
    "                tsp=[]\n",
    "                for s in range(len(sp)):\n",
    "                    tsp.append(sp[s].text)\n",
    "                speak=[]\n",
    "                place=[]\n",
    "                for m in range(len(tsp)):\n",
    "                    lc=tsp[m].split('(')\n",
    "                    speak.append(lc[0])\n",
    "                    try:\n",
    "                        lc[1]=lc[1].replace(')','')\n",
    "                        place.append(lc[1])\n",
    "                    except:\n",
    "                        place.append('')\n",
    "\n",
    "                for m in range(len(speak)):\n",
    "                    s=driver.find_element(By.XPATH,'/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[1]/h4').text\n",
    "                    SESSION.append(s)\n",
    "                    PERSONS.append(speak[m])\n",
    "                    COUNTRY.append(place[m])\n",
    "                    #speakers..............................\n",
    "                    try:\n",
    "                        su=driver.find_element(By.XPATH,'/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[4]/div['+str(j)+']/div[2]/h4').text                                        \n",
    "                        SUB_SESSION.append(su)\n",
    "                    except:\n",
    "                        SUB_SESSION.append(None)\n",
    "                    try:\n",
    "                        t=driver.find_element(By.XPATH,'/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[4]/div['+str(j)+']/div[2]/div[1]/div[2]/div[2]').text\n",
    "                        TIME.append(t)\n",
    "                    except:\n",
    "                        TIME.append(None)\n",
    "                    try:\n",
    "                        d=driver.find_element(By.XPATH,'/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[2]/div[1]/div[2]').text\n",
    "                        DATE.append(d)\n",
    "                    except:\n",
    "                        DATE.append(None)\n",
    "                    ROLE.append('Speaker')\n",
    "                \n",
    "            except:\n",
    "                s=driver.find_element(By.XPATH,'/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[1]/h4').text\n",
    "                SESSION.append(s)\n",
    "                PERSONS.append('')\n",
    "                COUNTRY.append('')\n",
    "                #speakers..............................\n",
    "                try:\n",
    "                    su=driver.find_element(By.XPATH,'/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[4]/div['+str(j)+']/div[2]/h4').text                                        \n",
    "                    SUB_SESSION.append(su)\n",
    "                except:\n",
    "                    SUB_SESSION.append(None)\n",
    "                try:\n",
    "                    t=driver.find_element(By.XPATH,'/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[4]/div['+str(j)+']/div[2]/div[1]/div[2]/div[2]').text\n",
    "                    TIME.append(t)\n",
    "                except:\n",
    "                    TIME.append(None)\n",
    "                try:\n",
    "                    d=driver.find_element(By.XPATH,'/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[2]/div[1]/div[2]').text\n",
    "                    DATE.append(d)\n",
    "                except:\n",
    "                    DATE.append(None)\n",
    "                ROLE.append('Speaker')\n",
    "            print(i,j)\n",
    "        except:\n",
    "            break\n",
    "    print('p: ',i)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 274,
   "id": "0a3bd9c8",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "''"
      ]
     },
     "execution_count": 274,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "PERSONS[len(PERSONS)-1]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 279,
   "id": "16e1937e",
   "metadata": {},
   "outputs": [],
   "source": [
    "# page==36\n",
    "driver.get(days[0])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 283,
   "id": "5299988e",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "ESMO 2019 Opening ceremony (ID 199)\n",
      "ESMO 2019 Opening ceremony (ID 199)\n",
      "ESMO 2019 Opening ceremony (ID 199)\n",
      "ESMO 2019 Opening ceremony (ID 199)\n",
      "ESMO 2019 Opening ceremony (ID 199)\n",
      "ESMO 2019 Opening ceremony (ID 199)\n",
      "Current markers in immunotherapy (ID 12)\n",
      "Current markers in immunotherapy (ID 12)\n",
      "Current markers in immunotherapy (ID 12)\n",
      "Current markers in immunotherapy (ID 12)\n",
      "Current markers in immunotherapy (ID 12)\n",
      "Current markers in immunotherapy (ID 12)\n",
      "Proffered Paper 1 - NSCLC, metastatic (ID 247)\n",
      "Proffered Paper 1 - NSCLC, metastatic (ID 247)\n",
      "Proffered Paper 1 - NSCLC, metastatic (ID 247)\n",
      "Proffered Paper 1 - NSCLC, metastatic (ID 247)\n",
      "Proffered Paper 1 - NSCLC, metastatic (ID 247)\n",
      "Proffered Paper 1 - NSCLC, metastatic (ID 247)\n",
      "Proffered Paper 1 - NSCLC, metastatic (ID 247)\n",
      "Proffered Paper 1 - NSCLC, metastatic (ID 247)\n",
      "Proffered Paper 1 - NSCLC, metastatic (ID 247)\n",
      "Proffered Paper 1 – Gastrointestinal tumours, non-colorectal (ID 225)\n",
      "Proffered Paper 1 – Gastrointestinal tumours, non-colorectal (ID 225)\n",
      "Proffered Paper 1 – Gastrointestinal tumours, non-colorectal (ID 225)\n",
      "Proffered Paper 1 – Gastrointestinal tumours, non-colorectal (ID 225)\n",
      "Proffered Paper 1 – Gastrointestinal tumours, non-colorectal (ID 225)\n",
      "Proffered Paper 1 – Gastrointestinal tumours, non-colorectal (ID 225)\n",
      "Proffered Paper 1 – Gastrointestinal tumours, non-colorectal (ID 225)\n",
      "Proffered Paper 1 – Gastrointestinal tumours, non-colorectal (ID 225)\n",
      "The clinical utility of analysing circulating tumor DNA in patients with colorectal cancer (CRC) (ID 76)\n",
      "The clinical utility of analysing circulating tumor DNA in patients with colorectal cancer (CRC) (ID 76)\n",
      "The clinical utility of analysing circulating tumor DNA in patients with colorectal cancer (CRC) (ID 76)\n",
      "The clinical utility of analysing circulating tumor DNA in patients with colorectal cancer (CRC) (ID 76)\n",
      "The clinical utility of analysing circulating tumor DNA in patients with colorectal cancer (CRC) (ID 76)\n",
      "The clinical utility of analysing circulating tumor DNA in patients with colorectal cancer (CRC) (ID 76)\n",
      "Proffered Paper – Genitourinary tumours, prostate (ID 228)\n",
      "Proffered Paper – Genitourinary tumours, prostate (ID 228)\n",
      "Proffered Paper – Genitourinary tumours, prostate (ID 228)\n",
      "Proffered Paper – Genitourinary tumours, prostate (ID 228)\n",
      "Proffered Paper – Genitourinary tumours, prostate (ID 228)\n",
      "Proffered Paper – Genitourinary tumours, prostate (ID 228)\n",
      "Proffered Paper – Genitourinary tumours, prostate (ID 228)\n",
      "Proffered Paper – Genitourinary tumours, prostate (ID 228)\n",
      "Frontline in mRCC: Ready to select treatment? (ID 18)\n",
      "Frontline in mRCC: Ready to select treatment? (ID 18)\n",
      "Frontline in mRCC: Ready to select treatment? (ID 18)\n",
      "Frontline in mRCC: Ready to select treatment? (ID 18)\n",
      "Frontline in mRCC: Ready to select treatment? (ID 18)\n",
      "Frontline in mRCC: Ready to select treatment? (ID 18)\n",
      "Multidisciplinary management of germline and somatic gene alterations in patients with metastatic breast cancer (ID 41)\n",
      "Multidisciplinary management of germline and somatic gene alterations in patients with metastatic breast cancer (ID 41)\n",
      "Multidisciplinary management of germline and somatic gene alterations in patients with metastatic breast cancer (ID 41)\n",
      "Multidisciplinary management of germline and somatic gene alterations in patients with metastatic breast cancer (ID 41)\n",
      "Multidisciplinary management of germline and somatic gene alterations in patients with metastatic breast cancer (ID 41)\n",
      "Multidisciplinary management of germline and somatic gene alterations in patients with metastatic breast cancer (ID 41)\n",
      "Proffered Paper 1 – Gynaecological cancers (ID 232)\n",
      "Proffered Paper 1 – Gynaecological cancers (ID 232)\n",
      "Proffered Paper 1 – Gynaecological cancers (ID 232)\n",
      "Proffered Paper 1 – Gynaecological cancers (ID 232)\n",
      "Proffered Paper 1 – Gynaecological cancers (ID 232)\n",
      "Proffered Paper 1 – Gynaecological cancers (ID 232)\n",
      "Proffered Paper 1 – Gynaecological cancers (ID 232)\n",
      "Proffered Paper 1 – Gynaecological cancers (ID 232)\n",
      "Special clinical scenarios in management of advanced melanoma (ID 68)\n",
      "Special clinical scenarios in management of advanced melanoma (ID 68)\n",
      "Special clinical scenarios in management of advanced melanoma (ID 68)\n",
      "Special clinical scenarios in management of advanced melanoma (ID 68)\n",
      "Special clinical scenarios in management of advanced melanoma (ID 68)\n",
      "Special clinical scenarios in management of advanced melanoma (ID 68)\n",
      "Preclinical models and imaging to guide clinical therapy (ID 58)\n",
      "Preclinical models and imaging to guide clinical therapy (ID 58)\n",
      "Preclinical models and imaging to guide clinical therapy (ID 58)\n",
      "Preclinical models and imaging to guide clinical therapy (ID 58)\n",
      "Preclinical models and imaging to guide clinical therapy (ID 58)\n",
      "Preclinical models and imaging to guide clinical therapy (ID 58)\n",
      "Is there a role for the addition of platinum-based chemotherapy to standard neoadjuvant chemotherapy in triple negative breast cancer (TNBC)? (ID 274)\n",
      "Is there a role for the addition of platinum-based chemotherapy to standard neoadjuvant chemotherapy in triple negative breast cancer (TNBC)? (ID 274)\n",
      "Is there a role for the addition of platinum-based chemotherapy to standard neoadjuvant chemotherapy in triple negative breast cancer (TNBC)? (ID 274)\n",
      "Is there a role for the addition of platinum-based chemotherapy to standard neoadjuvant chemotherapy in triple negative breast cancer (TNBC)? (ID 274)\n",
      "Is there a role for the addition of platinum-based chemotherapy to standard neoadjuvant chemotherapy in triple negative breast cancer (TNBC)? (ID 274)\n",
      "ESMO-EACR Collaborative session: From cancer genomes to combinatorial therapies (ID 198)\n",
      "ESMO-EACR Collaborative session: From cancer genomes to combinatorial therapies (ID 198)\n",
      "ESMO-EACR Collaborative session: From cancer genomes to combinatorial therapies (ID 198)\n",
      "ESMO-EACR Collaborative session: From cancer genomes to combinatorial therapies (ID 198)\n",
      "ESMO-EACR Collaborative session: From cancer genomes to combinatorial therapies (ID 198)\n",
      "ESMO-EACR Collaborative session: From cancer genomes to combinatorial therapies (ID 198)\n",
      "ESMO-EACR Collaborative session: From cancer genomes to combinatorial therapies (ID 198)\n",
      "ESMO-EACR Collaborative session: From cancer genomes to combinatorial therapies (ID 198)\n",
      "Biosimilars use in oncology: Clarifying concepts (ID 270)\n",
      "Biosimilars use in oncology: Clarifying concepts (ID 270)\n",
      "Biosimilars use in oncology: Clarifying concepts (ID 270)\n",
      "Biosimilars use in oncology: Clarifying concepts (ID 270)\n",
      "Biosimilars use in oncology: Clarifying concepts (ID 270)\n",
      "Biosimilars use in oncology: Clarifying concepts (ID 270)\n",
      "Biosimilars use in oncology: Clarifying concepts (ID 270)\n",
      "Biosimilars use in oncology: Clarifying concepts (ID 270)\n",
      "Biosimilars use in oncology: Clarifying concepts (ID 270)\n",
      "Practical use of liquid biopsy for advanced NSCLC (ID 55)\n",
      "Practical use of liquid biopsy for advanced NSCLC (ID 55)\n",
      "Practical use of liquid biopsy for advanced NSCLC (ID 55)\n",
      "Combination and sequence in advanced melanoma (ID 11)\n",
      "Combination and sequence in advanced melanoma (ID 11)\n",
      "Combination and sequence in advanced melanoma (ID 11)\n",
      "Proffered Paper – CNS tumours (ID 219)\n",
      "Proffered Paper – CNS tumours (ID 219)\n",
      "Proffered Paper – CNS tumours (ID 219)\n",
      "Proffered Paper – CNS tumours (ID 219)\n",
      "Proffered Paper – CNS tumours (ID 219)\n",
      "Proffered Paper – CNS tumours (ID 219)\n",
      "Proffered Paper – CNS tumours (ID 219)\n",
      "Proffered Paper – CNS tumours (ID 219)\n",
      "Proffered Paper – CNS tumours (ID 219)\n",
      "Proffered Paper – CNS tumours (ID 219)\n",
      "SCLC: Is it time for novel therapies? (ID 65)\n",
      "SCLC: Is it time for novel therapies? (ID 65)\n",
      "SCLC: Is it time for novel therapies? (ID 65)\n",
      "Innate immune system and anti-mitotic agents: Two fields getting together (ID 30)\n",
      "Innate immune system and anti-mitotic agents: Two fields getting together (ID 30)\n",
      "Innate immune system and anti-mitotic agents: Two fields getting together (ID 30)\n",
      "Innate immune system and anti-mitotic agents: Two fields getting together (ID 30)\n",
      "Innate immune system and anti-mitotic agents: Two fields getting together (ID 30)\n",
      "Innate immune system and anti-mitotic agents: Two fields getting together (ID 30)\n",
      "Innate immune system and anti-mitotic agents: Two fields getting together (ID 30)\n",
      "Innate immune system and anti-mitotic agents: Two fields getting together (ID 30)\n",
      "CNS complications and management in systemic cancer patients (ID 10)\n",
      "CNS complications and management in systemic cancer patients (ID 10)\n",
      "CNS complications and management in systemic cancer patients (ID 10)\n",
      "CNS complications and management in systemic cancer patients (ID 10)\n",
      "CNS complications and management in systemic cancer patients (ID 10)\n",
      "CNS complications and management in systemic cancer patients (ID 10)\n",
      "Partial breast radiation therapy: Which patients, when, and with what technique? (ID 51)\n",
      "Partial breast radiation therapy: Which patients, when, and with what technique? (ID 51)\n",
      "Partial breast radiation therapy: Which patients, when, and with what technique? (ID 51)\n",
      "ESMO-ESTRO Collaborative session: RTCT in stage III NSCLC: Prevention and management of toxicity including the use of immunotherapy (ID 268)\n",
      "ESMO-ESTRO Collaborative session: RTCT in stage III NSCLC: Prevention and management of toxicity including the use of immunotherapy (ID 268)\n",
      "ESMO-ESTRO Collaborative session: RTCT in stage III NSCLC: Prevention and management of toxicity including the use of immunotherapy (ID 268)\n",
      "ESMO-ESTRO Collaborative session: RTCT in stage III NSCLC: Prevention and management of toxicity including the use of immunotherapy (ID 268)\n",
      "ESMO-ESTRO Collaborative session: RTCT in stage III NSCLC: Prevention and management of toxicity including the use of immunotherapy (ID 268)\n",
      "ESMO-ESTRO Collaborative session: RTCT in stage III NSCLC: Prevention and management of toxicity including the use of immunotherapy (ID 268)\n",
      "ESMO-ESTRO Collaborative session: RTCT in stage III NSCLC: Prevention and management of toxicity including the use of immunotherapy (ID 268)\n",
      "ESMO-ESTRO Collaborative session: RTCT in stage III NSCLC: Prevention and management of toxicity including the use of immunotherapy (ID 268)\n",
      "ESMO-ESTRO Collaborative session: RTCT in stage III NSCLC: Prevention and management of toxicity including the use of immunotherapy (ID 268)\n",
      "ESMO-MASCC Collaborative session: Management of cancer and anticancer therapy induced side effects (ID 95)\n",
      "ESMO-MASCC Collaborative session: Management of cancer and anticancer therapy induced side effects (ID 95)\n",
      "ESMO-MASCC Collaborative session: Management of cancer and anticancer therapy induced side effects (ID 95)\n",
      "ESMO-MASCC Collaborative session: Management of cancer and anticancer therapy induced side effects (ID 95)\n",
      "ESMO-MASCC Collaborative session: Management of cancer and anticancer therapy induced side effects (ID 95)\n",
      "ESMO-MASCC Collaborative session: Management of cancer and anticancer therapy induced side effects (ID 95)\n",
      "ESMO-MASCC Collaborative session: Management of cancer and anticancer therapy induced side effects (ID 95)\n",
      "ESMO-MASCC Collaborative session: Management of cancer and anticancer therapy induced side effects (ID 95)\n",
      "The role of the medical oncologist in health policy: Using national cancer control plans to translate science into better patient care (ID 116)\n",
      "The role of the medical oncologist in health policy: Using national cancer control plans to translate science into better patient care (ID 116)\n",
      "The role of the medical oncologist in health policy: Using national cancer control plans to translate science into better patient care (ID 116)\n",
      "The role of the medical oncologist in health policy: Using national cancer control plans to translate science into better patient care (ID 116)\n",
      "The role of the medical oncologist in health policy: Using national cancer control plans to translate science into better patient care (ID 116)\n",
      "The role of the medical oncologist in health policy: Using national cancer control plans to translate science into better patient care (ID 116)\n",
      "The role of the medical oncologist in health policy: Using national cancer control plans to translate science into better patient care (ID 116)\n",
      "The role of the medical oncologist in health policy: Using national cancer control plans to translate science into better patient care (ID 116)\n",
      "Universal health coverage and cancer: What you and your country need to know (ID 145)\n",
      "Universal health coverage and cancer: What you and your country need to know (ID 145)\n",
      "Universal health coverage and cancer: What you and your country need to know (ID 145)\n",
      "Universal health coverage and cancer: What you and your country need to know (ID 145)\n",
      "Universal health coverage and cancer: What you and your country need to know (ID 145)\n",
      "Universal health coverage and cancer: What you and your country need to know (ID 145)\n",
      "Universal health coverage and cancer: What you and your country need to know (ID 145)\n",
      "Universal health coverage and cancer: What you and your country need to know (ID 145)\n",
      "Universal health coverage and cancer: What you and your country need to know (ID 145)\n",
      "ESMO-ESOP: Cytotoxic contamination in wards: Is it an occupational hazard? (ID 287)\n",
      "ESMO-ESOP: Cytotoxic contamination in wards: Is it an occupational hazard? (ID 287)\n",
      "ESMO-ESOP: Cytotoxic contamination in wards: Is it an occupational hazard? (ID 287)\n",
      "ESMO-ESOP: Cytotoxic contamination in wards: Is it an occupational hazard? (ID 287)\n",
      "ESMO-ESOP: Cytotoxic contamination in wards: Is it an occupational hazard? (ID 287)\n",
      "ESMO-ESOP: Cytotoxic contamination in wards: Is it an occupational hazard? (ID 287)\n",
      "ESMO-ESOP: Cytotoxic contamination in wards: Is it an occupational hazard? (ID 287)\n",
      "ESMO-ESOP: Cytotoxic contamination in wards: Is it an occupational hazard? (ID 287)\n",
      "ESMO-ESOP: Cytotoxic contamination in wards: Is it an occupational hazard? (ID 287)\n",
      "ESMO-ESOP: Cytotoxic contamination in wards: Is it an occupational hazard? (ID 287)\n",
      "ESMO-ESOI Collaborative session: Gastrointestinal stromal tumours: Imaging and treatment (ID 144)\n",
      "ESMO-ESOI Collaborative session: Gastrointestinal stromal tumours: Imaging and treatment (ID 144)\n",
      "ESMO-ESOI Collaborative session: Gastrointestinal stromal tumours: Imaging and treatment (ID 144)\n",
      "ESMO-ESOI Collaborative session: Gastrointestinal stromal tumours: Imaging and treatment (ID 144)\n",
      "ESMO-ESOI Collaborative session: Gastrointestinal stromal tumours: Imaging and treatment (ID 144)\n",
      "ESMO-ESOI Collaborative session: Gastrointestinal stromal tumours: Imaging and treatment (ID 144)\n",
      "ESMO-ESOI Collaborative session: Gastrointestinal stromal tumours: Imaging and treatment (ID 144)\n",
      "ESMO-ESOI Collaborative session: Gastrointestinal stromal tumours: Imaging and treatment (ID 144)\n",
      "ESMO-ESOI Collaborative session: Gastrointestinal stromal tumours: Imaging and treatment (ID 144)\n",
      "Placing the patient at the center of care (ID 132)\n",
      "Placing the patient at the center of care (ID 132)\n",
      "Placing the patient at the center of care (ID 132)\n",
      "Placing the patient at the center of care (ID 132)\n",
      "Placing the patient at the center of care (ID 132)\n",
      "Placing the patient at the center of care (ID 132)\n",
      "Placing the patient at the center of care (ID 132)\n",
      "Placing the patient at the center of care (ID 132)\n",
      "Drugs in combination (ID 133)\n",
      "Drugs in combination (ID 133)\n",
      "Drugs in combination (ID 133)\n",
      "Drugs in combination (ID 133)\n",
      "Drugs in combination (ID 133)\n",
      "Drugs in combination (ID 133)\n",
      "Drugs in combination (ID 133)\n",
      "Drugs in combination (ID 133)\n",
      "YO Mentorship session: Career paths in oncology (ID 103)\n",
      "YO Mentorship session: Career paths in oncology (ID 103)\n",
      "YO Mentorship session: Career paths in oncology (ID 103)\n",
      "YO Mentorship session: Career paths in oncology (ID 103)\n",
      "YO Mentorship session: Career paths in oncology (ID 103)\n",
      "YO Mentorship session: Career paths in oncology (ID 103)\n",
      "YO Mentorship session: Career paths in oncology (ID 103)\n",
      "YO Mentorship session: Career paths in oncology (ID 103)\n",
      "YO Mentorship session: Career paths in oncology (ID 103)\n",
      "YO Mentorship session: Career paths in oncology (ID 103)\n",
      "YO Mentorship session: Career paths in oncology (ID 103)\n",
      "YO Mentorship session: Career paths in oncology (ID 103)\n",
      "YO Mentorship session: Career paths in oncology (ID 103)\n",
      "YO Mentorship session: Career paths in oncology (ID 103)\n",
      "YO Mentorship session: Career paths in oncology (ID 103)\n",
      "YO Mentorship session: Career paths in oncology (ID 103)\n",
      "YO Vesalius talk: How to start your own group: Moving from fellow to PI without burnout (ID 97)\n",
      "YO Vesalius talk: How to start your own group: Moving from fellow to PI without burnout (ID 97)\n",
      "YO Vesalius talk: How to start your own group: Moving from fellow to PI without burnout (ID 97)\n",
      "YO Vesalius talk: How to start your own group: Moving from fellow to PI without burnout (ID 97)\n",
      "Clinical cases of solid tumours: Discussion forum for young oncologists (ID 105)\n",
      "Clinical cases of solid tumours: Discussion forum for young oncologists (ID 105)\n",
      "Clinical cases of solid tumours: Discussion forum for young oncologists (ID 105)\n",
      "Clinical cases of solid tumours: Discussion forum for young oncologists (ID 105)\n",
      "Clinical cases of solid tumours: Discussion forum for young oncologists (ID 105)\n",
      "Clinical cases of solid tumours: Discussion forum for young oncologists (ID 105)\n",
      "Proffered Paper 1 – Genitourinary tumours, non-prostate (ID 230)\n",
      "Proffered Paper 1 – Genitourinary tumours, non-prostate (ID 230)\n",
      "Proffered Paper 1 – Genitourinary tumours, non-prostate (ID 230)\n",
      "Proffered Paper 1 – Genitourinary tumours, non-prostate (ID 230)\n",
      "Proffered Paper 1 – Genitourinary tumours, non-prostate (ID 230)\n",
      "Proffered Paper 1 – Genitourinary tumours, non-prostate (ID 230)\n",
      "Proffered Paper 1 – Genitourinary tumours, non-prostate (ID 230)\n",
      "Proffered Paper 1 – Genitourinary tumours, non-prostate (ID 230)\n",
      "Proffered Paper - Breast cancer, metastatic (ID 217)\n",
      "Proffered Paper - Breast cancer, metastatic (ID 217)\n",
      "Proffered Paper - Breast cancer, metastatic (ID 217)\n",
      "Proffered Paper - Breast cancer, metastatic (ID 217)\n",
      "Proffered Paper - Breast cancer, metastatic (ID 217)\n",
      "Proffered Paper - Breast cancer, metastatic (ID 217)\n",
      "Proffered Paper - Breast cancer, metastatic (ID 217)\n",
      "Proffered Paper - Breast cancer, metastatic (ID 217)\n",
      "Proffered Paper - Breast cancer, metastatic (ID 217)\n",
      "Proffered Paper 1 – Gastrointestinal tumours, colorectal (ID 222)\n",
      "Proffered Paper 1 – Gastrointestinal tumours, colorectal (ID 222)\n",
      "Proffered Paper 1 – Gastrointestinal tumours, colorectal (ID 222)\n",
      "Proffered Paper 1 – Gastrointestinal tumours, colorectal (ID 222)\n",
      "Proffered Paper 1 – Gastrointestinal tumours, colorectal (ID 222)\n",
      "Proffered Paper 1 – Gastrointestinal tumours, colorectal (ID 222)\n",
      "Proffered Paper 1 – Gastrointestinal tumours, colorectal (ID 222)\n",
      "Proffered Paper 1 – Gastrointestinal tumours, colorectal (ID 222)\n",
      "Presidential Symposium I (ID 263)\n",
      "Presidential Symposium I (ID 263)\n",
      "Presidential Symposium I (ID 263)\n",
      "Presidential Symposium I (ID 263)\n",
      "Presidential Symposium I (ID 263)\n",
      "Presidential Symposium I (ID 263)\n",
      "Presidential Symposium I (ID 263)\n",
      "Presidential Symposium I (ID 263)\n",
      "Presidential Symposium I (ID 263)\n",
      "Presidential Symposium I (ID 263)\n",
      "Presidential Symposium I (ID 263)\n",
      "Beyond initial radical treatment of patients with lung cancer (ID 3)\n",
      "Beyond initial radical treatment of patients with lung cancer (ID 3)\n",
      "Beyond initial radical treatment of patients with lung cancer (ID 3)\n",
      "Beyond initial radical treatment of patients with lung cancer (ID 3)\n",
      "Beyond initial radical treatment of patients with lung cancer (ID 3)\n",
      "Beyond initial radical treatment of patients with lung cancer (ID 3)\n",
      "Beyond initial radical treatment of patients with lung cancer (ID 3)\n",
      "Beyond initial radical treatment of patients with lung cancer (ID 3)\n",
      "Next immunotherapy strategies for lung cancer (ID 43)\n",
      "Next immunotherapy strategies for lung cancer (ID 43)\n",
      "Next immunotherapy strategies for lung cancer (ID 43)\n",
      "Next immunotherapy strategies for lung cancer (ID 43)\n",
      "Next immunotherapy strategies for lung cancer (ID 43)\n",
      "Next immunotherapy strategies for lung cancer (ID 43)\n",
      "Next immunotherapy strategies for lung cancer (ID 43)\n",
      "Next immunotherapy strategies for lung cancer (ID 43)\n",
      "HPV vaccination for everybody? (ID 26)\n",
      "HPV vaccination for everybody? (ID 26)\n",
      "Optimal delivery of immuno-oncology (I-O) in advanced NSCLC (ID 47)\n",
      "Optimal delivery of immuno-oncology (I-O) in advanced NSCLC (ID 47)\n",
      "Optimal delivery of immuno-oncology (I-O) in advanced NSCLC (ID 47)\n",
      "Optimal delivery of immuno-oncology (I-O) in advanced NSCLC (ID 47)\n",
      "Optimal delivery of immuno-oncology (I-O) in advanced NSCLC (ID 47)\n",
      "Optimal delivery of immuno-oncology (I-O) in advanced NSCLC (ID 47)\n",
      "Optimal delivery of immuno-oncology (I-O) in advanced NSCLC (ID 47)\n",
      "Optimal delivery of immuno-oncology (I-O) in advanced NSCLC (ID 47)\n",
      "Challenges in the management of luminal ER + MBC (ID 9)\n",
      "Challenges in the management of luminal ER + MBC (ID 9)\n",
      "Challenges in the management of luminal ER + MBC (ID 9)\n",
      "Challenges in the management of luminal ER + MBC (ID 9)\n",
      "Challenges in the management of luminal ER + MBC (ID 9)\n",
      "Next challenges for cancer immunotherapy (ID 42)\n",
      "Next challenges for cancer immunotherapy (ID 42)\n",
      "Next challenges for cancer immunotherapy (ID 42)\n",
      "Next challenges for cancer immunotherapy (ID 42)\n",
      "Next challenges for cancer immunotherapy (ID 42)\n",
      "Next challenges for cancer immunotherapy (ID 42)\n",
      "Next challenges for cancer immunotherapy (ID 42)\n",
      "Next challenges for cancer immunotherapy (ID 42)\n",
      "Pushing forward with immunotherapy in upper GI cancers (ID 60)\n",
      "Pushing forward with immunotherapy in upper GI cancers (ID 60)\n",
      "Pushing forward with immunotherapy in upper GI cancers (ID 60)\n",
      "Pushing forward with immunotherapy in upper GI cancers (ID 60)\n",
      "Pushing forward with immunotherapy in upper GI cancers (ID 60)\n",
      "Pushing forward with immunotherapy in upper GI cancers (ID 60)\n",
      "Pushing forward with immunotherapy in upper GI cancers (ID 60)\n",
      "Pushing forward with immunotherapy in upper GI cancers (ID 60)\n",
      "Proffered Paper 2 – Genitourinary tumours, non-prostate (ID 231)\n",
      "Proffered Paper 2 – Genitourinary tumours, non-prostate (ID 231)\n",
      "Proffered Paper 2 – Genitourinary tumours, non-prostate (ID 231)\n",
      "Proffered Paper 2 – Genitourinary tumours, non-prostate (ID 231)\n",
      "Proffered Paper 2 – Genitourinary tumours, non-prostate (ID 231)\n",
      "Proffered Paper 2 – Genitourinary tumours, non-prostate (ID 231)\n",
      "Proffered Paper 2 – Genitourinary tumours, non-prostate (ID 231)\n",
      "Pancreatic cancer: Where are we now and where are we going? (ID 50)\n",
      "Pancreatic cancer: Where are we now and where are we going? (ID 50)\n",
      "Pancreatic cancer: Where are we now and where are we going? (ID 50)\n",
      "Pancreatic cancer: Where are we now and where are we going? (ID 50)\n",
      "Pancreatic cancer: Where are we now and where are we going? (ID 50)\n",
      "Pancreatic cancer: Where are we now and where are we going? (ID 50)\n",
      "Pancreatic cancer: Where are we now and where are we going? (ID 50)\n",
      "Proffered Paper – Translational research (ID 252)\n",
      "Proffered Paper – Translational research (ID 252)\n",
      "Proffered Paper – Translational research (ID 252)\n",
      "Proffered Paper – Translational research (ID 252)\n",
      "Proffered Paper – Translational research (ID 252)\n",
      "Proffered Paper – Translational research (ID 252)\n",
      "Proffered Paper – Translational research (ID 252)\n",
      "Proffered Paper – Translational research (ID 252)\n",
      "Precision medicine in melanoma therapy (ID 57)\n",
      "Precision medicine in melanoma therapy (ID 57)\n",
      "Precision medicine in melanoma therapy (ID 57)\n",
      "Precision medicine in melanoma therapy (ID 57)\n",
      "Precision medicine in melanoma therapy (ID 57)\n",
      "Precision medicine in melanoma therapy (ID 57)\n",
      "Precision medicine in melanoma therapy (ID 57)\n",
      "Precision medicine in melanoma therapy (ID 57)\n",
      "Treating endometrial cancer in the molecular age (ID 82)\n",
      "Treating endometrial cancer in the molecular age (ID 82)\n",
      "Treating endometrial cancer in the molecular age (ID 82)\n",
      "Treating endometrial cancer in the molecular age (ID 82)\n",
      "Treating endometrial cancer in the molecular age (ID 82)\n",
      "Treating endometrial cancer in the molecular age (ID 82)\n",
      "Proffered Paper – Melanoma and other skin tumours (ID 240)\n",
      "Proffered Paper – Melanoma and other skin tumours (ID 240)\n",
      "Proffered Paper – Melanoma and other skin tumours (ID 240)\n",
      "Proffered Paper – Melanoma and other skin tumours (ID 240)\n",
      "Proffered Paper – Melanoma and other skin tumours (ID 240)\n",
      "Proffered Paper – Melanoma and other skin tumours (ID 240)\n",
      "Proffered Paper – Melanoma and other skin tumours (ID 240)\n",
      "Proffered Paper – Melanoma and other skin tumours (ID 240)\n",
      "Proffered Paper – Melanoma and other skin tumours (ID 240)\n",
      "Proffered Paper – Melanoma and other skin tumours (ID 240)\n",
      "Novel therapeutic strategies in ABC: Immunotherapy, Antibody Drug Conjugates (ADCs) and beyond (ID 44)\n",
      "Novel therapeutic strategies in ABC: Immunotherapy, Antibody Drug Conjugates (ADCs) and beyond (ID 44)\n",
      "Novel therapeutic strategies in ABC: Immunotherapy, Antibody Drug Conjugates (ADCs) and beyond (ID 44)\n",
      "Novel therapeutic strategies in ABC: Immunotherapy, Antibody Drug Conjugates (ADCs) and beyond (ID 44)\n",
      "Novel therapeutic strategies in ABC: Immunotherapy, Antibody Drug Conjugates (ADCs) and beyond (ID 44)\n",
      "Novel therapeutic strategies in ABC: Immunotherapy, Antibody Drug Conjugates (ADCs) and beyond (ID 44)\n",
      "Proffered Paper 1 – Non-metastatic NSCLC and other thoracic malignancies (SCLC) (ID 243)\n",
      "Proffered Paper 1 – Non-metastatic NSCLC and other thoracic malignancies (SCLC) (ID 243)\n",
      "Proffered Paper 1 – Non-metastatic NSCLC and other thoracic malignancies (SCLC) (ID 243)\n",
      "Proffered Paper 1 – Non-metastatic NSCLC and other thoracic malignancies (SCLC) (ID 243)\n",
      "Proffered Paper 1 – Non-metastatic NSCLC and other thoracic malignancies (SCLC) (ID 243)\n",
      "Proffered Paper 1 – Non-metastatic NSCLC and other thoracic malignancies (SCLC) (ID 243)\n",
      "Proffered Paper 1 – Non-metastatic NSCLC and other thoracic malignancies (SCLC) (ID 243)\n",
      "Proffered Paper 1 – Non-metastatic NSCLC and other thoracic malignancies (SCLC) (ID 243)\n",
      "Proffered Paper 1 – Non-metastatic NSCLC and other thoracic malignancies (SCLC) (ID 243)\n",
      "Meeting the liquid biopsy family (ID 38)\n",
      "Meeting the liquid biopsy family (ID 38)\n",
      "Meeting the liquid biopsy family (ID 38)\n",
      "Meeting the liquid biopsy family (ID 38)\n",
      "Meeting the liquid biopsy family (ID 38)\n",
      "Meeting the liquid biopsy family (ID 38)\n",
      "ctDNA vs. tissue biopsy (ID 275)\n",
      "ctDNA vs. tissue biopsy (ID 275)\n",
      "ctDNA vs. tissue biopsy (ID 275)\n",
      "ctDNA vs. tissue biopsy (ID 275)\n",
      "ctDNA vs. tissue biopsy (ID 275)\n",
      "Poster Discussion – Melanoma and other skin tumours (ID 253)\n",
      "Poster Discussion – Melanoma and other skin tumours (ID 253)\n",
      "Poster Discussion – Melanoma and other skin tumours (ID 253)\n",
      "Poster Discussion – Melanoma and other skin tumours (ID 253)\n",
      "Poster Discussion – Melanoma and other skin tumours (ID 253)\n",
      "Poster Discussion – Melanoma and other skin tumours (ID 253)\n",
      "Poster Discussion – Melanoma and other skin tumours (ID 253)\n",
      "Poster Discussion – Melanoma and other skin tumours (ID 253)\n",
      "Poster Discussion – Melanoma and other skin tumours (ID 253)\n",
      "Poster Discussion – Melanoma and other skin tumours (ID 253)\n",
      "Poster Discussion – Melanoma and other skin tumours (ID 253)\n",
      "Poster Discussion – Melanoma and other skin tumours (ID 253)\n",
      "Poster Discussion – Melanoma and other skin tumours (ID 253)\n",
      "Poster Discussion – Melanoma and other skin tumours (ID 253)\n",
      "Poster Discussion – Melanoma and other skin tumours (ID 253)\n",
      "Poster Discussion – Melanoma and other skin tumours (ID 253)\n",
      "Poster Discussion – Melanoma and other skin tumours (ID 253)\n",
      "Poster Discussion – Melanoma and other skin tumours (ID 253)\n",
      "Poster Discussion – Melanoma and other skin tumours (ID 253)\n",
      "Poster Discussion – Melanoma and other skin tumours (ID 253)\n",
      "Poster Discussion – Melanoma and other skin tumours (ID 253)\n",
      "Poster Discussion – Melanoma and other skin tumours (ID 253)\n",
      "Poster Discussion – Melanoma and other skin tumours (ID 253)\n",
      "Treatment of the primary tumour in the metastatic setting (ID 87)\n",
      "Treatment of the primary tumour in the metastatic setting (ID 87)\n",
      "Treatment of the primary tumour in the metastatic setting (ID 87)\n",
      "Treatment of the primary tumour in the metastatic setting (ID 87)\n",
      "Treatment of the primary tumour in the metastatic setting (ID 87)\n",
      "Treatment of the primary tumour in the metastatic setting (ID 87)\n",
      "Treatment of the primary tumour in the metastatic setting (ID 87)\n",
      "Treatment of the primary tumour in the metastatic setting (ID 87)\n",
      "A family with MEN1 syndrome (ID 1)\n",
      "A family with MEN1 syndrome (ID 1)\n",
      "A family with MEN1 syndrome (ID 1)\n",
      "A family with MEN1 syndrome (ID 1)\n",
      "A family with MEN1 syndrome (ID 1)\n",
      "A family with MEN1 syndrome (ID 1)\n",
      "Proffered Paper – Supportive and palliative care (ID 251)\n",
      "Proffered Paper – Supportive and palliative care (ID 251)\n",
      "Proffered Paper – Supportive and palliative care (ID 251)\n",
      "Proffered Paper – Supportive and palliative care (ID 251)\n",
      "Proffered Paper – Supportive and palliative care (ID 251)\n",
      "Proffered Paper – Supportive and palliative care (ID 251)\n",
      "Proffered Paper – Supportive and palliative care (ID 251)\n",
      "Proffered Paper – Supportive and palliative care (ID 251)\n",
      "Proffered Paper – Supportive and palliative care (ID 251)\n",
      "Poster Discussion - Breast cancer, early stage (ID 218)\n",
      "Poster Discussion - Breast cancer, early stage (ID 218)\n",
      "Poster Discussion - Breast cancer, early stage (ID 218)\n",
      "Poster Discussion - Breast cancer, early stage (ID 218)\n",
      "Poster Discussion - Breast cancer, early stage (ID 218)\n",
      "Poster Discussion - Breast cancer, early stage (ID 218)\n",
      "Poster Discussion - Breast cancer, early stage (ID 218)\n",
      "Poster Discussion - Breast cancer, early stage (ID 218)\n",
      "Poster Discussion - Breast cancer, early stage (ID 218)\n",
      "Poster Discussion - Breast cancer, early stage (ID 218)\n",
      "Poster Discussion - Breast cancer, early stage (ID 218)\n",
      "Poster Discussion - Breast cancer, early stage (ID 218)\n",
      "Poster Discussion - Breast cancer, early stage (ID 218)\n",
      "Poster Discussion - Breast cancer, early stage (ID 218)\n",
      "Poster Discussion - Breast cancer, early stage (ID 218)\n",
      "Poster Discussion - Breast cancer, early stage (ID 218)\n",
      "Poster Discussion - Breast cancer, early stage (ID 218)\n",
      "Poster Discussion - Breast cancer, early stage (ID 218)\n",
      "Proffered Paper session - Basic Science (ID 214)\n",
      "Proffered Paper session - Basic Science (ID 214)\n",
      "Proffered Paper session - Basic Science (ID 214)\n",
      "Proffered Paper session - Basic Science (ID 214)\n",
      "Proffered Paper session - Basic Science (ID 214)\n",
      "Proffered Paper session - Basic Science (ID 214)\n",
      "Proffered Paper session - Basic Science (ID 214)\n",
      "Proffered Paper session - Basic Science (ID 214)\n",
      "Proffered Paper session - Basic Science (ID 214)\n",
      "Biology and early diagnosis of blood malignancies (ID 4)\n",
      "Biology and early diagnosis of blood malignancies (ID 4)\n",
      "Biology and early diagnosis of blood malignancies (ID 4)\n",
      "Biology and early diagnosis of blood malignancies (ID 4)\n",
      "Biology and early diagnosis of blood malignancies (ID 4)\n",
      "Biology and early diagnosis of blood malignancies (ID 4)\n",
      "Biology and early diagnosis of blood malignancies (ID 4)\n",
      "Biology and early diagnosis of blood malignancies (ID 4)\n",
      "Poster Discussion – Sarcoma (ID 259)\n",
      "Poster Discussion – Sarcoma (ID 259)\n",
      "Poster Discussion – Sarcoma (ID 259)\n",
      "Poster Discussion – Sarcoma (ID 259)\n",
      "Poster Discussion – Sarcoma (ID 259)\n",
      "Poster Discussion – Sarcoma (ID 259)\n",
      "Poster Discussion – Sarcoma (ID 259)\n",
      "Poster Discussion – Sarcoma (ID 259)\n",
      "Poster Discussion – Sarcoma (ID 259)\n",
      "Poster Discussion – Sarcoma (ID 259)\n",
      "Poster Discussion – Sarcoma (ID 259)\n",
      "Poster Discussion – Sarcoma (ID 259)\n",
      "Poster Discussion – Sarcoma (ID 259)\n",
      "Poster Discussion – Sarcoma (ID 259)\n",
      "Poster Discussion – Sarcoma (ID 259)\n",
      "Poster Discussion – Sarcoma (ID 259)\n",
      "Poster Discussion – Sarcoma (ID 259)\n",
      "The even rarer sarcomas: Treating the untreatable (ID 77)\n",
      "The even rarer sarcomas: Treating the untreatable (ID 77)\n",
      "The even rarer sarcomas: Treating the untreatable (ID 77)\n",
      "The even rarer sarcomas: Treating the untreatable (ID 77)\n",
      "The even rarer sarcomas: Treating the untreatable (ID 77)\n",
      "The even rarer sarcomas: Treating the untreatable (ID 77)\n",
      "The even rarer sarcomas: Treating the untreatable (ID 77)\n",
      "The even rarer sarcomas: Treating the untreatable (ID 77)\n",
      "The even rarer sarcomas: Treating the untreatable (ID 77)\n",
      "Poster Discussion – Head and neck cancer (ID 245)\n",
      "Poster Discussion – Head and neck cancer (ID 245)\n",
      "Poster Discussion – Head and neck cancer (ID 245)\n",
      "Poster Discussion – Head and neck cancer (ID 245)\n",
      "Poster Discussion – Head and neck cancer (ID 245)\n",
      "Poster Discussion – Head and neck cancer (ID 245)\n",
      "Poster Discussion – Head and neck cancer (ID 245)\n",
      "Poster Discussion – Head and neck cancer (ID 245)\n",
      "Poster Discussion – Head and neck cancer (ID 245)\n",
      "Poster Discussion – Head and neck cancer (ID 245)\n",
      "Poster Discussion – Head and neck cancer (ID 245)\n",
      "Poster Discussion – Head and neck cancer (ID 245)\n",
      "Poster Discussion – Head and neck cancer (ID 245)\n",
      "Poster Discussion – Head and neck cancer (ID 245)\n",
      "Poster Discussion – Head and neck cancer (ID 245)\n",
      "Poster Discussion – Head and neck cancer (ID 245)\n",
      "Poster Discussion – Head and neck cancer (ID 245)\n",
      "Poster Discussion – Head and neck cancer (ID 245)\n",
      "How to sequence treatment in platinum-sensitive relapsed ovarian cancer (ID 24)\n",
      "How to sequence treatment in platinum-sensitive relapsed ovarian cancer (ID 24)\n",
      "How to sequence treatment in platinum-sensitive relapsed ovarian cancer (ID 24)\n",
      "Poster Discussion – Supportive and palliative care (ID 260)\n",
      "Poster Discussion – Supportive and palliative care (ID 260)\n",
      "Poster Discussion – Supportive and palliative care (ID 260)\n",
      "Poster Discussion – Supportive and palliative care (ID 260)\n",
      "Poster Discussion – Supportive and palliative care (ID 260)\n",
      "Poster Discussion – Supportive and palliative care (ID 260)\n",
      "Poster Discussion – Supportive and palliative care (ID 260)\n",
      "Poster Discussion – Supportive and palliative care (ID 260)\n",
      "Poster Discussion – Supportive and palliative care (ID 260)\n",
      "Poster Discussion – Supportive and palliative care (ID 260)\n",
      "Poster Discussion – Supportive and palliative care (ID 260)\n",
      "Poster Discussion – Supportive and palliative care (ID 260)\n",
      "Poster Discussion – Supportive and palliative care (ID 260)\n",
      "Poster Discussion – Supportive and palliative care (ID 260)\n",
      "Poster Discussion – Supportive and palliative care (ID 260)\n",
      "Poster Discussion – Supportive and palliative care (ID 260)\n",
      "Poster Discussion – Supportive and palliative care (ID 260)\n",
      "Poster Discussion 1 – Immunotherapy of cancer (ID 248)\n",
      "Poster Discussion 1 – Immunotherapy of cancer (ID 248)\n",
      "Poster Discussion 1 – Immunotherapy of cancer (ID 248)\n",
      "Poster Discussion 1 – Immunotherapy of cancer (ID 248)\n",
      "Poster Discussion 1 – Immunotherapy of cancer (ID 248)\n",
      "Poster Discussion 1 – Immunotherapy of cancer (ID 248)\n",
      "Poster Discussion 1 – Immunotherapy of cancer (ID 248)\n",
      "Poster Discussion 1 – Immunotherapy of cancer (ID 248)\n",
      "Poster Discussion 1 – Immunotherapy of cancer (ID 248)\n",
      "Poster Discussion 1 – Immunotherapy of cancer (ID 248)\n",
      "Poster Discussion 1 – Immunotherapy of cancer (ID 248)\n",
      "Poster Discussion 1 – Immunotherapy of cancer (ID 248)\n",
      "Poster Discussion 1 – Immunotherapy of cancer (ID 248)\n",
      "Poster Discussion 1 – Immunotherapy of cancer (ID 248)\n",
      "Poster Discussion 1 – Immunotherapy of cancer (ID 248)\n",
      "Locally advanced rectal cancer: What is the best perioperative treatment in 2019? (ID 34)\n",
      "Locally advanced rectal cancer: What is the best perioperative treatment in 2019? (ID 34)\n",
      "Locally advanced rectal cancer: What is the best perioperative treatment in 2019? (ID 34)\n",
      "WHO grade II and III gliomas: State of the art management (ID 91)\n",
      "WHO grade II and III gliomas: State of the art management (ID 91)\n",
      "WHO grade II and III gliomas: State of the art management (ID 91)\n",
      "WHO grade II and III gliomas: State of the art management (ID 91)\n",
      "WHO grade II and III gliomas: State of the art management (ID 91)\n",
      "WHO grade II and III gliomas: State of the art management (ID 91)\n",
      "Managing the frail patients (ID 37)\n",
      "Managing the frail patients (ID 37)\n",
      "Managing the frail patients (ID 37)\n",
      "Managing the frail patients (ID 37)\n",
      "Managing the frail patients (ID 37)\n",
      "Managing the frail patients (ID 37)\n",
      "Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)\n",
      "Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)\n",
      "Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)\n",
      "Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)\n",
      "Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)\n",
      "Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)\n",
      "Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)\n",
      "Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)\n",
      "Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)\n",
      "Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)\n",
      "Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)\n",
      "Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)\n",
      "Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)\n",
      "Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)\n",
      "Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)\n",
      "Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)\n",
      "Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)\n",
      "Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)\n",
      "Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)\n",
      "Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)\n",
      "Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)\n",
      "Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)\n",
      "Poster Discussion – Gastrointestinal tumours, non-colorectal (ID 233)\n",
      "Proffered Paper session: Artificial intelligence and machine learning as tools for practice in oncology (ID 273)\n",
      "Proffered Paper session: Artificial intelligence and machine learning as tools for practice in oncology (ID 273)\n",
      "Proffered Paper session: Artificial intelligence and machine learning as tools for practice in oncology (ID 273)\n",
      "Proffered Paper session: Artificial intelligence and machine learning as tools for practice in oncology (ID 273)\n",
      "Proffered Paper session: Artificial intelligence and machine learning as tools for practice in oncology (ID 273)\n",
      "Proffered Paper session: Artificial intelligence and machine learning as tools for practice in oncology (ID 273)\n",
      "Proffered Paper session: Artificial intelligence and machine learning as tools for practice in oncology (ID 273)\n",
      "Proffered Paper session: Artificial intelligence and machine learning as tools for practice in oncology (ID 273)\n",
      "Metastasis, dormancy and late recurrence (ID 39)\n",
      "Metastasis, dormancy and late recurrence (ID 39)\n",
      "Metastasis, dormancy and late recurrence (ID 39)\n",
      "Is randomisation of clinical trials still the gold standard? (ID 31)\n",
      "Is randomisation of clinical trials still the gold standard? (ID 31)\n",
      "Is randomisation of clinical trials still the gold standard? (ID 31)\n",
      "Is randomisation of clinical trials still the gold standard? (ID 31)\n",
      "Is randomisation of clinical trials still the gold standard? (ID 31)\n",
      "Is randomisation of clinical trials still the gold standard? (ID 31)\n",
      "Poster Discussion – Developmental therapeutics (ID 226)\n",
      "Poster Discussion – Developmental therapeutics (ID 226)\n",
      "Poster Discussion – Developmental therapeutics (ID 226)\n",
      "Poster Discussion – Developmental therapeutics (ID 226)\n",
      "Poster Discussion – Developmental therapeutics (ID 226)\n",
      "Poster Discussion – Developmental therapeutics (ID 226)\n",
      "Poster Discussion – Developmental therapeutics (ID 226)\n",
      "Poster Discussion – Developmental therapeutics (ID 226)\n",
      "Poster Discussion – Developmental therapeutics (ID 226)\n",
      "Poster Discussion – Developmental therapeutics (ID 226)\n",
      "Poster Discussion – Developmental therapeutics (ID 226)\n",
      "Poster Discussion – Developmental therapeutics (ID 226)\n",
      "Poster Discussion – Developmental therapeutics (ID 226)\n",
      "Poster Discussion – Developmental therapeutics (ID 226)\n",
      "Poster Discussion – Developmental therapeutics (ID 226)\n",
      "Poster Discussion – Developmental therapeutics (ID 226)\n",
      "Poster Discussion – Developmental therapeutics (ID 226)\n",
      "Poster Discussion – Developmental therapeutics (ID 226)\n",
      "Poster Discussion – Developmental therapeutics (ID 226)\n",
      "Poster Discussion – Developmental therapeutics (ID 226)\n",
      "Poster Discussion – Developmental therapeutics (ID 226)\n",
      "Poster Discussion – Developmental therapeutics (ID 226)\n",
      "Poster Discussion – Developmental therapeutics (ID 226)\n",
      "Challenges in advanced GIST: Are we approaching cure? (ID 8)\n",
      "Challenges in advanced GIST: Are we approaching cure? (ID 8)\n",
      "Challenges in advanced GIST: Are we approaching cure? (ID 8)\n",
      "Radiopharmaceuticals to treat lethal prostate cancer (ID 62)\n",
      "Radiopharmaceuticals to treat lethal prostate cancer (ID 62)\n",
      "Radiopharmaceuticals to treat lethal prostate cancer (ID 62)\n",
      "Decision making at the point of care: When evidence-based medicines can’t help (ID 114)\n",
      "Decision making at the point of care: When evidence-based medicines can’t help (ID 114)\n",
      "Decision making at the point of care: When evidence-based medicines can’t help (ID 114)\n",
      "Decision making at the point of care: When evidence-based medicines can’t help (ID 114)\n",
      "Decision making at the point of care: When evidence-based medicines can’t help (ID 114)\n",
      "Decision making at the point of care: When evidence-based medicines can’t help (ID 114)\n",
      "Decision making at the point of care: When evidence-based medicines can’t help (ID 114)\n",
      "Decision making at the point of care: When evidence-based medicines can’t help (ID 114)\n",
      "Decision making at the point of care: When evidence-based medicines can’t help (ID 114)\n",
      "Decision making at the point of care: When evidence-based medicines can’t help (ID 114)\n",
      "Decision making at the point of care: When evidence-based medicines can’t help (ID 114)\n",
      "Decision making at the point of care: When evidence-based medicines can’t help (ID 114)\n",
      "Decision making at the point of care: When evidence-based medicines can’t help (ID 114)\n",
      "Decision making at the point of care: When evidence-based medicines can’t help (ID 114)\n",
      "Decision making at the point of care: When evidence-based medicines can’t help (ID 114)\n",
      "Decision making at the point of care: When evidence-based medicines can’t help (ID 114)\n",
      "Tackling the treatment options in triple negative metastatic breast cancer (ID 74)\n",
      "Tackling the treatment options in triple negative metastatic breast cancer (ID 74)\n",
      "Tackling the treatment options in triple negative metastatic breast cancer (ID 74)\n",
      "Biomarkers for patient selection for checkpoint inhibitors in HNSCC: Where do we stand? (ID 5)\n",
      "Biomarkers for patient selection for checkpoint inhibitors in HNSCC: Where do we stand? (ID 5)\n",
      "Biomarkers for patient selection for checkpoint inhibitors in HNSCC: Where do we stand? (ID 5)\n",
      "ESMO-MCBS: What have we learnt and how can we expand? (ID 205)\n",
      "ESMO-MCBS: What have we learnt and how can we expand? (ID 205)\n",
      "ESMO-MCBS: What have we learnt and how can we expand? (ID 205)\n",
      "ESMO-MCBS: What have we learnt and how can we expand? (ID 205)\n",
      "ESMO-MCBS: What have we learnt and how can we expand? (ID 205)\n",
      "ESMO-MCBS: What have we learnt and how can we expand? (ID 205)\n",
      "ESMO-MCBS: What have we learnt and how can we expand? (ID 205)\n",
      "ESMO-MCBS: What have we learnt and how can we expand? (ID 205)\n",
      "ESMO-MCBS: What have we learnt and how can we expand? (ID 205)\n",
      "Poster Discussion – CNS tumours (ID 224)\n",
      "Poster Discussion – CNS tumours (ID 224)\n",
      "Poster Discussion – CNS tumours (ID 224)\n",
      "Poster Discussion – CNS tumours (ID 224)\n",
      "Poster Discussion – CNS tumours (ID 224)\n",
      "Poster Discussion – CNS tumours (ID 224)\n",
      "Poster Discussion – CNS tumours (ID 224)\n",
      "Poster Discussion – CNS tumours (ID 224)\n",
      "Poster Discussion – CNS tumours (ID 224)\n",
      "Poster Discussion – CNS tumours (ID 224)\n",
      "Poster Discussion – CNS tumours (ID 224)\n",
      "Poster Discussion – CNS tumours (ID 224)\n",
      "Poster Discussion – CNS tumours (ID 224)\n",
      "Poster Discussion – CNS tumours (ID 224)\n",
      "Poster Discussion – CNS tumours (ID 224)\n",
      "Poster Discussion – CNS tumours (ID 224)\n",
      "Poster Discussion – CNS tumours (ID 224)\n",
      "Poster Discussion – CNS tumours (ID 224)\n",
      "ESMO Colloquium funded by Eisai Europe - Emerging Biotherapy Strategies in the treatment of solid tumours: Hope, Hype and Hurdles (ID 208)\n",
      "ESMO Colloquium funded by Eisai Europe - Emerging Biotherapy Strategies in the treatment of solid tumours: Hope, Hype and Hurdles (ID 208)\n",
      "ESMO Colloquium funded by Eisai Europe - Emerging Biotherapy Strategies in the treatment of solid tumours: Hope, Hype and Hurdles (ID 208)\n",
      "ESMO Colloquium funded by Eisai Europe - Emerging Biotherapy Strategies in the treatment of solid tumours: Hope, Hype and Hurdles (ID 208)\n",
      "ESMO Colloquium funded by Eisai Europe - Emerging Biotherapy Strategies in the treatment of solid tumours: Hope, Hype and Hurdles (ID 208)\n",
      "ESMO Colloquium funded by Eisai Europe - Emerging Biotherapy Strategies in the treatment of solid tumours: Hope, Hype and Hurdles (ID 208)\n",
      "ESMO Colloquium funded by Eisai Europe - Emerging Biotherapy Strategies in the treatment of solid tumours: Hope, Hype and Hurdles (ID 208)\n",
      "ESMO Colloquium funded by Eisai Europe - Emerging Biotherapy Strategies in the treatment of solid tumours: Hope, Hype and Hurdles (ID 208)\n",
      "ESMO Colloquium funded by Eisai Europe - Emerging Biotherapy Strategies in the treatment of solid tumours: Hope, Hype and Hurdles (ID 208)\n",
      "Proffered Paper – Haematological malignancies & pediatric oncology (ID 235)\n",
      "Proffered Paper – Haematological malignancies & pediatric oncology (ID 235)\n",
      "Proffered Paper – Haematological malignancies & pediatric oncology (ID 235)\n",
      "Proffered Paper – Haematological malignancies & pediatric oncology (ID 235)\n",
      "Proffered Paper – Haematological malignancies & pediatric oncology (ID 235)\n",
      "Proffered Paper – Haematological malignancies & pediatric oncology (ID 235)\n",
      "Proffered Paper – Haematological malignancies & pediatric oncology (ID 235)\n",
      "Proffered Paper – Haematological malignancies & pediatric oncology (ID 235)\n",
      "EONS 12: Opening session (ID 118)\n",
      "EONS 12: Opening session (ID 118)\n",
      "EONS 12: Opening session (ID 118)\n",
      "EONS 12: Opening session (ID 118)\n",
      "EONS 12: Opening session (ID 118)\n",
      "EONS 12: Opening session (ID 118)\n",
      "EONS 12: Opening session (ID 118)\n",
      "EONS 12: Opening session (ID 118)\n",
      "EONS 12: Opening session (ID 118)\n",
      "EONS 12: Opening session (ID 118)\n",
      "EONS 12: Patient safety in cancer care (ID 120)\n",
      "EONS 12: Patient safety in cancer care (ID 120)\n",
      "EONS 12: Patient safety in cancer care (ID 120)\n",
      "EONS 12: Patient safety in cancer care (ID 120)\n",
      "EONS 12: Patient safety in cancer care (ID 120)\n",
      "EONS 12: Patient safety in cancer care (ID 120)\n",
      "EONS 12: Patient safety in cancer care (ID 120)\n",
      "EONS 12 Symposium: Car-T Cells therapy: A New Treatment Challenge for Cancer Nurses (ID 280)\n",
      "EONS 12 Symposium: Car-T Cells therapy: A New Treatment Challenge for Cancer Nurses (ID 280)\n",
      "EONS 12 Symposium: Car-T Cells therapy: A New Treatment Challenge for Cancer Nurses (ID 280)\n",
      "EONS 12 Symposium: Car-T Cells therapy: A New Treatment Challenge for Cancer Nurses (ID 280)\n",
      "EONS 12 Symposium: Car-T Cells therapy: A New Treatment Challenge for Cancer Nurses (ID 280)\n",
      "EONS 12: Living with and beyond cancer (ID 123)\n",
      "EONS 12: Living with and beyond cancer (ID 123)\n",
      "EONS 12: Living with and beyond cancer (ID 123)\n",
      "EONS 12: Living with and beyond cancer (ID 123)\n",
      "EONS 12: Living with and beyond cancer (ID 123)\n",
      "EONS 12: Recent trends in palliative care (ID 125)\n",
      "EONS 12: Recent trends in palliative care (ID 125)\n",
      "EONS 12: Recent trends in palliative care (ID 125)\n",
      "EONS 12: Recent trends in palliative care (ID 125)\n",
      "EONS 12: Recent trends in palliative care (ID 125)\n",
      "EONS 12: Recent trends in palliative care (ID 125)\n",
      "EONS 12: Recent trends in palliative care (ID 125)\n",
      "Essential medicines, but not always available (ID 109)\n",
      "Essential medicines, but not always available (ID 109)\n",
      "Essential medicines, but not always available (ID 109)\n",
      "Essential medicines, but not always available (ID 109)\n",
      "Essential medicines, but not always available (ID 109)\n",
      "Essential medicines, but not always available (ID 109)\n",
      "Essential medicines, but not always available (ID 109)\n",
      "Essential medicines, but not always available (ID 109)\n",
      "How can truly innovative drugs be available for all patients? (ID 111)\n",
      "How can truly innovative drugs be available for all patients? (ID 111)\n",
      "How can truly innovative drugs be available for all patients? (ID 111)\n",
      "How can truly innovative drugs be available for all patients? (ID 111)\n",
      "How can truly innovative drugs be available for all patients? (ID 111)\n",
      "How can truly innovative drugs be available for all patients? (ID 111)\n",
      "How can truly innovative drugs be available for all patients? (ID 111)\n",
      "How can truly innovative drugs be available for all patients? (ID 111)\n",
      "Common but still rare: What happens when common cancers split into subgroups? (ID 134)\n",
      "Common but still rare: What happens when common cancers split into subgroups? (ID 134)\n",
      "Common but still rare: What happens when common cancers split into subgroups? (ID 134)\n",
      "Common but still rare: What happens when common cancers split into subgroups? (ID 134)\n",
      "Common but still rare: What happens when common cancers split into subgroups? (ID 134)\n",
      "Common but still rare: What happens when common cancers split into subgroups? (ID 134)\n",
      "Common but still rare: What happens when common cancers split into subgroups? (ID 134)\n",
      "Common but still rare: What happens when common cancers split into subgroups? (ID 134)\n",
      "Bedside rationing: To prescribe or not to prescribe? (ID 108)\n",
      "Bedside rationing: To prescribe or not to prescribe? (ID 108)\n",
      "Bedside rationing: To prescribe or not to prescribe? (ID 108)\n",
      "Bedside rationing: To prescribe or not to prescribe? (ID 108)\n",
      "Bedside rationing: To prescribe or not to prescribe? (ID 108)\n",
      "Bedside rationing: To prescribe or not to prescribe? (ID 108)\n",
      "Bedside rationing: To prescribe or not to prescribe? (ID 108)\n",
      "Fertility and pregnancy of cancer patients during and after treatment (ID 135)\n",
      "Fertility and pregnancy of cancer patients during and after treatment (ID 135)\n",
      "Fertility and pregnancy of cancer patients during and after treatment (ID 135)\n",
      "Fertility and pregnancy of cancer patients during and after treatment (ID 135)\n",
      "Fertility and pregnancy of cancer patients during and after treatment (ID 135)\n",
      "Fertility and pregnancy of cancer patients during and after treatment (ID 135)\n",
      "Fertility and pregnancy of cancer patients during and after treatment (ID 135)\n",
      "YO “boxing” session (ID 106)\n",
      "YO “boxing” session (ID 106)\n",
      "YO “boxing” session (ID 106)\n",
      "YO “boxing” session (ID 106)\n",
      "YO “boxing” session (ID 106)\n",
      "YO “boxing” session (ID 106)\n",
      "YO “boxing” session (ID 106)\n",
      "YO “boxing” session (ID 106)\n",
      "YO “boxing” session (ID 106)\n",
      "YO “boxing” session (ID 106)\n",
      "YO “boxing” session (ID 106)\n",
      "YO “boxing” session (ID 106)\n",
      "YO Brunch: Survivorship care for young adults with cancer (ID 98)\n",
      "YO Brunch: Survivorship care for young adults with cancer (ID 98)\n",
      "YO Brunch: Survivorship care for young adults with cancer (ID 98)\n",
      "YO Brunch: Survivorship care for young adults with cancer (ID 98)\n",
      "YO Brunch: Survivorship care for young adults with cancer (ID 98)\n",
      "2019 ESMO Annual General Assembly (ID 291)\n",
      "ESMO for medical students and young physicians (ID 104)\n",
      "ESMO for medical students and young physicians (ID 104)\n",
      "ESMO for medical students and young physicians (ID 104)\n",
      "ESMO for medical students and young physicians (ID 104)\n",
      "ESMO for medical students and young physicians (ID 104)\n",
      "ESMO for medical students and young physicians (ID 104)\n",
      "ESMO for medical students and young physicians (ID 104)\n",
      "ESMO for medical students and young physicians (ID 104)\n",
      "ESMO for medical students and young physicians (ID 104)\n",
      "Poster Display session 1 (ID 210)\n",
      "Poster Display session 1 (ID 210)\n",
      "Poster Display session 1 (ID 210)\n",
      "Poster Display session 1 (ID 210)\n",
      "Poster Display session 1 (ID 210)\n",
      "Poster Display session 1 (ID 210)\n",
      "Poster Display session 1 (ID 210)\n",
      "Poster Display session 1 (ID 210)\n",
      "Poster Display session 1 (ID 210)\n",
      "Poster Display session 1 (ID 210)\n",
      "Poster Display session 1 (ID 210)\n",
      "Poster Display session 1 (ID 210)\n",
      "Poster Display session 1 (ID 210)\n",
      "Poster Display session 1 (ID 210)\n",
      "Poster Display session 1 (ID 210)\n",
      "Poster Display session 1 (ID 210)\n",
      "Poster Display session 1 (ID 210)\n",
      "Poster Display session 1 (ID 210)\n",
      "Poster Display session 1 (ID 210)\n",
      "Poster Display session 1 (ID 210)\n",
      "EONS 12 Workshop: Present experiences and future directions of immunotherapy (ID 281)\n",
      "EONS 12 Workshop: Present experiences and future directions of immunotherapy (ID 281)\n",
      "EONS 12 Workshop: Present experiences and future directions of immunotherapy (ID 281)\n",
      "EONS 12 Workshop: Present experiences and future directions of immunotherapy (ID 281)\n",
      "EONS 12 Workshop: Present experiences and future directions of immunotherapy (ID 281)\n",
      "EONS 12 Workshop: Present experiences and future directions of immunotherapy (ID 281)\n",
      "Stratified treatment in metastatic colorectal cancer (ID 71)\n",
      "Stratified treatment in metastatic colorectal cancer (ID 71)\n",
      "Stratified treatment in metastatic colorectal cancer (ID 71)\n",
      "Stratified treatment in metastatic colorectal cancer (ID 71)\n",
      "Stratified treatment in metastatic colorectal cancer (ID 71)\n",
      "Stratified treatment in metastatic colorectal cancer (ID 71)\n",
      "Stratified treatment in metastatic colorectal cancer (ID 71)\n",
      "Stratified treatment in metastatic colorectal cancer (ID 71)\n",
      "Tackling the diversity of triple negative early breast cancer (TNBC) (ID 73)\n",
      "Tackling the diversity of triple negative early breast cancer (TNBC) (ID 73)\n",
      "Tackling the diversity of triple negative early breast cancer (TNBC) (ID 73)\n",
      "Tackling the diversity of triple negative early breast cancer (TNBC) (ID 73)\n",
      "Tackling the diversity of triple negative early breast cancer (TNBC) (ID 73)\n",
      "Tackling the diversity of triple negative early breast cancer (TNBC) (ID 73)\n",
      "Tackling the diversity of triple negative early breast cancer (TNBC) (ID 73)\n",
      "Tackling the diversity of triple negative early breast cancer (TNBC) (ID 73)\n",
      "Tackling the diversity of triple negative early breast cancer (TNBC) (ID 73)\n",
      "Where will future technologies take us in metastatic breast cancer? (ID 90)\n",
      "Where will future technologies take us in metastatic breast cancer? (ID 90)\n",
      "Where will future technologies take us in metastatic breast cancer? (ID 90)\n",
      "Where will future technologies take us in metastatic breast cancer? (ID 90)\n",
      "Where will future technologies take us in metastatic breast cancer? (ID 90)\n",
      "Where will future technologies take us in metastatic breast cancer? (ID 90)\n",
      "Where will future technologies take us in metastatic breast cancer? (ID 90)\n",
      "Where will future technologies take us in metastatic breast cancer? (ID 90)\n",
      "Presidential Symposium II (ID 264)\n",
      "Presidential Symposium II (ID 264)\n",
      "Presidential Symposium II (ID 264)\n",
      "Presidential Symposium II (ID 264)\n",
      "Presidential Symposium II (ID 264)\n",
      "Presidential Symposium II (ID 264)\n",
      "Presidential Symposium II (ID 264)\n",
      "Presidential Symposium II (ID 264)\n",
      "Proffered Paper 2 – Gynaecological cancers (ID 234)\n",
      "Proffered Paper 2 – Gynaecological cancers (ID 234)\n",
      "Proffered Paper 2 – Gynaecological cancers (ID 234)\n",
      "Proffered Paper 2 – Gynaecological cancers (ID 234)\n",
      "Proffered Paper 2 – Gynaecological cancers (ID 234)\n",
      "Proffered Paper 2 – Gynaecological cancers (ID 234)\n",
      "Proffered Paper 2 – Gynaecological cancers (ID 234)\n",
      "Proffered Paper 2 – Gynaecological cancers (ID 234)\n",
      "Proffered Paper 2 – Gastrointestinal tumours, non-colorectal (ID 227)\n",
      "Proffered Paper 2 – Gastrointestinal tumours, non-colorectal (ID 227)\n",
      "Proffered Paper 2 – Gastrointestinal tumours, non-colorectal (ID 227)\n",
      "Proffered Paper 2 – Gastrointestinal tumours, non-colorectal (ID 227)\n",
      "Proffered Paper 2 – Gastrointestinal tumours, non-colorectal (ID 227)\n",
      "Proffered Paper 2 – Gastrointestinal tumours, non-colorectal (ID 227)\n",
      "Proffered Paper 2 – Gastrointestinal tumours, non-colorectal (ID 227)\n",
      "Proffered Paper 2 – Gastrointestinal tumours, non-colorectal (ID 227)\n",
      "RAS signalling and cancer (ID 63)\n",
      "RAS signalling and cancer (ID 63)\n",
      "Update on novel therapies in ovarian cancer (ID 89)\n",
      "Update on novel therapies in ovarian cancer (ID 89)\n",
      "Update on novel therapies in ovarian cancer (ID 89)\n",
      "Update on novel therapies in ovarian cancer (ID 89)\n",
      "Update on novel therapies in ovarian cancer (ID 89)\n",
      "Update on novel therapies in ovarian cancer (ID 89)\n",
      "Update on novel therapies in ovarian cancer (ID 89)\n",
      "Update on novel therapies in ovarian cancer (ID 89)\n",
      "Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies (ID 255)\n",
      "Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies (ID 255)\n",
      "Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies (ID 255)\n",
      "Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies (ID 255)\n",
      "Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies (ID 255)\n",
      "Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies (ID 255)\n",
      "Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies (ID 255)\n",
      "Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies (ID 255)\n",
      "Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies (ID 255)\n",
      "Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies (ID 255)\n",
      "Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies (ID 255)\n",
      "Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies (ID 255)\n",
      "Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies (ID 255)\n",
      "Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies (ID 255)\n",
      "Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies (ID 255)\n",
      "Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies (ID 255)\n",
      "Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies (ID 255)\n",
      "Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies (ID 255)\n",
      "Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies (ID 255)\n",
      "Genomic tumour boards to deliver better prostate cancer care (ID 19)\n",
      "Genomic tumour boards to deliver better prostate cancer care (ID 19)\n",
      "Genomic tumour boards to deliver better prostate cancer care (ID 19)\n",
      "Genomic tumour boards to deliver better prostate cancer care (ID 19)\n",
      "Genomic tumour boards to deliver better prostate cancer care (ID 19)\n",
      "Genomic tumour boards to deliver better prostate cancer care (ID 19)\n",
      "Genomic tumour boards to deliver better prostate cancer care (ID 19)\n",
      "Genomic tumour boards to deliver better prostate cancer care (ID 19)\n",
      "Immunotherapy in thoracic malignancies: What has been achieved in 2019? (ID 27)\n",
      "Immunotherapy in thoracic malignancies: What has been achieved in 2019? (ID 27)\n",
      "Immunotherapy in thoracic malignancies: What has been achieved in 2019? (ID 27)\n",
      "Immunotherapy in thoracic malignancies: What has been achieved in 2019? (ID 27)\n",
      "Immunotherapy in thoracic malignancies: What has been achieved in 2019? (ID 27)\n",
      "Immunotherapy in thoracic malignancies: What has been achieved in 2019? (ID 27)\n",
      "Progress in the management of non-melanoma skin cancers (ID 59)\n",
      "Progress in the management of non-melanoma skin cancers (ID 59)\n",
      "Progress in the management of non-melanoma skin cancers (ID 59)\n",
      "Progress in the management of non-melanoma skin cancers (ID 59)\n",
      "Progress in the management of non-melanoma skin cancers (ID 59)\n",
      "Progress in the management of non-melanoma skin cancers (ID 59)\n",
      "DNA damage response modification as a therapeutic strategy in head and neck cancer (ID 14)\n",
      "DNA damage response modification as a therapeutic strategy in head and neck cancer (ID 14)\n",
      "DNA damage response modification as a therapeutic strategy in head and neck cancer (ID 14)\n",
      "DNA damage response modification as a therapeutic strategy in head and neck cancer (ID 14)\n",
      "DNA damage response modification as a therapeutic strategy in head and neck cancer (ID 14)\n",
      "DNA damage response modification as a therapeutic strategy in head and neck cancer (ID 14)\n",
      "DNA damage response modification as a therapeutic strategy in head and neck cancer (ID 14)\n",
      "DNA damage response modification as a therapeutic strategy in head and neck cancer (ID 14)\n",
      "DNA repair: From basic science to the clinic and back (ID 15)\n",
      "DNA repair: From basic science to the clinic and back (ID 15)\n",
      "DNA repair: From basic science to the clinic and back (ID 15)\n",
      "DNA repair: From basic science to the clinic and back (ID 15)\n",
      "DNA repair: From basic science to the clinic and back (ID 15)\n",
      "DNA repair: From basic science to the clinic and back (ID 15)\n",
      "Poster Discussion – Genitourinary tumours, non-prostate (ID 239)\n",
      "Poster Discussion – Genitourinary tumours, non-prostate (ID 239)\n",
      "Poster Discussion – Genitourinary tumours, non-prostate (ID 239)\n",
      "Poster Discussion – Genitourinary tumours, non-prostate (ID 239)\n",
      "Poster Discussion – Genitourinary tumours, non-prostate (ID 239)\n",
      "Poster Discussion – Genitourinary tumours, non-prostate (ID 239)\n",
      "Poster Discussion – Genitourinary tumours, non-prostate (ID 239)\n",
      "Poster Discussion – Genitourinary tumours, non-prostate (ID 239)\n",
      "Poster Discussion – Genitourinary tumours, non-prostate (ID 239)\n",
      "Poster Discussion – Genitourinary tumours, non-prostate (ID 239)\n",
      "Poster Discussion – Genitourinary tumours, non-prostate (ID 239)\n",
      "Poster Discussion – Genitourinary tumours, non-prostate (ID 239)\n",
      "Poster Discussion – Genitourinary tumours, non-prostate (ID 239)\n",
      "Poster Discussion – Genitourinary tumours, non-prostate (ID 239)\n",
      "Poster Discussion – Genitourinary tumours, non-prostate (ID 239)\n",
      "Poster Discussion – Genitourinary tumours, non-prostate (ID 239)\n",
      "Poster Discussion – Genitourinary tumours, non-prostate (ID 239)\n",
      "Poster Discussion – Genitourinary tumours, non-prostate (ID 239)\n",
      "Poster Discussion – Genitourinary tumours, non-prostate (ID 239)\n",
      "Poster Discussion – Genitourinary tumours, non-prostate (ID 239)\n",
      "Poster Discussion – Genitourinary tumours, non-prostate (ID 239)\n",
      "Poster Discussion – Genitourinary tumours, non-prostate (ID 239)\n",
      "Poster Discussion – Genitourinary tumours, non-prostate (ID 239)\n",
      "Poster Discussion - Breast cancer, metastatic (ID 220)\n",
      "Poster Discussion - Breast cancer, metastatic (ID 220)\n",
      "Poster Discussion - Breast cancer, metastatic (ID 220)\n",
      "Poster Discussion - Breast cancer, metastatic (ID 220)\n",
      "Poster Discussion - Breast cancer, metastatic (ID 220)\n",
      "Poster Discussion - Breast cancer, metastatic (ID 220)\n",
      "Poster Discussion - Breast cancer, metastatic (ID 220)\n",
      "Poster Discussion - Breast cancer, metastatic (ID 220)\n",
      "Poster Discussion - Breast cancer, metastatic (ID 220)\n",
      "Poster Discussion - Breast cancer, metastatic (ID 220)\n",
      "Poster Discussion - Breast cancer, metastatic (ID 220)\n",
      "Poster Discussion - Breast cancer, metastatic (ID 220)\n",
      "Poster Discussion - Breast cancer, metastatic (ID 220)\n",
      "Poster Discussion - Breast cancer, metastatic (ID 220)\n",
      "Poster Discussion - Breast cancer, metastatic (ID 220)\n",
      "Poster Discussion - Breast cancer, metastatic (ID 220)\n",
      "Poster Discussion - Breast cancer, metastatic (ID 220)\n",
      "Poster Discussion - Breast cancer, metastatic (ID 220)\n",
      "Poster Discussion - Breast cancer, metastatic (ID 220)\n",
      "Poster Discussion - Breast cancer, metastatic (ID 220)\n",
      "How to choose between single agent and combination immunotherapy (ID 22)\n",
      "How to choose between single agent and combination immunotherapy (ID 22)\n",
      "How to choose between single agent and combination immunotherapy (ID 22)\n",
      "Poster Discussion – Gastrointestinal tumours, colorectal (ID 229)\n",
      "Poster Discussion – Gastrointestinal tumours, colorectal (ID 229)\n",
      "Poster Discussion – Gastrointestinal tumours, colorectal (ID 229)\n",
      "Poster Discussion – Gastrointestinal tumours, colorectal (ID 229)\n",
      "Poster Discussion – Gastrointestinal tumours, colorectal (ID 229)\n",
      "Poster Discussion – Gastrointestinal tumours, colorectal (ID 229)\n",
      "Poster Discussion – Gastrointestinal tumours, colorectal (ID 229)\n",
      "Poster Discussion – Gastrointestinal tumours, colorectal (ID 229)\n",
      "Poster Discussion – Gastrointestinal tumours, colorectal (ID 229)\n",
      "Poster Discussion – Gastrointestinal tumours, colorectal (ID 229)\n",
      "Poster Discussion – Gastrointestinal tumours, colorectal (ID 229)\n",
      "Poster Discussion – Gastrointestinal tumours, colorectal (ID 229)\n",
      "Poster Discussion – Gastrointestinal tumours, colorectal (ID 229)\n",
      "Poster Discussion – Gastrointestinal tumours, colorectal (ID 229)\n",
      "Poster Discussion – Gastrointestinal tumours, colorectal (ID 229)\n",
      "Poster Discussion – Gastrointestinal tumours, colorectal (ID 229)\n",
      "Poster Discussion – Gastrointestinal tumours, colorectal (ID 229)\n",
      "Poster Discussion – Gastrointestinal tumours, colorectal (ID 229)\n",
      "Poster Discussion – Gastrointestinal tumours, colorectal (ID 229)\n",
      "Poster Discussion – NSCLC, metastatic (ID 256)\n",
      "Poster Discussion – NSCLC, metastatic (ID 256)\n",
      "Poster Discussion – NSCLC, metastatic (ID 256)\n",
      "Poster Discussion – NSCLC, metastatic (ID 256)\n",
      "Poster Discussion – NSCLC, metastatic (ID 256)\n",
      "Poster Discussion – NSCLC, metastatic (ID 256)\n",
      "Poster Discussion – NSCLC, metastatic (ID 256)\n",
      "Poster Discussion – NSCLC, metastatic (ID 256)\n",
      "Poster Discussion – NSCLC, metastatic (ID 256)\n",
      "Poster Discussion – NSCLC, metastatic (ID 256)\n",
      "Poster Discussion – NSCLC, metastatic (ID 256)\n",
      "Poster Discussion – NSCLC, metastatic (ID 256)\n",
      "Poster Discussion – NSCLC, metastatic (ID 256)\n",
      "Poster Discussion – NSCLC, metastatic (ID 256)\n",
      "Poster Discussion – NSCLC, metastatic (ID 256)\n",
      "Poster Discussion – NSCLC, metastatic (ID 256)\n",
      "Poster Discussion – NSCLC, metastatic (ID 256)\n",
      "Poster Discussion – NSCLC, metastatic (ID 256)\n",
      "Poster Discussion – NSCLC, metastatic (ID 256)\n",
      "Poster Discussion – NSCLC, metastatic (ID 256)\n",
      "Poster Discussion – NSCLC, metastatic (ID 256)\n",
      "ESMO Colloquium supported by Ipsen - Metastatic clear cell renal cell carcinoma How to navigate within multiple options and risk groups? What is the best sequence in a multi-line setting? (ID 209)\n",
      "ESMO Colloquium supported by Ipsen - Metastatic clear cell renal cell carcinoma How to navigate within multiple options and risk groups? What is the best sequence in a multi-line setting? (ID 209)\n",
      "ESMO Colloquium supported by Ipsen - Metastatic clear cell renal cell carcinoma How to navigate within multiple options and risk groups? What is the best sequence in a multi-line setting? (ID 209)\n",
      "ESMO Colloquium supported by Ipsen - Metastatic clear cell renal cell carcinoma How to navigate within multiple options and risk groups? What is the best sequence in a multi-line setting? (ID 209)\n",
      "ESMO Colloquium supported by Ipsen - Metastatic clear cell renal cell carcinoma How to navigate within multiple options and risk groups? What is the best sequence in a multi-line setting? (ID 209)\n",
      "ESMO Colloquium supported by Ipsen - Metastatic clear cell renal cell carcinoma How to navigate within multiple options and risk groups? What is the best sequence in a multi-line setting? (ID 209)\n",
      "ESMO Colloquium supported by Ipsen - Metastatic clear cell renal cell carcinoma How to navigate within multiple options and risk groups? What is the best sequence in a multi-line setting? (ID 209)\n",
      "ESMO Colloquium supported by Ipsen - Metastatic clear cell renal cell carcinoma How to navigate within multiple options and risk groups? What is the best sequence in a multi-line setting? (ID 209)\n",
      "ESMO Colloquium supported by Ipsen - Metastatic clear cell renal cell carcinoma How to navigate within multiple options and risk groups? What is the best sequence in a multi-line setting? (ID 209)\n",
      "ESMO Colloquium supported by Ipsen - Metastatic clear cell renal cell carcinoma How to navigate within multiple options and risk groups? What is the best sequence in a multi-line setting? (ID 209)\n",
      "ESMO Colloquium supported by Ipsen - Metastatic clear cell renal cell carcinoma How to navigate within multiple options and risk groups? What is the best sequence in a multi-line setting? (ID 209)\n",
      "ESMO Colloquium supported by Ipsen - Metastatic clear cell renal cell carcinoma How to navigate within multiple options and risk groups? What is the best sequence in a multi-line setting? (ID 209)\n",
      "Neo-adjuvant vs. adjuvant therapy or combination for locoregional / oligometastatic melanoma (ID 279)\n",
      "Neo-adjuvant vs. adjuvant therapy or combination for locoregional / oligometastatic melanoma (ID 279)\n",
      "Neo-adjuvant vs. adjuvant therapy or combination for locoregional / oligometastatic melanoma (ID 279)\n",
      "Neo-adjuvant vs. adjuvant therapy or combination for locoregional / oligometastatic melanoma (ID 279)\n",
      "Neo-adjuvant vs. adjuvant therapy or combination for locoregional / oligometastatic melanoma (ID 279)\n",
      "ESMO Clinical Practice Guidelines 1 (ID 203)\n",
      "ESMO Clinical Practice Guidelines 1 (ID 203)\n",
      "ESMO Clinical Practice Guidelines 1 (ID 203)\n",
      "ESMO Clinical Practice Guidelines 1 (ID 203)\n",
      "ESMO Clinical Practice Guidelines 1 (ID 203)\n",
      "ESMO Clinical Practice Guidelines 1 (ID 203)\n",
      "ESMO Clinical Practice Guidelines 1 (ID 203)\n",
      "ESMO Clinical Practice Guidelines 1 (ID 203)\n",
      "ESMO Clinical Practice Guidelines 1 (ID 203)\n",
      "ESMO Clinical Practice Guidelines 1 (ID 203)\n",
      "ESMO Clinical Practice Guidelines 1 (ID 203)\n",
      "ESMO Clinical Practice Guidelines 1 (ID 203)\n",
      "ESMO Clinical Practice Guidelines 1 (ID 203)\n",
      "ESMO Clinical Practice Guidelines 1 (ID 203)\n",
      "ESMO Clinical Practice Guidelines 1 (ID 203)\n",
      "ESMO Clinical Practice Guidelines 1 (ID 203)\n",
      "ESMO Clinical Practice Guidelines 2 (ID 204)\n",
      "ESMO Clinical Practice Guidelines 2 (ID 204)\n",
      "ESMO Clinical Practice Guidelines 2 (ID 204)\n",
      "ESMO Clinical Practice Guidelines 2 (ID 204)\n",
      "ESMO Clinical Practice Guidelines 2 (ID 204)\n",
      "ESMO Clinical Practice Guidelines 2 (ID 204)\n",
      "ESMO Clinical Practice Guidelines 2 (ID 204)\n",
      "ESMO Clinical Practice Guidelines 2 (ID 204)\n",
      "ESMO Clinical Practice Guidelines 2 (ID 204)\n",
      "ESMO Clinical Practice Guidelines 2 (ID 204)\n",
      "ESMO Clinical Practice Guidelines 2 (ID 204)\n",
      "ESMO Clinical Practice Guidelines 2 (ID 204)\n",
      "ESMO Clinical Practice Guidelines 2 (ID 204)\n",
      "ESMO Clinical Practice Guidelines 2 (ID 204)\n",
      "ESMO Clinical Practice Guidelines 2 (ID 204)\n",
      "ESMO Clinical Practice Guidelines 2 (ID 204)\n",
      "Circulating tumour cell counts as clinical trial endpoint in prostate cancer? (ID 277)\n",
      "Circulating tumour cell counts as clinical trial endpoint in prostate cancer? (ID 277)\n",
      "Circulating tumour cell counts as clinical trial endpoint in prostate cancer? (ID 277)\n",
      "Circulating tumour cell counts as clinical trial endpoint in prostate cancer? (ID 277)\n",
      "Circulating tumour cell counts as clinical trial endpoint in prostate cancer? (ID 277)\n",
      "Toxicity profiling of immunotherapy of cancer (ID 81)\n",
      "Toxicity profiling of immunotherapy of cancer (ID 81)\n",
      "Toxicity profiling of immunotherapy of cancer (ID 81)\n",
      "Toxicity profiling of immunotherapy of cancer (ID 81)\n",
      "Toxicity profiling of immunotherapy of cancer (ID 81)\n",
      "Toxicity profiling of immunotherapy of cancer (ID 81)\n",
      "Poster Discussion – Gynaecological cancers (ID 242)\n",
      "Poster Discussion – Gynaecological cancers (ID 242)\n",
      "Poster Discussion – Gynaecological cancers (ID 242)\n",
      "Poster Discussion – Gynaecological cancers (ID 242)\n",
      "Poster Discussion – Gynaecological cancers (ID 242)\n",
      "Poster Discussion – Gynaecological cancers (ID 242)\n",
      "Poster Discussion – Gynaecological cancers (ID 242)\n",
      "Poster Discussion – Gynaecological cancers (ID 242)\n",
      "Poster Discussion – Gynaecological cancers (ID 242)\n",
      "Poster Discussion – Gynaecological cancers (ID 242)\n",
      "Poster Discussion – Gynaecological cancers (ID 242)\n",
      "Poster Discussion – Gynaecological cancers (ID 242)\n",
      "Poster Discussion – Gynaecological cancers (ID 242)\n",
      "Overcoming symptom burden in upper GI cancer (ID 49)\n",
      "Overcoming symptom burden in upper GI cancer (ID 49)\n",
      "Overcoming symptom burden in upper GI cancer (ID 49)\n",
      "Overcoming symptom burden in upper GI cancer (ID 49)\n",
      "Overcoming symptom burden in upper GI cancer (ID 49)\n",
      "Overcoming symptom burden in upper GI cancer (ID 49)\n",
      "Overcoming symptom burden in upper GI cancer (ID 49)\n",
      "Overcoming symptom burden in upper GI cancer (ID 49)\n",
      "Overcoming symptom burden in upper GI cancer (ID 49)\n",
      "Overcoming symptom burden in upper GI cancer (ID 49)\n",
      "Management of body resources in patients with advanced cancer (ID 35)\n",
      "Management of body resources in patients with advanced cancer (ID 35)\n",
      "Management of body resources in patients with advanced cancer (ID 35)\n",
      "Management of body resources in patients with advanced cancer (ID 35)\n",
      "Management of body resources in patients with advanced cancer (ID 35)\n",
      "Management of body resources in patients with advanced cancer (ID 35)\n",
      "Poster Discussion – Genitourinary tumours, prostate (ID 237)\n",
      "Poster Discussion – Genitourinary tumours, prostate (ID 237)\n",
      "Poster Discussion – Genitourinary tumours, prostate (ID 237)\n",
      "Poster Discussion – Genitourinary tumours, prostate (ID 237)\n",
      "Poster Discussion – Genitourinary tumours, prostate (ID 237)\n",
      "Poster Discussion – Genitourinary tumours, prostate (ID 237)\n",
      "Poster Discussion – Genitourinary tumours, prostate (ID 237)\n",
      "Poster Discussion – Genitourinary tumours, prostate (ID 237)\n",
      "Poster Discussion – Genitourinary tumours, prostate (ID 237)\n",
      "Poster Discussion – Genitourinary tumours, prostate (ID 237)\n",
      "Poster Discussion – Genitourinary tumours, prostate (ID 237)\n",
      "Poster Discussion – Genitourinary tumours, prostate (ID 237)\n",
      "Poster Discussion – Genitourinary tumours, prostate (ID 237)\n",
      "Poster Discussion – Genitourinary tumours, prostate (ID 237)\n",
      "Poster Discussion – Genitourinary tumours, prostate (ID 237)\n",
      "Poster Discussion – Genitourinary tumours, prostate (ID 237)\n",
      "Poster Discussion – Genitourinary tumours, prostate (ID 237)\n",
      "Poster Discussion – Genitourinary tumours, prostate (ID 237)\n",
      "Poster Discussion – Genitourinary tumours, prostate (ID 237)\n",
      "Poster Discussion – Genitourinary tumours, prostate (ID 237)\n",
      "Poster Discussion – Genitourinary tumours, prostate (ID 237)\n",
      "Glioblastoma treatment: Where should the future lead? (ID 20)\n",
      "Glioblastoma treatment: Where should the future lead? (ID 20)\n",
      "Glioblastoma treatment: Where should the future lead? (ID 20)\n",
      "Glioblastoma treatment: Where should the future lead? (ID 20)\n",
      "Glioblastoma treatment: Where should the future lead? (ID 20)\n",
      "Glioblastoma treatment: Where should the future lead? (ID 20)\n",
      "Glioblastoma treatment: Where should the future lead? (ID 20)\n",
      "Glioblastoma treatment: Where should the future lead? (ID 20)\n",
      "Perioperative therapy in melanoma (ID 52)\n",
      "Perioperative therapy in melanoma (ID 52)\n",
      "Perioperative therapy in melanoma (ID 52)\n",
      "Perioperative therapy in melanoma (ID 52)\n",
      "Perioperative therapy in melanoma (ID 52)\n",
      "Perioperative therapy in melanoma (ID 52)\n",
      "Proffered Paper – Developmental therapeutics (ID 221)\n",
      "Proffered Paper – Developmental therapeutics (ID 221)\n",
      "Proffered Paper – Developmental therapeutics (ID 221)\n",
      "Proffered Paper – Developmental therapeutics (ID 221)\n",
      "Proffered Paper – Developmental therapeutics (ID 221)\n",
      "Proffered Paper – Developmental therapeutics (ID 221)\n",
      "Proffered Paper – Developmental therapeutics (ID 221)\n",
      "Proffered Paper – Developmental therapeutics (ID 221)\n",
      "Proffered Paper – Developmental therapeutics (ID 221)\n",
      "Molecular tumour board: Where do we stand? What’s next? (ID 40)\n",
      "Molecular tumour board: Where do we stand? What’s next? (ID 40)\n",
      "Molecular tumour board: Where do we stand? What’s next? (ID 40)\n",
      "Molecular tumour board: Where do we stand? What’s next? (ID 40)\n",
      "Molecular tumour board: Where do we stand? What’s next? (ID 40)\n",
      "Molecular tumour board: Where do we stand? What’s next? (ID 40)\n",
      "Molecular tumour board: Where do we stand? What’s next? (ID 40)\n",
      "Oligorecurrent and oligoprogressive NSCLC (ID 45)\n",
      "Oligorecurrent and oligoprogressive NSCLC (ID 45)\n",
      "Oligorecurrent and oligoprogressive NSCLC (ID 45)\n",
      "Oligorecurrent and oligoprogressive NSCLC (ID 45)\n",
      "Oligorecurrent and oligoprogressive NSCLC (ID 45)\n",
      "Oligorecurrent and oligoprogressive NSCLC (ID 45)\n",
      "Treatment developments in viral-associated HN malignancies (ID 84)\n",
      "Treatment developments in viral-associated HN malignancies (ID 84)\n",
      "Treatment developments in viral-associated HN malignancies (ID 84)\n",
      "Treatment developments in viral-associated HN malignancies (ID 84)\n",
      "Treatment developments in viral-associated HN malignancies (ID 84)\n",
      "Treatment developments in viral-associated HN malignancies (ID 84)\n",
      "ESMO-SIOG Collaborative session: Immunotherapy in older patients: Challenges and opportunities (ID 142)\n",
      "ESMO-SIOG Collaborative session: Immunotherapy in older patients: Challenges and opportunities (ID 142)\n",
      "ESMO-SIOG Collaborative session: Immunotherapy in older patients: Challenges and opportunities (ID 142)\n",
      "ESMO-SIOG Collaborative session: Immunotherapy in older patients: Challenges and opportunities (ID 142)\n",
      "ESMO-SIOG Collaborative session: Immunotherapy in older patients: Challenges and opportunities (ID 142)\n",
      "ESMO-SIOG Collaborative session: Immunotherapy in older patients: Challenges and opportunities (ID 142)\n",
      "ESMO-SIOG Collaborative session: Immunotherapy in older patients: Challenges and opportunities (ID 142)\n",
      "ESMO-SIOG Collaborative session: Immunotherapy in older patients: Challenges and opportunities (ID 142)\n",
      "Improving the outcomes from anal cancer treatment: Radiotherapy strategies and systemic therapies (ID 28)\n",
      "Improving the outcomes from anal cancer treatment: Radiotherapy strategies and systemic therapies (ID 28)\n",
      "Improving the outcomes from anal cancer treatment: Radiotherapy strategies and systemic therapies (ID 28)\n",
      "Improving the outcomes from anal cancer treatment: Radiotherapy strategies and systemic therapies (ID 28)\n",
      "The past year in sarcoma: Impact on clinical practice (ID 79)\n",
      "The past year in sarcoma: Impact on clinical practice (ID 79)\n",
      "The past year in sarcoma: Impact on clinical practice (ID 79)\n",
      "The past year in sarcoma: Impact on clinical practice (ID 79)\n",
      "The past year in sarcoma: Impact on clinical practice (ID 79)\n",
      "The past year in sarcoma: Impact on clinical practice (ID 79)\n",
      "Proffered Paper – NETs and endocrine tumours (ID 241)\n",
      "Proffered Paper – NETs and endocrine tumours (ID 241)\n",
      "Proffered Paper – NETs and endocrine tumours (ID 241)\n",
      "Proffered Paper – NETs and endocrine tumours (ID 241)\n",
      "Proffered Paper – NETs and endocrine tumours (ID 241)\n",
      "Proffered Paper – NETs and endocrine tumours (ID 241)\n",
      "Proffered Paper – NETs and endocrine tumours (ID 241)\n",
      "Proffered Paper – NETs and endocrine tumours (ID 241)\n",
      "Proffered Paper – NETs and endocrine tumours (ID 241)\n",
      "Early diagnosis of neuroendocrine tumours (NETs): Increasing awareness and optimising diagnostic work up (ID 17)\n",
      "Early diagnosis of neuroendocrine tumours (NETs): Increasing awareness and optimising diagnostic work up (ID 17)\n",
      "Early diagnosis of neuroendocrine tumours (NETs): Increasing awareness and optimising diagnostic work up (ID 17)\n",
      "Practicing oncology in elderly cancer patients (ID 139)\n",
      "Practicing oncology in elderly cancer patients (ID 139)\n",
      "Practicing oncology in elderly cancer patients (ID 139)\n",
      "Practicing oncology in elderly cancer patients (ID 139)\n",
      "Practicing oncology in elderly cancer patients (ID 139)\n",
      "Practicing oncology in elderly cancer patients (ID 139)\n",
      "Practicing oncology in elderly cancer patients (ID 139)\n",
      "Practicing oncology in elderly cancer patients (ID 139)\n",
      "Practicing oncology in elderly cancer patients (ID 139)\n",
      "Practicing oncology in elderly cancer patients (ID 139)\n",
      "Recent advances in thyroid cancer (ID 64)\n",
      "Recent advances in thyroid cancer (ID 64)\n",
      "Recent advances in thyroid cancer (ID 64)\n",
      "Recent advances in thyroid cancer (ID 64)\n",
      "Recent advances in thyroid cancer (ID 64)\n",
      "Recent advances in thyroid cancer (ID 64)\n",
      "Recent advances in thyroid cancer (ID 64)\n",
      "Poster Discussion session - Basic science (ID 215)\n",
      "Poster Discussion session - Basic science (ID 215)\n",
      "Poster Discussion session - Basic science (ID 215)\n",
      "Poster Discussion session - Basic science (ID 215)\n",
      "Poster Discussion session - Basic science (ID 215)\n",
      "Poster Discussion session - Basic science (ID 215)\n",
      "Poster Discussion session - Basic science (ID 215)\n",
      "Poster Discussion session - Basic science (ID 215)\n",
      "Poster Discussion session - Basic science (ID 215)\n",
      "Poster Discussion session - Basic science (ID 215)\n",
      "Poster Discussion session - Basic science (ID 215)\n",
      "Poster Discussion session - Basic science (ID 215)\n",
      "Poster Discussion session - Basic science (ID 215)\n",
      "Poster Discussion session - Basic science (ID 215)\n",
      "Poster Discussion session - Basic science (ID 215)\n",
      "Poster Discussion session - Basic science (ID 215)\n",
      "Poster Discussion session - Basic science (ID 215)\n",
      "Poster Discussion session - Basic science (ID 215)\n",
      "Poster Discussion session - Basic science (ID 215)\n",
      "ESMO Colloquium supported by Lilly Oncology - Metastatic gastro-intestinal cancer: Multiple treatment lines, extended pipeline of available drugs and use of predictive markers. How to best sequence the treatment proposal? (ID 182)\n",
      "ESMO Colloquium supported by Lilly Oncology - Metastatic gastro-intestinal cancer: Multiple treatment lines, extended pipeline of available drugs and use of predictive markers. How to best sequence the treatment proposal? (ID 182)\n",
      "ESMO Colloquium supported by Lilly Oncology - Metastatic gastro-intestinal cancer: Multiple treatment lines, extended pipeline of available drugs and use of predictive markers. How to best sequence the treatment proposal? (ID 182)\n",
      "ESMO Colloquium supported by Lilly Oncology - Metastatic gastro-intestinal cancer: Multiple treatment lines, extended pipeline of available drugs and use of predictive markers. How to best sequence the treatment proposal? (ID 182)\n",
      "ESMO Colloquium supported by Lilly Oncology - Metastatic gastro-intestinal cancer: Multiple treatment lines, extended pipeline of available drugs and use of predictive markers. How to best sequence the treatment proposal? (ID 182)\n",
      "ESMO Colloquium supported by Lilly Oncology - Metastatic gastro-intestinal cancer: Multiple treatment lines, extended pipeline of available drugs and use of predictive markers. How to best sequence the treatment proposal? (ID 182)\n",
      "Specificity of upper tract urothelial carcinoma biology and management (ID 69)\n",
      "Specificity of upper tract urothelial carcinoma biology and management (ID 69)\n",
      "Specificity of upper tract urothelial carcinoma biology and management (ID 69)\n",
      "Radiation-associated sarcoma (ID 61)\n",
      "Radiation-associated sarcoma (ID 61)\n",
      "Radiation-associated sarcoma (ID 61)\n",
      "Radiation-associated sarcoma (ID 61)\n",
      "Radiation-associated sarcoma (ID 61)\n",
      "Radiation-associated sarcoma (ID 61)\n",
      "Tumour educated platelets (ID 54)\n",
      "Tumour educated platelets (ID 54)\n",
      "Tumour educated platelets (ID 54)\n",
      "Liquid biopsies, tumour dormancy and minimal residual disease detection (ID 33)\n",
      "Liquid biopsies, tumour dormancy and minimal residual disease detection (ID 33)\n",
      "Liquid biopsies, tumour dormancy and minimal residual disease detection (ID 33)\n",
      "Liquid biopsies, tumour dormancy and minimal residual disease detection (ID 33)\n",
      "Liquid biopsies, tumour dormancy and minimal residual disease detection (ID 33)\n",
      "Poster Discussion 1 – Translational research (ID 261)\n",
      "Poster Discussion 1 – Translational research (ID 261)\n",
      "Poster Discussion 1 – Translational research (ID 261)\n",
      "Poster Discussion 1 – Translational research (ID 261)\n",
      "Poster Discussion 1 – Translational research (ID 261)\n",
      "Poster Discussion 1 – Translational research (ID 261)\n",
      "Poster Discussion 1 – Translational research (ID 261)\n",
      "Poster Discussion 1 – Translational research (ID 261)\n",
      "Poster Discussion 1 – Translational research (ID 261)\n",
      "Poster Discussion 1 – Translational research (ID 261)\n",
      "Poster Discussion 1 – Translational research (ID 261)\n",
      "Poster Discussion 1 – Translational research (ID 261)\n",
      "Poster Discussion 1 – Translational research (ID 261)\n",
      "Poster Discussion 1 – Translational research (ID 261)\n",
      "Defining optimal response in myeloma (ID 13)\n",
      "Defining optimal response in myeloma (ID 13)\n",
      "Defining optimal response in myeloma (ID 13)\n",
      "Defining optimal response in myeloma (ID 13)\n",
      "Defining optimal response in myeloma (ID 13)\n",
      "Defining optimal response in myeloma (ID 13)\n",
      "Proffered Paper session: Genomic characterization of cancer cells to guide precision medicine: Next steps (ID 286)\n",
      "Proffered Paper session: Genomic characterization of cancer cells to guide precision medicine: Next steps (ID 286)\n",
      "Proffered Paper session: Genomic characterization of cancer cells to guide precision medicine: Next steps (ID 286)\n",
      "Proffered Paper session: Genomic characterization of cancer cells to guide precision medicine: Next steps (ID 286)\n",
      "Proffered Paper session: Genomic characterization of cancer cells to guide precision medicine: Next steps (ID 286)\n",
      "Proffered Paper session: Genomic characterization of cancer cells to guide precision medicine: Next steps (ID 286)\n",
      "Proffered Paper session: Genomic characterization of cancer cells to guide precision medicine: Next steps (ID 286)\n",
      "Level playing field: Working for gender balance in oncology (ID 271)\n",
      "Level playing field: Working for gender balance in oncology (ID 271)\n",
      "Level playing field: Working for gender balance in oncology (ID 271)\n",
      "Level playing field: Working for gender balance in oncology (ID 271)\n",
      "Level playing field: Working for gender balance in oncology (ID 271)\n",
      "Level playing field: Working for gender balance in oncology (ID 271)\n",
      "Level playing field: Working for gender balance in oncology (ID 271)\n",
      "Level playing field: Working for gender balance in oncology (ID 271)\n",
      "Level playing field: Working for gender balance in oncology (ID 271)\n",
      "Level playing field: Working for gender balance in oncology (ID 271)\n",
      "Level playing field: Working for gender balance in oncology (ID 271)\n",
      "Level playing field: Working for gender balance in oncology (ID 271)\n",
      "Level playing field: Working for gender balance in oncology (ID 271)\n",
      "Level playing field: Working for gender balance in oncology (ID 271)\n",
      "Level playing field: Working for gender balance in oncology (ID 271)\n",
      "Level playing field: Working for gender balance in oncology (ID 271)\n",
      "Level playing field: Working for gender balance in oncology (ID 271)\n",
      "Level playing field: Working for gender balance in oncology (ID 271)\n",
      "6th ESMO Designated Centres of Integrated Oncology and Palliative Care and Awards Session – Community brainstorming on key areas (ID 290)\n",
      "6th ESMO Designated Centres of Integrated Oncology and Palliative Care and Awards Session – Community brainstorming on key areas (ID 290)\n",
      "6th ESMO Designated Centres of Integrated Oncology and Palliative Care and Awards Session – Community brainstorming on key areas (ID 290)\n",
      "6th ESMO Designated Centres of Integrated Oncology and Palliative Care and Awards Session – Community brainstorming on key areas (ID 290)\n",
      "6th ESMO Designated Centres of Integrated Oncology and Palliative Care and Awards Session – Community brainstorming on key areas (ID 290)\n",
      "6th ESMO Designated Centres of Integrated Oncology and Palliative Care and Awards Session – Community brainstorming on key areas (ID 290)\n",
      "6th ESMO Designated Centres of Integrated Oncology and Palliative Care and Awards Session – Community brainstorming on key areas (ID 290)\n",
      "6th ESMO Designated Centres of Integrated Oncology and Palliative Care and Awards Session – Community brainstorming on key areas (ID 290)\n",
      "6th ESMO Designated Centres of Integrated Oncology and Palliative Care and Awards Session – Community brainstorming on key areas (ID 290)\n",
      "6th ESMO Designated Centres of Integrated Oncology and Palliative Care and Awards Session – Community brainstorming on key areas (ID 290)\n",
      "6th ESMO Designated Centres of Integrated Oncology and Palliative Care and Awards Session – Community brainstorming on key areas (ID 290)\n",
      "6th ESMO Designated Centres of Integrated Oncology and Palliative Care and Awards Session – Community brainstorming on key areas (ID 290)\n",
      "ESMO Colloquium supported by Daiichi Sankyo Europe GmbH - Relapsed/Refractory FLT3-ITD mutated Acute Myeloid Leukemias (AML) (ID 207)\n",
      "ESMO Colloquium supported by Daiichi Sankyo Europe GmbH - Relapsed/Refractory FLT3-ITD mutated Acute Myeloid Leukemias (AML) (ID 207)\n",
      "ESMO Colloquium supported by Daiichi Sankyo Europe GmbH - Relapsed/Refractory FLT3-ITD mutated Acute Myeloid Leukemias (AML) (ID 207)\n",
      "ESMO Colloquium supported by Daiichi Sankyo Europe GmbH - Relapsed/Refractory FLT3-ITD mutated Acute Myeloid Leukemias (AML) (ID 207)\n",
      "ESMO Colloquium supported by Daiichi Sankyo Europe GmbH - Relapsed/Refractory FLT3-ITD mutated Acute Myeloid Leukemias (AML) (ID 207)\n",
      "ESMO Colloquium supported by Daiichi Sankyo Europe GmbH - Relapsed/Refractory FLT3-ITD mutated Acute Myeloid Leukemias (AML) (ID 207)\n",
      "ESMO Colloquium supported by Daiichi Sankyo Europe GmbH - Relapsed/Refractory FLT3-ITD mutated Acute Myeloid Leukemias (AML) (ID 207)\n",
      "ESMO Colloquium supported by Daiichi Sankyo Europe GmbH - Relapsed/Refractory FLT3-ITD mutated Acute Myeloid Leukemias (AML) (ID 207)\n",
      "EONS 12: Collaborative session EONS YCN - ESMO YOC: Addressing the needs of young cancer professionals (ID 129)\n",
      "EONS 12: Collaborative session EONS YCN - ESMO YOC: Addressing the needs of young cancer professionals (ID 129)\n",
      "EONS 12: Collaborative session EONS YCN - ESMO YOC: Addressing the needs of young cancer professionals (ID 129)\n",
      "EONS 12: Collaborative session EONS YCN - ESMO YOC: Addressing the needs of young cancer professionals (ID 129)\n",
      "EONS 12: Cancer nursing workforce issues (ID 130)\n",
      "EONS 12: Cancer nursing workforce issues (ID 130)\n",
      "EONS 12: Cancer nursing workforce issues (ID 130)\n",
      "EONS 12: Cancer nursing workforce issues (ID 130)\n",
      "EONS 12: Cancer nursing workforce issues (ID 130)\n",
      "EONS 12: Cancer nursing workforce issues (ID 130)\n",
      "EONS 12: Cancer nursing workforce issues (ID 130)\n",
      "EONS 12 Symposium: Advanced Symptom Management (cancer related fatigue (CRF), management of cancer-induced cachexia and nutritional interventions) (ID 282)\n",
      "EONS 12 Symposium: Advanced Symptom Management (cancer related fatigue (CRF), management of cancer-induced cachexia and nutritional interventions) (ID 282)\n",
      "EONS 12 Symposium: Advanced Symptom Management (cancer related fatigue (CRF), management of cancer-induced cachexia and nutritional interventions) (ID 282)\n",
      "EONS 12 Symposium: Advanced Symptom Management (cancer related fatigue (CRF), management of cancer-induced cachexia and nutritional interventions) (ID 282)\n",
      "EONS 12 Symposium: Advanced Symptom Management (cancer related fatigue (CRF), management of cancer-induced cachexia and nutritional interventions) (ID 282)\n",
      "EONS 12 Symposium: Advanced Symptom Management (cancer related fatigue (CRF), management of cancer-induced cachexia and nutritional interventions) (ID 282)\n",
      "EONS 12: Clinical cancer nursing based on evidence (ID 131)\n",
      "EONS 12: Clinical cancer nursing based on evidence (ID 131)\n",
      "EONS 12: Clinical cancer nursing based on evidence (ID 131)\n",
      "EONS 12: Clinical cancer nursing based on evidence (ID 131)\n",
      "EONS 12: Clinical cancer nursing based on evidence (ID 131)\n",
      "EONS 12: Clinical cancer nursing based on evidence (ID 131)\n",
      "EONS 12: Clinical cancer nursing based on evidence (ID 131)\n",
      "EONS 12: Collaborative session EONS-ESMO: What is the point of cancer prevention for oncology staff? (ID 127)\n",
      "EONS 12: Collaborative session EONS-ESMO: What is the point of cancer prevention for oncology staff? (ID 127)\n",
      "EONS 12: Collaborative session EONS-ESMO: What is the point of cancer prevention for oncology staff? (ID 127)\n",
      "EONS 12: Collaborative session EONS-ESMO: What is the point of cancer prevention for oncology staff? (ID 127)\n",
      "EONS 12: Collaborative session EONS-ESMO: What is the point of cancer prevention for oncology staff? (ID 127)\n",
      "EONS 12: Collaborative session EONS-MASCC: Cancer Survivor vs Survivorship: Clash of cultures or words? (ID 128)\n",
      "EONS 12: Collaborative session EONS-MASCC: Cancer Survivor vs Survivorship: Clash of cultures or words? (ID 128)\n",
      "EONS 12: Collaborative session EONS-MASCC: Cancer Survivor vs Survivorship: Clash of cultures or words? (ID 128)\n",
      "EONS 12: Collaborative session EONS-MASCC: Cancer Survivor vs Survivorship: Clash of cultures or words? (ID 128)\n",
      "Immunotherapies: A revolution in cancer treatment, but are they accessible for all patients? (ID 113)\n",
      "Immunotherapies: A revolution in cancer treatment, but are they accessible for all patients? (ID 113)\n",
      "Immunotherapies: A revolution in cancer treatment, but are they accessible for all patients? (ID 113)\n",
      "Immunotherapies: A revolution in cancer treatment, but are they accessible for all patients? (ID 113)\n",
      "Immunotherapies: A revolution in cancer treatment, but are they accessible for all patients? (ID 113)\n",
      "Immunotherapies: A revolution in cancer treatment, but are they accessible for all patients? (ID 113)\n",
      "Immunotherapies: A revolution in cancer treatment, but are they accessible for all patients? (ID 113)\n",
      "Immunotherapies: A revolution in cancer treatment, but are they accessible for all patients? (ID 113)\n",
      "Poster Discussion - Public policy (ID 258)\n",
      "Poster Discussion - Public policy (ID 258)\n",
      "Poster Discussion - Public policy (ID 258)\n",
      "Poster Discussion - Public policy (ID 258)\n",
      "Poster Discussion - Public policy (ID 258)\n",
      "Poster Discussion - Public policy (ID 258)\n",
      "Poster Discussion - Public policy (ID 258)\n",
      "Poster Discussion - Public policy (ID 258)\n",
      "Poster Discussion - Public policy (ID 258)\n",
      "Poster Discussion - Public policy (ID 258)\n",
      "Poster Discussion - Public policy (ID 258)\n",
      "Poster Discussion - Public policy (ID 258)\n",
      "Poster Discussion - Public policy (ID 258)\n",
      "Poster Discussion - Public policy (ID 258)\n",
      "Poster Discussion - Public policy (ID 258)\n",
      "Poster Discussion - Public policy (ID 258)\n",
      "Poster Discussion - Public policy (ID 258)\n",
      "Poster Discussion - Public policy (ID 258)\n",
      "Poster Discussion - Public policy (ID 258)\n",
      "Poster Discussion - Public policy (ID 258)\n",
      "Poster Discussion - Public policy (ID 258)\n",
      "Poster Discussion - Public policy (ID 258)\n",
      "Poster Discussion - Public policy (ID 258)\n",
      "Organ-specific immunity and cancer (ID 136)\n",
      "Organ-specific immunity and cancer (ID 136)\n",
      "Organ-specific immunity and cancer (ID 136)\n",
      "Organ-specific immunity and cancer (ID 136)\n",
      "Organ-specific immunity and cancer (ID 136)\n",
      "Organ-specific immunity and cancer (ID 136)\n",
      "Organ-specific immunity and cancer (ID 136)\n",
      "Organ-specific immunity and cancer (ID 136)\n",
      "The promise of Machine Learning in medical oncology (ID 110)\n",
      "The promise of Machine Learning in medical oncology (ID 110)\n",
      "The promise of Machine Learning in medical oncology (ID 110)\n",
      "The promise of Machine Learning in medical oncology (ID 110)\n",
      "The promise of Machine Learning in medical oncology (ID 110)\n",
      "How can we better support cancer patients suffering from fatigue? (ID 137)\n",
      "How can we better support cancer patients suffering from fatigue? (ID 137)\n",
      "How can we better support cancer patients suffering from fatigue? (ID 137)\n",
      "How can we better support cancer patients suffering from fatigue? (ID 137)\n",
      "How can we better support cancer patients suffering from fatigue? (ID 137)\n",
      "How can we better support cancer patients suffering from fatigue? (ID 137)\n",
      "How can we better support cancer patients suffering from fatigue? (ID 137)\n",
      "How can we better support cancer patients suffering from fatigue? (ID 137)\n",
      "How can we better support cancer patients suffering from fatigue? (ID 137)\n",
      "YO Brunch: Beyond PDFS: New endpoints in immuno-oncology (ID 99)\n",
      "YO Brunch: Beyond PDFS: New endpoints in immuno-oncology (ID 99)\n",
      "YO Brunch: Beyond PDFS: New endpoints in immuno-oncology (ID 99)\n",
      "YO Brunch: Beyond PDFS: New endpoints in immuno-oncology (ID 99)\n",
      "YO Masterclass: Next generation predictive biomarkers in oncology (ID 96)\n",
      "YO Masterclass: Next generation predictive biomarkers in oncology (ID 96)\n",
      "YO Masterclass: Next generation predictive biomarkers in oncology (ID 96)\n",
      "YO Masterclass: Next generation predictive biomarkers in oncology (ID 96)\n",
      "YO Masterclass: Next generation predictive biomarkers in oncology (ID 96)\n",
      "YO Masterclass: Next generation predictive biomarkers in oncology (ID 96)\n",
      "YO Masterclass: Next generation predictive biomarkers in oncology (ID 96)\n",
      "YO Masterclass: Next generation predictive biomarkers in oncology (ID 96)\n",
      "YO Masterclass: Next generation predictive biomarkers in oncology (ID 96)\n",
      "YO Masterclass: Next generation predictive biomarkers in oncology (ID 96)\n",
      "YO Masterclass: Next generation predictive biomarkers in oncology (ID 96)\n",
      "Coping with cancer pain: ESMO patient guide on cancer pain management (ID 288)\n",
      "Coping with cancer pain: ESMO patient guide on cancer pain management (ID 288)\n",
      "Coping with cancer pain: ESMO patient guide on cancer pain management (ID 288)\n",
      "Sex and gender-sensitive medicine: Are we ready to switch paradigm? (ID 289)\n",
      "Sex and gender-sensitive medicine: Are we ready to switch paradigm? (ID 289)\n",
      "Sex and gender-sensitive medicine: Are we ready to switch paradigm? (ID 289)\n",
      "Sex and gender-sensitive medicine: Are we ready to switch paradigm? (ID 289)\n",
      "Poster Display session 2 (ID 211)\n",
      "Poster Display session 2 (ID 211)\n",
      "Poster Display session 2 (ID 211)\n",
      "Poster Display session 2 (ID 211)\n",
      "Poster Display session 2 (ID 211)\n",
      "Poster Display session 2 (ID 211)\n",
      "Poster Display session 2 (ID 211)\n",
      "Poster Display session 2 (ID 211)\n",
      "Poster Display session 2 (ID 211)\n",
      "Poster Display session 2 (ID 211)\n",
      "Poster Display session 2 (ID 211)\n",
      "Poster Display session 2 (ID 211)\n",
      "Poster Display session 2 (ID 211)\n",
      "Poster Display session 2 (ID 211)\n",
      "Poster Display session 2 (ID 211)\n",
      "Poster Display session 2 (ID 211)\n",
      "Poster Display session 2 (ID 211)\n",
      "Poster Display session 2 (ID 211)\n",
      "Poster Display session 2 (ID 211)\n",
      "EONS 12 Workshop: Navigating through a wealth of research methods used by cancer nurses with a focus on PROs (ID 283)\n",
      "EONS 12 Workshop: Navigating through a wealth of research methods used by cancer nurses with a focus on PROs (ID 283)\n",
      "EONS 12 Workshop: Navigating through a wealth of research methods used by cancer nurses with a focus on PROs (ID 283)\n",
      "EONS 12 Workshop: Navigating through a wealth of research methods used by cancer nurses with a focus on PROs (ID 283)\n",
      "EONS 12 Workshop: Navigating through a wealth of research methods used by cancer nurses with a focus on PROs (ID 283)\n",
      "Proffered Paper 2 – Gastrointestinal tumours, colorectal (ID 223)\n",
      "Proffered Paper 2 – Gastrointestinal tumours, colorectal (ID 223)\n",
      "Proffered Paper 2 – Gastrointestinal tumours, colorectal (ID 223)\n",
      "Proffered Paper 2 – Gastrointestinal tumours, colorectal (ID 223)\n",
      "Proffered Paper 2 – Gastrointestinal tumours, colorectal (ID 223)\n",
      "Proffered Paper 2 – Gastrointestinal tumours, colorectal (ID 223)\n",
      "Proffered Paper 2 – Gastrointestinal tumours, colorectal (ID 223)\n",
      "Proffered Paper 2 – Gastrointestinal tumours, colorectal (ID 223)\n",
      "Proffered Paper – Immunotherapy of cancer (ID 238)\n",
      "Proffered Paper – Immunotherapy of cancer (ID 238)\n",
      "Proffered Paper – Immunotherapy of cancer (ID 238)\n",
      "Proffered Paper – Immunotherapy of cancer (ID 238)\n",
      "Proffered Paper – Immunotherapy of cancer (ID 238)\n",
      "Proffered Paper – Immunotherapy of cancer (ID 238)\n",
      "Proffered Paper – Immunotherapy of cancer (ID 238)\n",
      "Proffered Paper – Immunotherapy of cancer (ID 238)\n",
      "Adjuvant treatment duration for high-risk stage II colon cancer (ID 269)\n",
      "Adjuvant treatment duration for high-risk stage II colon cancer (ID 269)\n",
      "Adjuvant treatment duration for high-risk stage II colon cancer (ID 269)\n",
      "Adjuvant treatment duration for high-risk stage II colon cancer (ID 269)\n",
      "Adjuvant treatment duration for high-risk stage II colon cancer (ID 269)\n",
      "Adjuvant treatment duration for high-risk stage II colon cancer (ID 269)\n",
      "Adjuvant treatment duration for high-risk stage II colon cancer (ID 269)\n",
      "Adjuvant treatment duration for high-risk stage II colon cancer (ID 269)\n",
      "Adjuvant treatment duration for high-risk stage II colon cancer (ID 269)\n",
      "Adjuvant treatment duration for high-risk stage II colon cancer (ID 269)\n",
      "Adjuvant treatment duration for high-risk stage II colon cancer (ID 269)\n",
      "Adjuvant treatment duration for high-risk stage II colon cancer (ID 269)\n",
      "Adjuvant treatment duration for high-risk stage II colon cancer (ID 269)\n",
      "Presidential Symposium III (ID 265)\n",
      "Presidential Symposium III (ID 265)\n",
      "Presidential Symposium III (ID 265)\n",
      "Presidential Symposium III (ID 265)\n",
      "Presidential Symposium III (ID 265)\n",
      "Presidential Symposium III (ID 265)\n",
      "Presidential Symposium III (ID 265)\n",
      "Presidential Symposium III (ID 265)\n",
      "Presidential Symposium III (ID 265)\n",
      "Presidential Symposium III (ID 265)\n",
      "Presidential Symposium III (ID 265)\n",
      "Proffered Paper 2 - NSCLC, metastatic (ID 257)\n",
      "Proffered Paper 2 - NSCLC, metastatic (ID 257)\n",
      "Proffered Paper 2 - NSCLC, metastatic (ID 257)\n",
      "Proffered Paper 2 - NSCLC, metastatic (ID 257)\n",
      "Proffered Paper 2 - NSCLC, metastatic (ID 257)\n",
      "Proffered Paper 2 - NSCLC, metastatic (ID 257)\n",
      "Proffered Paper 2 - NSCLC, metastatic (ID 257)\n",
      "Proffered Paper 2 - NSCLC, metastatic (ID 257)\n",
      "Selecting and sequencing therapy in previously untreated urothelial cancer (ID 66)\n",
      "Selecting and sequencing therapy in previously untreated urothelial cancer (ID 66)\n",
      "Selecting and sequencing therapy in previously untreated urothelial cancer (ID 66)\n",
      "Selecting and sequencing therapy in previously untreated urothelial cancer (ID 66)\n",
      "Selecting and sequencing therapy in previously untreated urothelial cancer (ID 66)\n",
      "Selecting and sequencing therapy in previously untreated urothelial cancer (ID 66)\n",
      "Selecting and sequencing therapy in previously untreated urothelial cancer (ID 66)\n",
      "Selecting and sequencing therapy in previously untreated urothelial cancer (ID 66)\n",
      "Caloric restriction mimetics, autophagy and cancer (ID 7)\n",
      "Caloric restriction mimetics, autophagy and cancer (ID 7)\n",
      "The next horizon in metastatic non-small cell targeted therapy (ID 78)\n",
      "The next horizon in metastatic non-small cell targeted therapy (ID 78)\n",
      "The next horizon in metastatic non-small cell targeted therapy (ID 78)\n",
      "The next horizon in metastatic non-small cell targeted therapy (ID 78)\n",
      "The next horizon in metastatic non-small cell targeted therapy (ID 78)\n",
      "The next horizon in metastatic non-small cell targeted therapy (ID 78)\n",
      "The next horizon in metastatic non-small cell targeted therapy (ID 78)\n",
      "Optimal adjuvant and neo-adjuvant therapy in HER-2+ patients (ID 46)\n",
      "Optimal adjuvant and neo-adjuvant therapy in HER-2+ patients (ID 46)\n",
      "Optimal adjuvant and neo-adjuvant therapy in HER-2+ patients (ID 46)\n",
      "Optimal adjuvant and neo-adjuvant therapy in HER-2+ patients (ID 46)\n",
      "Optimal adjuvant and neo-adjuvant therapy in HER-2+ patients (ID 46)\n",
      "Optimal adjuvant and neo-adjuvant therapy in HER-2+ patients (ID 46)\n",
      "Targeting tumour metabolism to impact outcome from metastatic prostate cancers (ID 75)\n",
      "Targeting tumour metabolism to impact outcome from metastatic prostate cancers (ID 75)\n",
      "Targeting tumour metabolism to impact outcome from metastatic prostate cancers (ID 75)\n",
      "Targeting tumour metabolism to impact outcome from metastatic prostate cancers (ID 75)\n",
      "Targeting tumour metabolism to impact outcome from metastatic prostate cancers (ID 75)\n",
      "Targeting tumour metabolism to impact outcome from metastatic prostate cancers (ID 75)\n",
      "Targeting tumour metabolism to impact outcome from metastatic prostate cancers (ID 75)\n",
      "Targeting tumour metabolism to impact outcome from metastatic prostate cancers (ID 75)\n",
      "Tumour neoantigens (ID 88)\n",
      "Tumour neoantigens (ID 88)\n",
      "Tumour neoantigens (ID 88)\n",
      "Tumour neoantigens (ID 88)\n",
      "Tumour neoantigens (ID 88)\n",
      "Tumour neoantigens (ID 88)\n",
      "Tumour neoantigens (ID 88)\n",
      "Tumour neoantigens (ID 88)\n",
      "How to handle comorbidities in the treatment decision of stages I to III NSCLC (ID 23)\n",
      "How to handle comorbidities in the treatment decision of stages I to III NSCLC (ID 23)\n",
      "How to handle comorbidities in the treatment decision of stages I to III NSCLC (ID 23)\n",
      "How to handle comorbidities in the treatment decision of stages I to III NSCLC (ID 23)\n",
      "How to handle comorbidities in the treatment decision of stages I to III NSCLC (ID 23)\n",
      "How to handle comorbidities in the treatment decision of stages I to III NSCLC (ID 23)\n",
      "Proffered Paper 2 – Non-metastatic NSCLC and other thoracic malignancies (mesothelioma and thymic carcinoma) (ID 246)\n",
      "Proffered Paper 2 – Non-metastatic NSCLC and other thoracic malignancies (mesothelioma and thymic carcinoma) (ID 246)\n",
      "Proffered Paper 2 – Non-metastatic NSCLC and other thoracic malignancies (mesothelioma and thymic carcinoma) (ID 246)\n",
      "Proffered Paper 2 – Non-metastatic NSCLC and other thoracic malignancies (mesothelioma and thymic carcinoma) (ID 246)\n",
      "Proffered Paper 2 – Non-metastatic NSCLC and other thoracic malignancies (mesothelioma and thymic carcinoma) (ID 246)\n",
      "Proffered Paper 2 – Non-metastatic NSCLC and other thoracic malignancies (mesothelioma and thymic carcinoma) (ID 246)\n",
      "Proffered Paper 2 – Non-metastatic NSCLC and other thoracic malignancies (mesothelioma and thymic carcinoma) (ID 246)\n",
      "Proffered Paper 2 – Non-metastatic NSCLC and other thoracic malignancies (mesothelioma and thymic carcinoma) (ID 246)\n",
      "Proffered Paper 2 – Non-metastatic NSCLC and other thoracic malignancies (mesothelioma and thymic carcinoma) (ID 246)\n",
      "Which are the preferred platforms for IO biomarkers discovery? (ID 267)\n",
      "Which are the preferred platforms for IO biomarkers discovery? (ID 267)\n",
      "Which are the preferred platforms for IO biomarkers discovery? (ID 267)\n",
      "Which are the preferred platforms for IO biomarkers discovery? (ID 267)\n",
      "Which are the preferred platforms for IO biomarkers discovery? (ID 267)\n",
      "Which are the preferred platforms for IO biomarkers discovery? (ID 267)\n",
      "Which are the preferred platforms for IO biomarkers discovery? (ID 267)\n",
      "Survivor care in the times of innovative therapies (ID 72)\n",
      "Survivor care in the times of innovative therapies (ID 72)\n",
      "Survivor care in the times of innovative therapies (ID 72)\n",
      "Survivor care in the times of innovative therapies (ID 72)\n",
      "Survivor care in the times of innovative therapies (ID 72)\n",
      "Survivor care in the times of innovative therapies (ID 72)\n",
      "Survivor care in the times of innovative therapies (ID 72)\n",
      "Survivor care in the times of innovative therapies (ID 72)\n",
      "Proffered Paper – Head and neck cancer (ID 236)\n",
      "Proffered Paper – Head and neck cancer (ID 236)\n",
      "Proffered Paper – Head and neck cancer (ID 236)\n",
      "Proffered Paper – Head and neck cancer (ID 236)\n",
      "Proffered Paper – Head and neck cancer (ID 236)\n",
      "Proffered Paper – Head and neck cancer (ID 236)\n",
      "Proffered Paper – Head and neck cancer (ID 236)\n",
      "Proffered Paper – Head and neck cancer (ID 236)\n",
      "Proffered Paper – Head and neck cancer (ID 236)\n",
      "Proffered Paper - Breast cancer, early stage (ID 216)\n",
      "Proffered Paper - Breast cancer, early stage (ID 216)\n",
      "Proffered Paper - Breast cancer, early stage (ID 216)\n",
      "Proffered Paper - Breast cancer, early stage (ID 216)\n",
      "Proffered Paper - Breast cancer, early stage (ID 216)\n",
      "Proffered Paper - Breast cancer, early stage (ID 216)\n",
      "Proffered Paper - Breast cancer, early stage (ID 216)\n",
      "Proffered Paper - Breast cancer, early stage (ID 216)\n",
      "Can we turn cold tumours into hot? (ID 276)\n",
      "Can we turn cold tumours into hot? (ID 276)\n",
      "Can we turn cold tumours into hot? (ID 276)\n",
      "Can we turn cold tumours into hot? (ID 276)\n",
      "Can we turn cold tumours into hot? (ID 276)\n",
      "Individualised dosing of commonly used anti-cancer agents (ID 29)\n",
      "Individualised dosing of commonly used anti-cancer agents (ID 29)\n",
      "Individualised dosing of commonly used anti-cancer agents (ID 29)\n",
      "Individualised dosing of commonly used anti-cancer agents (ID 29)\n",
      "Individualised dosing of commonly used anti-cancer agents (ID 29)\n",
      "Individualised dosing of commonly used anti-cancer agents (ID 29)\n",
      "Individualised dosing of commonly used anti-cancer agents (ID 29)\n",
      "Individualised dosing of commonly used anti-cancer agents (ID 29)\n",
      "Individualised dosing of commonly used anti-cancer agents (ID 29)\n",
      "Treatment de-escalation in HPV+ oropharyngeal cancer? (ID 278)\n",
      "Treatment de-escalation in HPV+ oropharyngeal cancer? (ID 278)\n",
      "Treatment de-escalation in HPV+ oropharyngeal cancer? (ID 278)\n",
      "Treatment de-escalation in HPV+ oropharyngeal cancer? (ID 278)\n",
      "Treatment de-escalation in HPV+ oropharyngeal cancer? (ID 278)\n",
      "Treating young patients with BRCA-mutated early breast cancers (ID 83)\n",
      "Treating young patients with BRCA-mutated early breast cancers (ID 83)\n",
      "Treating young patients with BRCA-mutated early breast cancers (ID 83)\n",
      "Treating young patients with BRCA-mutated early breast cancers (ID 83)\n",
      "Treating young patients with BRCA-mutated early breast cancers (ID 83)\n",
      "Treating young patients with BRCA-mutated early breast cancers (ID 83)\n",
      "Single cell cancer analysis (ID 67)\n",
      "Single cell cancer analysis (ID 67)\n",
      "Single cell cancer analysis (ID 67)\n",
      "Single cell cancer analysis (ID 67)\n",
      "Single cell cancer analysis (ID 67)\n",
      "How to use the available results of precision medicine clinical trials (ID 25)\n",
      "How to use the available results of precision medicine clinical trials (ID 25)\n",
      "How to use the available results of precision medicine clinical trials (ID 25)\n",
      "How to use the available results of precision medicine clinical trials (ID 25)\n",
      "How to use the available results of precision medicine clinical trials (ID 25)\n",
      "How to use the available results of precision medicine clinical trials (ID 25)\n",
      "How to use the available results of precision medicine clinical trials (ID 25)\n",
      "How to use the available results of precision medicine clinical trials (ID 25)\n",
      "How to use the available results of precision medicine clinical trials (ID 25)\n",
      "Bronchial neuroendocrine tumours (ID 6)\n",
      "Bronchial neuroendocrine tumours (ID 6)\n",
      "Bronchial neuroendocrine tumours (ID 6)\n",
      "Bronchial neuroendocrine tumours (ID 6)\n",
      "Bronchial neuroendocrine tumours (ID 6)\n",
      "Bronchial neuroendocrine tumours (ID 6)\n",
      "Poster Discussion 2 – Immunotherapy of cancer (ID 250)\n",
      "Poster Discussion 2 – Immunotherapy of cancer (ID 250)\n",
      "Poster Discussion 2 – Immunotherapy of cancer (ID 250)\n",
      "Poster Discussion 2 – Immunotherapy of cancer (ID 250)\n",
      "Poster Discussion 2 – Immunotherapy of cancer (ID 250)\n",
      "Poster Discussion 2 – Immunotherapy of cancer (ID 250)\n",
      "Poster Discussion 2 – Immunotherapy of cancer (ID 250)\n",
      "Poster Discussion 2 – Immunotherapy of cancer (ID 250)\n",
      "Poster Discussion 2 – Immunotherapy of cancer (ID 250)\n",
      "Poster Discussion 2 – Immunotherapy of cancer (ID 250)\n",
      "Poster Discussion 2 – Immunotherapy of cancer (ID 250)\n",
      "Poster Discussion 2 – Immunotherapy of cancer (ID 250)\n",
      "Poster Discussion 2 – Immunotherapy of cancer (ID 250)\n",
      "Poster Discussion 2 – Immunotherapy of cancer (ID 250)\n",
      "Poster Discussion 2 – Immunotherapy of cancer (ID 250)\n",
      "Young patients with stage IB2 cervical cancer (ID 92)\n",
      "Young patients with stage IB2 cervical cancer (ID 92)\n",
      "Young patients with stage IB2 cervical cancer (ID 92)\n",
      "Young patients with stage IB2 cervical cancer (ID 92)\n",
      "Young patients with stage IB2 cervical cancer (ID 92)\n",
      "Young patients with stage IB2 cervical cancer (ID 92)\n",
      "Proffered Paper - Sarcoma (ID 249)\n",
      "Proffered Paper - Sarcoma (ID 249)\n",
      "Proffered Paper - Sarcoma (ID 249)\n",
      "Proffered Paper - Sarcoma (ID 249)\n",
      "Proffered Paper - Sarcoma (ID 249)\n",
      "Proffered Paper - Sarcoma (ID 249)\n",
      "Proffered Paper - Sarcoma (ID 249)\n",
      "Proffered Paper - Sarcoma (ID 249)\n",
      "Proffered Paper - Sarcoma (ID 249)\n",
      "Proffered Paper - Sarcoma (ID 249)\n",
      "Proffered Paper - Sarcoma (ID 249)\n",
      "How do we personalise treatment in stage III NSCLC? (ID 21)\n",
      "How do we personalise treatment in stage III NSCLC? (ID 21)\n",
      "How do we personalise treatment in stage III NSCLC? (ID 21)\n",
      "Options and limitations in oligometastatic disease and metastatic colorectal cancer (mCRC) (ID 48)\n",
      "Options and limitations in oligometastatic disease and metastatic colorectal cancer (mCRC) (ID 48)\n",
      "Options and limitations in oligometastatic disease and metastatic colorectal cancer (mCRC) (ID 48)\n",
      "Options and limitations in oligometastatic disease and metastatic colorectal cancer (mCRC) (ID 48)\n",
      "Options and limitations in oligometastatic disease and metastatic colorectal cancer (mCRC) (ID 48)\n",
      "Options and limitations in oligometastatic disease and metastatic colorectal cancer (mCRC) (ID 48)\n",
      "Options and limitations in oligometastatic disease and metastatic colorectal cancer (mCRC) (ID 48)\n",
      "Treatment of locally recurrent head and neck cancers (ID 85)\n",
      "Treatment of locally recurrent head and neck cancers (ID 85)\n",
      "Treatment of locally recurrent head and neck cancers (ID 85)\n",
      "Treatment of locally recurrent head and neck cancers (ID 85)\n",
      "Treatment of locally recurrent head and neck cancers (ID 85)\n",
      "Treatment of locally recurrent head and neck cancers (ID 85)\n",
      "Management of lymphomas in light of the updated WHO classification (ID 36)\n",
      "Management of lymphomas in light of the updated WHO classification (ID 36)\n",
      "Management of lymphomas in light of the updated WHO classification (ID 36)\n",
      "Management of lymphomas in light of the updated WHO classification (ID 36)\n",
      "Management of lymphomas in light of the updated WHO classification (ID 36)\n",
      "Management of lymphomas in light of the updated WHO classification (ID 36)\n",
      "Poster Discussion 2 – Translational research (ID 262)\n",
      "Poster Discussion 2 – Translational research (ID 262)\n",
      "Poster Discussion 2 – Translational research (ID 262)\n",
      "Poster Discussion 2 – Translational research (ID 262)\n",
      "Poster Discussion 2 – Translational research (ID 262)\n",
      "Poster Discussion 2 – Translational research (ID 262)\n",
      "Poster Discussion 2 – Translational research (ID 262)\n",
      "Poster Discussion 2 – Translational research (ID 262)\n",
      "Poster Discussion 2 – Translational research (ID 262)\n",
      "Poster Discussion 2 – Translational research (ID 262)\n",
      "Poster Discussion 2 – Translational research (ID 262)\n",
      "Poster Discussion 2 – Translational research (ID 262)\n",
      "Poster Discussion 2 – Translational research (ID 262)\n",
      "Treatment of pelvic node-positive prostate cancer (ID 86)\n",
      "Treatment of pelvic node-positive prostate cancer (ID 86)\n",
      "Treatment of pelvic node-positive prostate cancer (ID 86)\n",
      "Treatment of pelvic node-positive prostate cancer (ID 86)\n",
      "Treatment of pelvic node-positive prostate cancer (ID 86)\n",
      "Treatment of pelvic node-positive prostate cancer (ID 86)\n",
      "Precision medicine for sarcoma: Are we there yet? (ID 56)\n",
      "Precision medicine for sarcoma: Are we there yet? (ID 56)\n",
      "Precision medicine for sarcoma: Are we there yet? (ID 56)\n",
      "Precision medicine for sarcoma: Are we there yet? (ID 56)\n",
      "Precision medicine for sarcoma: Are we there yet? (ID 56)\n",
      "Precision medicine for sarcoma: Are we there yet? (ID 56)\n",
      "Are big data, deep learning and AI methods changing cancer care and research? (ID 2)\n",
      "Are big data, deep learning and AI methods changing cancer care and research? (ID 2)\n",
      "Are big data, deep learning and AI methods changing cancer care and research? (ID 2)\n",
      "Are big data, deep learning and AI methods changing cancer care and research? (ID 2)\n",
      "Peritoneal metastases from colorectal cancer (ID 53)\n",
      "Peritoneal metastases from colorectal cancer (ID 53)\n",
      "Peritoneal metastases from colorectal cancer (ID 53)\n",
      "Peritoneal metastases from colorectal cancer (ID 53)\n",
      "Peritoneal metastases from colorectal cancer (ID 53)\n",
      "Peritoneal metastases from colorectal cancer (ID 53)\n",
      "ESMO Colloquium supported by Celgene - Pancreatic cancer: Can better understanding of biology improve resectability and survival? (ID 117)\n",
      "ESMO Colloquium supported by Celgene - Pancreatic cancer: Can better understanding of biology improve resectability and survival? (ID 117)\n",
      "ESMO Colloquium supported by Celgene - Pancreatic cancer: Can better understanding of biology improve resectability and survival? (ID 117)\n",
      "ESMO Colloquium supported by Celgene - Pancreatic cancer: Can better understanding of biology improve resectability and survival? (ID 117)\n",
      "ESMO Colloquium supported by Celgene - Pancreatic cancer: Can better understanding of biology improve resectability and survival? (ID 117)\n",
      "ESMO Colloquium supported by Celgene - Pancreatic cancer: Can better understanding of biology improve resectability and survival? (ID 117)\n",
      "ESMO Colloquium supported by Celgene - Pancreatic cancer: Can better understanding of biology improve resectability and survival? (ID 117)\n",
      "ESMO Colloquium supported by Celgene - Pancreatic cancer: Can better understanding of biology improve resectability and survival? (ID 117)\n",
      "ESMO Colloquium supported by Celgene - Pancreatic cancer: Can better understanding of biology improve resectability and survival? (ID 117)\n",
      "ESMO Colloquium supported by Celgene - Pancreatic cancer: Can better understanding of biology improve resectability and survival? (ID 117)\n",
      "ESMO Colloquium supported by Celgene - Pancreatic cancer: Can better understanding of biology improve resectability and survival? (ID 117)\n",
      "Squamous cell carcinoma of the oesophagus (ID 70)\n",
      "Squamous cell carcinoma of the oesophagus (ID 70)\n",
      "Squamous cell carcinoma of the oesophagus (ID 70)\n",
      "Is there a role for immunotherapy in gliomas? (ID 32)\n",
      "Is there a role for immunotherapy in gliomas? (ID 32)\n",
      "Is there a role for immunotherapy in gliomas? (ID 32)\n",
      "Poster Discussion – NETs and endocrine tumours (ID 254)\n",
      "Poster Discussion – NETs and endocrine tumours (ID 254)\n",
      "Poster Discussion – NETs and endocrine tumours (ID 254)\n",
      "Poster Discussion – NETs and endocrine tumours (ID 254)\n",
      "Poster Discussion – NETs and endocrine tumours (ID 254)\n",
      "Poster Discussion – NETs and endocrine tumours (ID 254)\n",
      "Poster Discussion – NETs and endocrine tumours (ID 254)\n",
      "Poster Discussion – NETs and endocrine tumours (ID 254)\n",
      "Poster Discussion – NETs and endocrine tumours (ID 254)\n",
      "Poster Discussion – NETs and endocrine tumours (ID 254)\n",
      "Poster Discussion – NETs and endocrine tumours (ID 254)\n",
      "Poster Discussion – NETs and endocrine tumours (ID 254)\n",
      "Poster Discussion – NETs and endocrine tumours (ID 254)\n",
      "Poster Discussion – NETs and endocrine tumours (ID 254)\n",
      "Poster Discussion – NETs and endocrine tumours (ID 254)\n",
      "Poster Discussion – NETs and endocrine tumours (ID 254)\n",
      "Poster Discussion – NETs and endocrine tumours (ID 254)\n",
      "Poster Discussion – NETs and endocrine tumours (ID 254)\n",
      "The promise of cure: Chemotherapy free therapies in CLL (ID 80)\n",
      "The promise of cure: Chemotherapy free therapies in CLL (ID 80)\n",
      "The promise of cure: Chemotherapy free therapies in CLL (ID 80)\n",
      "Poster Discussion – Haematological malignancies (ID 244)\n",
      "Poster Discussion – Haematological malignancies (ID 244)\n",
      "Poster Discussion – Haematological malignancies (ID 244)\n",
      "Poster Discussion – Haematological malignancies (ID 244)\n",
      "Poster Discussion – Haematological malignancies (ID 244)\n",
      "Poster Discussion – Haematological malignancies (ID 244)\n",
      "Poster Discussion – Haematological malignancies (ID 244)\n",
      "Poster Discussion – Haematological malignancies (ID 244)\n",
      "Poster Discussion – Haematological malignancies (ID 244)\n",
      "Poster Discussion – Haematological malignancies (ID 244)\n",
      "ESMO-SIOPE/AYA Collaborative session: Genetics and precision medicine for AYA with cancer (ID 143)\n",
      "ESMO-SIOPE/AYA Collaborative session: Genetics and precision medicine for AYA with cancer (ID 143)\n",
      "ESMO-SIOPE/AYA Collaborative session: Genetics and precision medicine for AYA with cancer (ID 143)\n",
      "ESMO-SIOPE/AYA Collaborative session: Genetics and precision medicine for AYA with cancer (ID 143)\n",
      "ESMO-SIOPE/AYA Collaborative session: Genetics and precision medicine for AYA with cancer (ID 143)\n",
      "ESMO-SIOPE/AYA Collaborative session: Genetics and precision medicine for AYA with cancer (ID 143)\n",
      "ESMO-SIOPE/AYA Collaborative session: Genetics and precision medicine for AYA with cancer (ID 143)\n",
      "ESMO-SIOPE/AYA Collaborative session: Genetics and precision medicine for AYA with cancer (ID 143)\n",
      "Drug interaction and the key role of kidney function in onco-haematology (ID 16)\n",
      "Drug interaction and the key role of kidney function in onco-haematology (ID 16)\n",
      "Drug interaction and the key role of kidney function in onco-haematology (ID 16)\n",
      "Relevance of patient reported outcomes (ID 107)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Relevance of patient reported outcomes (ID 107)\n",
      "Relevance of patient reported outcomes (ID 107)\n",
      "Relevance of patient reported outcomes (ID 107)\n",
      "Proffered Paper - Public policy (ID 266)\n",
      "Proffered Paper - Public policy (ID 266)\n",
      "Proffered Paper - Public policy (ID 266)\n",
      "Proffered Paper - Public policy (ID 266)\n",
      "Proffered Paper - Public policy (ID 266)\n",
      "Proffered Paper - Public policy (ID 266)\n",
      "Proffered Paper - Public policy (ID 266)\n",
      "Proffered Paper - Public policy (ID 266)\n",
      "Proffered Paper - Public policy (ID 266)\n",
      "ESMO Colloquium supported by Apogenix - Recurrent glioblastoma management: Challenges and opportunities (ID 206)\n",
      "ESMO Colloquium supported by Apogenix - Recurrent glioblastoma management: Challenges and opportunities (ID 206)\n",
      "ESMO Colloquium supported by Apogenix - Recurrent glioblastoma management: Challenges and opportunities (ID 206)\n",
      "ESMO Colloquium supported by Apogenix - Recurrent glioblastoma management: Challenges and opportunities (ID 206)\n",
      "ESMO Colloquium supported by Apogenix - Recurrent glioblastoma management: Challenges and opportunities (ID 206)\n",
      "ESMO Colloquium supported by Apogenix - Recurrent glioblastoma management: Challenges and opportunities (ID 206)\n",
      "ESMO Colloquium supported by Apogenix - Recurrent glioblastoma management: Challenges and opportunities (ID 206)\n",
      "ESMO Colloquium supported by Apogenix - Recurrent glioblastoma management: Challenges and opportunities (ID 206)\n",
      "ESMO Colloquium supported by Apogenix - Recurrent glioblastoma management: Challenges and opportunities (ID 206)\n",
      "ESMO Colloquium supported by Apogenix - Recurrent glioblastoma management: Challenges and opportunities (ID 206)\n",
      "ESMO Colloquium supported by Apogenix - Recurrent glioblastoma management: Challenges and opportunities (ID 206)\n",
      "ESMO Colloquium supported by Apogenix - Recurrent glioblastoma management: Challenges and opportunities (ID 206)\n",
      "“Doctor, you need help” - Burnout in practising oncologists and ways to tackle it. Psychological support for oncologists: When, where and how (ID 115)\n",
      "“Doctor, you need help” - Burnout in practising oncologists and ways to tackle it. Psychological support for oncologists: When, where and how (ID 115)\n",
      "“Doctor, you need help” - Burnout in practising oncologists and ways to tackle it. Psychological support for oncologists: When, where and how (ID 115)\n",
      "“Doctor, you need help” - Burnout in practising oncologists and ways to tackle it. Psychological support for oncologists: When, where and how (ID 115)\n",
      "“Doctor, you need help” - Burnout in practising oncologists and ways to tackle it. Psychological support for oncologists: When, where and how (ID 115)\n",
      "“Doctor, you need help” - Burnout in practising oncologists and ways to tackle it. Psychological support for oncologists: When, where and how (ID 115)\n",
      "“Doctor, you need help” - Burnout in practising oncologists and ways to tackle it. Psychological support for oncologists: When, where and how (ID 115)\n",
      "“Doctor, you need help” - Burnout in practising oncologists and ways to tackle it. Psychological support for oncologists: When, where and how (ID 115)\n",
      "Practicing oncology: Special issues in real life (ID 140)\n",
      "Practicing oncology: Special issues in real life (ID 140)\n",
      "Practicing oncology: Special issues in real life (ID 140)\n",
      "Practicing oncology: Special issues in real life (ID 140)\n",
      "Practicing oncology: Special issues in real life (ID 140)\n",
      "Practicing oncology: Special issues in real life (ID 140)\n",
      "Practicing oncology: Special issues in real life (ID 140)\n",
      "Practicing oncology: Special issues in real life (ID 140)\n",
      "Practicing oncology: Special issues in real life (ID 140)\n",
      "Practicing oncology: Special issues in real life (ID 140)\n",
      "EONS 12: Collaborative session EONS-SIOG: Meeting the needs of elderly patients with cancer (ID 126)\n",
      "EONS 12: Collaborative session EONS-SIOG: Meeting the needs of elderly patients with cancer (ID 126)\n",
      "EONS 12: Collaborative session EONS-SIOG: Meeting the needs of elderly patients with cancer (ID 126)\n",
      "EONS 12: Collaborative session EONS-SIOG: Meeting the needs of elderly patients with cancer (ID 126)\n",
      "EONS 12: Palliative care (ID 124)\n",
      "EONS 12: Palliative care (ID 124)\n",
      "EONS 12: Palliative care (ID 124)\n",
      "EONS 12: Palliative care (ID 124)\n",
      "EONS 12: Palliative care (ID 124)\n",
      "EONS 12: Palliative care (ID 124)\n",
      "EONS 12: Palliative care (ID 124)\n",
      "EONS 12: Patient/public involvement in cancer care (ID 121)\n",
      "EONS 12: Patient/public involvement in cancer care (ID 121)\n",
      "EONS 12: Patient/public involvement in cancer care (ID 121)\n",
      "EONS 12: Patient/public involvement in cancer care (ID 121)\n",
      "EONS 12 Symposium: Uncommon and Rare Cancers: international collaboration on symptom management with a focus on renal and liver cancers (ID 284)\n",
      "EONS 12 Symposium: Uncommon and Rare Cancers: international collaboration on symptom management with a focus on renal and liver cancers (ID 284)\n",
      "EONS 12 Symposium: Uncommon and Rare Cancers: international collaboration on symptom management with a focus on renal and liver cancers (ID 284)\n",
      "EONS 12 Symposium: Uncommon and Rare Cancers: international collaboration on symptom management with a focus on renal and liver cancers (ID 284)\n",
      "EONS 12 Symposium: Uncommon and Rare Cancers: international collaboration on symptom management with a focus on renal and liver cancers (ID 284)\n",
      "EONS 12: Creating a safety culture in cancer care (ID 122)\n",
      "EONS 12: Creating a safety culture in cancer care (ID 122)\n",
      "EONS 12: Creating a safety culture in cancer care (ID 122)\n",
      "EONS 12: Creating a safety culture in cancer care (ID 122)\n",
      "EONS 12: Creating a safety culture in cancer care (ID 122)\n",
      "EONS 12: Creating a safety culture in cancer care (ID 122)\n",
      "EONS 12: Creating a safety culture in cancer care (ID 122)\n",
      "EONS 12: Closing session (ID 119)\n",
      "EONS 12: Closing session (ID 119)\n",
      "EONS 12: Closing session (ID 119)\n",
      "EONS 12: Closing session (ID 119)\n",
      "EONS 12: Closing session (ID 119)\n",
      "EONS 12: Closing session (ID 119)\n",
      "EONS 12: Closing session (ID 119)\n",
      "EONS 12: Closing session (ID 119)\n",
      "EONS 12: Closing session (ID 119)\n",
      "EONS 12: Closing session (ID 119)\n",
      "EONS 12: Closing session (ID 119)\n",
      "EONS 12: Closing session (ID 119)\n",
      "EONS 12: Closing session (ID 119)\n",
      "The Hans Keulen Memorial Debate (ID 138)\n",
      "The Hans Keulen Memorial Debate (ID 138)\n",
      "The Hans Keulen Memorial Debate (ID 138)\n",
      "The Hans Keulen Memorial Debate (ID 138)\n",
      "The Hans Keulen Memorial Debate (ID 138)\n",
      "Surviving a cancer diagnosis with a good QoL (ID 112)\n",
      "Surviving a cancer diagnosis with a good QoL (ID 112)\n",
      "Surviving a cancer diagnosis with a good QoL (ID 112)\n",
      "Surviving a cancer diagnosis with a good QoL (ID 112)\n",
      "Surviving a cancer diagnosis with a good QoL (ID 112)\n",
      "Surviving a cancer diagnosis with a good QoL (ID 112)\n",
      "Surviving a cancer diagnosis with a good QoL (ID 112)\n",
      "Surviving a cancer diagnosis with a good QoL (ID 112)\n",
      "YO Brunch: How to use social networks and web-based information systems to be up to date in oncology? (ID 100)\n",
      "YO Brunch: How to use social networks and web-based information systems to be up to date in oncology? (ID 100)\n",
      "YO Brunch: How to use social networks and web-based information systems to be up to date in oncology? (ID 100)\n",
      "YO Brunch: How to use social networks and web-based information systems to be up to date in oncology? (ID 100)\n",
      "ESMO Fellowship Programme (ID 102)\n",
      "ESMO Fellowship Programme (ID 102)\n",
      "ESMO Fellowship Programme (ID 102)\n",
      "ESMO Fellowship Programme (ID 102)\n",
      "ESMO Fellowship Programme (ID 102)\n",
      "ESMO Fellowship Programme (ID 102)\n",
      "ESMO Fellowship Programme (ID 102)\n",
      "ESMO Fellowship Programme (ID 102)\n",
      "Poster Display session 3 (ID 212)\n",
      "Poster Display session 3 (ID 212)\n",
      "Poster Display session 3 (ID 212)\n",
      "Poster Display session 3 (ID 212)\n",
      "Poster Display session 3 (ID 212)\n",
      "Poster Display session 3 (ID 212)\n",
      "Poster Display session 3 (ID 212)\n",
      "Poster Display session 3 (ID 212)\n",
      "Poster Display session 3 (ID 212)\n",
      "Poster Display session 3 (ID 212)\n",
      "Poster Display session 3 (ID 212)\n",
      "Poster Display session 3 (ID 212)\n",
      "Poster Display session 3 (ID 212)\n",
      "Poster Display session 3 (ID 212)\n",
      "Poster Display session 3 (ID 212)\n",
      "Poster Display session 3 (ID 212)\n",
      "Poster Display session 3 (ID 212)\n",
      "Poster Display session 3 (ID 212)\n",
      "Poster Display session 3 (ID 212)\n",
      "EONS 12 Workshop: Utilising technology in symptom management and patient safety (ID 285)\n",
      "EONS 12 Workshop: Utilising technology in symptom management and patient safety (ID 285)\n",
      "EONS 12 Workshop: Utilising technology in symptom management and patient safety (ID 285)\n",
      "EONS 12 Workshop: Utilising technology in symptom management and patient safety (ID 285)\n",
      "EONS 12 Workshop: Utilising technology in symptom management and patient safety (ID 285)\n",
      "Congress Highlights 1 (ID 93)\n",
      "Congress Highlights 1 (ID 93)\n",
      "Congress Highlights 1 (ID 93)\n",
      "Congress Highlights 1 (ID 93)\n",
      "Congress Highlights 1 (ID 93)\n",
      "Congress Highlights 1 (ID 93)\n",
      "Congress Highlights 1 (ID 93)\n",
      "Congress Highlights 1 (ID 93)\n",
      "Congress Highlights 1 (ID 93)\n",
      "Congress Highlights 1 (ID 93)\n",
      "Congress Highlights 1 (ID 93)\n",
      "Congress Highlights 1 (ID 93)\n",
      "Congress Highlights 1 (ID 93)\n",
      "Congress Highlights 1 (ID 93)\n",
      "Congress Highlights 2 (ID 94)\n",
      "Congress Highlights 2 (ID 94)\n",
      "Congress Highlights 2 (ID 94)\n",
      "Congress Highlights 2 (ID 94)\n",
      "Congress Highlights 2 (ID 94)\n",
      "Congress Highlights 2 (ID 94)\n",
      "Congress Highlights 2 (ID 94)\n",
      "Congress Highlights 2 (ID 94)\n",
      "Congress Highlights 2 (ID 94)\n",
      "Congress Highlights 2 (ID 94)\n",
      "Congress Highlights 2 (ID 94)\n",
      "Congress Highlights 2 (ID 94)\n",
      "Congress Highlights 2 (ID 94)\n"
     ]
    }
   ],
   "source": [
    "for i in range(len(SESSION)):\n",
    "    print(SESSION[i])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 282,
   "id": "afdf2c79",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Emile E. Voest \n",
      "Eric Van Cutsem \n",
      "Charles Swanton \n",
      "Cristiana Sessa \n",
      "Angelo Di Leo \n",
      "\n",
      "Antoni Ribas \n",
      "Samra Turajlic \n",
      "Kevin J. Harrington \n",
      "Samra Turajlic \n",
      "Florent Petitprez \n",
      "\n",
      "Lizza Hendriks \n",
      "Tony S.K. Mok \n",
      "Laura Q. Chow \n",
      "Yanjun Xu \n",
      "Lizza Hendriks \n",
      "David Spigel \n",
      "Roy S. Herbst \n",
      "Luis Paz-Ares \n",
      "Naiyer Rizvi \n",
      "Ian Chau \n",
      "Per Pfeiffer \n",
      "Thomas Yau \n",
      "Michael Lee \n",
      "Arndt Vogel \n",
      "Volker Kunzmann \n",
      "Arndt Vogel \n",
      "Per Pfeiffer \n",
      "Julien Taieb \n",
      "Takayuki Yoshino \n",
      "Michael Speicher \n",
      "Clara Montagut Viladot \n",
      "Takayuki Yoshino \n",
      "\n",
      "Johann S. De Bono \n",
      "Eleni Efstathiou \n",
      "Matthew R. Smith \n",
      "Nicholas D. James \n",
      "Karim Fizazi \n",
      "Chris Parker \n",
      "Claire L. Vale \n",
      "Gert De Meerleer \n",
      "Camillo Guglielmo Porta \n",
      "Manuela Schmidinger \n",
      "Camillo Guglielmo Porta \n",
      "Laurence Albiges \n",
      "Toni K. Choueiri \n",
      "\n",
      "Judith Balmana \n",
      "Judith Balmana \n",
      "Clare Turnbull \n",
      "Shani Paluch-Shimon \n",
      "Judith Balmana \n",
      "\n",
      "Domenica Lorusso \n",
      "Ana Oaknin \n",
      "Nicoletta Colombo \n",
      "Bradley J. Monk \n",
      "Antonio González Martín \n",
      "Panagiotis A. Konstantinopoulos \n",
      "Susana Banerjee \n",
      "Domenica Lorusso \n",
      "Ana M. Arance \n",
      "Paul Lorigan \n",
      "Paul Lorigan \n",
      "Alexander M. Menzies \n",
      "Dirk Schadendorf \n",
      "\n",
      "Tony Lahoutte \n",
      "Sergio Quezada \n",
      "Sergio Quezada \n",
      "Jos Jonkers \n",
      "Tony Lahoutte \n",
      "\n",
      "Martine Piccart \n",
      "Martine Piccart \n",
      "Rebecca Dent \n",
      "Hope S. Rugo \n",
      "Martine Piccart \n",
      "Daniel Peeper \n",
      "Josep Tabernero \n",
      "Josep Tabernero \n",
      "Daniel Peeper \n",
      "Rodrigo Dienstmann \n",
      "Fatima Mechta-Grigoriou \n",
      "Fabrice André \n",
      "Daniel Peeper \n",
      "E.G. Elisabeth De Vries \n",
      "\n",
      "E.G. Elisabeth De Vries \n",
      "Rosa Giuliani \n",
      "Pekka Kurki \n",
      "João Gonçalves \n",
      "Murray Aitken \n",
      "\n",
      "\n",
      "Maurice Perol \n",
      "Daniel Shao Weng Tan \n",
      "Maurice Perol \n",
      "Caroline Robert \n",
      "Bartosz Chmielowski \n",
      "Caroline Robert \n",
      "Paul M. Clement \n",
      "Martin J. Van den Bent \n",
      "Fabrice Barlesi \n",
      "Emilie Le Rhun \n",
      "Paul M. Clement \n",
      "Nader Sanai \n",
      "Carlos Kamiya-Matsuoka \n",
      "Giuseppe Lombardi \n",
      "Mario Caccese \n",
      "Juan M. Sepulveda Sanchez \n",
      "Fiona H. Blackhall \n",
      "Charles M. Rudin \n",
      "Fiona H. Blackhall \n",
      "Joan Seoane \n",
      "Iain M. Hagan \n",
      "Iain M. Hagan \n",
      "Hiro Funabiki \n",
      "Vincenzo Bronte \n",
      "Thomas B. Powles \n",
      "Joan Seoane \n",
      "Joan Seoane \n",
      "Matthias Preusser \n",
      "Martin J. Van den Bent \n",
      "Patrick Roth \n",
      "Emilie Le Rhun \n",
      "Matthias Preusser \n",
      "\n",
      "Charlotte Coles \n",
      "Philip Poortmans \n",
      "Charlotte Coles \n",
      "Dirk De Ruysscher \n",
      "Florian Strasser \n",
      "\n",
      "Dirk De Ruysscher \n",
      "Jann Arends \n",
      "Fiona McDonald \n",
      "Florian Strasser \n",
      "Dirk De Ruysscher \n",
      "Florian Strasser \n",
      "Karin Jordan \n",
      "Rajesh Lalla \n",
      "Karin Jordan \n",
      "Robert E. Coleman \n",
      "Karin Jordan \n",
      "Matti S. Aapro \n",
      "Stephane Champiat \n",
      "Rajesh Lalla \n",
      "Giuseppe Curigliano \n",
      "Jose M. Martin-Moreno \n",
      "Jose M. Martin-Moreno \n",
      "Mirzagaleb N. Tillyashaykhov \n",
      "Vsevolod B. Matveev \n",
      "Gunta Purkalne \n",
      "Jose M. Martin-Moreno \n",
      "Rosa Giuliani \n",
      "Fatima Cardoso \n",
      "André Ilbawi \n",
      "André Ilbawi \n",
      "André Ilbawi \n",
      "Dario Trapani \n",
      "André Ilbawi \n",
      "Melanie Bertram \n",
      "Fatima Cardoso \n",
      "Fatima Cardoso \n",
      "Dirk Arnold \n",
      "Klaus H. Meier \n",
      "\n",
      "Dirk Arnold \n",
      "Klaus H. Meier \n",
      "Matthew N. Fowler \n",
      "Ewelina Korczowska \n",
      "Zinta Podniece \n",
      "\n",
      "Klaus H. Meier \n",
      "Emile E. Voest \n",
      "Regina Beets-Tan \n",
      "Daniele Regge \n",
      "Giovanni E. Grignani \n",
      "William Allum \n",
      "Daniele Regge \n",
      "William Allum \n",
      "Giovanni E. Grignani \n",
      "Jean-Yves Blay \n",
      "Nicolas Philippou \n",
      "Gilliosa Spurrier-Bernard \n",
      "Nicolas Philippou \n",
      "Lesley Henson \n",
      "Nathan I. Cherny \n",
      "George Samoutis \n",
      "Kathy R. Oliver \n",
      "Gilliosa Spurrier-Bernard \n",
      "Ananda Plate \n",
      "Bettina Ryll \n",
      "Bettina Ryll \n",
      "Katheryn Elun Morgan \n",
      "Francesco Pignatti \n",
      "Carla Deakin \n",
      "Linda Van Saase \n",
      "Bettina Ryll \n",
      "Teresa M. Amaral \n",
      "Kevin Punie \n",
      "Manuela Schmidinger \n",
      "Evandro De Azambuja \n",
      "Livio Trusolino \n",
      "Therese Sorlie \n",
      "Leticia De Mattos-Arruda \n",
      "Laurence Albiges \n",
      "Gaia Schiavon \n",
      "Jean-Charles Soria \n",
      "Michiel H. Strijbos \n",
      "Stefan Rauh \n",
      "Stein Kaasa \n",
      "Carla I. Ripamonti \n",
      "Razvan-Ovidiu Curca \n",
      "Jutta Kappes \n",
      "Guillem Argiles Martinez \n",
      "Susana Banerjee \n",
      "Michiel H. Strijbos \n",
      "Fatima Cardoso \n",
      "Claudia Cardone \n",
      "Mehmet A. Ozturk \n",
      "Radu A. Vidra \n",
      "Elena Elez Fernández \n",
      "John B. Haanen \n",
      "Teresa Troiani \n",
      "Laurence Albiges \n",
      "Ignacio Duran Martinez \n",
      "Chung-Han Lee \n",
      "Scott T. Tagawa \n",
      "Ignacio Duran Martinez \n",
      "Christopher J. Hoimes \n",
      "Thomas B. Powles \n",
      "Yohann Loriot \n",
      "Rebecca Dent \n",
      "Shani Paluch-Shimon \n",
      "Hope S. Rugo \n",
      "Javier Cortés \n",
      "Leisha A. Emens \n",
      "Giampaolo Bianchini \n",
      "Joyce O'Shaughnessy \n",
      "Sara M. Tolaney \n",
      "Mafalda Oliveira \n",
      "Claus-Henning Koehne \n",
      "Demetris Papamichael \n",
      "Julien Taieb \n",
      "Noelia Tarazona Llavero \n",
      "Clara Montagut Viladot \n",
      "Dion Morton \n",
      "Jianmin Xu \n",
      "Claus-Henning Koehne \n",
      "Andres Cervantes \n",
      "Solange Peters \n",
      "Antonio González Martín \n",
      "Isabelle L. Ray-Coquard \n",
      "Ana Oaknin \n",
      "Robert L. Coleman \n",
      "Mansoor Raza Mirza \n",
      "Solange Peters \n",
      "Sanjay Popat \n",
      "Suresh S. Ramalingam \n",
      "Pasi A. Jänne \n",
      "Thierry Berghmans \n",
      "Anne-Marie C. Dingemans \n",
      "\n",
      "Anne-Marie C. Dingemans \n",
      "Virginie Westeel \n",
      "Paul E. Van Schil \n",
      "Regine D. Ihlen \n",
      "Thierry Berghmans \n",
      "Marina C. Garassino \n",
      "Luis Paz-Ares \n",
      "Marina C. Garassino \n",
      "Lisa Derosa \n",
      "Naiyer Rizvi \n",
      "Gianpietro Dotti \n",
      "Marina C. Garassino \n",
      "Luis Paz-Ares \n",
      "Lisa F. Licitra \n",
      "Jack Cuzick \n",
      "Federico Cappuzzo \n",
      "Solange Peters \n",
      "Federico Cappuzzo \n",
      "Solange Peters \n",
      "Martin Reck \n",
      "Rafal Dziadziuszko \n",
      "Benjamin Besse \n",
      "Solange Peters \n",
      "Fatima Cardoso \n",
      "Fatima Cardoso \n",
      "Fabrice André \n",
      "Matthew Ellis \n",
      "\n",
      "Laurence Buisseret \n",
      "Aurélien Marabelle \n",
      "Aurélien Marabelle \n",
      "Benjamin Besse \n",
      "Aurélien Marabelle \n",
      "Bertrand Routy \n",
      "George Coukos \n",
      "\n",
      "Markus Moehler \n",
      "Kei Muro \n",
      "Kei Muro \n",
      "Markus Moehler \n",
      "Russell Petty \n",
      "Kei Muro \n",
      "Yelena Y. Janjigian \n",
      "Markus Moehler \n",
      "Maria De Santis \n",
      "Jan Oldenburg \n",
      "Tim Q. Eisen \n",
      "Marc-Oliver Grimm \n",
      "Cristina Suárez \n",
      "Silke Gillessen \n",
      "Jan Oldenburg \n",
      "Michel P. Ducreux \n",
      "David A. Tuveson \n",
      "David A. Tuveson \n",
      "Michel P. Ducreux \n",
      "Stefano Cascinu \n",
      "Eileen M. O'Reilly \n",
      "\n",
      "Sabine C. Linn \n",
      "Jose A. Lopez-Martin \n",
      "Karim Fizazi \n",
      "Benedetta Pellegrino \n",
      "Sabine C. Linn \n",
      "Jason Luke \n",
      "Geoffrey R. Oxnard \n",
      "Jose A. Lopez-Martin \n",
      "Paolo A. Ascierto \n",
      "Olivier A. Michielin \n",
      "Paolo A. Ascierto \n",
      "Caroline Robert \n",
      "Antoni Ribas \n",
      "Christian U. Blank \n",
      "Paolo A. Ascierto \n",
      "Olivier A. Michielin \n",
      "Mansoor Raza Mirza \n",
      "Susana Banerjee \n",
      "Christian Marth \n",
      "Carien L. Creutzberg \n",
      "Mansoor Raza Mirza \n",
      "\n",
      "Piotr Rutkowski \n",
      "Bartosz Chmielowski \n",
      "Reinhard Dummer \n",
      "Dirk Schadendorf \n",
      "Jeffrey S. Weber \n",
      "Bartosz Chmielowski \n",
      "James M. Larkin \n",
      "Ana M. Arance \n",
      "Georgina V. Long \n",
      "Ulrich Keilholz \n",
      "Giuseppe Curigliano \n",
      "Sibylle Loibl \n",
      "Giuseppe Curigliano \n",
      "Sherene Loi \n",
      "Andrew Tutt \n",
      "\n",
      "Johan F. Vansteenkiste \n",
      "Anne-Marie C. Dingemans \n",
      "Luis Paz-Ares \n",
      "Martin Reck \n",
      "Johan F. Vansteenkiste \n",
      "Jeffrey Bogart \n",
      "Ying Cheng \n",
      "Christine Hann \n",
      "Rafal Dziadziuszko \n",
      "Michail Ignatiadis \n",
      "Ulrik N. Lassen \n",
      "Michail Ignatiadis \n",
      "Christian Rolfo \n",
      "Martijn P. Lolkema \n",
      "\n",
      "Christian Rolfo \n",
      "Christian Rolfo \n",
      "Dennis \n",
      "Stefan Sleijfer \n",
      "Christian Rolfo \n",
      "Paolo A. Ascierto \n",
      "Salvador Martin Algarra \n",
      "Ana M. Arance \n",
      "Piotr Rutkowski \n",
      "Jason A. Chesney \n",
      "Elizabeth M. Burton \n",
      "Paolo A. Ascierto \n",
      "\n",
      "Henrik Jespersen \n",
      "Jean Jacques Grob \n",
      "Paul Nathan \n",
      "Neil Gross \n",
      "Ana M. Arance \n",
      "\n",
      "Elisa A. Rozeman \n",
      "Christian U. Blank \n",
      "Piotr Rutkowski \n",
      "\n",
      "Jeffrey S. Weber \n",
      "Krisztian Homicsko \n",
      "Hanna Eriksson \n",
      "Salvador Martin Algarra \n",
      "\n",
      "Rachel Giles \n",
      "Bertrand Tombal \n",
      "Bertrand Tombal \n",
      "Charles Swanton \n",
      "Nicholas D. James \n",
      "Andrea Necchi \n",
      "Axel Bex \n",
      "\n",
      "Marianne E. Pavel \n",
      "Ashley Grossman \n",
      "Ashley Grossman \n",
      "Andrea Frilling \n",
      "Marianne E. Pavel \n",
      "\n",
      "Karin Jordan \n",
      "Florian Scotté \n",
      "Robin Lewis Jones \n",
      "Serena Di Cosimo \n",
      "Manuel Sanchez Canovas \n",
      "Jorn Herrstedt \n",
      "Samy Alsirafy \n",
      "Victoria Memoli \n",
      "Florian Scotté \n",
      "Laura Biganzoli \n",
      "Carmen Criscitiello \n",
      "Peter Kern \n",
      "Mattea Reinisch \n",
      "Veronique D'Hondt \n",
      "Peter Kern \n",
      "\n",
      "Vincent De Jong \n",
      "Jenny Furlanetto \n",
      "Nienke De Glas \n",
      "Laura Biganzoli \n",
      "\n",
      "Frederik Marmé \n",
      "Per Eystein Lønning \n",
      "Hans P. Eikesdal \n",
      "Tess O'Meara \n",
      "Carmen Criscitiello \n",
      "\n",
      "Iain M. Hagan \n",
      "Thomas Helleday \n",
      "Jeffrey H. Rothman \n",
      "Debottam Sinha \n",
      "Yiting Sun \n",
      "Iain M. Hagan \n",
      "Clelia Coutzac \n",
      "Aanchal P. Kaur \n",
      "Bertrand Routy \n",
      "Leticia Quintanilla Fend \n",
      "Liran Shlush \n",
      "Liran Shlush \n",
      "Leticia Quintanilla Fend \n",
      "Liran Shlush \n",
      "Jude Fitzgibbon \n",
      "Davide Rossi \n",
      "Leticia Quintanilla Fend \n",
      "Andrew Hayes \n",
      "Emanuela Palmerini \n",
      "Hans-Ulrich Schildhaus \n",
      "Francois Gouin \n",
      "Armelle Dufresne \n",
      "Peter Reichardt \n",
      "Andrew Hayes \n",
      "\n",
      "Javier Martin Broto \n",
      "Nathalie Gaspar \n",
      "Angela Hirbe \n",
      "Emanuela Palmerini \n",
      "\n",
      "Florent Petitprez \n",
      "Maud Toulmonde \n",
      "Hans-Ulrich Schildhaus \n",
      "\n",
      "Suzanne George \n",
      "Maud Toulmonde \n",
      "Suzanne George \n",
      "Hans-Ulrich Schildhaus \n",
      "Silvia Stacchiotti \n",
      "Sebastian Bauer \n",
      "Suzanne George \n",
      "Ralf Herold \n",
      "Maud Toulmonde \n",
      "Laura D. Locati \n",
      "Jean-Pascal Machiels \n",
      "Amanda Psyrri \n",
      "Shih-min Lin \n",
      "Paolo Bossi \n",
      "Haitham Mirghani \n",
      "Laura D. Locati \n",
      "\n",
      "Ezra Cohen \n",
      "Adam J. Luginbuhl \n",
      "Siddharth Sheth \n",
      "Yungan Tao \n",
      "Jean-Pascal Machiels \n",
      "\n",
      "Danny Rischin \n",
      "Jérome Fayette \n",
      "Amanda Psyrri \n",
      "\n",
      "Robert L. Coleman \n",
      "Sandro Pignata \n",
      "Robert L. Coleman \n",
      "Paolo Bossi \n",
      "Anton Snegovoy \n",
      "Stein Kaasa \n",
      "Zachary W. Veitch \n",
      "Jean-Marie Michot \n",
      "Matthaios Kapiris \n",
      "Paolo Bossi \n",
      "\n",
      "Louise Raunkilde \n",
      "Naoya Yamazaki \n",
      "John C. Wells \n",
      "Anton Snegovoy \n",
      "\n",
      "Tai Chung Lam \n",
      "Ali Alkan \n",
      "Stein Kaasa \n",
      "\n",
      "Inge-Marie Svane \n",
      "Fiona Thistlethwaite \n",
      "Xueming Du \n",
      "Przemyslaw Twardowski \n",
      "Jeroen Creemers \n",
      "Joshua Tobias \n",
      "Eszter Somogyi \n",
      "Inge-Marie Svane \n",
      "\n",
      "Hiroyoshi Hattori \n",
      "Marcus O. Butler \n",
      "Maartje W. Rohaan \n",
      "Zhitao Ying \n",
      "Fiona Thistlethwaite \n",
      "\n",
      "Ramon Salazar \n",
      "Claus Rödel \n",
      "Ramon Salazar \n",
      "Anna Sophie Berghoff \n",
      "Anna Sophie Berghoff \n",
      "Felix Sahm \n",
      "Frederic Dhermain \n",
      "Anna Sophie Berghoff \n",
      "\n",
      "Jorn Herrstedt \n",
      "Jorn Herrstedt \n",
      "Fabio Gomes \n",
      "Siri Rostoft \n",
      "Marije Hamaker \n",
      "\n",
      "Hanneke W. Van Laarhoven \n",
      "Florian Lordick \n",
      "Russell Petty \n",
      "Ana C. Raimundo \n",
      "Stefano Cascinu \n",
      "Michael Davidson \n",
      "Hanneke W. Van Laarhoven \n",
      "\n",
      "Eric Van Cutsem \n",
      "Peter Hall \n",
      "Pascal Hammel \n",
      "Philippe Merle \n",
      "Florian Lordick \n",
      "\n",
      "Karthikeyan Murugesan \n",
      "Lorenza Rimassa \n",
      "Jingyuan Wang \n",
      "Min Hwan Kim \n",
      "Russell Petty \n",
      "\n",
      "Luis Garcia Rodriguez \n",
      "Ahmed Kaseb \n",
      "Ana C. Raimundo \n",
      "Anton Berns \n",
      "Fatima Cardoso \n",
      "\n",
      "Marta Ligero \n",
      "Yara Abdou \n",
      "Nikos Paragios \n",
      "Christos Sotiriou \n",
      "Giles Wainrib \n",
      "David Cameron \n",
      "Christoph Klein \n",
      "David Cameron \n",
      "Udai Banerji \n",
      "Udai Banerji \n",
      "Urania Dafni \n",
      "Francesco Pignatti \n",
      "Christophe Massard \n",
      "\n",
      "Christian Dittrich \n",
      "Hendrik-Tobias Arkenau \n",
      "Udai Banerji \n",
      "Ulrik N. Lassen \n",
      "Timothy R Wilson \n",
      "Robert Charles Doebele \n",
      "Alexander Drilon \n",
      "David M. Hyman \n",
      "Christian Dittrich \n",
      "\n",
      "Ramaswamy Govindan \n",
      "Ryan B. Corcoran \n",
      "Alice Chen \n",
      "Apostolia Maria Tsimberidou \n",
      "Hendrik-Tobias Arkenau \n",
      "\n",
      "Magnus Dillon \n",
      "Agostina Stradella \n",
      "Mark Voskoboynik \n",
      "Udai Banerji \n",
      "\n",
      "Petri Bono \n",
      "Funda Meric-Bernstam \n",
      "Sylvie Bonvalot \n",
      "Sebastian Bauer \n",
      "Sylvie Bonvalot \n",
      "Aristotelis Bamias \n",
      "Chris Parker \n",
      "Aristotelis Bamias \n",
      "Dirk Arnold \n",
      "Stefan Rauh \n",
      "Dirk Arnold \n",
      "Jean-Luc Molitor \n",
      "Maurice Perol \n",
      "\n",
      "Stefan Rauh \n",
      "Maike Collienne \n",
      "\n",
      "Stefan Rauh \n",
      "Matti S. Aapro \n",
      "\n",
      "Jean-Luc Molitor \n",
      "Jann Arends \n",
      "\n",
      "Dirk Arnold \n",
      "Valentina Guarneri \n",
      "Suzette Delaloge \n",
      "Valentina Guarneri \n",
      "Amanda Psyrri \n",
      "Tanguy Seiwert \n",
      "Amanda Psyrri \n",
      "Nathan I. Cherny \n",
      "E.G. Elisabeth De Vries \n",
      "E.G. Elisabeth De Vries \n",
      "Shani Paluch-Shimon \n",
      "Derk Jan De Groot \n",
      "Nathan I. Cherny \n",
      "Dilyara Kaidarova \n",
      "André Ilbawi \n",
      "E.G. Elisabeth De Vries \n",
      "Dieta Brandsma \n",
      "Olivier Chinot \n",
      "Patrick Roth \n",
      "Maximilian Mair \n",
      "Hironori Matsunaga \n",
      "Wafa Boulfoul \n",
      "Olivier Chinot \n",
      "\n",
      "Maria Angeles V. Vaz Salgado \n",
      "Pegah Mir Seyed Nazari \n",
      "Coline Montegut \n",
      "Maria Martinez Garcia \n",
      "Patrick Roth \n",
      "\n",
      "Ariane Steindl \n",
      "Ariane Steindl \n",
      "Dieta Brandsma \n",
      "\n",
      "Laurence Albiges \n",
      "Laurence Albiges \n",
      "Jeffrey Evans \n",
      "\n",
      "Ignacio Melero \n",
      "\n",
      "Viktor Gruenwald \n",
      "\n",
      "\n",
      "Anastasios Stathis \n",
      "Stefan S. Bielack \n",
      "Jarrod Longcor \n",
      "Amer Zeidan \n",
      "Anastasios Stathis \n",
      "Lucas Moreno \n",
      "Jill Boss \n",
      "Stefan S. Bielack \n",
      "Andreas Charalambous \n",
      "Lena Sharp \n",
      "Andreas Charalambous \n",
      "Lena Sharp \n",
      "Nuria Domenech \n",
      "Maria Teresa Moreno-Casbas \n",
      "Hester Vermeulen \n",
      "Seyma I. Pasalak \n",
      "Amanda Drury \n",
      "\n",
      "Daniel Kelly \n",
      "Ciara Kirke \n",
      "Oili Papinaho \n",
      "Rebecca Verity \n",
      "Anne Gerber \n",
      "Paul Sessink \n",
      "\n",
      "Eugenia Trigoso Arjona \n",
      "Elaine R. Vickers \n",
      "Martina Spalt \n",
      "Cassandra I. Andersson Vila \n",
      "\n",
      "Patricia Fox \n",
      "Constantina Papadopoulou \n",
      "Paul D'Alton \n",
      "Emma Hainsworth \n",
      "\n",
      "Wendy Oldenmenger \n",
      "Saskia C. Teunissen \n",
      "Kristina Karp \n",
      "Yasemin Eskigulek \n",
      "Mary Nevin \n",
      "Nurul Huda \n",
      "\n",
      "Alexandru Eniu \n",
      "Vlad Voiculescu \n",
      "Vlad Voiculescu \n",
      "Alexandru Eniu \n",
      "Zeba Aziz \n",
      "Nicola Magrini \n",
      "\n",
      "\n",
      "E.G. Elisabeth De Vries \n",
      "Kiusiang Tay-Teo \n",
      "Bengt Jönsson \n",
      "Valérie Paris \n",
      "Georgie Linscott \n",
      "Kiusiang Tay-Teo \n",
      "\n",
      "\n",
      "Simon Ekman \n",
      "Fredrik Johansson \n",
      "Simon Ekman \n",
      "Merel Hennink \n",
      "Matthias Scheffler \n",
      "Iain Galloway \n",
      "\n",
      "Fredrik Johansson \n",
      "Scott Berry \n",
      "Paolo G. Casali \n",
      "Scott Berry \n",
      "Guillem Lopez Casasnovas \n",
      "Vlad Voiculescu \n",
      "Jan Helge Solbakk \n",
      "\n",
      "Tanja Spanic \n",
      "Jan Geissler \n",
      "Ananda Plate \n",
      "Matteo Lambertini \n",
      "Fedro A. Peccatori \n",
      "Tanja Spanic \n",
      "\n",
      "Matteo Lambertini \n",
      "Anna Sophie Berghoff \n",
      "\n",
      "\n",
      "Evandro De Azambuja \n",
      "Carmen Criscitiello \n",
      "Javier Cortés \n",
      "\n",
      "\n",
      "Alfredo Addeo \n",
      "Enriqueta Felip \n",
      "Solange Peters \n",
      "Ioannis Litos \n",
      "Christoph Oing \n",
      "Hege Sagstuen Haugnes \n",
      "Ines V. Luis \n",
      "\n",
      "\n",
      "Andres Cervantes \n",
      "Anna Sophie Berghoff \n",
      "Andres Cervantes \n",
      "Anna Sophie Berghoff \n",
      "Kok Haw Jonathan Lim \n",
      "Mila Petrova \n",
      "Teresa M. Amaral \n",
      "Laurids Ø. Poulsen \n",
      "Kevin Punie \n",
      "Caroline Dive \n",
      "Iain M. Hagan \n",
      "Li-Shuang Ai \n",
      "Nunzia Matrone \n",
      "Nicola Gaynor \n",
      "Maysa Al-natsheh \n",
      "Vilma Petrikaite \n",
      "Iniobong A. Charles \n",
      "Hitomi Kawaji \n",
      "Chengwei Lin \n",
      "Fumi Tetsuo \n",
      "Xinyan Zhang \n",
      "Olga Simonova \n",
      "John J. Park \n",
      "Sungchan Jang \n",
      "Seung-hun Jang \n",
      "Hideaki Karasawa \n",
      "Jung-jyh Hung \n",
      "Xin Guo \n",
      "Pietro Paolo Vitiello \n",
      "Hein Jambroers \n",
      "Hein Jambroers \n",
      "Aileen O’Meara \n",
      "Scott Tomlins \n",
      "Rose Ellard \n",
      "\n",
      "Alexander Stein \n",
      "Livio Trusolino \n",
      "Alexander Stein \n",
      "Andrea Sartore-Bianchi \n",
      "Alexander Stein \n",
      "Rodrigo Dienstmann \n",
      "Owen J. Sansom \n",
      "Livio Trusolino \n",
      "Rebecca Dent \n",
      "Veronique C. Dieras \n",
      "Rebecca Dent \n",
      "Carsten Denkert \n",
      "Javier Cortés \n",
      "Veronique C. Dieras \n",
      "Rebecca Dent \n",
      "Sibylle Loibl \n",
      "Veronique C. Dieras \n",
      "Fabrice André \n",
      "Jorge S. Reis-Filho \n",
      "Jorge S. Reis-Filho \n",
      "Monica Arnedos \n",
      "Jorge S. Reis-Filho \n",
      "Nicholas Turner \n",
      "Nikos Paragios \n",
      "Fabrice André \n",
      "Fatima Cardoso \n",
      "Fortunato Ciardiello \n",
      "George Sledge \n",
      "Dennis J. Slamon \n",
      "Sibylle Loibl \n",
      "Peter Schmid \n",
      "Veronique C. Dieras \n",
      "Sherene Loi \n",
      "Jonathan A. Ledermann \n",
      "Isabelle L. Ray-Coquard \n",
      "Kathleen N. Moore \n",
      "David M. Gershenson \n",
      "Jonathan A. Ledermann \n",
      "Robert W. Naumann \n",
      "Vicky Makker \n",
      "Nicoletta Colombo \n",
      "Kei Muro \n",
      "Eileen M. O'Reilly \n",
      "Yoon-Koo Kang \n",
      "Jiafu Ji \n",
      "Salah-Eddin Al-Batran \n",
      "Yoon-Koo Kang \n",
      "Kohei Shitara \n",
      "Kei Muro \n",
      "Caroline Dive \n",
      "Dafna Bar-Sagi \n",
      "Jonathan A. Ledermann \n",
      "Ana Oaknin \n",
      "Jonathan A. Ledermann \n",
      "Lana Kandalaft \n",
      "Antonio González Martín \n",
      "Jonathan A. Ledermann \n",
      "Charlie Gourley \n",
      "Ana Oaknin \n",
      "Virginie Westeel \n",
      "Wilfried E. Eberhardt \n",
      "Giuseppe Lo Russo \n",
      "Bartomeu Massuti \n",
      "Masahiro Tsuboi \n",
      "Yi-Long Wu \n",
      "Virginie Westeel \n",
      "\n",
      "Solange Peters \n",
      "Yoshitaka Zenke \n",
      "Johan F. Vansteenkiste \n",
      "Wilfried E. Eberhardt \n",
      "\n",
      "Shaorong Yu \n",
      "Ikuo Sekine \n",
      "Davey Daniel \n",
      "Sjaak A. Burgers \n",
      "Giuseppe Lo Russo \n",
      "\n",
      "Joaquin Mateo \n",
      "Mark A. Rubin \n",
      "Mark A. Rubin \n",
      "Scott Tomlins \n",
      "Johann S. De Bono \n",
      "Mark A. Rubin \n",
      "Ros Eeles \n",
      "Joaquin Mateo \n",
      "Alessandra Curioni \n",
      "Johan F. Vansteenkiste \n",
      "Ad Verhagen \n",
      "Kevin Franks \n",
      "Alessandra Curioni \n",
      "\n",
      "Reinhard Dummer \n",
      "Mario Mandala \n",
      "Jürgen C. Becker \n",
      "Reinhard Dummer \n",
      "Axel Hauschild \n",
      "\n",
      "Irene Brana \n",
      "Amanda Psyrri \n",
      "Irene Brana \n",
      "Eric Deutsch \n",
      "Magnus Dillon \n",
      "Kevin J. Harrington \n",
      "Irene Brana \n",
      "Amanda Psyrri \n",
      "Ivan Dikic \n",
      "Thomas Helleday \n",
      "Ivan Dikic \n",
      "Thanos Halazonetis \n",
      "Thomas Helleday \n",
      "\n",
      "Joaquim Bellmunt \n",
      "Guillermo A. De Velasco Oria de Rueda \n",
      "Viktor Gruenwald \n",
      "Christian K. Kollmannsberger \n",
      "Michiel S. Van der Heijden \n",
      "Andrea Necchi \n",
      "Alain Ravaud \n",
      "Joaquim Bellmunt \n",
      "\n",
      "Lewis Au \n",
      "Laurence Albiges \n",
      "Yann Vano \n",
      "Toni K. Choueiri \n",
      "Guillermo A. De Velasco Oria de Rueda \n",
      "\n",
      "Eric Jonasch \n",
      "Toni K. Choueiri \n",
      "Viktor Gruenwald \n",
      "\n",
      "Elena Farè \n",
      "Christoph Seidel \n",
      "Rachel Giles \n",
      "Christian K. Kollmannsberger \n",
      "Alexandru Eniu \n",
      "Aleix Prat \n",
      "Sherko Kümmel \n",
      "Miguel Martín \n",
      "Joan Albanell \n",
      "Francois-Clement Bidard \n",
      "Aleix Prat \n",
      "\n",
      "Soohyeon Lee \n",
      "Yen-Shen Lu \n",
      "Alexandru Eniu \n",
      "\n",
      "Binghe Xu \n",
      "Vahit Ozmen \n",
      "Sherko Kümmel \n",
      "\n",
      "Jaeho Jeong \n",
      "Zefei Jiang \n",
      "Miguel Martín \n",
      "\n",
      "John B. Haanen \n",
      "Ignacio Melero \n",
      "John B. Haanen \n",
      "Pia J. Österlund \n",
      "Demetris Papamichael \n",
      "Ramon Salazar \n",
      "Andrea Sartore-Bianchi \n",
      "Filippo Pietrantonio \n",
      "Yoshiaki Nakamura \n",
      "John H. Strickler \n",
      "Ramon Salazar \n",
      "\n",
      "Jonathan M. Loree \n",
      "Caroline B. Thomsen \n",
      "Elisa Fontana \n",
      "Manuel Valladares-Ayerbes \n",
      "Pia J. Österlund \n",
      "\n",
      "Nick West \n",
      "Niharika B. Mettu \n",
      "Demetris Papamichael \n",
      "\n",
      "Fiona H. Blackhall \n",
      "Ross Soo \n",
      "Federico Cappuzzo \n",
      "Steven F. Powell \n",
      "Luis Paz-Ares \n",
      "Mark Socinski \n",
      "Andrea Ardizzoni \n",
      "Federico Cappuzzo \n",
      "\n",
      "Tony S.K. Mok \n",
      "Yuan-Kai Shi \n",
      "Steffie L. Groenland \n",
      "D. Ross Camidge \n",
      "Fiona H. Blackhall \n",
      "\n",
      "Filippo Guglielmo Maria M. De Braud \n",
      "Lorenza Landi \n",
      "D. Ross Camidge \n",
      "Jhanelle E. Gray \n",
      "Ross Soo \n",
      "\n",
      "Bernard Escudier \n",
      "Manuela Schmidinger \n",
      "Bernard Escudier \n",
      "Manuela Schmidinger \n",
      "\n",
      "Camillo Guglielmo Porta \n",
      "\n",
      "Ronald De Wit \n",
      "\n",
      "Bernard Escudier \n",
      "\n",
      "Manuela Schmidinger \n",
      "Ana M. Arance \n",
      "Ana M. Arance \n",
      "Alexander C. Van Akkooi \n",
      "Mario Mandala \n",
      "Ana M. Arance \n",
      "George Pentheroudakis \n",
      "Cristiana Sessa \n",
      "George Pentheroudakis \n",
      "Cristiana Sessa \n",
      "Irina Tsibulak \n",
      "Mansoor Raza Mirza \n",
      "\n",
      "Roberto Ferrara \n",
      "Noemi Reguart \n",
      "\n",
      "Ricardo Jorge Pereira Mestre \n",
      "Thomas B. Powles \n",
      "\n",
      "George Zarkavelis \n",
      "Guillem Argiles Martinez \n",
      "\n",
      "George Pentheroudakis \n",
      "Cristiana Sessa \n",
      "George Pentheroudakis \n",
      "Cristiana Sessa \n",
      "Rebecca Lee \n",
      "Olivier A. Michielin \n",
      "\n",
      "Juliane Brandt \n",
      "Fausto Roila \n",
      "\n",
      "Daire Hanna \n",
      "Arndt Vogel \n",
      "\n",
      "Bernadett E. Szabados \n",
      "Shahrokh F. Shariat \n",
      "\n",
      "Henrik Grönberg \n",
      "Henrik Grönberg \n",
      "Davis Olmos \n",
      "David Lorente Estelles \n",
      "Henrik Grönberg \n",
      "John B. Haanen \n",
      "John B. Haanen \n",
      "Stephane Champiat \n",
      "John B. Haanen \n",
      "Camillo Ribi \n",
      "\n",
      "Sven Mahner \n",
      "Robert L. Coleman \n",
      "Ana Oaknin \n",
      "Michael L. Friedlander \n",
      "Fabian Tinquaut \n",
      "Yvette Drew \n",
      "Sven Mahner \n",
      "\n",
      "Carien L. Creutzberg \n",
      "Charlie Gourley \n",
      "Valerie Heong \n",
      "Robert L. Coleman \n",
      "\n",
      "Anna D. Wagner \n",
      "Stephen Pereira \n",
      "\n",
      "Antonin Levy \n",
      "\n",
      "Anna D. Wagner \n",
      "\n",
      "Pompiliu Piso \n",
      "\n",
      "\n",
      "Stein Kaasa \n",
      "Florian Scotté \n",
      "Vickie Baracos \n",
      "Jann Arends \n",
      "Stein Kaasa \n",
      "\n",
      "Elena Castro \n",
      "Henrik Grönberg \n",
      "Cora N. Sternberg \n",
      "Matthew R. Smith \n",
      "Emmanuel S. Antonarakis \n",
      "Wassim Abida \n",
      "Johann S. De Bono \n",
      "Elena Castro \n",
      "\n",
      "Sebastien J. Hotte \n",
      "Karim Fizazi \n",
      "Julie N. Graff \n",
      "Scott T. Tagawa \n",
      "Nicholas D. James \n",
      "Cora N. Sternberg \n",
      "\n",
      "Martin R. Stockler \n",
      "Syed Adnan Ali \n",
      "Neeraj Agarwal \n",
      "Henrik Grönberg \n",
      "\n",
      "Nicolaus Andratschke \n",
      "Emilie Le Rhun \n",
      "Emilie Le Rhun \n",
      "Martin J. Van den Bent \n",
      "Nicolaus Andratschke \n",
      "Ulirch Herrlinger \n",
      "Simone P. Niclou \n",
      "Nicolaus Andratschke \n",
      "Piotr Rutkowski \n",
      "Piotr Rutkowski \n",
      "Alexander C. Van Akkooi \n",
      "Georgina V. Long \n",
      "Alexander M. Eggermont \n",
      "\n",
      "Emiliano Calvo \n",
      "Ruth Plummer \n",
      "Lillian L. Siu \n",
      "Philippe Cassier \n",
      "Aung Naing \n",
      "Christophe Massard \n",
      "Shoko N. Noda \n",
      "Steffie L. Groenland \n",
      "Christophe Le Tourneau \n",
      "Elena Garralda \n",
      "Sabine C. Linn \n",
      "David Huntsman \n",
      "Philippe Bedard \n",
      "Giulia Siravegna \n",
      "Matthew G. Krebs \n",
      "\n",
      "Lizza Hendriks \n",
      "Lizza Hendriks \n",
      "Suresh Senan \n",
      "Ramon Rami-Porta \n",
      "Mary E. O'Brien \n",
      "\n",
      "Paolo Bossi \n",
      "Anthony T. Chan \n",
      "Anthony T. Chan \n",
      "Shreerang Bhide \n",
      "Christian Simon \n",
      "\n",
      "Demetris Papamichael \n",
      "Siri Rostoft \n",
      "Silvio Monfardini \n",
      "Demetris Papamichael \n",
      "Siri Rostoft \n",
      "Jacek Witkowski \n",
      "Ravindran Kanesvaran \n",
      "Siri Rostoft \n",
      "David Sebag-Montefiore \n",
      "David Sebag-Montefiore \n",
      "Dominik Modest \n",
      "David Sebag-Montefiore \n",
      "Robin Lewis Jones \n",
      "Daniela Katz \n",
      "Jeremy Whelan \n",
      "Alessandro Gronchi \n",
      "Robin Lewis Jones \n",
      "\n",
      "Enrique Grande \n",
      "George Pentheroudakis \n",
      "Jianming Xu \n",
      "Lori J. Wirth \n",
      "Sander Ebbers \n",
      "Enrique Grande \n",
      "Gennady Bratslavsky \n",
      "Jaume Capdevila \n",
      "George Pentheroudakis \n",
      "Kjell Oeberg \n",
      "Christos Toumpanakis \n",
      "Kjell Oeberg \n",
      "Etienne Brain \n",
      "Hendrik K. Van Halteren \n",
      "Hendrik K. Van Halteren \n",
      "Hendrik K. Van Halteren \n",
      "Etienne Brain \n",
      "Hendrik K. Van Halteren \n",
      "Siri Rostoft \n",
      "Hendrik K. Van Halteren \n",
      "Etienne Brain \n",
      "Etienne Brain \n",
      "Enrique Grande \n",
      "Enrique Grande \n",
      "Kate Newbold \n",
      "Furio Pacini \n",
      "Jaume Capdevila \n",
      "Sebastiano Filetti \n",
      "Enrique Grande \n",
      "Joan Seoane \n",
      "Sheila Singh \n",
      "Thomas Helleday \n",
      "Fenge Li \n",
      "Claudia Maletzki \n",
      "Prahlad Raninga \n",
      "Giulia Mazzaschi \n",
      "Sheila Singh \n",
      "\n",
      "Francisco Martínez Jiménez \n",
      "Jeffrey S. Ross \n",
      "Adam Jendrisak \n",
      "Thomas Helleday \n",
      "\n",
      "Bo Xu \n",
      "Ran Xue \n",
      "Perla Pucci \n",
      "Joan Seoane \n",
      "\n",
      "Florian Lordick \n",
      "Florian Lordick \n",
      "Salah-Eddin Al-Batran \n",
      "Michel P. Ducreux \n",
      "Jean-Luc Raoul \n",
      "Florian Lordick \n",
      "Javier Puente \n",
      "Maria De Santis \n",
      "Javier Puente \n",
      "Rick L. Haas \n",
      "Rick L. Haas \n",
      "Suzanne George \n",
      "Ulrich Kneser \n",
      "Rick L. Haas \n",
      "\n",
      "Ivan Dikic \n",
      "Myron Best \n",
      "Ivan Dikic \n",
      "Rodrigo Dienstmann \n",
      "Rodrigo Dienstmann \n",
      "Caroline Dive \n",
      "Filippo Giancotti \n",
      "\n",
      "Jos Jonkers \n",
      "Pierre Saintigny \n",
      "Dominique Trudel \n",
      "Philip Jermann \n",
      "Yulei Wang \n",
      "Marine Bruand \n",
      "Jos Jonkers \n",
      "\n",
      "Eva M Garrido-Martin \n",
      "Mairead G. McNamara \n",
      "Jonathan Baden \n",
      "Daniel Backenroth \n",
      "Pierre Saintigny \n",
      "\n",
      "Jesus F. San-Miguel \n",
      "Jesus F. San-Miguel \n",
      "Jesus F. San-Miguel \n",
      "Hervé Avet-Loiseau \n",
      "Sally F. Barrington \n",
      "\n",
      "Joaquin Mateo \n",
      "Ruth Plummer \n",
      "Joaquin Mateo \n",
      "Edwin Cuppen \n",
      "Emile E. Voest \n",
      "Ruth Plummer \n",
      "Joaquin Mateo \n",
      "Solange Peters \n",
      "\n",
      "Solange Peters \n",
      "Sabine Oertelt-Prigione \n",
      "Michelle McIsaac \n",
      "Guillem Argiles Martinez \n",
      "\n",
      "Pilar Garrido Lopez \n",
      "Helena Linardou \n",
      "Anne Letsch \n",
      "Erika Martinelli \n",
      "Giuseppe Curigliano \n",
      "Chiara Cremolini \n",
      "Fedro A. Peccatori \n",
      "Marina C. Garassino \n",
      "Enriqueta Felip \n",
      "Susana Banerjee \n",
      "Michiel H. Strijbos \n",
      "Stein Kaasa \n",
      "Gudrun M. Kreye \n",
      "\n",
      "Stein Kaasa \n",
      "Lewis Rowett \n",
      "Gudrun M. Kreye \n",
      "Stein Kaasa \n",
      "Gouri Shankar Bhattacharyya \n",
      "\n",
      "Stein Kaasa \n",
      "Stein Kaasa \n",
      "Gudrun M. Kreye \n",
      "Jorge Cortes \n",
      "Jorge Cortes \n",
      "Lars Bullinger \n",
      "Gert Ossenkoppele \n",
      "Jorge Cortes \n",
      "Lars Bullinger \n",
      "Gert Ossenkoppele \n",
      "Jorge Cortes \n",
      "Merel Van Klinken \n",
      "Sara T. Parreira \n",
      "Christoph Oing \n",
      "\n",
      "Patrick Crombez \n",
      "Lisa Smeds Alenius \n",
      "Eugenia Trigoso Arjona \n",
      "Merel Van Klinken \n",
      "Patrick Crombez \n",
      "Virpi Sulosaari \n",
      "\n",
      "Johan De Munter \n",
      "Robert S. Greene \n",
      "Lorena Arribas \n",
      "Cloconi Constantina \n",
      "Harald Titzer \n",
      "Johan De Munter \n",
      "Grigorios Kotronoulas \n",
      "Andri Christou \n",
      "Maria C. Katapodi \n",
      "Cristina Llanos Principe \n",
      "Marie-therése Crafoord \n",
      "Mille G. Christiansen \n",
      "\n",
      "Theresa Wiseman \n",
      "Lena Sharp \n",
      "Gilberto Morgan \n",
      "Matti Järvinen \n",
      "\n",
      "Harald Titzer \n",
      "Julia Ruíz Pato \n",
      "Raymond Chan \n",
      "\n",
      "Christian U. Blank \n",
      "Bettina Ryll \n",
      "Christian U. Blank \n",
      "Miklos Pless \n",
      "Kjetil Tasken \n",
      "André Ilbawi \n",
      "Bettina Ryll \n",
      "\n",
      "Jose Maria Borras \n",
      "Jose M. Martin-Moreno \n",
      "Barbara Melosky \n",
      "Francesco Perrone \n",
      "Kerstin N. Vokinger \n",
      "Joanna Gotfrit \n",
      "Michael S. Reilly \n",
      "Luis Sánchez- Rubio Ferrández \n",
      "Barbara Melosky \n",
      "\n",
      "Sara C. Altuna \n",
      "Janneke E. Walraven \n",
      "Branko Zakotnik \n",
      "Jose Maria Borras \n",
      "\n",
      "Susen Burock \n",
      "Ivan Lyra-Gonzalez \n",
      "Isabelle Borget \n",
      "Francesco Perrone \n",
      "\n",
      "Gayathri Delanerolle \n",
      "Manola Bettio \n",
      "Zeting Qiu \n",
      "Bettina Ryll \n",
      "Olivier A. Michielin \n",
      "Bettina Ryll \n",
      "Olivier A. Michielin \n",
      "Erik Näsman \n",
      "Cliona O'Farrelly \n",
      "Eric Tartour \n",
      "\n",
      "Rudolf S. Fehrmann \n",
      "Rudolf S. Fehrmann \n",
      "Manuel Salto-Tellez \n",
      "Marco Marsella \n",
      "\n",
      "Charlotte Roffiaen \n",
      "Guy Bouguet \n",
      "Charlotte Roffiaen \n",
      "Guy Bouguet \n",
      "Joachim Weis \n",
      "Matti S. Aapro \n",
      "Joachim Wiskemann \n",
      "Guy Bouguet \n",
      "Charlotte Roffiaen \n",
      "Kok Haw Jonathan Lim \n",
      "Laurids Ø. Poulsen \n",
      "Aurélien Marabelle \n",
      "\n",
      "Guillem Argiles Martinez \n",
      "Therese Sorlie \n",
      "Paolo G. Nuciforo \n",
      "\n",
      "Philipp Kickingereder \n",
      "\n",
      "\n",
      "Klaus Pantel \n",
      "\n",
      "Niels Halama \n",
      "\n",
      "Kathi Apostolidis \n",
      "Antje Koller \n",
      "Carla I. Ripamonti \n",
      "Susanna Grego \n",
      "Sabine Oertelt-Prigione \n",
      "Solange Peters \n",
      "Anna D. Wagner \n",
      "Aleix Prat \n",
      "Benedetta Conte \n",
      "Sonja B. Vliek \n",
      "Gustavo Werutsky \n",
      "Mark De Ridder \n",
      "Justin Stebbing \n",
      "Axel Berthelot \n",
      "Maria Vittoria Dieci \n",
      "Mellissa Y. Williamson \n",
      "Hans Tesch \n",
      "Elena Fountzila \n",
      "Agnieszka Badora-Rybicka \n",
      "Jean-Marc A. Nabholtz \n",
      "Ulku Yalcintas Arslan \n",
      "Samir Beslija \n",
      "Dario Loparco \n",
      "Lowell L. Hart \n",
      "Emily Coffey \n",
      "Daniel J. Reinhorn \n",
      "Raymond Chan \n",
      "Manuela Eicher \n",
      "Theresa Wiseman \n",
      "Theresa Wiseman \n",
      "\n",
      "Ramon Salazar \n",
      "Takayuki Yoshino \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Josep Tabernero \n",
      "Ramon Salazar \n",
      "Federico Innocenti \n",
      "Alfredo Falcone \n",
      "Thomas Seufferlein \n",
      "Andrew T. Chan \n",
      "Marleen Kok \n",
      "Francois Ghiringhelli \n",
      "Luis A. Diaz \n",
      "Aurélien Marabelle \n",
      "Francois Ghiringhelli \n",
      "Siddharth Sheth \n",
      "Susan Domchek \n",
      "Marleen Kok \n",
      "Claus-Henning Koehne \n",
      "Alberto Sobrero \n",
      "Takayuki Yoshino \n",
      "Alberto Sobrero \n",
      "Claus-Henning Koehne \n",
      "Alberto Sobrero \n",
      "Takayuki Yoshino \n",
      "Timothy J. Iveson \n",
      "Sara Lonardi \n",
      "Ioannis Souglakos \n",
      "Alberto Sobrero \n",
      "Claus-Henning Koehne \n",
      "Takayuki Yoshino \n",
      "Florian Lordick \n",
      "Josep Tabernero \n",
      "Ghassan K. Abou-Alfa \n",
      "Byoung Chul Cho \n",
      "Ian Chau \n",
      "Maha Hussain \n",
      "Eleni Efstathiou \n",
      "Ronald De Wit \n",
      "Silke Gillessen \n",
      "Enrique Grande \n",
      "Thomas B. Powles \n",
      "Yasushi Goto \n",
      "David Planchard \n",
      "Qing Zhou \n",
      "Shingo Miyamoto \n",
      "Yasushi Goto \n",
      "Shirish M. Gadgeel \n",
      "Aaron S. Mansfield \n",
      "Geoffrey R. Oxnard \n",
      "Joaquim Bellmunt \n",
      "Eva Comperat \n",
      "Eva Comperat \n",
      "Joaquim Bellmunt \n",
      "Arlene O. Siefker-Radtke \n",
      "Yohann Loriot \n",
      "Michiel S. Van der Heijden \n",
      "Joaquim Bellmunt \n",
      "Ian Chau \n",
      "Guido Kroemer \n",
      "Luis Paz-Ares \n",
      "David Planchard \n",
      "Tony S.K. Mok \n",
      "Pasi A. Jänne \n",
      "David Planchard \n",
      "Luis Paz-Ares \n",
      "\n",
      "Aleix Prat \n",
      "Giampaolo Bianchini \n",
      "Aleix Prat \n",
      "Lisa Carey \n",
      "Nadia Harbeck \n",
      "\n",
      "Andrea Alimonti \n",
      "Pier Paolo Pandolfi \n",
      "Pier Paolo Pandolfi \n",
      "Andrea Alimonti \n",
      "Pier Paolo Pandolfi \n",
      "Arkaitz Carracedo Perez \n",
      "Massimiliano Mazzone \n",
      "Andrea Alimonti \n",
      "Alberto Bardelli \n",
      "Pia Kvistborg \n",
      "Pia Kvistborg \n",
      "Alberto Bardelli \n",
      "Antoni Ribas \n",
      "Yardena Samuels \n",
      "Pia Kvistborg \n",
      "Alberto Bardelli \n",
      "Johan F. Vansteenkiste \n",
      "Ad Verhagen \n",
      "Paul Baas \n",
      "Alessandro Brunelli \n",
      "Thierry Berghmans \n",
      "\n",
      "Paul E. Van Schil \n",
      "Enriqueta Felip \n",
      "Sanjay Popat \n",
      "Gerard Zalcman \n",
      "Maria Pagano \n",
      "Nicolas Girard \n",
      "Yannis Metaxas \n",
      "Shoichi Itoh \n",
      "Paul Baas \n",
      "John B. Haanen \n",
      "Sergio Quezada \n",
      "Sergio Quezada \n",
      "Daniela S. Thommen \n",
      "Dominic G. Rothwell \n",
      "Sergio Quezada \n",
      "John B. Haanen \n",
      "Antonio A. Vigano \n",
      "Matti S. Aapro \n",
      "Antonio A. Vigano \n",
      "Gregory Armstrong \n",
      "Antonio A. Vigano \n",
      "Isabel White \n",
      "Nicolas Barizien \n",
      "Matti S. Aapro \n",
      "Florence Huguet \n",
      "Lisa F. Licitra \n",
      "Jean Bourhis \n",
      "Mingyuan Chen \n",
      "Rachel Galot \n",
      "Marco C. Merlano \n",
      "Joel Guigay \n",
      "David A. Jones \n",
      "Florence Huguet \n",
      "Giuseppe Curigliano \n",
      "Veronique C. Dieras \n",
      "Joseph Sparano \n",
      "Michael Untch \n",
      "Antonio Llombart Cussac \n",
      "Aranzazu Fernandez-Martinez \n",
      "Ji Hyun Park \n",
      "Christos Sotiriou \n",
      "Fiona Thistlethwaite \n",
      "Fiona Thistlethwaite \n",
      "Alberto Bardelli \n",
      "Thomas Gajewski \n",
      "Fiona Thistlethwaite \n",
      "Emiliano Calvo \n",
      "Ron H. Mathijssen \n",
      "Emiliano Calvo \n",
      "Marzia Del Re \n",
      "Ron H. Mathijssen \n",
      "Markus Joerger \n",
      "Hans Gelderblom \n",
      "Emiliano Calvo \n",
      "Ron H. Mathijssen \n",
      "Jean Bourhis \n",
      "Jean Bourhis \n",
      "Christian Simon \n",
      "Hisham Mehanna \n",
      "Jean Bourhis \n",
      "Oreste Gentilini \n",
      "Amelia McCartney \n",
      "Oreste Gentilini \n",
      "Brigitte Offersen \n",
      "Matteo Lambertini \n",
      "\n",
      "Carlos Caldas \n",
      "Andreas Trumpp \n",
      "Andreas Trumpp \n",
      "Carlos Caldas \n",
      "\n",
      "Christian Dittrich \n",
      "Emiliano Calvo \n",
      "Christian Dittrich \n",
      "Xavier Paoletti \n",
      "Patrick Schoeffski \n",
      "Tim Maughan \n",
      "Christophe Le Tourneau \n",
      "Emiliano Calvo \n",
      "Christian Dittrich \n",
      "Nicola Fazio \n",
      "Christina Thirlwell \n",
      "Christina Thirlwell \n",
      "Massimo Milione \n",
      "Eva Segelov \n",
      "\n",
      "Laurence Buisseret \n",
      "Bernard Escudier \n",
      "Markus Moehler \n",
      "David F. McDermott \n",
      "Chung-Han Lee \n",
      "Bernard Escudier \n",
      "\n",
      "Daniel V. Catenacci \n",
      "Haeseong Park \n",
      "Markus Moehler \n",
      "\n",
      "Martin Reck \n",
      "Benjamin Fairfax \n",
      "Laurence Buisseret \n",
      "\n",
      "Domenica Lorusso \n",
      "Domenica Lorusso \n",
      "Sven Mahner \n",
      "Mary McCormack \n",
      "Remy Nout \n",
      "\n",
      "Sebastian Bauer \n",
      "Maud Toulmonde \n",
      "Margaret Von Mehren \n",
      "Heikki Joensuu \n",
      "Florence Duffaud \n",
      "Robin Lewis Jones \n",
      "Jean-Emmanuel Kurtz \n",
      "Ioannis Boukovinas \n",
      "Javier Martin Broto \n",
      "Brian A. Van Tine \n",
      "Maud Toulmonde \n",
      "Miklos Pless \n",
      "Wilfried E. Eberhardt \n",
      "Miklos Pless \n",
      "Demetris Papamichael \n",
      "Demetris Papamichael \n",
      "Maria A. Hawkins \n",
      "Beate Rau \n",
      "Richard H. Wilson \n",
      "Thierry De Baere \n",
      "\n",
      "Sjoukje F. Oosting \n",
      "Sjoukje F. Oosting \n",
      "Ingeborg Tinhofer-Keilholz \n",
      "Hisham Mehanna \n",
      "Pierre Blanchard \n",
      "\n",
      "Michele E. Ghielmini \n",
      "Marek Trneny \n",
      "Marek Trneny \n",
      "Silvia Montoto \n",
      "Francesco D'Amore \n",
      "\n",
      "Alberto Bardelli \n",
      "Dennis \n",
      "Sai-Hong I. Ou \n",
      "Alberto Puccini \n",
      "Christian Furlan Freguia \n",
      "Alberto Bardelli \n",
      "\n",
      "Filippo Pietrantonio \n",
      "Evgeny Imyanitov \n",
      "Marzia Del Re \n",
      "Francesca Battaglin \n",
      "Dennis \n",
      "\n",
      "Chris Parker \n",
      "Chris Parker \n",
      "Alberto Briganti \n",
      "Gert De Meerleer \n",
      "Silke Gillessen \n",
      "\n",
      "Enrique De Alava \n",
      "Daniela Katz \n",
      "Olivier Delattre \n",
      "Daniela Katz \n",
      "Enrique De Alava \n",
      "\n",
      "Stefan Sleijfer \n",
      "Stefan Sleijfer \n",
      "Bissan Al-Lazikani \n",
      "Stefan Sleijfer \n",
      "Julien Taieb \n",
      "Beate Rau \n",
      "Beate Rau \n",
      "Julien Taieb \n",
      "Frederic Bibeau \n",
      "\n",
      "Margaret A. Tempero \n",
      "Margaret A. Tempero \n",
      "David Chang \n",
      "\n",
      "Thierry Conroy \n",
      "\n",
      "Massimo Falconi \n",
      "\n",
      "Margaret A. Tempero \n",
      "\n",
      "Margaret A. Tempero \n",
      "Per Pfeiffer \n",
      "Tom Crosby \n",
      "Per Pfeiffer \n",
      "Martin J. Van den Bent \n",
      "Michael Weller \n",
      "Martin J. Van den Bent \n",
      "Nicola Fazio \n",
      "Rocio Garcia-Carbonero \n",
      "Sophie Leboulleux \n",
      "Marianne E. Pavel \n",
      "Antoine Hollebecque \n",
      "Enrique Grande \n",
      "Nicola Fazio \n",
      "\n",
      "Martine Bocchini \n",
      "Johan Botling \n",
      "Rocio Garcia-Carbonero \n",
      "\n",
      "Makoto Tahara \n",
      "Sebastien J. Hotte \n",
      "Sara Gil Bernabé \n",
      "Valentina Yakushina \n",
      "Sophie Leboulleux \n",
      "\n",
      "Davide Rossi \n",
      "Michael J. Hallek \n",
      "Davide Rossi \n",
      "Maria Gomes da Silva \n",
      "Markus G. Manz \n",
      "Davide Dalu \n",
      "Frederic Amant \n",
      "Hyeonah Lee \n",
      "Maria Gomes da Silva \n",
      "\n",
      "Hye Jin Kang \n",
      "Markus G. Manz \n",
      "\n",
      "Stefan S. Bielack \n",
      "Emmanouil Saloustros \n",
      "Emmanouil Saloustros \n",
      "Thomas Grünewald \n",
      "Christian Kratz \n",
      "Antonis Kattamis \n",
      "Linda Battistuzzi \n",
      "Stefan S. Bielack \n",
      "Ben Sprangers \n",
      "Vincent Launay-Vacher \n",
      "Ben Sprangers \n",
      "E.G. Elisabeth De Vries \n",
      "Gilliosa Spurrier-Bernard \n",
      "Deborah Schrag \n",
      "Gilliosa Spurrier-Bernard \n",
      "E.G. Elisabeth De Vries \n",
      "Peter M. Ellis \n",
      "Apoorva Ambavane \n",
      "Aida Bujosa Rodríguez \n",
      "Mercè Obach \n",
      "E.G. Elisabeth De Vries \n",
      "Patricia Marino \n",
      "Amanda K. Herbrand \n",
      "Bengt Jönsson \n",
      "Emilie Le Rhun \n",
      "Matthias Preusser \n",
      "Matthias Preusser \n",
      "Emilie Le Rhun \n",
      "\n",
      "Matthias Preusser \n",
      "\n",
      "Michael Weller \n",
      "\n",
      "Wolfgang Wick \n",
      "\n",
      "Emilie Le Rhun \n",
      "Michiel H. Strijbos \n",
      "Ana Fröbe \n",
      "Ana Fröbe \n",
      "Michiel H. Strijbos \n",
      "Pierfrancesco Franco \n",
      "Ana Fröbe \n",
      "\n",
      "Michiel H. Strijbos \n",
      "Gabor Lakatos \n",
      "Hendrik K. Van Halteren \n",
      "Gabor Lakatos \n",
      "Gabor Lakatos \n",
      "Michel P. Ducreux \n",
      "Hendrik K. Van Halteren \n",
      "Christof Vulsteke \n",
      "Michiel H. Strijbos \n",
      "Kevin Punie \n",
      "Hendrik K. Van Halteren \n",
      "Wendy Oldenmenger \n",
      "Lorna McWilliams \n",
      "Cindy Kenis \n",
      "\n",
      "Cristina Lacerda \n",
      "Andreas Charalambous \n",
      "Tom Lormans \n",
      "Julie Armoogum \n",
      "Sarah Lea \n",
      "Matthew N. Fowler \n",
      "\n",
      "Lena Sharp \n",
      "Mio Fredriksson \n",
      "Theresa Wiseman \n",
      "Jacqueline Daly \n",
      "Daniel Kelly \n",
      "Helena C. Ullgren \n",
      "Bruno Danielle \n",
      "Paz O. Férnandez \n",
      "\n",
      "Lena Sharp \n",
      "Rebecca Verity \n",
      "Johan De Munter \n",
      "Wendy Oldenmenger \n",
      "Lisa Kennedy Sheldon \n",
      "Laura Fennimore \n",
      "\n",
      "Andreas Charalambous \n",
      "Lena Sharp \n",
      "Andreas Charalambous \n",
      "Cassandra I. Andersson Vila \n",
      "Foteini Antonopoulou \n",
      "Mary A. Tanay \n",
      "Andrea Salamon \n",
      "Estelle Mougin \n",
      "\n",
      "\n",
      "Sara T. Parreira \n",
      "Lena Sharp \n",
      "Andreas Charalambous \n",
      "Kathy R. Oliver \n",
      "Jan Helge Solbakk \n",
      "Gilliosa Spurrier-Bernard \n",
      "Ananda Plate \n",
      "Anna Sophie Berghoff \n",
      "Andrew Bottomley \n",
      "Janine Nuver \n",
      "Janine Nuver \n",
      "Madeline Pe \n",
      "Andrew Bottomley \n",
      "Isabelle Lebrocquy \n",
      "Roger Wilson \n",
      "\n",
      "Matteo Lambertini \n",
      "Mila Petrova \n",
      "Gilberto Morgan \n",
      "\n",
      "Evandro De Azambuja \n",
      "Guillem Argiles Martinez \n",
      "Evandro De Azambuja \n",
      "Angela Lamarca \n",
      "Antonio Di Meglio \n",
      "Valentina Gambardella \n",
      "Guillem Argiles Martinez \n",
      "\n",
      "Rodrigo Dienstmann \n",
      "Kelly Dufraing \n",
      "Kim N. Chi \n",
      "Xiaoliang Shi \n",
      "Aurelie Moreira \n",
      "Jonathan Baden \n",
      "Sander Bins \n",
      "Jennifer M. Johnson \n",
      "Xiaolong Jiao \n",
      "Julien Masliah-Planchon \n",
      "Etienne Rouleau \n",
      "Andjelija Z. Bujak \n",
      "Bram De Laere \n",
      "Min Kyeong Kim \n",
      "Yasuyuki Kawamoto \n",
      "Mishima Saori \n",
      "Andres Correa \n",
      "Junghee Lee \n",
      "Arsela Prelaj \n",
      "Andreas Charalambous \n",
      "Wendy Oldenmenger \n",
      "Grigorios Kotronoulas \n",
      "Erik Van Muilekom \n",
      "\n",
      "Fatima Cardoso \n",
      "Emile E. Voest \n",
      "Caroline Dive \n",
      "Sabine C. Linn \n",
      "Elena Garralda \n",
      "Joaquin Mateo \n",
      "Jan Oldenburg \n",
      "\n",
      "Sjoukje F. Oosting \n",
      "Emilie Le Rhun \n",
      "Wolfgang Janni \n",
      "Rebecca Dent \n",
      "Isabelle L. Ray-Coquard \n",
      "Fernanda Herrera \n",
      "Fortunato Ciardiello \n",
      "Jean-Yves Blay \n",
      "Claus-Henning Koehne \n",
      "Ian Chau \n",
      "Eric Baudin \n",
      "Fredericus A. Eskens \n",
      "Michele E. Ghielmini \n",
      "\n",
      "Javier Martin Broto \n",
      "Florian Scotté \n",
      "Piotr Rutkowski \n",
      "Silvia Novello \n",
      "Simon Ekman \n"
     ]
    }
   ],
   "source": [
    "for i in range(len(PERSONS)):\n",
    "    print(PERSONS[i])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 255,
   "id": "a1d2c72a",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'Barcelona, Spain'"
      ]
     },
     "execution_count": 255,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "SESSION.pop()\n",
    "SUB_SESSION.pop()\n",
    "TIME.pop()\n",
    "PERSONS.pop()\n",
    "DATE.pop()\n",
    "ROLE.pop()\n",
    "COUNTRY.pop()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 281,
   "id": "61c554d4",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1940\n",
      "1940\n",
      "1940\n",
      "1940\n",
      "1940\n",
      "1940\n",
      "1940\n"
     ]
    }
   ],
   "source": [
    "print(len(SESSION))\n",
    "print(len(SUB_SESSION))\n",
    "print(len(TIME))\n",
    "print(len(PERSONS))\n",
    "print(len(DATE))\n",
    "print(len(ROLE))\n",
    "print(len(COUNTRY))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "f09a75df",
   "metadata": {},
   "outputs": [],
   "source": [
    "/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[4]/div[4]/div[2]/div[1]/div[2]/div[2]\n",
    "/html/body/div[1]/div[3]/div/div/div/div[3]/div/div[2]/div[4]/div[3]/div[2]/div[1]/div[2]/div[2]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 285,
   "id": "cfbf1ec5",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1940"
      ]
     },
     "execution_count": 285,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "CONFERENCE=[]\n",
    "for i in range(len(SESSION)):\n",
    "    CONFERENCE.append('European society for Medical Oncology, ESMO - 2020')\n",
    "len(CONFERENCE)    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 286,
   "id": "037e6996",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 287,
   "id": "5022c196",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1940"
      ]
     },
     "execution_count": 287,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(CONFERENCE)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 288,
   "id": "4cfa8e98",
   "metadata": {},
   "outputs": [],
   "source": [
    "Data=pd.DataFrame()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 289,
   "id": "1682b1e8",
   "metadata": {},
   "outputs": [],
   "source": [
    "Data[\"CONFERENCE\"]=CONFERENCE\n",
    "Data['SESSION_NAMES']=SESSION\n",
    "Data[\"SUB_SESSION\"]=SUB_SESSION\n",
    "Data[\"NAMES\"]=PERSONS\n",
    "Data[\"ROLE\"]=ROLE\n",
    "Data[\"COUNTRY\"]=COUNTRY\n",
    "Data[\"TIME\"]=TIME\n",
    "Data[\"DATE\"]=DATE"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 290,
   "id": "d4250c05",
   "metadata": {},
   "outputs": [
    {
     "ename": "IndexError",
     "evalue": "index 8 is out of bounds for axis 0 with size 8",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mIndexError\u001b[0m                                Traceback (most recent call last)",
      "Input \u001b[1;32mIn [290]\u001b[0m, in \u001b[0;36m<cell line: 1>\u001b[1;34m()\u001b[0m\n\u001b[1;32m----> 1\u001b[0m Data\u001b[38;5;241m=\u001b[39mData\u001b[38;5;241m.\u001b[39mdrop(\u001b[43mData\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mcolumns\u001b[49m\u001b[43m[\u001b[49m\u001b[43m[\u001b[49m\u001b[38;5;241;43m8\u001b[39;49m\u001b[43m]\u001b[49m\u001b[43m]\u001b[49m,axis\u001b[38;5;241m=\u001b[39m\u001b[38;5;241m1\u001b[39m)\n",
      "File \u001b[1;32mC:\\ProgramData\\Anaconda3\\lib\\site-packages\\pandas\\core\\indexes\\base.py:5055\u001b[0m, in \u001b[0;36mIndex.__getitem__\u001b[1;34m(self, key)\u001b[0m\n\u001b[0;32m   5048\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m com\u001b[38;5;241m.\u001b[39mis_bool_indexer(key):\n\u001b[0;32m   5049\u001b[0m     \u001b[38;5;66;03m# if we have list[bools, length=1e5] then doing this check+convert\u001b[39;00m\n\u001b[0;32m   5050\u001b[0m     \u001b[38;5;66;03m#  takes 166 µs + 2.1 ms and cuts the ndarray.__getitem__\u001b[39;00m\n\u001b[0;32m   5051\u001b[0m     \u001b[38;5;66;03m#  time below from 3.8 ms to 496 µs\u001b[39;00m\n\u001b[0;32m   5052\u001b[0m     \u001b[38;5;66;03m# if we already have ndarray[bool], the overhead is 1.4 µs or .25%\u001b[39;00m\n\u001b[0;32m   5053\u001b[0m     key \u001b[38;5;241m=\u001b[39m np\u001b[38;5;241m.\u001b[39masarray(key, dtype\u001b[38;5;241m=\u001b[39m\u001b[38;5;28mbool\u001b[39m)\n\u001b[1;32m-> 5055\u001b[0m result \u001b[38;5;241m=\u001b[39m \u001b[43mgetitem\u001b[49m\u001b[43m(\u001b[49m\u001b[43mkey\u001b[49m\u001b[43m)\u001b[49m\n\u001b[0;32m   5056\u001b[0m \u001b[38;5;66;03m# Because we ruled out integer above, we always get an arraylike here\u001b[39;00m\n\u001b[0;32m   5057\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m result\u001b[38;5;241m.\u001b[39mndim \u001b[38;5;241m>\u001b[39m \u001b[38;5;241m1\u001b[39m:\n",
      "\u001b[1;31mIndexError\u001b[0m: index 8 is out of bounds for axis 0 with size 8"
     ]
    }
   ],
   "source": [
    "Data=Data.drop(Data.columns[[8]],axis=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 291,
   "id": "eed2a7de",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>CONFERENCE</th>\n",
       "      <th>SESSION_NAMES</th>\n",
       "      <th>SUB_SESSION</th>\n",
       "      <th>NAMES</th>\n",
       "      <th>ROLE</th>\n",
       "      <th>COUNTRY</th>\n",
       "      <th>TIME</th>\n",
       "      <th>DATE</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>European society for Medical Oncology, ESMO - ...</td>\n",
       "      <td>ESMO 2019 Opening ceremony (ID 199)</td>\n",
       "      <td>Welcome to ESMO 2019, opening speeches and awa...</td>\n",
       "      <td>Emile E. Voest</td>\n",
       "      <td>Speaker</td>\n",
       "      <td>Amsterdam, Netherlands</td>\n",
       "      <td>11:45 - 11:48</td>\n",
       "      <td>27.09.2019</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>European society for Medical Oncology, ESMO - ...</td>\n",
       "      <td>ESMO 2019 Opening ceremony (ID 199)</td>\n",
       "      <td>ESMO Award lecture: Innovative thinking and re...</td>\n",
       "      <td>Eric Van Cutsem</td>\n",
       "      <td>Speaker</td>\n",
       "      <td>Leuven, Belgium</td>\n",
       "      <td>11:48 - 12:05</td>\n",
       "      <td>27.09.2019</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>European society for Medical Oncology, ESMO - ...</td>\n",
       "      <td>ESMO 2019 Opening ceremony (ID 199)</td>\n",
       "      <td>ESMO Award for Translational Resesarch lecture...</td>\n",
       "      <td>Charles Swanton</td>\n",
       "      <td>Speaker</td>\n",
       "      <td>London, United Kingdom</td>\n",
       "      <td>12:05 - 12:22</td>\n",
       "      <td>27.09.2019</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>European society for Medical Oncology, ESMO - ...</td>\n",
       "      <td>ESMO 2019 Opening ceremony (ID 199)</td>\n",
       "      <td>ESMO Women for Oncology Award lecture: Fosteri...</td>\n",
       "      <td>Cristiana Sessa</td>\n",
       "      <td>Speaker</td>\n",
       "      <td>Bellinzona, Switzerland</td>\n",
       "      <td>12:22 - 12:39</td>\n",
       "      <td>27.09.2019</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>European society for Medical Oncology, ESMO - ...</td>\n",
       "      <td>ESMO 2019 Opening ceremony (ID 199)</td>\n",
       "      <td>ESMO Lifetime Achievement Award lecture: Adjuv...</td>\n",
       "      <td>Angelo Di Leo</td>\n",
       "      <td>Speaker</td>\n",
       "      <td>Prato, PO, Italy</td>\n",
       "      <td>12:39 - 12:56</td>\n",
       "      <td>27.09.2019</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1935</th>\n",
       "      <td>European society for Medical Oncology, ESMO - ...</td>\n",
       "      <td>Congress Highlights 2 (ID 94)</td>\n",
       "      <td>Sarcoma (ID 410)</td>\n",
       "      <td>Javier Martin Broto</td>\n",
       "      <td>Speaker</td>\n",
       "      <td>Seville, Spain</td>\n",
       "      <td>11:00 - 11:20</td>\n",
       "      <td>01.10.2019</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1936</th>\n",
       "      <td>European society for Medical Oncology, ESMO - ...</td>\n",
       "      <td>Congress Highlights 2 (ID 94)</td>\n",
       "      <td>Supportive and palliative care (ID 411)</td>\n",
       "      <td>Florian Scotté</td>\n",
       "      <td>Speaker</td>\n",
       "      <td>Suresnes, France</td>\n",
       "      <td>11:20 - 11:40</td>\n",
       "      <td>01.10.2019</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1937</th>\n",
       "      <td>European society for Medical Oncology, ESMO - ...</td>\n",
       "      <td>Congress Highlights 2 (ID 94)</td>\n",
       "      <td>Melanoma and other skin tumours (ID 412)</td>\n",
       "      <td>Piotr Rutkowski</td>\n",
       "      <td>Speaker</td>\n",
       "      <td>Warsaw, Poland</td>\n",
       "      <td>11:40 - 12:00</td>\n",
       "      <td>01.10.2019</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1938</th>\n",
       "      <td>European society for Medical Oncology, ESMO - ...</td>\n",
       "      <td>Congress Highlights 2 (ID 94)</td>\n",
       "      <td>Non-metastatic NSCLC and other thoracic malign...</td>\n",
       "      <td>Silvia Novello</td>\n",
       "      <td>Speaker</td>\n",
       "      <td>Orbassano, Italy</td>\n",
       "      <td>12:00 - 12:20</td>\n",
       "      <td>01.10.2019</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1939</th>\n",
       "      <td>European society for Medical Oncology, ESMO - ...</td>\n",
       "      <td>Congress Highlights 2 (ID 94)</td>\n",
       "      <td>NSCLC, metastatic (ID 414)</td>\n",
       "      <td>Simon Ekman</td>\n",
       "      <td>Speaker</td>\n",
       "      <td>Solna, Sweden</td>\n",
       "      <td>12:20 - 12:40</td>\n",
       "      <td>01.10.2019</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1940 rows × 8 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                             CONFERENCE  \\\n",
       "0     European society for Medical Oncology, ESMO - ...   \n",
       "1     European society for Medical Oncology, ESMO - ...   \n",
       "2     European society for Medical Oncology, ESMO - ...   \n",
       "3     European society for Medical Oncology, ESMO - ...   \n",
       "4     European society for Medical Oncology, ESMO - ...   \n",
       "...                                                 ...   \n",
       "1935  European society for Medical Oncology, ESMO - ...   \n",
       "1936  European society for Medical Oncology, ESMO - ...   \n",
       "1937  European society for Medical Oncology, ESMO - ...   \n",
       "1938  European society for Medical Oncology, ESMO - ...   \n",
       "1939  European society for Medical Oncology, ESMO - ...   \n",
       "\n",
       "                            SESSION_NAMES  \\\n",
       "0     ESMO 2019 Opening ceremony (ID 199)   \n",
       "1     ESMO 2019 Opening ceremony (ID 199)   \n",
       "2     ESMO 2019 Opening ceremony (ID 199)   \n",
       "3     ESMO 2019 Opening ceremony (ID 199)   \n",
       "4     ESMO 2019 Opening ceremony (ID 199)   \n",
       "...                                   ...   \n",
       "1935        Congress Highlights 2 (ID 94)   \n",
       "1936        Congress Highlights 2 (ID 94)   \n",
       "1937        Congress Highlights 2 (ID 94)   \n",
       "1938        Congress Highlights 2 (ID 94)   \n",
       "1939        Congress Highlights 2 (ID 94)   \n",
       "\n",
       "                                            SUB_SESSION                 NAMES  \\\n",
       "0     Welcome to ESMO 2019, opening speeches and awa...       Emile E. Voest    \n",
       "1     ESMO Award lecture: Innovative thinking and re...      Eric Van Cutsem    \n",
       "2     ESMO Award for Translational Resesarch lecture...      Charles Swanton    \n",
       "3     ESMO Women for Oncology Award lecture: Fosteri...      Cristiana Sessa    \n",
       "4     ESMO Lifetime Achievement Award lecture: Adjuv...        Angelo Di Leo    \n",
       "...                                                 ...                   ...   \n",
       "1935                                   Sarcoma (ID 410)  Javier Martin Broto    \n",
       "1936            Supportive and palliative care (ID 411)       Florian Scotté    \n",
       "1937           Melanoma and other skin tumours (ID 412)      Piotr Rutkowski    \n",
       "1938  Non-metastatic NSCLC and other thoracic malign...       Silvia Novello    \n",
       "1939                         NSCLC, metastatic (ID 414)          Simon Ekman    \n",
       "\n",
       "         ROLE                  COUNTRY           TIME        DATE  \n",
       "0     Speaker   Amsterdam, Netherlands  11:45 - 11:48  27.09.2019  \n",
       "1     Speaker          Leuven, Belgium  11:48 - 12:05  27.09.2019  \n",
       "2     Speaker   London, United Kingdom  12:05 - 12:22  27.09.2019  \n",
       "3     Speaker  Bellinzona, Switzerland  12:22 - 12:39  27.09.2019  \n",
       "4     Speaker         Prato, PO, Italy  12:39 - 12:56  27.09.2019  \n",
       "...       ...                      ...            ...         ...  \n",
       "1935  Speaker           Seville, Spain  11:00 - 11:20  01.10.2019  \n",
       "1936  Speaker         Suresnes, France  11:20 - 11:40  01.10.2019  \n",
       "1937  Speaker           Warsaw, Poland  11:40 - 12:00  01.10.2019  \n",
       "1938  Speaker         Orbassano, Italy  12:00 - 12:20  01.10.2019  \n",
       "1939  Speaker            Solna, Sweden  12:20 - 12:40  01.10.2019  \n",
       "\n",
       "[1940 rows x 8 columns]"
      ]
     },
     "execution_count": 291,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "Data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 292,
   "id": "1f3c660d",
   "metadata": {},
   "outputs": [],
   "source": [
    "Data.to_excel(\"ESMO_2019.xlsx\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "d654c332",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "38276d81",
   "metadata": {},
   "outputs": [],
   "source": [
    "tt = pd.ExcelFile('ESMO_2019.xlsx').parse('Sheet1')\n",
    "sub=tt['SUB_SESSION']\n",
    "names=tt['NAMES']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "4a4695c2",
   "metadata": {},
   "outputs": [],
   "source": [
    "Initial=[]\n",
    "First=[]\n",
    "Middle=[]\n",
    "Last=[]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "6b4d8b4e",
   "metadata": {},
   "outputs": [],
   "source": [
    "def NameDivider(Name):\n",
    "    inti=\"\"\n",
    "    first=\"\"\n",
    "    last=\"\"\n",
    "    midd=[]\n",
    "    temp=str(Name).split(\" \")\n",
    "    for i in range(len(temp)):\n",
    "        if(len(temp[i])==2 and i==1):\n",
    "            if(temp[i][1]=='.'):\n",
    "                inti=temp[i][0]\n",
    "            continue\n",
    "        if(i==0):\n",
    "           first=temp[i]\n",
    "           continue\n",
    "        if(i==len(temp)-1):\n",
    "           last=temp[i]\n",
    "           continue\n",
    "        else:\n",
    "           midd.append(temp[i])\n",
    "    if(midd==[]):\n",
    "           mid=\"\"\n",
    "    if(midd!=[]):\n",
    "           mid=\" \".join(midd)\n",
    "    return inti,first,mid,last\n",
    "\n",
    "\n",
    "for j in range(len(names)):\n",
    "    inti,first,mid,lst=NameDivider(names[j])\n",
    "    Initial.append(inti)\n",
    "    First.append(first)\n",
    "    Middle.append(mid)\n",
    "    Last.append(lst)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "7ef14675",
   "metadata": {},
   "outputs": [],
   "source": [
    "search=['Gadolinium',\n",
    "'MRI+Contrast Agent',\n",
    "'Focal liver lesions',\n",
    "'Liver metastases',\n",
    "'Nephrogenic Systemic Fibrosis',\n",
    "'Colorectal Cancer+Liver Metastasis'\n",
    "'Breast Cancer+Liver Metastasis',\n",
    "'Lung Cancer+Liver Metastatsis',\n",
    "'Gastric Cancer+Liver Metastasis',\n",
    "'Primary Liver Cancer',\n",
    "'Gadolinium toxicity',\n",
    "'Gadolinium deposition']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "0f4ca3d0",
   "metadata": {},
   "outputs": [],
   "source": [
    "s_ele=[]\n",
    "found=[]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "f5400b7e",
   "metadata": {},
   "outputs": [],
   "source": [
    "for i in range(len(sub)):\n",
    "    f=-1\n",
    "    for j in range(len(search)):\n",
    "        if('+' not in search[j]):\n",
    "            if(search[j].lower() in sub[i].lower()):\n",
    "                f=j\n",
    "        else:\n",
    "            temp=search[j].split('+')\n",
    "            if((temp[0] in sub[i].lower()) and (temp[1] in sub[i].lower())):\n",
    "                f=j\n",
    "    if(f!=-1):\n",
    "        s_ele.append(search[j])\n",
    "        found.append('Found')\n",
    "    else:\n",
    "        s_ele.append('No search term')\n",
    "        found.append('Not found')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "bf945b3a",
   "metadata": {},
   "outputs": [],
   "source": [
    "bt=pd.DataFrame()\n",
    "bt['Session ST']=found\n",
    "bt['InSession']=s_ele\n",
    "# bt['Abstract ST']=ab_found\n",
    "# bt['InAbstract']=ab_s_ele\n",
    "bt['Initial']=Initial\n",
    "bt['First Name']=First\n",
    "bt['Middle Name']=Middle\n",
    "bt['Last Name']=Last"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "3ad16f97",
   "metadata": {},
   "outputs": [],
   "source": [
    "bt.to_excel('search_terms_2019.xlsx')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "76c55c6e",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.12"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
